data_2kf4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kf4 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.643 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 21.8 t . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 109.123 -0.695 . . . . 40.0 109.123 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -177.57 153.79 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.094 -0.706 . . . . 40.0 109.094 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.2 p-10 -144.38 26.1 1.48 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.066 -1.021 . . . . 40.0 110.729 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.1 p -104.73 153.83 20.78 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.694 0.759 . . . . 40.0 109.779 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -56.99 -63.63 1.15 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.008 -1.057 . . . . 40.0 110.515 -179.267 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.651 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.8 OUTLIER -58.11 -41.76 84.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.481 -0.762 . . . . 40.0 109.781 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.6 -44.98 90.85 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 109.897 -1.281 . . . . 40.0 109.897 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.7 t -66.61 -43.41 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.485 -1.009 . . . . 40.0 108.608 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.93 -57.48 12.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.367 -0.605 . . . . 40.0 109.367 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.25 -55.63 14.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.514 -0.741 . . . . 40.0 109.039 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.654 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 38.0 t80 -52.4 -52.64 52.71 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.03 0.443 . . . . 40.0 110.268 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 18' ' ' HIS . 4.7 tt -71.42 -52.19 19.85 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.254 0.549 . . . . 40.0 110.68 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 11' ' ' ALA . 56.7 mt-30 -52.85 -28.94 25.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.113 -1.617 . . . . 40.0 109.939 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.8 m -91.1 -52.51 4.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.887 -1.133 . . . . 40.0 110.682 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -97.6 12.34 33.87 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.255 -0.903 . . . . 40.0 110.525 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.569 ' N ' ' O ' ' A' ' 14' ' ' LEU . 22.5 m80 43.36 25.04 0.06 Allowed 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.528 -0.733 . . . . 40.0 110.979 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.451 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 5.4 pttp -137.14 160.58 38.57 Favored 'General case' 0 C--O 1.182 -2.467 0 O-C-N 121.397 -0.814 . . . . 40.0 109.774 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 mp -80.07 146.08 62.39 Favored Pre-proline 0 C--N 1.266 -3.045 0 O-C-N 120.879 -1.138 . . . . 40.0 108.608 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.654 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 71.2 Cg_exo -41.26 156.11 0.06 OUTLIER 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.056 2.504 . . . . 40.0 113.982 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.643 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -67.35 49.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.178 -0.951 . . . . 40.0 109.352 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -172.98 26.58 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.941 -1.099 . . . . 40.0 110.236 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -120.12 109.11 15.07 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.913 -1.115 . . . . 40.0 110.394 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.5 pt -119.02 134.1 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.959 -1.126 . . . . 40.0 107.959 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.523 ' HB ' ' CG ' ' A' ' 54' ' ' ASP . 0.7 OUTLIER -71.78 172.59 9.55 Favored 'General case' 0 N--CA 1.508 2.444 0 CA-C-O 123.677 1.704 . . . . 40.0 113.249 -175.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.565 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 14.9 mtmt -60.67 -39.31 87.92 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 106.519 -1.66 . . . . 40.0 106.519 176.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.468 ' C ' ' O ' ' A' ' 27' ' ' LYS . 2.6 m -32.24 -74.3 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.533 -0.914 . . . . 40.0 108.533 175.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.572 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.8 mp0 -65.97 -57.49 7.68 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.116 -1.439 . . . . 40.0 107.116 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.572 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -30.22 -55.01 0.18 Allowed 'General case' 0 N--CA 1.53 3.559 0 O-C-N 119.931 -1.731 . . . . 40.0 109.78 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -56.13 -66.7 0.39 Allowed 'General case' 0 N--CA 1.525 3.31 0 O-C-N 120.033 -1.667 . . . . 40.0 113.679 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.71 -32.21 59.26 Favored 'General case' 0 N--CA 1.524 3.233 0 O-C-N 121.473 -0.767 . . . . 40.0 109.751 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.03 -22.35 66.79 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.178 -1.576 . . . . 40.0 108.633 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.36 51.27 0.4 Allowed Glycine 0 N--CA 1.503 3.144 0 N-CA-C 110.049 -1.22 . . . . 40.0 110.049 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.608 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -84.67 138.96 32.37 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.18 -1.188 . . . . 40.0 108.048 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.7 t -134.81 130.01 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.788 0 CA-C-O 121.74 0.781 . . . . 40.0 110.205 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.426 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -58.23 -50.37 73.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.935 -0.478 . . . . 40.0 110.005 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 76.4 p -70.36 45.45 0.08 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.573 -0.704 . . . . 40.0 110.123 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.511 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 2.0 ttpm? -177.14 -49.24 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.857 -0.794 . . . . 40.0 108.857 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.48 59.98 8.53 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 108.213 -1.955 . . . . 40.0 108.213 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.608 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -76.69 161.18 28.73 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.483 -1.01 . . . . 40.0 110.931 -177.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.52 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 48.8 tp -173.73 -68.5 0.01 OUTLIER 'General case' 0 C--O 1.194 -1.838 0 O-C-N 121.233 -0.917 . . . . 40.0 110.524 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.24 -20.45 64.24 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.504 -1.372 . . . . 40.0 109.318 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.4 p-10 -75.98 -61.88 1.78 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.925 -0.768 . . . . 40.0 108.925 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.418 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 26.9 m -80.11 -12.68 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.582 -0.699 . . . . 40.0 109.67 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . . . -146.1 71.82 13.4 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.329 -0.857 . . . . 40.0 109.67 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -56.27 116.78 3.42 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.787 2.325 . . . . 40.0 113.375 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.87 36.67 52.14 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.757 -1.337 . . . . 40.0 109.757 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 23' ' ' ASN . 6.8 mmtm -133.66 163.24 29.88 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 121.688 -0.889 . . . . 40.0 109.386 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.0 m -138.2 163.5 31.57 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.201 1.001 . . . . 40.0 111.135 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.489 HG22 HD11 ' A' ' 51' ' ' ILE . 39.0 mm -80.83 123.2 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 CA-C-N 115.208 -0.905 . . . . 40.0 110.38 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . 176.94 155.63 13.99 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.468 -1.453 . . . . 40.0 109.468 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.441 ' HA3' HG23 ' A' ' 26' ' ' THR . . . 117.36 -11.04 14.47 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.685 -1.245 . . . . 40.0 110.972 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.523 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 5.0 m-20 -72.63 -151.42 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.762 0 O-C-N 121.187 -1.184 . . . . 40.0 109.807 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -132.59 144.02 38.03 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.021 0 N-CA-C 108.256 -1.016 . . . . 40.0 108.256 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.62 ' O ' ' N ' ' A' ' 58' ' ' ASN . 15.3 t80 -112.7 90.81 3.44 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.195 -0.941 . . . . 40.0 109.157 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.652 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -59.72 38.34 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.708 0.766 . . . . 40.0 111.0 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.62 ' N ' ' O ' ' A' ' 56' ' ' PHE . 45.5 t30 34.77 37.82 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.032 -1.042 . . . . 40.0 110.964 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.652 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.4 mtm180 -70.23 38.08 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.956 -1.09 . . . . 40.0 109.85 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.657 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 12.4 mt-10 -145.47 -6.76 0.62 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.132 -0.98 . . . . 40.0 110.3 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.73 36.52 72.38 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.045 -1.622 . . . . 40.0 109.045 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.657 ' HZ1' ' CD ' ' A' ' 60' ' ' GLU . 3.5 mttp -121.4 13.75 11.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.602 -0.94 . . . . 40.0 109.692 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.422 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -138.05 143.21 38.61 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.514 -0.741 . . . . 40.0 109.584 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -61.61 123.89 13.57 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.528 2.152 . . . . 40.0 112.322 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.504 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -103.02 -177.22 26.65 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 110.115 -1.194 . . . . 40.0 110.115 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.412 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 10.8 tttt -179.01 153.93 0.65 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.385 -1.068 . . . . 40.0 108.56 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.0 p -73.46 56.75 0.51 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.923 -1.111 . . . . 40.0 109.024 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.37 80.44 0.03 OUTLIER Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.694 -1.362 . . . . 40.0 109.694 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.575 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -176.05 177.41 1.6 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.795 -0.826 . . . . 40.0 108.847 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.575 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 59.5 m -155.28 155.77 34.36 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.2 -0.937 . . . . 40.0 109.898 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.687 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 28.8 m95 -125.01 140.61 52.76 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.874 -0.516 . . . . 40.0 110.038 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.598 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -131.88 150.54 52.12 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.95 -1.094 . . . . 40.0 109.679 179.206 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.565 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -115.62 168.65 9.83 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.137 0.97 . . . . 40.0 111.926 -179.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.411 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . . . -164.53 139.49 5.6 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.399 0.619 . . . . 40.0 110.217 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.65 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.2 OUTLIER -61.34 153.43 26.68 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.055 0.455 . . . . 40.0 111.056 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.415 ' HA ' HD12 ' A' ' 76' ' ' ILE . 42.4 mm -135.8 146.64 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.411 -0.805 . . . . 40.0 110.2 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 55.37 71.49 0.54 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.409 0.623 . . . . 40.0 110.85 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.52 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 66.4 t80 -131.89 156.6 45.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.1 -1.0 . . . . 40.0 109.247 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' A' ' 80' ' ' SER . 21.0 p -136.87 -73.18 0.43 Allowed 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.181 0.515 . . . . 40.0 109.776 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.561 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -153.13 104.82 2.84 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.664 -0.648 . . . . 40.0 109.885 -178.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.454 ' N ' ' OH ' ' A' ' 78' ' ' TYR . . . 160.1 -100.36 0.19 Allowed Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.936 -1.266 . . . . 40.0 109.936 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.465 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 35.6 t80 -143.3 -169.95 3.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.738 -0.86 . . . . 40.0 109.541 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.634 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.5 mtm180 -71.65 -156.5 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.925 0.869 . . . . 40.0 110.423 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.467 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 12.9 p30 -166.17 -150.06 0.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.079 -1.082 . . . . 40.0 108.079 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 100' ' ' THR . 71.5 p -102.87 -8.91 20.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.742 -1.224 . . . . 40.0 109.467 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.674 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -85.73 113.27 21.78 Favored 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 121.788 0.804 . . . . 40.0 111.812 -179.245 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.803 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.09 149.66 46.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.878 -1.139 . . . . 40.0 110.625 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.5 tt -116.56 138.8 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.988 0.899 . . . . 40.0 109.853 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.41 ' CD2' ' HZ ' ' A' ' 106' ' ' PHE . 3.1 mm? -117.82 126.2 51.97 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.541 -0.911 . . . . 40.0 108.541 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.686 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -119.79 129.32 54.4 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.876 -0.787 . . . . 40.0 108.876 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.687 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.5 p -93.13 158.31 15.83 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.285 1.041 . . . . 40.0 112.538 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.0 p -69.07 -17.11 63.83 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.345 -0.983 . . . . 40.0 108.345 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.477 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -86.72 9.01 20.17 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.5 -0.88 . . . . 40.0 109.428 179.714 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.46 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.29 26.77 0.54 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.517 -0.739 . . . . 40.0 110.175 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.3 mt -96.21 137.64 34.99 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.304 -0.872 . . . . 40.0 108.894 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.457 HG23 HD12 ' A' ' 96' ' ' ILE . 42.1 mm -111.99 121.18 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.508 -0.745 . . . . 40.0 110.589 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.407 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.4 m-85 -122.93 144.71 49.05 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 120.307 -0.557 . . . . 40.0 109.534 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.674 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 5.2 tptp -133.78 145.14 49.52 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.193 -0.942 . . . . 40.0 110.723 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.52 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.4 t -125.21 167.32 15.01 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.738 -0.838 . . . . 40.0 108.738 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.416 ' O ' ' OG ' ' A' ' 85' ' ' SER . 55.8 p -140.62 -9.05 1.08 Allowed 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.416 -0.803 . . . . 40.0 109.76 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.1 p30 -107.23 13.74 26.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.126 -0.984 . . . . 40.0 110.107 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 84.02 62.8 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.244 0.545 . . . . 40.0 109.982 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.634 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 32.6 m-85 70.88 -22.05 0.19 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.582 -0.699 . . . . 40.0 111.076 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.462 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.5 mt-30 -44.57 -74.21 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.1 -1.0 . . . . 40.0 110.125 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.48 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 21.1 p -105.14 164.2 12.0 Favored 'General case' 0 C--O 1.198 -1.652 0 N-CA-C 107.78 -1.193 . . . . 40.0 107.78 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.41 ' HZ ' ' CD2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -138.27 139.01 38.99 Favored 'General case' 0 C--N 1.269 -2.9 0 O-C-N 121.45 -0.781 . . . . 40.0 110.07 -179.442 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 37.5 m -125.27 137.23 54.08 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.497 -0.927 . . . . 40.0 108.497 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.642 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 16.3 tttp -83.52 146.23 28.47 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.877 -1.139 . . . . 40.0 109.559 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.2 pt -122.29 -33.99 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 C-N-CA 119.65 -0.82 . . . . 40.0 109.153 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.651 HH21 ' CG ' ' A' ' 8' ' ' ASP . 73.6 mtt180 . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 118.266 -0.873 . . . . 40.0 109.102 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.647 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 10.4 t . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.218 0.533 . . . . 40.0 109.942 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -175.73 151.05 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 108.992 -0.744 . . . . 40.0 108.992 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -141.88 23.13 2.09 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 120.866 -1.146 . . . . 40.0 110.738 -177.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.7 p -105.16 153.38 21.61 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.634 0.73 . . . . 40.0 110.239 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -56.42 -62.97 1.36 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.968 -1.083 . . . . 40.0 111.354 -179.283 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.623 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.7 OUTLIER -58.88 -41.56 87.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.062 -1.024 . . . . 40.0 109.639 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.43 -46.18 73.68 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.093 -1.203 . . . . 40.0 110.093 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.8 t -67.95 -42.79 85.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 O-C-N 121.69 -0.888 . . . . 40.0 108.66 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -59.74 -61.07 2.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.457 -0.777 . . . . 40.0 109.549 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.29 -56.73 6.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.574 -0.704 . . . . 40.0 109.465 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.743 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 41.3 t80 -51.44 -53.18 39.64 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 116.153 -0.476 . . . . 40.0 110.758 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' A' ' 18' ' ' HIS . 1.8 tt -72.27 -51.08 22.51 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 121.165 0.507 . . . . 40.0 110.732 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 11' ' ' ALA . 66.3 mt-30 -52.06 -26.39 10.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.107 -1.621 . . . . 40.0 110.549 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.3 m -93.44 -47.84 6.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.53 -1.356 . . . . 40.0 111.449 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.46 ' O ' ' N ' ' A' ' 19' ' ' LYS . 90.5 m-85 -104.01 19.11 20.66 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.933 -1.104 . . . . 40.0 109.673 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.426 ' N ' ' O ' ' A' ' 14' ' ' LEU . 32.8 m80 40.66 25.58 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.717 0 O-C-N 121.035 -1.041 . . . . 40.0 110.863 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.495 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 3.8 pttp -137.34 157.49 46.49 Favored 'General case' 0 C--O 1.185 -2.311 0 CA-C-O 121.809 0.814 . . . . 40.0 110.466 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.48 146.11 65.03 Favored Pre-proline 0 C--N 1.271 -2.827 0 N-CA-C 108.534 -0.913 . . . . 40.0 108.534 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.743 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 88.3 Cg_exo -40.46 155.97 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.369 2.713 . . . . 40.0 114.217 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.647 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -67.22 48.44 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.897 0.856 . . . . 40.0 109.84 -179.226 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -173.13 25.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.981 -1.074 . . . . 40.0 110.52 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -118.27 109.26 16.11 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.193 -1.003 . . . . 40.0 110.07 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.429 HG22 HD12 ' A' ' 25' ' ' ILE . 11.5 pt -118.33 133.98 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.78 -1.193 . . . . 40.0 107.78 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.512 ' OG1' ' OG ' ' A' ' 28' ' ' SER . 0.6 OUTLIER -69.38 174.96 4.31 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 124.158 1.933 . . . . 40.0 112.559 -177.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.535 ' HB3' ' NE2' ' A' ' 31' ' ' GLN . 17.8 mtmt -64.28 -36.7 84.94 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.704 -1.591 . . . . 40.0 106.704 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.512 ' OG ' ' OG1' ' A' ' 26' ' ' THR . 4.4 m -35.95 -70.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.049 0.928 . . . . 40.0 109.674 175.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.507 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.2 mp0 -66.49 -52.42 46.25 Favored 'General case' 0 C--O 1.204 -1.295 0 CA-C-N 114.319 -1.31 . . . . 40.0 108.47 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.507 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -42.64 -50.66 5.41 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 119.988 -1.695 . . . . 40.0 109.352 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.535 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 32.9 mt-30 -56.28 -63.94 1.02 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.389 -0.82 . . . . 40.0 111.083 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.91 -22.87 67.06 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.017 -1.052 . . . . 40.0 109.887 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.8 tp -68.15 -23.5 64.88 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.994 -1.066 . . . . 40.0 108.178 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.04 53.4 0.26 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.419 -1.072 . . . . 40.0 110.419 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.584 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -87.81 140.15 29.8 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.263 -1.139 . . . . 40.0 109.456 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.9 t -134.65 130.73 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.041 0 O-C-N 121.685 -0.634 . . . . 40.0 109.807 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.427 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -59.57 -48.95 79.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.726 -0.609 . . . . 40.0 109.588 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.3 p -70.12 46.89 0.08 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.44 -0.787 . . . . 40.0 110.01 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.531 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.7 ttpm? -179.12 -51.72 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.076 -0.713 . . . . 40.0 109.076 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.28 60.53 7.4 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 108.58 -1.808 . . . . 40.0 108.58 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.584 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -76.24 159.83 30.24 Favored 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.749 -0.854 . . . . 40.0 111.063 -178.043 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.607 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 63.9 tp -172.64 -69.89 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.751 -0.78 . . . . 40.0 110.249 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.46 -19.93 58.17 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.924 -1.11 . . . . 40.0 109.556 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 4.5 p-10 -77.02 -61.91 1.82 Allowed 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.696 -0.853 . . . . 40.0 108.696 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.429 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 22.4 m -79.08 -11.58 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 109.356 -0.609 . . . . 40.0 109.356 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -149.8 74.69 9.36 Favored Pre-proline 0 N--CA 1.49 1.546 0 CA-C-O 122.259 1.028 . . . . 40.0 109.977 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.9 117.8 4.58 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 124.044 3.163 . . . . 40.0 113.106 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.429 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 73.69 40.08 46.85 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.867 -1.693 . . . . 40.0 108.867 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.429 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 6.7 mmtm -136.04 169.59 17.36 Favored 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 121.884 0.85 . . . . 40.0 110.571 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.6 m -144.85 160.7 40.87 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.713 -1.242 . . . . 40.0 111.856 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.448 HG22 HD11 ' A' ' 51' ' ' ILE . 11.4 mm -80.61 125.78 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-N 115.167 -0.924 . . . . 40.0 110.502 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.95 157.29 15.17 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.543 -1.423 . . . . 40.0 109.543 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.467 ' C ' HG21 ' A' ' 26' ' ' THR . . . 116.03 -9.02 18.48 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.539 -1.315 . . . . 40.0 110.169 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.444 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 5.1 m-20 -74.53 -151.9 0.03 OUTLIER 'General case' 0 C--O 1.196 -1.716 0 O-C-N 120.417 -1.637 . . . . 40.0 109.242 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.74 143.93 38.88 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.829 0 N-CA-C 107.878 -1.156 . . . . 40.0 107.878 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.653 ' O ' ' N ' ' A' ' 58' ' ' ASN . 12.6 t80 -112.14 89.79 3.16 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.952 -0.699 . . . . 40.0 109.247 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.646 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.8 p -58.83 38.39 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.821 0.82 . . . . 40.0 110.803 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.653 ' N ' ' O ' ' A' ' 56' ' ' PHE . 44.1 t30 33.84 38.19 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.237 -0.914 . . . . 40.0 110.708 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.646 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.2 mtm180 -68.89 35.68 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.67 -1.268 . . . . 40.0 110.163 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.63 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 14.5 mt-10 -145.35 -2.56 0.77 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.748 -1.22 . . . . 40.0 110.225 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.25 38.59 57.1 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.436 -1.466 . . . . 40.0 109.436 -178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.63 ' HZ1' ' CD ' ' A' ' 60' ' ' GLU . 5.5 mttp -121.21 12.82 11.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.373 -1.075 . . . . 40.0 109.334 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.453 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.5 mt -137.89 144.4 43.91 Favored Pre-proline 0 N--CA 1.496 1.834 0 CA-C-O 121.395 0.617 . . . . 40.0 109.467 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.83 123.2 12.19 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.536 2.157 . . . . 40.0 112.657 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.522 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.85 -177.98 26.79 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.054 -1.218 . . . . 40.0 110.054 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.421 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 8.8 tttt -177.66 153.15 0.85 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.026 -1.101 . . . . 40.0 108.026 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.6 p -72.25 53.03 0.27 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.833 -1.167 . . . . 40.0 109.395 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.97 80.13 0.03 OUTLIER Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.923 -1.271 . . . . 40.0 109.923 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.576 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -173.55 178.84 2.22 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.696 -0.885 . . . . 40.0 108.833 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.576 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 100.0 m -155.61 155.17 32.82 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.361 -0.935 . . . . 40.0 110.199 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.686 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 30.5 m95 -124.77 139.84 53.48 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.247 0.546 . . . . 40.0 110.064 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.586 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.91 148.92 52.74 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 120.756 -1.215 . . . . 40.0 109.436 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.442 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -115.01 168.47 9.89 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 122.181 0.991 . . . . 40.0 111.79 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -162.96 138.95 7.09 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.593 0.711 . . . . 40.0 111.121 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.669 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.3 OUTLIER -61.08 154.52 22.7 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.509 -0.744 . . . . 40.0 110.804 -179.654 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.401 ' HA ' HD12 ' A' ' 76' ' ' ILE . 40.1 mm -137.61 144.09 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 119.796 -0.762 . . . . 40.0 110.607 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 58.7 70.09 0.68 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.574 -0.704 . . . . 40.0 110.884 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.607 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 66.1 t80 -131.9 157.8 43.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.222 -0.924 . . . . 40.0 109.928 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.588 ' OG1' ' N ' ' A' ' 80' ' ' SER . 22.1 p -139.41 -70.15 0.41 Allowed 'General case' 0 N--CA 1.511 2.621 0 O-C-N 121.73 -0.606 . . . . 40.0 109.501 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.588 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.9 OUTLIER -154.42 105.76 2.69 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.737 -0.468 . . . . 40.0 109.737 -178.696 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.7 -103.93 0.23 Allowed Glycine 0 N--CA 1.498 2.774 0 C-N-CA 119.585 -1.293 . . . . 40.0 110.091 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 43.9 t80 -139.96 -166.66 2.13 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.086 -0.709 . . . . 40.0 109.086 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.633 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.4 mtm180 -73.95 -154.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.133 -0.979 . . . . 40.0 110.413 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.49 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 11.7 p30 -167.87 -150.99 0.1 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.08 -1.082 . . . . 40.0 108.08 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 100' ' ' THR . 80.6 p -102.98 -6.92 21.89 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.904 -1.123 . . . . 40.0 109.452 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.669 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -88.14 113.92 24.24 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 121.737 0.779 . . . . 40.0 111.47 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.807 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.22 149.78 44.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.979 -1.076 . . . . 40.0 110.675 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.1 tt -116.8 139.79 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 122.126 0.965 . . . . 40.0 109.865 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.95 126.02 51.54 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.792 -0.818 . . . . 40.0 108.792 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.674 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.78 129.15 55.09 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.882 -0.784 . . . . 40.0 108.882 179.664 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.686 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 5.0 p -94.15 159.41 15.16 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 122.344 1.069 . . . . 40.0 112.219 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.3 p -69.91 -16.16 63.18 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.427 -0.953 . . . . 40.0 108.427 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.475 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -88.11 8.99 24.21 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.129 -0.628 . . . . 40.0 109.512 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.449 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.69 26.52 0.49 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.94 -0.475 . . . . 40.0 110.055 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.5 mt -95.55 137.08 35.11 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.305 -0.872 . . . . 40.0 109.499 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.424 HG23 HD12 ' A' ' 96' ' ' ILE . 39.7 mm -111.51 119.25 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.846 -0.533 . . . . 40.0 110.411 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.405 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.6 m-85 -121.96 144.3 48.96 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 109.688 -0.486 . . . . 40.0 109.688 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.669 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 4.7 tptp -133.77 144.45 49.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.188 -0.945 . . . . 40.0 110.591 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.588 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.8 t -123.57 166.03 16.14 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.673 -0.862 . . . . 40.0 108.673 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.401 ' O ' ' OG ' ' A' ' 85' ' ' SER . 41.6 p -139.51 -10.84 1.21 Allowed 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.441 -0.787 . . . . 40.0 109.536 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.2 p30 -107.56 13.87 26.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.01 -1.056 . . . . 40.0 110.508 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 84.27 61.24 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.669 -0.644 . . . . 40.0 110.275 178.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.633 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 27.6 m-85 71.71 -21.16 0.22 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.497 -0.752 . . . . 40.0 110.972 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.454 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.7 mt-30 -44.38 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.119 -0.988 . . . . 40.0 109.88 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.454 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 22.7 p -105.29 168.95 8.74 Favored 'General case' 0 C--O 1.196 -1.721 0 N-CA-C 107.702 -1.221 . . . . 40.0 107.702 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.82 139.68 32.78 Favored 'General case' 0 C--N 1.267 -2.994 0 O-C-N 121.411 -0.806 . . . . 40.0 109.706 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.5 m -125.43 136.33 53.29 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.922 -1.14 . . . . 40.0 107.922 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.647 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 18.8 tttp -85.37 145.9 27.26 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.971 -1.081 . . . . 40.0 109.823 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.1 pt -121.44 -32.14 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 120.95 -1.094 . . . . 40.0 109.651 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.647 ' C ' ' HZ3' ' A' ' 108' ' ' LYS . 80.6 mtt180 . . . . . 0 N--CA 1.486 1.328 0 O-C-N 121.165 -0.959 . . . . 40.0 108.971 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.614 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 15.1 t . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.119 -0.697 . . . . 40.0 109.119 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -178.57 152.26 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.884 -0.784 . . . . 40.0 108.884 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -143.26 24.24 1.79 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.939 -1.101 . . . . 40.0 110.687 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.5 p -105.57 152.98 22.4 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.594 0.712 . . . . 40.0 110.169 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -55.36 -64.56 0.8 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.985 -1.072 . . . . 40.0 110.981 -179.038 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.619 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.52 -41.86 81.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.025 -1.047 . . . . 40.0 110.035 -179.007 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.38 -45.46 75.29 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.759 -1.336 . . . . 40.0 109.759 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 77.5 t -68.08 -42.68 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.792 -0.828 . . . . 40.0 109.276 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.89 -57.96 10.47 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.592 -0.892 . . . . 40.0 108.592 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.8 -56.64 9.57 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.116 -0.698 . . . . 40.0 109.116 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.72 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 40.3 t80 -51.69 -52.8 45.46 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.134 0.492 . . . . 40.0 110.525 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 18' ' ' HIS . 1.6 tt -72.55 -51.9 17.93 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.813 -0.554 . . . . 40.0 111.166 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 11' ' ' ALA . 63.9 mt-30 -50.92 -27.79 8.31 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.292 -1.505 . . . . 40.0 110.617 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 m -93.0 -49.79 5.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.901 -1.125 . . . . 40.0 111.395 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 19' ' ' LYS . 87.9 m-85 -100.16 16.55 23.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.989 -1.069 . . . . 40.0 109.585 -178.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 14' ' ' LEU . 16.9 m80 39.75 26.56 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.472 -0.767 . . . . 40.0 110.733 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 17' ' ' TYR . 3.8 pttp -137.01 159.8 40.82 Favored 'General case' 0 C--O 1.185 -2.336 0 CA-C-O 121.977 0.894 . . . . 40.0 110.617 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.95 145.33 61.26 Favored Pre-proline 0 C--N 1.268 -2.971 0 O-C-N 121.071 -1.018 . . . . 40.0 108.402 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.72 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 86.7 Cg_exo -39.29 155.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 123.43 2.753 . . . . 40.0 114.358 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.614 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -68.2 51.34 0.07 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.075 -1.015 . . . . 40.0 109.379 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -175.71 27.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 40.0 110.51 179.089 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -119.65 109.33 15.53 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.494 -1.379 . . . . 40.0 109.973 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.456 HG22 HD12 ' A' ' 25' ' ' ILE . 20.4 pt -117.85 132.27 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.135 -1.061 . . . . 40.0 108.135 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.501 HG21 ' C ' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -69.59 173.94 5.53 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 123.787 1.756 . . . . 40.0 113.244 -177.591 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.493 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 17.4 mtmt -63.53 -37.46 87.4 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.802 -1.555 . . . . 40.0 106.802 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.453 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 5.6 m -37.09 -70.87 0.08 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 122.184 0.992 . . . . 40.0 109.371 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.511 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.5 mp0 -65.35 -57.27 8.8 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.131 -1.433 . . . . 40.0 107.131 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.511 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -37.21 -51.67 1.03 Allowed 'General case' 0 N--CA 1.511 2.579 0 O-C-N 120.685 -1.259 . . . . 40.0 109.176 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -57.34 -63.95 1.05 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.437 -1.414 . . . . 40.0 111.485 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.42 -22.41 66.15 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 120.398 -1.439 . . . . 40.0 110.066 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 59.0 tp -68.64 -26.08 65.15 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.414 -1.328 . . . . 40.0 107.414 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 124.26 47.15 0.24 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.991 -0.844 . . . . 40.0 110.991 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.604 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.36 143.39 32.22 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.865 -1.373 . . . . 40.0 109.7 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.22 128.73 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 O-C-N 121.472 -0.767 . . . . 40.0 109.612 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -58.27 -49.96 75.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.778 -0.576 . . . . 40.0 109.602 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.6 p -70.07 47.21 0.08 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.356 -0.84 . . . . 40.0 109.967 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.567 ' HZ1' ' CG ' ' A' ' 41' ' ' ASN . 1.1 ttpm? -179.32 -50.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.022 -0.733 . . . . 40.0 109.022 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.56 60.03 8.85 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 108.26 -1.936 . . . . 40.0 108.26 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.604 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -75.82 162.45 28.15 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.593 -0.946 . . . . 40.0 111.007 -177.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.497 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 43.7 tp -174.12 -70.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.748 -0.781 . . . . 40.0 110.274 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.94 -21.21 63.21 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.906 -1.121 . . . . 40.0 109.571 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.0 p-10 -74.19 -62.8 1.39 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.711 -0.848 . . . . 40.0 108.711 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.439 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 16.1 m -79.35 -11.62 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.568 -0.531 . . . . 40.0 109.568 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -148.56 72.25 10.72 Favored Pre-proline 0 N--CA 1.486 1.34 0 CA-C-O 121.883 0.849 . . . . 40.0 109.449 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.8 118.18 5.01 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.994 2.463 . . . . 40.0 113.923 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.51 36.71 48.48 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.272 -1.531 . . . . 40.0 109.272 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -134.37 163.95 28.52 Favored 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.614 0.721 . . . . 40.0 109.864 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.6 m -138.97 163.75 31.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 40.0 111.173 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 51' ' ' ILE . 13.0 mm -81.45 126.98 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-N 115.548 -0.751 . . . . 40.0 110.43 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.28 157.46 15.88 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.492 -1.443 . . . . 40.0 109.492 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.501 ' C ' HG21 ' A' ' 26' ' ' THR . . . 117.5 -10.34 14.53 Favored Glycine 0 N--CA 1.499 2.895 0 C-N-CA 118.945 -1.598 . . . . 40.0 110.369 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.496 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 4.6 m-20 -75.29 -151.62 0.03 OUTLIER 'General case' 0 C--O 1.197 -1.675 0 O-C-N 120.948 -1.325 . . . . 40.0 109.847 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.1 142.16 44.22 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.944 0 CA-C-N 114.86 -1.064 . . . . 40.0 108.665 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.624 ' O ' ' N ' ' A' ' 58' ' ' ASN . 15.1 t80 -111.4 90.66 3.4 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.875 -0.787 . . . . 40.0 108.875 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.647 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -59.63 38.56 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.605 0.717 . . . . 40.0 110.823 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' A' ' 56' ' ' PHE . 43.5 t30 33.82 38.07 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.012 -1.055 . . . . 40.0 111.33 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.647 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.5 mtm180 -69.03 34.66 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.951 -1.093 . . . . 40.0 110.483 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.642 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 15.5 mt-10 -144.1 -2.86 0.88 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.13 -0.981 . . . . 40.0 110.285 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.26 38.02 56.08 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.418 -1.473 . . . . 40.0 109.418 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.642 ' HZ1' ' CD ' ' A' ' 60' ' ' GLU . 4.9 mttp -120.89 13.29 11.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.593 -0.946 . . . . 40.0 109.295 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.461 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -138.7 142.98 36.0 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.705 -0.622 . . . . 40.0 109.616 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -60.69 123.32 12.76 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.499 2.133 . . . . 40.0 112.629 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.496 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.96 -177.63 26.69 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.935 -1.266 . . . . 40.0 109.935 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -178.94 153.05 0.61 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.041 -1.096 . . . . 40.0 108.041 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.8 p -71.84 54.95 0.27 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.885 -1.134 . . . . 40.0 109.239 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.31 79.64 0.03 OUTLIER Glycine 0 N--CA 1.5 2.92 0 N-CA-C 110.137 -1.185 . . . . 40.0 110.137 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.579 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.92 179.06 1.69 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.694 -0.886 . . . . 40.0 109.082 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.579 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 99.9 m -155.81 154.77 31.87 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.405 -0.918 . . . . 40.0 109.8 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.676 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 29.9 m95 -124.02 140.6 52.81 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.723 -0.473 . . . . 40.0 109.723 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.602 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.81 149.49 52.43 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.837 -1.164 . . . . 40.0 109.574 179.55 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.493 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -114.33 168.15 10.09 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.068 -1.02 . . . . 40.0 112.185 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.15 136.72 4.97 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.544 -0.723 . . . . 40.0 110.798 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.656 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.2 OUTLIER -59.21 154.49 16.11 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 120.881 0.372 . . . . 40.0 111.102 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.0 mm -137.8 146.06 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.682 -0.807 . . . . 40.0 110.456 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 57.64 69.96 0.69 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.316 0.579 . . . . 40.0 110.534 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.483 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 68.6 t80 -131.01 155.9 46.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.082 -1.011 . . . . 40.0 110.045 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 80' ' ' SER . 23.9 p -137.23 -72.66 0.43 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.822 -0.549 . . . . 40.0 109.557 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.572 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.9 OUTLIER -153.05 106.14 2.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 122.071 -0.393 . . . . 40.0 110.132 -179.084 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.8 -105.11 0.25 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.706 -1.357 . . . . 40.0 109.706 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 41.5 t80 -138.81 -166.05 1.94 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.006 -0.702 . . . . 40.0 109.175 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.644 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.6 mtm180 -74.21 -154.69 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.265 -0.897 . . . . 40.0 110.008 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.597 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 8.1 p30 -167.02 -150.79 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.178 -1.045 . . . . 40.0 108.178 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 100' ' ' THR . 59.4 p -102.5 -8.14 21.3 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 120.823 -1.173 . . . . 40.0 109.155 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.668 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.13 114.29 23.6 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-O 121.832 0.825 . . . . 40.0 111.456 -179.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.819 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.01 150.53 45.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.916 -1.115 . . . . 40.0 110.959 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.0 tt -116.92 140.43 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 122.304 1.049 . . . . 40.0 110.01 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.409 ' CD2' ' HZ ' ' A' ' 106' ' ' PHE . 3.0 mm? -119.33 125.19 48.46 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.349 -0.982 . . . . 40.0 108.349 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.677 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -119.16 129.88 55.24 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.913 -0.773 . . . . 40.0 108.913 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.676 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.1 p -94.91 159.47 15.02 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.438 1.113 . . . . 40.0 112.96 -178.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.1 p -69.58 -16.92 63.5 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.097 -1.075 . . . . 40.0 108.097 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.473 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -87.81 9.26 22.4 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.658 -0.817 . . . . 40.0 109.556 179.632 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.468 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.98 26.95 0.58 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.581 -0.699 . . . . 40.0 110.249 179.451 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.8 mt -96.22 136.25 36.93 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.424 -0.798 . . . . 40.0 109.164 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.441 HG23 HD12 ' A' ' 96' ' ' ILE . 39.8 mm -110.8 120.43 61.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.505 -0.747 . . . . 40.0 110.554 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -123.03 144.56 49.19 Favored 'General case' 0 N--CA 1.504 2.265 0 C-N-CA 120.467 -0.493 . . . . 40.0 109.804 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.668 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 6.0 tptp -133.71 144.31 49.04 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.592 -0.693 . . . . 40.0 110.722 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.56 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.7 t -124.21 166.47 15.79 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.632 -0.877 . . . . 40.0 108.632 177.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.416 ' O ' ' OG ' ' A' ' 85' ' ' SER . 40.4 p -140.33 -8.35 1.14 Allowed 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.314 -0.866 . . . . 40.0 109.702 178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.1 p30 -108.67 13.03 25.42 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.058 -1.026 . . . . 40.0 110.06 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 84.56 62.44 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.318 0.58 . . . . 40.0 110.34 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.644 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 27.1 m-85 71.23 -21.92 0.2 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.459 -0.776 . . . . 40.0 110.868 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.461 ' H ' ' C ' ' A' ' 102' ' ' ALA . 2.0 mt-30 -44.18 -74.28 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.333 -0.855 . . . . 40.0 109.69 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.459 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 25.3 p -105.53 166.58 10.34 Favored 'General case' 0 C--O 1.194 -1.82 0 N-CA-C 107.82 -1.178 . . . . 40.0 107.82 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.409 ' HZ ' ' CD2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -139.42 138.82 36.82 Favored 'General case' 0 C--N 1.27 -2.87 0 O-C-N 121.441 -0.787 . . . . 40.0 109.973 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.2 m -124.17 136.73 54.4 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.182 -1.044 . . . . 40.0 108.182 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.606 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 19.0 tttp -85.64 146.32 26.91 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.704 -1.247 . . . . 40.0 109.616 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.5 pt -121.67 -34.08 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.244 -0.91 . . . . 40.0 109.476 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.619 HH21 ' CG ' ' A' ' 8' ' ' ASP . 78.2 mtt180 . . . . . 0 N--CA 1.488 1.452 0 O-C-N 121.197 -0.939 . . . . 40.0 108.875 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.632 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 18.5 t . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.471 -0.566 . . . . 40.0 109.471 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 tt -175.74 153.7 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.909 -0.775 . . . . 40.0 108.909 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -143.95 25.88 1.57 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.8 -1.188 . . . . 40.0 110.506 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.7 p -105.3 153.61 21.38 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.469 0.652 . . . . 40.0 109.638 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -56.97 -64.0 1.02 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.115 -0.991 . . . . 40.0 110.817 -178.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.641 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.39 -42.01 81.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.379 -0.826 . . . . 40.0 109.705 -179.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.68 -45.95 76.57 Favored Glycine 0 N--CA 1.503 3.101 0 N-CA-C 109.968 -1.253 . . . . 40.0 109.968 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.7 t -66.95 -42.6 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.767 -0.843 . . . . 40.0 108.933 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.88 -58.4 8.59 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.842 -0.799 . . . . 40.0 108.842 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.07 -56.2 9.78 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.843 -0.799 . . . . 40.0 108.843 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.683 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 35.7 t80 -52.92 -51.81 59.99 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 116.084 -0.507 . . . . 40.0 110.673 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 18' ' ' HIS . 5.1 tt -72.28 -51.4 21.02 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.575 -0.703 . . . . 40.0 110.942 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 11' ' ' ALA . 54.9 mt-30 -52.9 -28.26 22.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.271 -1.518 . . . . 40.0 110.285 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.1 m -92.96 -51.25 5.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.085 -1.009 . . . . 40.0 110.825 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -98.17 10.3 40.87 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.994 -1.066 . . . . 40.0 110.205 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.573 ' N ' ' O ' ' A' ' 14' ' ' LEU . 20.1 m80 44.56 23.73 0.08 Allowed 'General case' 0 N--CA 1.52 3.067 0 O-C-N 121.42 -0.8 . . . . 40.0 110.879 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.5 pttp -135.62 160.94 36.93 Favored 'General case' 0 C--O 1.182 -2.496 0 O-C-N 121.399 -0.813 . . . . 40.0 109.566 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mp -80.47 147.0 62.68 Favored Pre-proline 0 C--N 1.268 -2.964 0 N-CA-C 108.26 -1.015 . . . . 40.0 108.26 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.683 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 83.7 Cg_exo -42.28 157.49 0.07 OUTLIER 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 123.26 2.64 . . . . 40.0 113.633 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.632 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -66.86 49.1 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.049 -1.032 . . . . 40.0 109.871 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -172.14 24.92 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.925 -1.109 . . . . 40.0 110.139 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -117.52 106.74 13.47 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.508 -1.37 . . . . 40.0 110.63 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.4 pt -116.47 133.92 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.061 -1.024 . . . . 40.0 108.37 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.472 ' OG1' ' CB ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -69.09 172.38 6.86 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-O 123.588 1.661 . . . . 40.0 112.96 -177.491 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.488 ' HB3' ' NE2' ' A' ' 31' ' ' GLN . 12.8 mtmt -62.65 -38.78 91.64 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 105.483 -2.043 . . . . 40.0 105.483 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.472 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 11.4 m -34.75 -71.68 0.06 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.103 -0.953 . . . . 40.0 108.792 175.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.55 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.1 mp0 -66.25 -59.5 3.67 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 118.509 -1.276 . . . . 40.0 107.578 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.55 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -31.43 -55.52 0.26 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 119.503 1.047 . . . . 40.0 110.445 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.488 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 25.9 mt-30 -58.0 -63.59 1.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.497 -1.377 . . . . 40.0 111.109 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.29 -27.05 63.71 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.732 -1.23 . . . . 40.0 110.621 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.7 tp -68.56 -22.52 64.48 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 108.485 -0.932 . . . . 40.0 108.485 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.42 48.99 0.25 Allowed Glycine 0 N--CA 1.496 2.687 0 C-N-CA 120.948 -0.644 . . . . 40.0 111.686 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.609 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -85.7 137.9 32.5 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.115 -1.226 . . . . 40.0 110.194 179.45 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.4 t -134.37 132.12 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.093 0 O-C-N 121.394 -0.816 . . . . 40.0 110.412 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.429 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -59.26 -48.92 79.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.708 -0.62 . . . . 40.0 109.487 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.7 p -69.71 45.75 0.07 Allowed 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 121.635 0.731 . . . . 40.0 110.527 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.47 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.6 ttpm? -178.3 -51.42 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.121 -0.696 . . . . 40.0 109.121 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.6 59.84 8.68 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 108.221 -1.952 . . . . 40.0 108.221 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.609 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -76.51 160.6 29.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.661 -0.906 . . . . 40.0 111.32 -177.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.516 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 61.8 tp -174.77 -68.67 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.913 -1.117 . . . . 40.0 110.911 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.29 -20.31 58.6 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.49 -1.381 . . . . 40.0 109.573 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 2.6 p-10 -75.95 -64.8 1.01 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.712 -0.847 . . . . 40.0 108.712 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.469 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 30.3 m -77.18 -12.68 14.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 109.415 -0.587 . . . . 40.0 109.415 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -145.6 72.08 14.04 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.56 -0.713 . . . . 40.0 110.086 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -56.91 116.79 3.45 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.73 2.287 . . . . 40.0 114.976 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.38 37.33 47.79 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.344 -1.503 . . . . 40.0 109.344 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.478 ' HD3' ' HA ' ' A' ' 23' ' ' ASN . 7.1 mmtt -132.6 171.03 14.35 Favored 'General case' 0 N--CA 1.508 2.446 0 CA-C-O 122.078 0.942 . . . . 40.0 110.226 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.3 m -145.69 162.06 38.44 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.884 -1.135 . . . . 40.0 111.501 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.408 HG22 HD11 ' A' ' 51' ' ' ILE . 18.8 mm -81.81 123.84 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-N 115.401 -0.818 . . . . 40.0 110.881 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.46 155.86 13.53 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.109 -1.596 . . . . 40.0 109.109 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.44 -12.19 10.36 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.278 -1.439 . . . . 40.0 110.402 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.45 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 5.0 m-20 -74.1 -154.22 0.03 OUTLIER 'General case' 0 C--O 1.193 -1.911 0 O-C-N 121.182 -1.187 . . . . 40.0 110.308 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 mp -128.57 142.74 43.11 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.868 0 CA-C-N 115.476 -0.784 . . . . 40.0 109.084 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.633 ' O ' ' N ' ' A' ' 58' ' ' ASN . 12.7 t80 -111.08 90.18 3.26 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.333 -0.855 . . . . 40.0 109.169 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.633 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -59.45 38.78 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 122.023 0.916 . . . . 40.0 110.842 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.633 ' N ' ' O ' ' A' ' 56' ' ' PHE . 45.7 t30 34.14 38.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.193 -0.942 . . . . 40.0 110.618 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.633 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 11.2 mtm180 -69.89 37.97 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.765 -1.209 . . . . 40.0 109.992 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.634 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 13.0 mt-10 -146.14 -6.92 0.56 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.038 -1.039 . . . . 40.0 109.968 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.31 37.53 74.03 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 109.424 -1.471 . . . . 40.0 109.424 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.634 ' HZ1' ' CD ' ' A' ' 60' ' ' GLU . 4.5 mttp -121.11 12.35 11.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.802 -0.822 . . . . 40.0 109.3 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.408 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -136.89 142.53 38.95 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.681 -0.637 . . . . 40.0 109.455 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -61.91 122.7 11.35 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.597 2.198 . . . . 40.0 112.27 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.489 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.05 -178.02 27.82 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.033 -1.227 . . . . 40.0 110.033 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -177.76 154.14 0.91 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.42 -1.047 . . . . 40.0 108.267 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.5 p -72.05 53.79 0.27 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.981 -1.074 . . . . 40.0 109.183 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.42 79.61 0.03 OUTLIER Glycine 0 N--CA 1.498 2.806 0 N-CA-C 110.017 -1.233 . . . . 40.0 110.017 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.574 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.14 178.53 2.08 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.734 -0.863 . . . . 40.0 108.991 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.574 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 98.9 m -155.42 155.53 33.74 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.202 -0.936 . . . . 40.0 109.823 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.672 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 29.1 m95 -125.07 140.64 52.72 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.834 -0.542 . . . . 40.0 109.636 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.593 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -131.35 147.32 52.56 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.105 -0.997 . . . . 40.0 110.162 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.39 168.64 9.38 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 122.466 1.127 . . . . 40.0 112.352 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.94 136.54 3.57 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.668 -0.645 . . . . 40.0 111.039 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.658 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.3 OUTLIER -58.58 154.51 14.1 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.016 0.436 . . . . 40.0 110.832 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.3 mm -137.57 146.18 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.477 -0.764 . . . . 40.0 109.733 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 56.44 70.94 0.6 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.491 0.662 . . . . 40.0 110.948 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.516 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 68.8 t80 -132.04 156.08 46.92 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.993 -1.067 . . . . 40.0 109.903 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.557 ' OG1' ' N ' ' A' ' 80' ' ' SER . 23.6 p -136.27 -73.92 0.44 Allowed 'General case' 0 N--CA 1.509 2.479 0 CA-C-O 121.284 0.564 . . . . 40.0 110.059 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.557 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -152.23 105.91 3.1 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.078 -0.712 . . . . 40.0 109.078 -178.815 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.84 -105.6 0.27 Allowed Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.417 -1.373 . . . . 40.0 110.28 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.474 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 40.0 t80 -138.36 -166.09 1.93 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.987 -0.745 . . . . 40.0 108.987 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.639 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.2 mtm180 -75.12 -155.92 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.045 -1.034 . . . . 40.0 110.343 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.541 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 10.8 p30 -165.33 -150.37 0.13 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.978 -1.119 . . . . 40.0 107.978 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 100' ' ' THR . 82.6 p -103.58 -8.15 20.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.78 -1.2 . . . . 40.0 109.152 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.665 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -86.0 113.37 22.04 Favored 'General case' 0 N--CA 1.507 2.414 0 CA-C-O 121.79 0.805 . . . . 40.0 111.713 -179.167 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.81 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.63 150.38 46.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.033 . . . . 40.0 110.988 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.9 tt -116.73 141.56 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 122.107 0.956 . . . . 40.0 109.847 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -121.37 123.99 43.45 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.944 -1.132 . . . . 40.0 107.944 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.687 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.09 129.5 55.58 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.918 0.866 . . . . 40.0 108.783 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.672 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 3.8 p -94.14 158.63 15.52 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 122.228 1.013 . . . . 40.0 112.445 -177.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.7 p -69.82 -15.87 63.18 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.443 -0.947 . . . . 40.0 108.443 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.482 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -88.02 8.2 27.65 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.61 -0.836 . . . . 40.0 109.423 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.463 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 79.36 26.07 0.42 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.675 -0.64 . . . . 40.0 110.344 179.699 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.1 mt -95.75 138.84 32.83 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.451 -0.781 . . . . 40.0 109.18 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.436 HG23 HD12 ' A' ' 96' ' ' ILE . 40.4 mm -112.91 120.21 62.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.71 -0.619 . . . . 40.0 110.426 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.429 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.4 m-85 -122.03 144.49 48.87 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 109.296 -0.631 . . . . 40.0 109.296 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.665 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 3.3 tptp -133.17 146.14 51.26 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.367 -0.933 . . . . 40.0 110.965 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.523 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.6 t -125.63 166.6 16.44 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 109.141 -0.689 . . . . 40.0 109.141 177.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.403 ' O ' ' OG ' ' A' ' 85' ' ' SER . 55.5 p -139.97 -9.69 1.17 Allowed 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.327 -0.858 . . . . 40.0 109.585 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.509 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.1 p30 -108.09 15.99 23.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.195 -0.941 . . . . 40.0 110.417 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 83.01 60.7 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.86 -0.525 . . . . 40.0 110.689 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.639 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 27.5 m-85 71.35 -20.46 0.23 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.546 -0.721 . . . . 40.0 110.847 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.459 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.6 mt-30 -44.92 -73.4 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.044 -1.035 . . . . 40.0 109.877 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.443 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 23.8 p -105.86 164.79 11.67 Favored 'General case' 0 C--O 1.195 -1.813 0 N-CA-C 107.791 -1.189 . . . . 40.0 107.791 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.95 138.2 37.11 Favored 'General case' 0 C--N 1.269 -2.915 0 O-C-N 121.306 -0.872 . . . . 40.0 109.989 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 53.3 m -124.12 137.42 54.56 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.119 -1.067 . . . . 40.0 108.119 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.629 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 18.4 tttp -84.64 145.18 28.14 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.906 -1.121 . . . . 40.0 109.601 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.4 pt -120.53 -34.68 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.175 -0.953 . . . . 40.0 109.262 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.641 HH21 ' CG ' ' A' ' 8' ' ' ASP . 79.6 mtt180 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 40.0 108.86 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.63 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 19.8 t . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 109.045 -0.724 . . . . 40.0 109.045 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 tt -174.34 154.07 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.9 -0.778 . . . . 40.0 108.9 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -144.22 26.12 1.51 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.016 -1.053 . . . . 40.0 110.593 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.0 p -104.0 153.83 20.38 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.566 0.698 . . . . 40.0 109.609 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -57.11 -63.49 1.2 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.839 -1.163 . . . . 40.0 110.511 -179.217 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.643 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.9 OUTLIER -57.31 -41.93 80.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.096 -1.002 . . . . 40.0 109.655 -179.476 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.35 -44.96 84.86 Favored Glycine 0 N--CA 1.503 3.11 0 N-CA-C 110.243 -1.143 . . . . 40.0 110.243 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.3 t -67.28 -42.99 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.523 -0.986 . . . . 40.0 108.828 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.88 -59.13 5.87 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.974 -0.75 . . . . 40.0 108.974 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.23 -56.79 7.08 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.913 -0.773 . . . . 40.0 108.913 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.676 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 34.2 t80 -52.15 -53.01 48.24 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 116.116 -0.493 . . . . 40.0 110.61 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.588 ' O ' ' N ' ' A' ' 18' ' ' HIS . 4.4 tt -71.67 -51.21 24.23 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.301 0.572 . . . . 40.0 110.851 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 11' ' ' ALA . 58.6 mt-30 -53.57 -28.58 32.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.233 -1.542 . . . . 40.0 110.178 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.6 m -91.46 -52.63 4.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.805 -1.184 . . . . 40.0 110.524 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -97.68 12.26 34.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.279 -0.888 . . . . 40.0 110.576 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.588 ' N ' ' O ' ' A' ' 14' ' ' LEU . 23.7 m80 42.7 25.64 0.05 Allowed 'General case' 0 N--CA 1.512 2.643 0 O-C-N 121.237 -0.914 . . . . 40.0 111.151 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 pttp -137.0 160.9 37.56 Favored 'General case' 0 C--O 1.185 -2.329 0 O-C-N 121.44 -0.787 . . . . 40.0 109.559 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.4 mp -80.3 145.57 60.22 Favored Pre-proline 0 C--N 1.265 -3.101 0 O-C-N 120.744 -1.223 . . . . 40.0 108.764 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.676 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 72.6 Cg_exo -40.99 155.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.831 2.354 . . . . 40.0 113.417 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.63 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -65.61 49.97 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.05 -1.031 . . . . 40.0 109.356 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -171.91 26.21 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.703 -1.248 . . . . 40.0 110.639 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -119.82 108.39 14.32 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.789 -1.194 . . . . 40.0 109.674 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.6 pt -119.66 128.86 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.483 1.135 . . . . 40.0 108.612 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.508 ' HB ' ' CG ' ' A' ' 54' ' ' ASP . 0.4 OUTLIER -63.78 169.34 4.18 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-O 123.561 1.648 . . . . 40.0 114.091 -176.264 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.484 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 12.8 mtmt -58.51 -42.45 87.68 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 104.676 -2.342 . . . . 40.0 104.676 176.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.508 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 7.7 m -32.35 -72.97 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 116.293 -0.412 . . . . 40.0 110.261 176.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.485 ' O ' ' C ' ' A' ' 30' ' ' ALA . 3.1 mp0 -64.02 -54.86 27.71 Favored 'General case' 0 C--O 1.193 -1.909 0 N-CA-C 106.558 -1.645 . . . . 40.0 106.558 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -36.11 -55.2 0.78 Allowed 'General case' 0 N--CA 1.514 2.753 0 O-C-N 120.591 -1.318 . . . . 40.0 110.412 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.401 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 38.7 mt-30 -56.35 -67.6 0.29 Allowed 'General case' 0 N--CA 1.507 2.425 0 O-C-N 120.681 -1.262 . . . . 40.0 111.088 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.14 -26.86 61.23 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 119.93 -1.731 . . . . 40.0 110.58 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.4 tp -67.17 -21.56 65.8 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.36 -0.978 . . . . 40.0 108.36 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.59 40.45 0.53 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.851 -0.9 . . . . 40.0 110.851 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.574 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -77.68 139.97 39.51 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.435 -1.627 . . . . 40.0 109.521 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.2 t -136.44 131.27 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.607 0 O-C-N 121.74 -0.6 . . . . 40.0 109.896 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -58.45 -50.13 74.81 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 116.612 -0.267 . . . . 40.0 110.386 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.5 p -69.98 46.23 0.08 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.427 -0.796 . . . . 40.0 110.232 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.494 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 2.3 ttpm? -178.33 -51.91 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.989 -0.745 . . . . 40.0 108.989 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.1 61.83 5.73 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 108.412 -1.875 . . . . 40.0 108.412 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.574 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -78.92 161.25 26.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.607 -0.937 . . . . 40.0 110.101 -178.347 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.477 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 56.2 tp -173.56 -67.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.676 -0.81 . . . . 40.0 110.515 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.26 -19.29 65.29 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 120.571 -1.331 . . . . 40.0 109.973 -178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 5.9 p-10 -75.41 -63.41 1.29 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.857 -0.794 . . . . 40.0 108.857 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.419 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 35.2 m -78.13 -15.85 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.715 -0.616 . . . . 40.0 109.654 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -142.74 72.89 19.66 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 40.0 109.622 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -56.91 117.62 4.34 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.819 2.346 . . . . 40.0 113.28 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.85 35.97 48.86 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.996 -1.242 . . . . 40.0 109.996 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.45 ' HD3' ' HA ' ' A' ' 23' ' ' ASN . 7.0 mmtt -133.48 162.63 31.35 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 121.899 -0.765 . . . . 40.0 109.86 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.3 m -138.01 165.83 25.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.095 -1.003 . . . . 40.0 111.244 -177.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.438 HG22 HD11 ' A' ' 51' ' ' ILE . 15.5 mm -83.26 124.72 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.54 0.686 . . . . 40.0 111.144 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.81 157.82 17.23 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 119.539 -1.315 . . . . 40.0 110.417 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.16 -7.66 18.77 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.653 -1.379 . . . . 40.0 109.653 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.508 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 6.8 m-20 -74.31 -153.83 0.03 OUTLIER 'General case' 0 C--O 1.189 -2.106 0 O-C-N 121.375 -1.073 . . . . 40.0 110.194 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -131.68 141.29 46.07 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.027 0 N-CA-C 108.355 -0.98 . . . . 40.0 108.355 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.618 ' O ' ' N ' ' A' ' 58' ' ' ASN . 14.4 t80 -110.69 90.94 3.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 40.0 108.772 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.656 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.6 p -60.27 39.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.625 -0.672 . . . . 40.0 110.858 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.618 ' N ' ' O ' ' A' ' 56' ' ' PHE . 47.5 t30 34.35 38.19 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.104 -0.998 . . . . 40.0 111.051 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.656 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 11.4 mtm180 -71.25 38.92 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.027 -1.046 . . . . 40.0 109.847 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.659 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 11.7 mt-10 -146.24 -6.34 0.56 Allowed 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.441 -0.787 . . . . 40.0 110.195 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.28 36.48 62.65 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 109.129 -1.588 . . . . 40.0 109.129 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.659 ' HZ1' ' CD ' ' A' ' 60' ' ' GLU . 3.5 mttp -120.67 12.58 11.47 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.717 -0.872 . . . . 40.0 109.652 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.437 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.4 mt -137.54 144.41 44.87 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.451 -0.781 . . . . 40.0 109.394 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -62.5 124.75 14.77 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.441 2.094 . . . . 40.0 112.674 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.499 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.22 -178.29 27.57 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 110.054 -1.218 . . . . 40.0 110.054 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.423 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 10.3 tttt -178.03 153.15 0.78 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.272 -1.134 . . . . 40.0 108.625 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.5 p -73.09 55.3 0.42 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.755 -1.215 . . . . 40.0 109.099 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.28 78.94 0.03 OUTLIER Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.477 -1.449 . . . . 40.0 109.477 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.552 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -173.66 175.93 2.84 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.759 -0.848 . . . . 40.0 108.95 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.552 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 87.6 m -154.44 155.25 34.62 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.135 -0.978 . . . . 40.0 110.062 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.697 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 30.2 m95 -124.68 140.71 52.68 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 121.267 0.556 . . . . 40.0 110.246 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.596 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -131.63 149.83 52.36 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.881 -1.137 . . . . 40.0 110.216 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.484 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -113.35 167.76 10.3 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.321 1.057 . . . . 40.0 111.91 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.67 137.85 4.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.754 -0.591 . . . . 40.0 110.378 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.667 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.2 OUTLIER -59.82 153.69 20.13 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.959 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.41 HD13 ' HB ' ' A' ' 88' ' ' ILE . 42.7 mm -136.18 144.8 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.419 -0.801 . . . . 40.0 110.04 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 56.28 70.82 0.61 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.486 0.66 . . . . 40.0 110.598 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.479 ' OH ' ' N ' ' A' ' 81' ' ' GLY . 62.4 t80 -130.73 155.49 46.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.132 -0.98 . . . . 40.0 109.34 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.574 ' OG1' ' N ' ' A' ' 80' ' ' SER . 24.0 p -134.96 -73.46 0.47 Allowed 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.63 0.729 . . . . 40.0 110.064 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.574 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -153.46 105.69 2.86 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.03 -0.729 . . . . 40.0 109.03 -178.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.479 ' N ' ' OH ' ' A' ' 78' ' ' TYR . . . 159.13 -102.35 0.21 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.733 -1.347 . . . . 40.0 109.733 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 35.4 t80 -140.81 -167.55 2.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.638 -0.919 . . . . 40.0 109.895 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.639 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.3 mtm180 -74.19 -157.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.179 -0.95 . . . . 40.0 110.147 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.566 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 11.4 p30 -164.59 -149.25 0.12 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.939 -1.134 . . . . 40.0 107.939 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 64.1 p -103.94 -9.07 19.18 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.809 -1.182 . . . . 40.0 109.409 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.652 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -85.67 113.77 22.13 Favored 'General case' 0 N--CA 1.509 2.481 0 CA-C-O 121.787 0.803 . . . . 40.0 111.688 -179.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.806 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.43 150.22 46.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.986 -1.071 . . . . 40.0 110.617 179.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.41 ' HB ' HD13 ' A' ' 76' ' ' ILE . 7.3 tt -116.4 140.78 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-O 122.131 0.967 . . . . 40.0 109.833 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.422 ' CD2' ' HZ ' ' A' ' 106' ' ' PHE . 3.0 mm? -119.24 125.99 50.44 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.361 -0.978 . . . . 40.0 108.361 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.666 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -119.89 129.4 54.35 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.824 -0.806 . . . . 40.0 108.824 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.697 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 2.9 p -94.1 157.8 15.91 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 122.297 1.046 . . . . 40.0 112.448 -178.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.7 p -68.41 -17.49 64.23 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.559 -0.904 . . . . 40.0 108.559 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.485 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -85.82 8.54 19.66 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.567 -0.853 . . . . 40.0 109.482 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.466 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.9 25.39 0.5 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.611 -0.68 . . . . 40.0 110.496 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.5 mt -95.71 138.02 33.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.135 -0.978 . . . . 40.0 109.108 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.458 HG23 HD12 ' A' ' 96' ' ' ILE . 43.1 mm -112.04 121.16 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.587 -0.696 . . . . 40.0 110.417 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.41 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.5 m-85 -122.98 144.95 48.9 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 120.245 -0.582 . . . . 40.0 109.496 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.652 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 5.3 tptp -133.7 145.71 50.14 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.083 -1.011 . . . . 40.0 110.84 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.474 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.2 t -125.89 168.36 13.98 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.761 -0.829 . . . . 40.0 108.761 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.2 p -141.79 -8.15 0.95 Allowed 'General case' 0 N--CA 1.51 2.544 0 O-C-N 121.21 -0.931 . . . . 40.0 109.717 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.514 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.2 p30 -108.81 16.63 22.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.125 -0.984 . . . . 40.0 110.104 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 81.85 61.18 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.221 0.534 . . . . 40.0 110.217 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.639 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 31.5 m-85 71.41 -20.43 0.23 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.577 -0.702 . . . . 40.0 110.87 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.451 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.6 mt-30 -45.2 -74.34 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.024 -1.047 . . . . 40.0 110.001 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.488 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 23.6 p -104.59 164.02 12.05 Favored 'General case' 0 C--O 1.194 -1.829 0 O-C-N 120.901 -1.124 . . . . 40.0 108.115 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HZ ' ' CD2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -137.9 139.68 39.95 Favored 'General case' 0 C--N 1.273 -2.753 0 O-C-N 121.351 -0.843 . . . . 40.0 109.932 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 30.5 m -126.73 137.01 53.19 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.156 -1.053 . . . . 40.0 108.156 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.632 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 14.9 tttp -83.87 146.05 28.29 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.837 -1.164 . . . . 40.0 109.679 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.5 pt -121.75 -33.77 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.283 -0.885 . . . . 40.0 109.043 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.643 HH21 ' CG ' ' A' ' 8' ' ' ASP . 72.2 mtt180 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 118.173 -0.918 . . . . 40.0 108.993 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.658 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 17.6 t . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 109.389 -0.596 . . . . 40.0 109.389 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 tt -176.4 152.64 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.27 -0.894 . . . . 40.0 109.169 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -142.71 24.16 1.89 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.805 -1.185 . . . . 40.0 111.215 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.9 p -105.74 153.16 22.25 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.679 0.752 . . . . 40.0 110.172 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -55.96 -63.11 1.29 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.036 -1.04 . . . . 40.0 111.052 -178.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.631 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -58.56 -41.08 84.81 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.506 -0.746 . . . . 40.0 109.745 -179.35 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.35 -45.14 89.39 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.712 -1.355 . . . . 40.0 109.712 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.1 t -67.39 -43.68 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.578 -0.954 . . . . 40.0 108.787 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -59.94 -59.15 5.88 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.947 -0.76 . . . . 40.0 108.947 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.24 -56.74 8.37 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.951 -0.759 . . . . 40.0 108.951 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.68 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 39.9 t80 -52.3 -51.96 55.63 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.048 0.451 . . . . 40.0 110.441 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 18' ' ' HIS . 2.2 tt -72.04 -52.58 16.24 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.64 -0.663 . . . . 40.0 111.056 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.472 ' N ' ' O ' ' A' ' 11' ' ' ALA . 63.7 mt-30 -51.59 -27.25 10.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.23 -1.544 . . . . 40.0 110.721 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 m -92.35 -49.84 5.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.585 -1.322 . . . . 40.0 111.347 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 19' ' ' LYS . 92.7 m-85 -100.85 16.0 26.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.845 -1.159 . . . . 40.0 110.114 -177.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 14' ' ' LEU . 25.1 m80 41.43 24.25 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.8 -0.563 . . . . 40.0 110.976 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 17' ' ' TYR . 3.6 pttp -135.48 158.78 43.51 Favored 'General case' 0 C--O 1.178 -2.7 0 O-C-N 121.177 -0.952 . . . . 40.0 110.771 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mp -79.25 144.28 62.13 Favored Pre-proline 0 C--N 1.271 -2.847 0 O-C-N 120.9 -1.125 . . . . 40.0 108.88 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.68 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 81.8 Cg_exo -38.73 155.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.003 0 C-N-CA 123.803 3.002 . . . . 40.0 114.433 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.658 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -67.61 50.11 0.05 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.283 1.039 . . . . 40.0 109.253 -179.51 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -173.86 26.24 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.129 -0.982 . . . . 40.0 110.552 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -120.21 111.92 18.42 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.294 -1.504 . . . . 40.0 110.122 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.414 HG22 HD12 ' A' ' 25' ' ' ILE . 23.0 pt -118.28 138.22 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.248 -1.019 . . . . 40.0 108.248 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.53 ' OG1' ' OG ' ' A' ' 28' ' ' SER . 0.6 OUTLIER -72.4 168.93 17.42 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 123.372 1.558 . . . . 40.0 113.357 -178.283 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.477 ' O ' ' C ' ' A' ' 28' ' ' SER . 24.3 mtmt -60.66 -39.38 88.14 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 105.801 -1.925 . . . . 40.0 105.801 176.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.53 ' OG ' ' OG1' ' A' ' 26' ' ' THR . 1.1 m -36.37 -70.86 0.08 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.749 -0.834 . . . . 40.0 108.749 176.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.56 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.7 mp0 -64.22 -55.43 21.69 Favored 'General case' 0 C--O 1.201 -1.473 0 N-CA-C 106.098 -1.815 . . . . 40.0 106.098 -176.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.56 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -35.44 -51.87 0.62 Allowed 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 118.562 -1.255 . . . . 40.0 109.573 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -55.45 -68.43 0.2 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.992 -1.067 . . . . 40.0 111.67 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.37 -24.31 54.54 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.263 -0.898 . . . . 40.0 111.141 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.7 tp -69.88 -21.2 63.35 Favored 'General case' 0 N--CA 1.509 2.475 0 N-CA-C 106.878 -1.527 . . . . 40.0 106.878 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.7 43.61 0.53 Allowed Glycine 0 N--CA 1.504 3.184 0 N-CA-C 111.523 -0.631 . . . . 40.0 111.523 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.54 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -77.88 138.97 39.2 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.725 -1.456 . . . . 40.0 109.531 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.9 t -135.7 130.33 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.685 0 O-C-N 121.154 -0.966 . . . . 40.0 109.302 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.48 -46.74 86.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.832 -0.543 . . . . 40.0 110.014 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.5 p -71.45 44.01 0.09 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.431 0.634 . . . . 40.0 110.644 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.585 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 ttpm? -177.43 -50.5 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.495 -0.753 . . . . 40.0 109.174 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.18 59.26 9.24 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 108.934 -1.666 . . . . 40.0 108.934 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.585 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.82 160.87 30.14 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 121.453 -1.028 . . . . 40.0 110.641 -177.846 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.569 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 57.1 tp -173.32 -69.5 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.999 -1.063 . . . . 40.0 110.385 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.07 -23.0 63.43 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 120.947 -1.096 . . . . 40.0 110.028 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.4 p-10 -73.28 -64.89 0.89 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.702 0.763 . . . . 40.0 109.218 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.463 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 28.7 m -76.78 -15.17 14.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 109.205 -0.665 . . . . 40.0 109.205 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.487 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . . . -144.22 71.34 16.29 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.501 -0.749 . . . . 40.0 110.16 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.04 117.16 3.8 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 123.375 2.717 . . . . 40.0 113.788 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.61 37.73 52.13 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.167 -1.573 . . . . 40.0 109.167 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.498 ' HD3' ' HA ' ' A' ' 23' ' ' ASN . 8.5 mmtm -135.2 162.3 32.92 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 108.856 -0.794 . . . . 40.0 108.856 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 65.7 m -138.22 166.55 23.9 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.326 1.06 . . . . 40.0 110.594 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.473 HG22 HD11 ' A' ' 51' ' ' ILE . 18.7 mm -84.1 124.11 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-N 115.876 -0.602 . . . . 40.0 111.508 -179.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 178.08 159.67 23.18 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.506 -1.438 . . . . 40.0 109.506 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.75 -7.17 19.94 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.623 -1.275 . . . . 40.0 110.92 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.437 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 5.2 m-20 -76.02 -152.26 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.381 -1.658 . . . . 40.0 110.072 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.7 mp -131.12 143.85 39.54 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.016 0 N-CA-C 108.327 -0.99 . . . . 40.0 108.327 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.636 ' O ' ' N ' ' A' ' 58' ' ' ASN . 13.7 t80 -113.51 90.97 3.48 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.217 -0.927 . . . . 40.0 108.78 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.653 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.6 p -59.07 38.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.705 0.764 . . . . 40.0 110.735 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.636 ' N ' ' O ' ' A' ' 56' ' ' PHE . 43.5 t30 34.67 38.57 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.293 -0.88 . . . . 40.0 110.671 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.653 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.8 mtm180 -69.91 36.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -0.94 . . . . 40.0 110.483 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.659 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 14.6 mt-10 -145.36 -4.82 0.68 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.135 -0.978 . . . . 40.0 110.332 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.65 36.97 66.32 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 109.635 -1.386 . . . . 40.0 109.635 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.659 ' HZ1' ' CD ' ' A' ' 60' ' ' GLU . 5.1 mttp -120.36 12.3 11.65 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.575 -0.956 . . . . 40.0 109.502 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.412 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -136.4 142.93 41.35 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.564 -0.71 . . . . 40.0 109.36 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -61.75 122.72 11.41 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.392 2.061 . . . . 40.0 112.344 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.489 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -101.18 -178.27 28.92 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 110.535 -1.026 . . . . 40.0 110.535 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.406 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 8.9 tttt -177.6 152.75 0.83 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.138 -1.213 . . . . 40.0 108.267 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.4 p -72.07 53.62 0.27 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.841 -1.162 . . . . 40.0 109.258 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.401 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 151.26 80.34 0.03 OUTLIER Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.826 -1.31 . . . . 40.0 109.826 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.559 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.96 177.31 2.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.533 -0.981 . . . . 40.0 109.037 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.559 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 90.1 m -154.75 154.92 33.59 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.124 -0.985 . . . . 40.0 110.043 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.693 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 30.0 m95 -124.14 139.86 53.52 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.384 0.612 . . . . 40.0 109.671 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.609 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.52 149.83 52.01 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 120.794 -1.191 . . . . 40.0 109.897 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.454 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -116.19 167.69 10.78 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.068 -1.02 . . . . 40.0 112.006 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -162.9 138.57 6.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.653 -0.654 . . . . 40.0 111.351 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.679 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.2 OUTLIER -59.6 154.22 18.12 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.656 -0.652 . . . . 40.0 110.934 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.428 ' HA ' HD12 ' A' ' 76' ' ' ILE . 42.7 mm -137.43 145.87 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.499 -0.75 . . . . 40.0 110.394 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 57.38 70.08 0.68 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.483 0.659 . . . . 40.0 110.524 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.569 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 70.2 t80 -131.86 155.65 47.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.039 -1.038 . . . . 40.0 110.112 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.609 ' OG1' ' N ' ' A' ' 80' ' ' SER . 19.2 p -136.64 -73.34 0.44 Allowed 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.124 0.488 . . . . 40.0 110.202 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.609 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -153.01 106.47 3.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.554 -0.716 . . . . 40.0 109.416 -178.466 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.93 -104.32 0.24 Allowed Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.747 -1.341 . . . . 40.0 109.747 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.481 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 47.2 t80 -139.94 -167.01 2.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 122.013 -0.698 . . . . 40.0 109.382 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.638 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.1 mtm180 -73.12 -154.34 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.166 -0.959 . . . . 40.0 110.075 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.555 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 11.6 p30 -168.05 -150.24 0.1 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.262 -1.014 . . . . 40.0 108.262 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 100' ' ' THR . 71.6 p -103.3 -8.0 20.66 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.64 -1.288 . . . . 40.0 109.313 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.671 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.6 114.15 23.95 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-O 122.063 0.935 . . . . 40.0 111.473 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.803 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.28 151.0 47.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.871 -1.143 . . . . 40.0 110.426 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.7 tt -117.99 136.71 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.794 0.807 . . . . 40.0 109.825 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.409 ' CD2' ' HZ ' ' A' ' 106' ' ' PHE . 3.1 mm? -115.84 125.16 52.3 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.798 -0.815 . . . . 40.0 108.798 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.682 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.94 129.53 55.22 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.077 0.942 . . . . 40.0 108.997 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.693 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 3.7 p -94.65 158.9 15.32 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 122.41 1.1 . . . . 40.0 112.504 -177.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.7 p -68.59 -18.14 64.27 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.234 -1.025 . . . . 40.0 108.234 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.496 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -86.32 9.17 18.66 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.666 -0.646 . . . . 40.0 109.647 179.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.462 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.76 26.48 0.64 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.661 -0.649 . . . . 40.0 110.361 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.9 mt -95.99 137.47 35.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.118 -0.989 . . . . 40.0 109.093 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.425 HG23 HD12 ' A' ' 96' ' ' ILE . 40.2 mm -111.77 119.15 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.634 -0.666 . . . . 40.0 110.564 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.429 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 8.0 m-85 -121.83 144.32 48.9 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.357 -0.537 . . . . 40.0 109.766 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.671 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 4.8 tptp -133.25 144.5 49.8 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.372 -0.83 . . . . 40.0 110.849 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.6 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.9 t -123.12 166.69 14.76 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 108.84 -0.8 . . . . 40.0 108.84 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.408 ' O ' ' OG ' ' A' ' 85' ' ' SER . 45.0 p -140.29 -10.31 1.1 Allowed 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.556 -0.715 . . . . 40.0 109.672 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.1 p30 -107.75 12.7 27.15 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.007 -1.058 . . . . 40.0 110.203 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 84.97 61.82 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.404 0.621 . . . . 40.0 110.305 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.638 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 23.2 m-85 71.62 -21.9 0.21 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.446 -0.784 . . . . 40.0 110.812 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.457 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.9 mt-30 -44.37 -73.41 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.091 -1.006 . . . . 40.0 109.932 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.461 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 22.0 p -106.07 166.4 10.53 Favored 'General case' 0 C--O 1.193 -1.9 0 N-CA-C 107.763 -1.199 . . . . 40.0 107.763 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.409 ' HZ ' ' CD2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -140.06 139.16 35.86 Favored 'General case' 0 C--N 1.27 -2.887 0 O-C-N 121.065 -1.022 . . . . 40.0 109.779 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.1 m -124.65 136.35 53.85 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.355 -0.98 . . . . 40.0 108.355 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.621 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 19.3 tttp -84.95 145.54 27.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.779 -1.201 . . . . 40.0 109.652 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.8 pt -120.71 -34.42 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.884 -1.135 . . . . 40.0 109.318 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.631 HH21 ' CG ' ' A' ' 8' ' ' ASP . 78.7 mtt180 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.081 -1.012 . . . . 40.0 108.769 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.628 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 17.0 t . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.319 -0.623 . . . . 40.0 109.319 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -178.27 151.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.393 -0.817 . . . . 40.0 109.587 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -142.53 23.96 1.93 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.16 -0.963 . . . . 40.0 111.684 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.6 p -105.85 153.98 21.17 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.981 0.896 . . . . 40.0 110.456 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.498 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -56.39 -64.48 0.85 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.617 -1.302 . . . . 40.0 110.833 -179.288 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.616 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -56.84 -41.43 77.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.05 -1.032 . . . . 40.0 110.034 -179.294 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.21 -44.99 84.17 Favored Glycine 0 N--CA 1.504 3.181 0 N-CA-C 110.164 -1.174 . . . . 40.0 110.164 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.5 t -68.77 -42.49 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.587 -0.949 . . . . 40.0 108.798 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.35 -59.38 5.49 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.489 -0.93 . . . . 40.0 108.489 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.23 -56.77 8.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.55 -0.719 . . . . 40.0 109.334 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.694 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 40.8 t80 -52.74 -51.41 60.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.915 -0.491 . . . . 40.0 110.353 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 18' ' ' HIS . 4.0 tt -72.36 -51.4 20.71 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.7 -0.625 . . . . 40.0 110.945 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 11' ' ' ALA . 57.3 mt-30 -52.39 -28.36 19.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.051 -1.655 . . . . 40.0 110.129 179.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 m -91.53 -51.28 5.34 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.781 -1.2 . . . . 40.0 111.249 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -99.04 12.8 34.96 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.29 -0.881 . . . . 40.0 110.258 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 14' ' ' LEU . 20.7 m80 42.47 25.67 0.05 OUTLIER 'General case' 0 N--CA 1.516 2.856 0 O-C-N 121.477 -0.764 . . . . 40.0 110.92 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.9 pttp -136.63 158.61 44.03 Favored 'General case' 0 C--O 1.184 -2.367 0 CA-C-O 121.916 0.865 . . . . 40.0 110.188 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mp -78.31 147.83 73.12 Favored Pre-proline 0 C--N 1.265 -3.093 0 O-C-N 120.659 -1.275 . . . . 40.0 108.684 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.694 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 83.3 Cg_exo -41.47 156.09 0.07 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 123.272 2.648 . . . . 40.0 114.102 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.628 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -67.07 49.49 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.124 0.964 . . . . 40.0 109.48 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -173.67 26.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.902 . . . . 40.0 110.701 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -118.19 109.75 16.74 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.76 -1.213 . . . . 40.0 110.487 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.4 pt -119.07 132.88 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.169 -1.049 . . . . 40.0 108.169 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.485 HG21 ' C ' ' A' ' 53' ' ' GLY . 0.4 OUTLIER -69.48 173.35 6.03 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-O 124.24 1.972 . . . . 40.0 113.443 -177.395 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.633 ' HB3' ' NE2' ' A' ' 31' ' ' GLN . 14.6 mtmt -62.53 -40.12 95.75 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.266 -1.753 . . . . 40.0 106.266 177.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.48 ' C ' ' O ' ' A' ' 27' ' ' LYS . 2.9 m -32.97 -74.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 123.028 1.394 . . . . 40.0 109.666 174.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.501 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.4 mp0 -63.13 -56.47 16.49 Favored 'General case' 0 C--O 1.2 -1.509 0 CA-C-N 114.392 -1.277 . . . . 40.0 108.041 -177.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -38.26 -51.64 1.48 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.956 -1.09 . . . . 40.0 109.918 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.633 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 24.1 mt-30 -56.85 -64.63 0.81 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.676 -1.265 . . . . 40.0 110.351 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.47 -25.29 64.29 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.113 -0.992 . . . . 40.0 109.471 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.1 tp -65.66 -24.52 67.04 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.729 -0.841 . . . . 40.0 108.729 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.11 48.22 0.29 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.243 -1.143 . . . . 40.0 110.243 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.579 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -85.72 137.47 32.79 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.461 -1.023 . . . . 40.0 109.906 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.5 t -134.16 131.41 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.705 0 O-C-N 121.49 -0.756 . . . . 40.0 109.956 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -58.64 -47.92 82.77 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.743 -0.836 . . . . 40.0 108.743 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.1 p -69.87 43.64 0.06 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.627 -0.67 . . . . 40.0 110.907 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.505 ' HZ1' ' CG ' ' A' ' 41' ' ' ASN . 1.1 ttpm? -176.8 -49.83 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.314 -0.866 . . . . 40.0 109.13 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.17 59.7 9.11 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 108.349 -1.9 . . . . 40.0 108.349 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.579 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -76.57 159.84 29.96 Favored 'General case' 0 C--N 1.29 -2.004 0 O-C-N 121.654 -0.909 . . . . 40.0 110.833 -177.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.549 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 56.1 tp -173.92 -68.32 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.53 -0.868 . . . . 40.0 111.04 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.64 -22.08 63.44 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.812 -1.18 . . . . 40.0 109.36 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.5 p-10 -74.64 -62.3 1.58 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.13 -0.693 . . . . 40.0 109.13 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 45' ' ' VAL . 26.4 m -78.56 -13.52 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 N-CA-C 109.122 -0.696 . . . . 40.0 109.122 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -147.12 72.57 12.14 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.637 -0.664 . . . . 40.0 110.058 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -56.7 118.58 5.45 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 123.178 2.586 . . . . 40.0 113.911 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.37 39.64 56.69 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.69 -1.364 . . . . 40.0 109.69 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.422 ' NZ ' ' HB3' ' A' ' 23' ' ' ASN . 7.2 mmtm -134.39 168.89 18.09 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.859 0.838 . . . . 40.0 109.829 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.7 m -144.39 160.83 40.4 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 120.827 -1.171 . . . . 40.0 111.381 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.436 HG22 HD11 ' A' ' 51' ' ' ILE . 17.3 mm -81.25 123.04 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-N 115.437 -0.801 . . . . 40.0 110.557 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . 177.16 154.56 12.2 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.555 -1.418 . . . . 40.0 109.555 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.485 ' C ' HG21 ' A' ' 26' ' ' THR . . . 120.54 -13.55 10.08 Favored Glycine 0 N--CA 1.497 2.713 0 C-N-CA 119.162 -1.494 . . . . 40.0 111.236 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.476 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 4.3 m-20 -71.41 -152.0 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.747 0 O-C-N 121.202 -1.176 . . . . 40.0 109.781 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.37 142.63 42.84 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 CA-C-N 115.256 -0.884 . . . . 40.0 109.236 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.652 ' O ' ' N ' ' A' ' 58' ' ' ASN . 11.1 t80 -111.17 89.76 3.14 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.347 -0.845 . . . . 40.0 109.696 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.669 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.9 p -58.71 38.38 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.921 0.867 . . . . 40.0 110.774 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.652 ' N ' ' O ' ' A' ' 56' ' ' PHE . 40.8 t30 33.66 40.01 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.275 -0.89 . . . . 40.0 110.484 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.669 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 11.4 mtm180 -70.85 37.23 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.957 -1.089 . . . . 40.0 110.056 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.635 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 14.1 mt-10 -146.6 -1.05 0.72 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.998 -1.064 . . . . 40.0 110.29 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 51.11 39.42 41.65 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.681 -1.368 . . . . 40.0 109.681 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.635 ' HZ1' ' CD ' ' A' ' 60' ' ' GLU . 3.5 mttp -121.68 12.34 10.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.657 -0.908 . . . . 40.0 109.366 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.456 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.5 mt -137.33 143.62 42.18 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.66 -0.65 . . . . 40.0 109.541 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.38 122.68 11.46 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.296 1.997 . . . . 40.0 112.137 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.5 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.98 -177.29 26.69 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.866 -1.293 . . . . 40.0 109.866 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -177.94 154.73 0.92 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 107.871 -1.159 . . . . 40.0 107.871 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.2 p -73.2 55.47 0.44 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.995 -1.066 . . . . 40.0 109.172 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.98 81.4 0.04 OUTLIER Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.753 -1.339 . . . . 40.0 109.753 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.559 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.31 178.29 2.06 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.493 -1.004 . . . . 40.0 108.713 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.559 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 92.4 m -155.24 153.01 29.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.017 -1.052 . . . . 40.0 109.921 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.696 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 28.8 m95 -122.7 140.38 52.93 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.194 0.521 . . . . 40.0 110.006 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.587 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -131.42 147.11 52.53 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 120.96 -1.087 . . . . 40.0 110.392 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.84 168.2 9.76 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.979 -1.076 . . . . 40.0 112.278 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.402 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . . . -163.76 139.75 6.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.241 -0.912 . . . . 40.0 110.225 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.662 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.2 OUTLIER -61.29 154.71 23.0 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 120.976 0.417 . . . . 40.0 110.576 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.409 ' CD1' ' HB ' ' A' ' 88' ' ' ILE . 32.6 mm -138.11 146.01 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.587 -0.696 . . . . 40.0 110.325 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 56.4 71.05 0.59 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.582 0.706 . . . . 40.0 110.839 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.549 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 67.7 t80 -132.45 156.66 46.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 40.0 109.471 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.596 ' OG1' ' N ' ' A' ' 80' ' ' SER . 21.4 p -137.97 -72.44 0.42 Allowed 'General case' 0 N--CA 1.511 2.614 0 CA-C-O 121.44 0.638 . . . . 40.0 109.491 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.596 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.7 OUTLIER -152.99 105.69 2.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.653 -0.654 . . . . 40.0 109.57 -178.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.06 -103.96 0.23 Allowed Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.467 -1.349 . . . . 40.0 110.156 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 49.2 t80 -142.16 -167.55 2.5 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.53 -0.915 . . . . 40.0 108.53 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.659 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.3 mtm180 -72.9 -156.48 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.04 -1.038 . . . . 40.0 110.398 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.501 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 10.1 p30 -165.67 -149.38 0.11 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.132 -1.062 . . . . 40.0 108.132 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.402 ' H ' ' HB2' ' A' ' 84' ' ' ASN . 60.3 p -104.14 -7.46 20.16 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 120.804 -1.185 . . . . 40.0 109.252 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.689 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.97 113.09 23.28 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-O 121.898 0.856 . . . . 40.0 111.642 -179.263 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.81 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.44 150.06 46.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.055 -1.028 . . . . 40.0 110.391 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.409 ' HB ' ' CD1' ' A' ' 76' ' ' ILE . 5.1 tt -116.69 141.51 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 122.404 1.097 . . . . 40.0 109.777 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.41 ' CD2' ' HZ ' ' A' ' 106' ' ' PHE . 2.8 mm? -121.02 124.42 44.8 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.294 -1.002 . . . . 40.0 108.294 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.679 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.15 129.38 55.49 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.82 0.819 . . . . 40.0 108.816 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.696 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.2 p -93.56 159.99 14.99 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 122.322 1.058 . . . . 40.0 112.467 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.4 p -70.04 -18.11 63.28 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.241 -1.022 . . . . 40.0 108.241 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.457 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -86.15 8.69 19.96 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.052 -0.659 . . . . 40.0 109.498 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.447 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.88 26.79 0.6 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.497 -0.752 . . . . 40.0 109.955 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 27.1 mt -94.94 137.2 34.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.121 -0.987 . . . . 40.0 108.471 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.406 HG23 HD12 ' A' ' 96' ' ' ILE . 37.2 mm -112.15 119.84 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.533 -0.73 . . . . 40.0 110.338 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -122.2 144.74 48.78 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.935 -0.706 . . . . 40.0 109.663 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.689 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 3.7 tptp -133.66 145.04 49.59 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.109 -0.995 . . . . 40.0 110.87 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.521 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.5 t -124.01 167.12 14.6 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 109.02 -0.733 . . . . 40.0 109.02 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 38.7 p -140.47 -9.43 1.09 Allowed 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.213 -0.93 . . . . 40.0 109.922 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.514 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.2 p30 -108.16 13.27 26.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 40.0 109.997 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 84.36 62.08 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.263 0.554 . . . . 40.0 110.308 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.659 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 22.7 m-85 70.61 -20.64 0.2 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.722 -0.611 . . . . 40.0 110.864 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.467 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.7 mt-30 -44.07 -73.7 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.162 -0.961 . . . . 40.0 109.472 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.433 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 22.0 p -106.25 167.88 9.52 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 107.316 -1.364 . . . . 40.0 107.316 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.41 ' HZ ' ' CD2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -140.32 140.12 35.57 Favored 'General case' 0 C--N 1.268 -2.966 0 O-C-N 121.645 -0.66 . . . . 40.0 109.866 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.2 m -125.14 135.75 52.94 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.267 -1.012 . . . . 40.0 108.267 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.62 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 19.3 tttp -84.56 145.91 27.82 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.801 -1.187 . . . . 40.0 109.619 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.1 pt -121.03 -35.01 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.445 -0.785 . . . . 40.0 109.476 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.62 ' C ' ' HZ3' ' A' ' 108' ' ' LYS . 78.9 mtt180 . . . . . 0 N--CA 1.488 1.474 0 O-C-N 121.169 -0.957 . . . . 40.0 109.091 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.607 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 12.8 t . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 109.786 -0.45 . . . . 40.0 109.786 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -175.01 153.55 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 109.375 -0.602 . . . . 40.0 109.375 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -144.58 24.68 1.54 Allowed 'General case' 0 N--CA 1.484 1.23 0 O-C-N 120.853 -1.154 . . . . 40.0 110.36 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.9 p -105.95 152.34 23.45 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.792 0.806 . . . . 40.0 109.541 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -55.24 -65.1 0.65 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.987 -1.071 . . . . 40.0 110.922 -178.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.594 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.7 OUTLIER -56.71 -41.75 77.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.344 -0.847 . . . . 40.0 110.304 -179.286 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.96 -44.87 87.8 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.255 -1.538 . . . . 40.0 109.255 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.1 t -67.48 -42.42 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.837 -0.801 . . . . 40.0 108.879 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -61.65 -57.66 11.14 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.553 -0.717 . . . . 40.0 109.212 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.25 -56.64 8.71 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.615 0.722 . . . . 40.0 109.186 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.673 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 41.7 t80 -53.31 -52.49 58.96 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.147 0.499 . . . . 40.0 110.677 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 18' ' ' HIS . 1.2 tt -71.98 -51.61 21.07 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.594 -0.692 . . . . 40.0 110.132 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 11' ' ' ALA . 63.1 mt-30 -51.25 -29.43 14.46 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.278 -1.514 . . . . 40.0 110.273 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m -90.04 -50.77 5.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.841 -1.162 . . . . 40.0 111.627 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 19' ' ' LYS . 87.7 m-85 -99.88 14.81 29.14 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.386 -0.821 . . . . 40.0 109.874 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 14' ' ' LEU . 19.9 m80 41.82 24.01 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.532 0 CA-C-O 121.407 0.622 . . . . 40.0 111.141 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 17' ' ' TYR . 4.4 pttp -134.31 158.66 43.22 Favored 'General case' 0 C--O 1.184 -2.373 0 O-C-N 121.305 -0.872 . . . . 40.0 109.939 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.28 145.06 63.55 Favored Pre-proline 0 C--N 1.263 -3.173 0 O-C-N 120.945 -1.097 . . . . 40.0 109.554 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.673 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 82.3 Cg_exo -37.94 155.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.512 2.578 0 C-N-CA 123.473 2.782 . . . . 40.0 114.7 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.607 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -67.73 50.37 0.05 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.138 -0.976 . . . . 40.0 108.964 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -174.94 24.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 118.952 -1.099 . . . . 40.0 110.764 -179.42 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -118.26 109.78 16.74 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.981 0.896 . . . . 40.0 110.332 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.462 HG22 HD12 ' A' ' 25' ' ' ILE . 12.5 pt -118.47 134.13 63.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.931 -1.137 . . . . 40.0 107.931 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.511 ' OG1' ' CB ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -70.32 173.43 6.81 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 124.092 1.901 . . . . 40.0 113.371 -177.339 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.492 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 16.8 mtmt -63.29 -35.83 81.67 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 106.648 -1.612 . . . . 40.0 106.648 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.511 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 5.1 m -37.54 -70.24 0.1 Allowed 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 122.28 1.038 . . . . 40.0 108.962 175.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.476 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.2 mp0 -68.1 -50.0 57.62 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.988 -1.115 . . . . 40.0 107.988 -178.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.476 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -43.18 -49.4 6.49 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.263 -1.375 . . . . 40.0 108.888 177.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.4 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 34.3 mt-30 -59.68 -62.08 2.14 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.275 -0.891 . . . . 40.0 111.454 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.01 -24.15 66.87 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.219 -0.925 . . . . 40.0 109.118 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.2 tp -68.1 -21.57 64.95 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.236 -0.986 . . . . 40.0 108.596 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.35 43.75 0.46 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.266 -1.133 . . . . 40.0 110.266 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.542 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -80.96 143.22 32.74 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.034 -1.274 . . . . 40.0 109.38 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.9 t -140.99 131.54 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.755 0 O-C-N 120.969 -1.082 . . . . 40.0 109.217 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -58.25 -48.78 79.36 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.913 -0.492 . . . . 40.0 110.342 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.3 p -70.82 45.63 0.09 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.158 -0.963 . . . . 40.0 110.263 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.438 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 ttpm? -177.07 -51.43 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.892 -0.781 . . . . 40.0 108.892 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.7 58.93 10.18 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 108.202 -1.959 . . . . 40.0 108.202 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.542 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -75.56 159.52 31.16 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.77 -0.841 . . . . 40.0 110.288 -177.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.514 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 59.4 tp -173.76 -66.75 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.232 -0.987 . . . . 40.0 110.538 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.68 -19.91 62.86 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.03 -1.044 . . . . 40.0 109.935 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.7 p-10 -78.11 -61.34 2.03 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.681 -0.859 . . . . 40.0 108.681 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.1 m -78.74 -10.17 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.412 0 O-C-N 121.644 -0.66 . . . . 40.0 110.088 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . . . -150.37 71.54 9.15 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.393 -0.817 . . . . 40.0 109.838 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.96 117.5 4.2 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 123.649 2.899 . . . . 40.0 113.135 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.81 37.89 43.54 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.081 -1.208 . . . . 40.0 110.081 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 46' ' ' ALA . 7.3 mmtm -134.99 173.6 11.54 Favored 'General case' 0 N--CA 1.511 2.585 0 CA-C-O 121.72 0.771 . . . . 40.0 110.537 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.424 ' HG ' ' C ' ' A' ' 49' ' ' LYS . 67.0 m -147.54 162.76 38.42 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.954 -1.091 . . . . 40.0 112.013 -176.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 51' ' ' ILE . 8.6 mm -82.72 124.23 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 115.26 -0.882 . . . . 40.0 110.643 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.55 157.56 17.15 Favored Glycine 0 N--CA 1.5 2.927 0 N-CA-C 109.64 -1.384 . . . . 40.0 109.64 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.422 ' HA3' HG23 ' A' ' 26' ' ' THR . . . 117.63 -9.83 14.5 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 118.938 -1.601 . . . . 40.0 110.107 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.438 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 5.3 m-20 -75.69 -151.97 0.04 OUTLIER 'General case' 0 C--O 1.193 -1.897 0 O-C-N 120.8 -1.412 . . . . 40.0 109.853 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.4 mp -130.68 142.39 43.8 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 CA-C-N 115.102 -0.954 . . . . 40.0 108.679 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.613 ' O ' ' N ' ' A' ' 58' ' ' ASN . 12.9 t80 -110.3 90.96 3.47 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.095 -0.706 . . . . 40.0 109.095 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.659 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.9 p -60.3 38.74 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.457 -0.777 . . . . 40.0 110.705 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.613 ' N ' ' O ' ' A' ' 56' ' ' PHE . 45.6 t30 33.89 38.95 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.13 -0.981 . . . . 40.0 110.721 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.659 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.5 mtm180 -69.34 35.52 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.119 -0.988 . . . . 40.0 110.086 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.657 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 15.1 mt-10 -144.86 -3.74 0.77 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.052 -1.03 . . . . 40.0 110.348 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.16 37.91 60.09 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.275 -1.53 . . . . 40.0 109.275 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.657 ' HZ1' ' CD ' ' A' ' 60' ' ' GLU . 5.0 mttp -120.32 11.66 11.54 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.537 -0.978 . . . . 40.0 109.778 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.438 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -136.88 143.98 44.72 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 109.389 -0.597 . . . . 40.0 109.389 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.83 124.64 14.91 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.605 2.203 . . . . 40.0 112.267 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.503 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -104.33 -178.75 25.1 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.076 -1.21 . . . . 40.0 110.076 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.417 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 9.5 tttt -177.16 152.57 0.89 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.363 -1.08 . . . . 40.0 108.435 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.6 p -71.3 53.41 0.19 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.304 -1.497 . . . . 40.0 109.438 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.48 80.16 0.03 OUTLIER Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.084 -1.206 . . . . 40.0 110.084 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.577 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -175.36 178.83 1.6 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.706 -0.879 . . . . 40.0 108.864 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.577 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 87.1 m -155.52 155.98 34.38 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.331 -0.947 . . . . 40.0 109.83 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.676 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 27.5 m95 -124.91 140.01 53.31 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.78 -0.452 . . . . 40.0 109.78 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.606 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.64 149.55 52.25 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.738 -1.226 . . . . 40.0 109.685 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.492 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -115.79 168.82 9.71 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 122.283 1.04 . . . . 40.0 112.304 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.13 138.5 4.66 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.846 -0.615 . . . . 40.0 111.11 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.661 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.4 OUTLIER -60.41 154.79 19.64 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.453 0.644 . . . . 40.0 111.091 179.495 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 76' ' ' ILE . 40.2 mm -137.82 145.19 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 119.962 -0.695 . . . . 40.0 110.596 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 57.83 68.4 0.85 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.738 -0.601 . . . . 40.0 110.697 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.48 ' CG ' ' N ' ' A' ' 79' ' ' THR . 61.0 t80 -129.84 157.2 42.9 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.097 -1.002 . . . . 40.0 109.867 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.541 ' OG1' ' N ' ' A' ' 80' ' ' SER . 24.2 p -137.31 -71.07 0.44 Allowed 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.517 -0.739 . . . . 40.0 109.718 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.541 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.9 OUTLIER -153.68 107.15 2.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.6 -0.687 . . . . 40.0 109.388 -178.344 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.28 -107.22 0.31 Allowed Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.667 -1.254 . . . . 40.0 110.191 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.477 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 41.6 t80 -137.29 -166.73 1.98 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.772 -0.84 . . . . 40.0 109.355 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.664 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.8 mtm180 -73.99 -155.5 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.805 -1.184 . . . . 40.0 109.643 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -166.52 -150.75 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.888 -1.153 . . . . 40.0 107.888 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 100' ' ' THR . 60.1 p -102.32 -7.49 22.02 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.004 -1.06 . . . . 40.0 109.539 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.679 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.67 113.88 23.76 Favored 'General case' 0 N--CA 1.509 2.505 0 CA-C-O 121.89 0.852 . . . . 40.0 111.552 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.803 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.35 148.55 43.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.951 -1.093 . . . . 40.0 110.84 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.5 tt -114.72 140.06 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-O 122.144 0.973 . . . . 40.0 110.158 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.415 ' CD2' ' HZ ' ' A' ' 106' ' ' PHE . 3.1 mm? -118.77 125.13 48.92 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.609 -0.886 . . . . 40.0 108.609 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.672 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -119.52 129.41 54.68 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.594 0.711 . . . . 40.0 109.203 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.676 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.7 p -93.93 160.14 14.86 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.668 1.223 . . . . 40.0 112.797 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.1 p -69.92 -17.03 63.31 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.138 -1.06 . . . . 40.0 108.138 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.467 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -88.19 10.03 20.87 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 119.773 -0.771 . . . . 40.0 109.686 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.458 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.6 27.36 0.62 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.765 -0.585 . . . . 40.0 110.259 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.0 mt -96.48 136.93 36.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.273 -0.892 . . . . 40.0 109.061 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.455 HG23 HD12 ' A' ' 96' ' ' ILE . 41.1 mm -111.72 119.95 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.772 -0.58 . . . . 40.0 110.649 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.402 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.7 m-85 -122.91 144.57 49.14 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 120.524 -0.47 . . . . 40.0 109.934 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.679 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 4.2 tptp -134.29 145.02 48.68 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.042 -1.036 . . . . 40.0 110.593 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.577 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.6 t -123.37 166.9 14.54 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.567 -0.901 . . . . 40.0 108.567 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.411 ' O ' ' OG ' ' A' ' 85' ' ' SER . 35.8 p -139.73 -10.29 1.19 Allowed 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.03 -1.044 . . . . 40.0 109.723 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.563 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.1 p30 -107.13 10.78 30.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.25 -0.907 . . . . 40.0 110.259 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 86.68 63.06 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.346 0.593 . . . . 40.0 110.494 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.664 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 24.4 m-85 70.61 -23.23 0.17 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.369 -0.832 . . . . 40.0 110.883 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.469 ' H ' ' C ' ' A' ' 102' ' ' ALA . 2.0 mt-30 -43.4 -73.45 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.293 -0.879 . . . . 40.0 109.97 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.444 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 24.8 p -106.18 167.53 9.75 Favored 'General case' 0 C--O 1.196 -1.756 0 N-CA-C 107.718 -1.215 . . . . 40.0 107.718 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.415 ' HZ ' ' CD2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -140.93 139.16 34.27 Favored 'General case' 0 C--N 1.268 -2.942 0 O-C-N 121.51 -0.744 . . . . 40.0 109.836 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.7 m -124.48 135.98 53.65 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.143 -1.058 . . . . 40.0 108.143 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.632 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 18.1 tttp -84.64 145.57 27.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.903 -1.123 . . . . 40.0 109.656 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.6 pt -121.35 -34.42 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.157 -0.964 . . . . 40.0 109.528 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.632 ' C ' ' HZ3' ' A' ' 108' ' ' LYS . 76.3 mtt180 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 118.176 -0.916 . . . . 40.0 108.969 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.636 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 17.9 t . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 108.992 -0.744 . . . . 40.0 108.992 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -175.9 153.79 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.066 -0.716 . . . . 40.0 109.066 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -144.43 26.05 1.48 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.109 -0.994 . . . . 40.0 110.688 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.2 p -104.26 151.94 22.81 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 121.463 0.649 . . . . 40.0 109.473 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -55.25 -64.16 0.93 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.716 -1.24 . . . . 40.0 110.734 -179.191 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.605 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.7 OUTLIER -57.03 -41.83 79.32 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.193 -0.942 . . . . 40.0 110.107 -179.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.4 -45.28 84.18 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.702 -1.359 . . . . 40.0 109.702 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.1 t -67.09 -43.36 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 121.674 -0.898 . . . . 40.0 108.824 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.43 -58.79 6.99 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.283 -0.636 . . . . 40.0 109.283 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.56 -56.47 9.8 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.118 -0.989 . . . . 40.0 109.358 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.697 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 39.0 t80 -51.49 -53.07 41.19 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.942 -0.572 . . . . 40.0 110.418 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 18' ' ' HIS . 1.9 tt -72.74 -50.1 26.79 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.336 0.589 . . . . 40.0 110.982 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 11' ' ' ALA . 63.3 mt-30 -53.17 -28.27 25.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.059 -1.65 . . . . 40.0 109.925 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.9 m -91.61 -51.14 5.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.014 -1.054 . . . . 40.0 110.763 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.416 ' O ' ' N ' ' A' ' 19' ' ' LYS . 84.9 m-85 -99.11 14.03 30.79 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.268 -0.895 . . . . 40.0 110.427 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.544 ' N ' ' O ' ' A' ' 14' ' ' LEU . 20.9 m80 41.95 25.01 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 O-C-N 121.565 -0.71 . . . . 40.0 111.023 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 17' ' ' TYR . 4.1 pttp -134.89 158.65 43.71 Favored 'General case' 0 C--O 1.185 -2.3 0 O-C-N 121.2 -0.937 . . . . 40.0 109.967 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mp -79.35 146.03 65.44 Favored Pre-proline 0 C--N 1.269 -2.905 0 N-CA-C 107.961 -1.126 . . . . 40.0 107.961 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.697 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 82.2 Cg_exo -39.34 157.72 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 123.213 2.608 . . . . 40.0 114.6 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.636 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.8 OUTLIER -69.47 51.26 0.1 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.817 -1.177 . . . . 40.0 109.62 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.447 ' HA ' ' HD3' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -175.92 26.71 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.026 -1.047 . . . . 40.0 110.149 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -119.59 109.72 16.02 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.498 -1.376 . . . . 40.0 111.045 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.0 pt -116.85 134.94 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.441 -0.904 . . . . 40.0 108.704 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.484 ' OG1' ' OG ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -69.51 169.98 11.5 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 123.756 1.741 . . . . 40.0 113.269 -177.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.471 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 23.1 mtmt -62.34 -37.87 87.31 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 105.96 -1.867 . . . . 40.0 105.96 177.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.484 ' OG ' ' OG1' ' A' ' 26' ' ' THR . 1.1 m -37.69 -70.84 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.667 -0.864 . . . . 40.0 108.667 176.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.545 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.5 mp0 -63.34 -57.62 9.79 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 106.823 -1.547 . . . . 40.0 106.823 -177.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.545 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -33.31 -52.03 0.36 Allowed 'General case' 0 N--CA 1.509 2.525 0 C-N-CA 119.165 -1.014 . . . . 40.0 109.251 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -56.52 -67.06 0.34 Allowed 'General case' 0 N--CA 1.516 2.864 0 O-C-N 120.906 -1.121 . . . . 40.0 111.524 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.4 -21.64 62.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.746 -1.221 . . . . 40.0 110.494 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.5 tp -70.54 -24.47 62.81 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.349 -1.352 . . . . 40.0 107.349 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.7 48.15 0.28 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.6 -1.0 . . . . 40.0 110.6 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.595 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.14 142.31 33.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.009 -1.289 . . . . 40.0 108.633 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.7 t -136.47 128.24 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 N-CA-C 108.439 -0.948 . . . . 40.0 108.439 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -59.12 -48.58 81.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.776 -0.577 . . . . 40.0 109.531 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.7 p -70.83 46.95 0.1 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.028 -1.045 . . . . 40.0 109.899 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.563 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -178.6 -50.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.916 -0.772 . . . . 40.0 108.916 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.39 59.8 8.85 Favored Glycine 0 N--CA 1.503 3.146 0 N-CA-C 108.593 -1.803 . . . . 40.0 108.593 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.595 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -76.6 160.56 29.32 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.344 -1.092 . . . . 40.0 111.59 -177.293 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.516 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 45.5 tp -172.46 -70.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.451 -0.9 . . . . 40.0 110.529 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.98 -21.45 61.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.852 -1.155 . . . . 40.0 109.77 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 5.0 p-10 -75.87 -62.64 1.52 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.185 -0.672 . . . . 40.0 109.185 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.414 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 15.8 m -77.76 -13.28 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 109.063 -0.718 . . . . 40.0 109.063 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -147.74 72.92 11.54 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 121.34 -0.85 . . . . 40.0 110.148 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.68 118.04 4.81 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.01 2.474 . . . . 40.0 113.959 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.441 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 75.16 36.48 45.64 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.25 -1.54 . . . . 40.0 109.25 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 23' ' ' ASN . 7.3 mmtm -135.5 163.55 29.82 Favored 'General case' 0 N--CA 1.511 2.586 0 CA-C-O 121.739 0.781 . . . . 40.0 110.364 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.5 m -138.56 166.57 23.99 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 122.12 0.962 . . . . 40.0 111.325 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.474 HG22 HD11 ' A' ' 51' ' ' ILE . 10.3 mm -83.98 121.66 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 115.344 -0.843 . . . . 40.0 111.689 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 178.27 155.24 13.86 Favored Glycine 0 N--CA 1.502 3.097 0 C-N-CA 119.847 -1.168 . . . . 40.0 110.604 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.7 -7.87 12.04 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.342 -1.409 . . . . 40.0 110.217 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.415 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 4.5 m-20 -75.65 -150.79 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.088 -1.242 . . . . 40.0 109.824 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -132.36 143.33 40.23 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.882 0 CA-C-N 115.067 -0.969 . . . . 40.0 108.848 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.644 ' O ' ' N ' ' A' ' 58' ' ' ASN . 14.9 t80 -112.04 89.68 3.13 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.488 -0.93 . . . . 40.0 108.488 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.667 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.8 p -59.23 37.57 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.597 0.713 . . . . 40.0 110.611 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.644 ' N ' ' O ' ' A' ' 56' ' ' PHE . 44.2 t30 34.42 39.18 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.066 -1.021 . . . . 40.0 110.656 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.667 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.8 mtm180 -70.02 35.54 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.731 -1.231 . . . . 40.0 110.45 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.623 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 14.8 mt-10 -144.91 -1.85 0.84 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.033 -1.042 . . . . 40.0 109.943 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.58 37.84 50.91 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.662 -1.375 . . . . 40.0 109.662 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.623 ' HZ1' ' CD ' ' A' ' 60' ' ' GLU . 4.3 mttp -119.89 12.36 12.04 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.458 -1.025 . . . . 40.0 109.407 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.464 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -137.54 143.85 42.55 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.702 -0.624 . . . . 40.0 109.646 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.54 123.74 13.32 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.505 2.137 . . . . 40.0 112.466 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.515 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -103.43 -177.81 26.16 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.205 -1.158 . . . . 40.0 110.205 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.408 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 8.4 tttt -178.12 154.09 0.84 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 108.024 -1.102 . . . . 40.0 108.024 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.4 p -73.29 56.04 0.47 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.774 -1.204 . . . . 40.0 109.041 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.16 81.76 0.04 OUTLIER Glycine 0 N--CA 1.498 2.815 0 N-CA-C 109.899 -1.28 . . . . 40.0 109.899 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.57 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -177.34 178.18 1.11 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.544 -0.974 . . . . 40.0 108.874 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.57 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 92.8 m -154.97 155.12 33.65 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.219 -0.926 . . . . 40.0 109.945 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.695 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 29.7 m95 -123.36 139.45 54.02 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.708 -0.479 . . . . 40.0 109.708 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.564 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.26 149.02 52.14 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.705 -1.247 . . . . 40.0 109.713 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.471 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -114.52 169.94 8.68 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.897 -1.127 . . . . 40.0 112.331 -179.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.99 137.24 3.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.745 -0.597 . . . . 40.0 110.958 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.656 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.3 OUTLIER -59.14 154.54 15.76 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 120.917 0.389 . . . . 40.0 110.896 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.405 HD13 ' HB ' ' A' ' 88' ' ' ILE . 41.6 mm -137.09 144.33 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.323 -0.861 . . . . 40.0 110.294 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 57.77 71.05 0.6 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.527 -0.733 . . . . 40.0 110.58 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.516 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 69.2 t80 -131.67 155.06 48.27 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.866 -1.146 . . . . 40.0 109.804 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.596 ' OG1' ' N ' ' A' ' 80' ' ' SER . 27.2 p -135.79 -73.05 0.45 Allowed 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.618 -0.676 . . . . 40.0 110.138 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.596 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -153.65 102.32 2.54 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.481 -0.562 . . . . 40.0 109.481 -177.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.01 -103.08 0.21 Allowed Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.855 -1.164 . . . . 40.0 110.397 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.486 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 45.8 t80 -141.3 -166.95 2.29 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.842 -0.799 . . . . 40.0 108.955 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.649 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.9 mtm180 -73.45 -154.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 40.0 110.429 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.588 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 9.4 p30 -167.58 -150.91 0.11 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.333 -0.988 . . . . 40.0 108.333 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 100' ' ' THR . 82.5 p -102.82 -8.06 21.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.799 -1.188 . . . . 40.0 109.309 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.691 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.25 113.67 23.19 Favored 'General case' 0 N--CA 1.509 2.48 0 CA-C-O 121.794 0.807 . . . . 40.0 111.483 -179.537 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.8 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.73 150.79 46.53 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.852 -1.155 . . . . 40.0 110.551 179.606 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.405 ' HB ' HD13 ' A' ' 76' ' ' ILE . 4.9 tt -116.93 141.02 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.511 -0.743 . . . . 40.0 109.908 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.54 124.95 47.67 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.574 -0.899 . . . . 40.0 108.574 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.677 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.66 129.53 55.35 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.873 0.844 . . . . 40.0 108.776 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.695 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.9 p -94.69 159.66 14.97 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 122.581 1.181 . . . . 40.0 112.413 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.6 p -69.42 -17.81 63.69 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.117 -1.068 . . . . 40.0 108.117 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.471 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -87.06 10.06 17.75 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.778 -0.769 . . . . 40.0 109.736 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.453 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.66 26.54 0.65 Allowed 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.62 -0.675 . . . . 40.0 110.259 179.253 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.5 mt -95.69 135.55 37.24 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.362 -0.837 . . . . 40.0 109.092 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.478 HG23 HD12 ' A' ' 96' ' ' ILE . 38.6 mm -110.96 119.02 58.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-O 121.389 0.614 . . . . 40.0 110.722 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -122.28 144.88 48.72 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 120.276 -0.57 . . . . 40.0 109.637 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.691 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 4.8 tptp -133.83 144.42 48.95 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.19 -0.943 . . . . 40.0 110.644 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.576 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.7 t -123.17 166.7 14.77 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 108.688 -0.856 . . . . 40.0 108.688 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.429 ' O ' ' OG ' ' A' ' 85' ' ' SER . 40.7 p -140.08 -9.82 1.15 Allowed 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.277 -0.889 . . . . 40.0 109.66 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.2 p30 -108.47 14.01 25.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 40.0 110.261 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 84.41 61.92 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.13 0.491 . . . . 40.0 110.329 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.649 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 24.6 m-85 70.73 -21.64 0.19 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.494 -0.754 . . . . 40.0 110.881 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.466 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.2 mt-30 -43.72 -72.55 0.06 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.088 -1.007 . . . . 40.0 109.599 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.419 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 26.4 p -107.41 169.44 8.58 Favored 'General case' 0 C--O 1.193 -1.9 0 N-CA-C 108.048 -1.093 . . . . 40.0 108.048 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.42 140.13 33.57 Favored 'General case' 0 C--N 1.272 -2.794 0 O-C-N 121.355 -0.84 . . . . 40.0 110.114 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 46.4 m -125.31 135.51 52.55 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.551 -0.907 . . . . 40.0 108.551 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.677 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 21.7 tttp -84.46 145.08 28.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.759 -1.213 . . . . 40.0 109.879 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.1 pt -120.32 -34.72 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.172 -0.955 . . . . 40.0 109.527 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.677 ' C ' ' HZ3' ' A' ' 108' ' ' LYS . 78.3 mtt180 . . . . . 0 N--CA 1.487 1.378 0 O-C-N 121.186 -0.946 . . . . 40.0 108.638 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.648 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 20.7 t . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 109.294 -0.632 . . . . 40.0 109.294 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 tt -177.1 152.4 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 108.981 -0.748 . . . . 40.0 108.981 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -144.29 25.78 1.52 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.733 -1.229 . . . . 40.0 110.604 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.4 p -105.38 152.82 22.49 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.528 0.68 . . . . 40.0 110.057 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -56.29 -62.74 1.51 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.459 -1.401 . . . . 40.0 111.482 -179.198 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.647 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -59.1 -40.83 86.54 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.976 -1.077 . . . . 40.0 109.738 -179.345 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.45 -44.88 85.3 Favored Glycine 0 N--CA 1.507 3.377 0 N-CA-C 109.682 -1.367 . . . . 40.0 109.682 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.5 t -67.55 -43.48 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.805 -0.821 . . . . 40.0 108.976 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.88 -56.48 20.64 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.967 -0.753 . . . . 40.0 108.967 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.04 -56.02 14.63 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.89 -0.782 . . . . 40.0 108.89 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.656 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 38.7 t80 -53.02 -51.78 60.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 122.017 -0.427 . . . . 40.0 110.87 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 18' ' ' HIS . 3.9 tt -71.89 -51.06 24.14 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 121.414 0.626 . . . . 40.0 110.43 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 11' ' ' ALA . 58.8 mt-30 -53.22 -28.77 28.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 119.983 -1.698 . . . . 40.0 110.316 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.3 m -92.31 -50.18 5.78 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.612 -1.305 . . . . 40.0 110.964 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.401 ' O ' ' N ' ' A' ' 19' ' ' LYS . 86.5 m-85 -99.28 12.47 36.15 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.89 -1.131 . . . . 40.0 110.308 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.569 ' N ' ' O ' ' A' ' 14' ' ' LEU . 23.5 m80 42.6 24.2 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.916 0 CA-C-O 121.484 0.659 . . . . 40.0 111.226 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 17' ' ' TYR . 5.1 pttp -135.98 156.57 48.54 Favored 'General case' 0 C--O 1.183 -2.413 0 CA-C-O 121.646 0.736 . . . . 40.0 109.804 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mp -77.62 145.63 71.6 Favored Pre-proline 0 C--N 1.268 -2.976 0 O-C-N 120.899 -1.126 . . . . 40.0 109.71 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.656 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 88.9 Cg_exo -40.33 155.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 123.267 2.645 . . . . 40.0 113.922 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.648 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -66.06 49.19 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.15 0.976 . . . . 40.0 109.376 -179.016 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -173.92 26.99 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.189 -0.944 . . . . 40.0 110.687 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -119.59 108.26 14.27 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.523 -1.361 . . . . 40.0 109.628 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.7 pt -116.94 132.11 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 C-N-CA 119.436 -0.905 . . . . 40.0 108.89 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.566 ' OG1' ' CB ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -67.17 172.02 5.1 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 123.609 1.671 . . . . 40.0 113.536 -177.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.501 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 19.5 mtmt -63.36 -35.99 82.23 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 106.458 -1.682 . . . . 40.0 106.458 176.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.566 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 5.1 m -35.56 -71.7 0.07 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 123.57 1.652 . . . . 40.0 109.222 175.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.504 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.1 mp0 -65.53 -56.18 13.76 Favored 'General case' 0 C--O 1.192 -1.93 0 N-CA-C 107.488 -1.301 . . . . 40.0 107.488 -177.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.504 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -37.26 -50.29 0.99 Allowed 'General case' 0 N--CA 1.517 2.914 0 O-C-N 120.574 -1.329 . . . . 40.0 110.647 178.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -58.93 -62.04 2.18 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.382 -1.449 . . . . 40.0 110.848 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.81 -25.98 67.83 Favored 'General case' 0 N--CA 1.512 2.662 0 O-C-N 120.679 -1.263 . . . . 40.0 110.027 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.0 tp -65.02 -25.33 67.8 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.178 -1.045 . . . . 40.0 108.178 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.33 46.2 0.33 Allowed Glycine 0 N--CA 1.502 3.068 0 N-CA-C 110.244 -1.142 . . . . 40.0 110.244 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.476 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -80.54 139.85 36.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.969 -1.312 . . . . 40.0 109.422 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.7 t -136.09 130.15 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.241 0 CA-C-O 121.6 0.714 . . . . 40.0 109.576 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -57.47 -48.18 79.87 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.298 -0.63 . . . . 40.0 109.298 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.2 p -69.7 44.85 0.06 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.33 -0.856 . . . . 40.0 110.704 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.529 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.5 ttpm? -178.48 -51.99 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.203 -0.936 . . . . 40.0 109.066 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.43 62.68 4.89 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 108.788 -1.725 . . . . 40.0 108.788 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.529 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -78.78 160.1 27.57 Favored 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.495 -1.003 . . . . 40.0 111.024 -177.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.561 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 52.0 tp -173.67 -69.4 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.479 -0.763 . . . . 40.0 110.544 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.37 -21.76 64.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.731 -1.231 . . . . 40.0 109.31 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 4.8 p-10 -74.16 -62.8 1.39 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.221 -0.659 . . . . 40.0 109.221 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.418 ' H ' HG23 ' A' ' 45' ' ' VAL . 29.8 m -80.4 -10.04 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.914 -0.491 . . . . 40.0 110.298 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -148.21 72.23 11.06 Favored Pre-proline 0 N--CA 1.489 1.487 0 CA-C-O 121.489 0.662 . . . . 40.0 109.518 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -55.35 115.53 2.51 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 123.779 2.986 . . . . 40.0 113.381 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.72 38.2 57.06 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.992 -1.243 . . . . 40.0 109.992 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.446 ' HD3' ' HA ' ' A' ' 23' ' ' ASN . 6.3 mmtt -133.12 163.3 29.57 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.795 -0.827 . . . . 40.0 110.008 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.2 m -139.13 161.1 38.23 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 122.432 1.11 . . . . 40.0 110.84 -176.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.437 HG22 HD11 ' A' ' 51' ' ' ILE . 19.6 mm -79.93 124.78 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 114.619 -1.173 . . . . 40.0 110.721 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.24 156.12 13.22 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 119.529 -1.319 . . . . 40.0 109.967 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.29 -10.73 13.06 Favored Glycine 0 N--CA 1.502 3.091 0 C-N-CA 119.531 -1.319 . . . . 40.0 110.163 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.443 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 4.9 m-20 -72.62 -151.15 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.538 -1.566 . . . . 40.0 109.68 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.4 mp -132.72 141.0 46.18 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 CA-C-N 115.132 -0.94 . . . . 40.0 109.304 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.634 ' C ' ' H ' ' A' ' 58' ' ' ASN . 11.7 t80 -109.28 91.76 3.77 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.295 -0.878 . . . . 40.0 109.198 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.624 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.5 p -60.27 38.21 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.92 0.867 . . . . 40.0 110.625 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.634 ' H ' ' C ' ' A' ' 56' ' ' PHE . 44.8 t30 33.97 39.27 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.407 -0.808 . . . . 40.0 110.659 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.624 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.3 mtm180 -70.37 36.3 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.516 -1.365 . . . . 40.0 110.348 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.652 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 15.1 mt-10 -145.17 -2.76 0.78 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.347 -0.845 . . . . 40.0 109.954 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.29 37.95 56.09 Favored Glycine 0 N--CA 1.502 3.098 0 N-CA-C 109.579 -1.409 . . . . 40.0 109.579 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.652 ' HZ1' ' CD ' ' A' ' 60' ' ' GLU . 5.8 mttp -120.1 11.46 11.66 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.267 -1.137 . . . . 40.0 109.505 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.4 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.5 mt -136.38 144.26 46.88 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.64 -0.663 . . . . 40.0 109.498 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.53 123.8 13.04 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.188 1.925 . . . . 40.0 112.527 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.505 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.67 -175.84 27.05 Favored Glycine 0 N--CA 1.5 2.901 0 N-CA-C 110.235 -1.146 . . . . 40.0 110.235 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 68' ' ' GLY . 9.0 tttt -179.12 152.17 0.54 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.065 -1.256 . . . . 40.0 107.791 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.6 p -70.87 53.53 0.16 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.643 -1.286 . . . . 40.0 109.106 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 150.89 80.98 0.03 OUTLIER Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.277 -1.129 . . . . 40.0 110.277 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.553 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.67 177.97 1.99 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.735 -0.862 . . . . 40.0 108.799 179.105 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.553 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 96.7 m -154.36 155.16 34.56 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.254 -0.904 . . . . 40.0 110.039 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TRP . . . . . 0.718 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 31.8 m95 -124.99 138.92 54.21 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.982 -0.449 . . . . 40.0 109.893 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.547 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.68 147.71 52.38 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.028 -1.045 . . . . 40.0 109.88 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.501 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -113.24 168.74 9.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.679 -1.263 . . . . 40.0 111.9 -179.379 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.45 139.56 5.71 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.799 0.809 . . . . 40.0 111.063 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.685 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.2 OUTLIER -60.51 154.83 19.88 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.85 -0.531 . . . . 40.0 111.275 179.641 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.9 mm -138.14 145.4 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.513 -0.742 . . . . 40.0 109.946 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 56.77 70.69 0.63 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.499 0.666 . . . . 40.0 110.782 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.561 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 65.6 t80 -132.29 154.9 49.21 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.917 -1.114 . . . . 40.0 109.436 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.574 ' OG1' ' N ' ' A' ' 80' ' ' SER . 22.9 p -136.17 -72.16 0.45 Allowed 'General case' 0 N--CA 1.507 2.385 0 CA-C-O 121.214 0.531 . . . . 40.0 109.934 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.574 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.5 OUTLIER -153.4 103.67 2.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.387 -0.821 . . . . 40.0 109.299 -178.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.42 -106.19 0.27 Allowed Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.608 -1.282 . . . . 40.0 110.212 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.469 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 52.4 t80 -138.21 -165.16 1.75 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.789 -0.819 . . . . 40.0 108.789 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.647 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.1 mtm180 -75.72 -155.84 0.06 Allowed 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.335 -1.478 . . . . 40.0 109.961 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASN . . . . . 0.547 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 9.5 p30 -165.13 -149.18 0.12 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.217 -1.031 . . . . 40.0 108.217 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.7 p -104.21 -7.58 20.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.709 -1.244 . . . . 40.0 108.929 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.639 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -87.6 113.42 23.27 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-O 121.878 0.846 . . . . 40.0 111.71 -179.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.811 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.55 150.61 46.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.879 -1.138 . . . . 40.0 110.519 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.7 tt -117.3 139.26 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-O 122.831 1.301 . . . . 40.0 110.028 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.86 124.44 47.16 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.421 -0.955 . . . . 40.0 108.421 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.678 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.54 129.5 55.39 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.846 0.831 . . . . 40.0 109.125 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.718 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.5 p -93.35 159.21 15.36 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 122.268 1.032 . . . . 40.0 112.221 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.8 p -69.23 -18.41 63.88 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.805 -1.183 . . . . 40.0 107.805 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.485 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -86.05 9.4 17.3 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.189 -0.604 . . . . 40.0 109.629 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.447 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.12 26.72 0.72 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.503 -0.748 . . . . 40.0 110.3 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.8 mt -96.29 134.99 38.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.398 -0.814 . . . . 40.0 109.156 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.412 HG23 HD12 ' A' ' 96' ' ' ILE . 39.2 mm -109.52 120.66 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.438 -0.788 . . . . 40.0 110.452 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -122.95 144.18 49.41 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 109.239 -0.652 . . . . 40.0 109.239 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.639 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 4.7 tptp -133.89 144.84 49.13 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 119.569 -0.852 . . . . 40.0 110.979 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.535 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.8 t -122.95 166.74 14.58 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 108.939 -0.764 . . . . 40.0 108.939 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 40.7 p -140.3 -9.0 1.13 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.36 -0.837 . . . . 40.0 109.626 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.506 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.2 p30 -108.58 14.63 24.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.958 -1.089 . . . . 40.0 110.285 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 83.45 61.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.21 0.528 . . . . 40.0 110.539 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.647 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 28.5 m-85 71.23 -20.83 0.21 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.59 -0.694 . . . . 40.0 110.651 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.464 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.7 mt-30 -44.83 -74.13 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.074 -1.016 . . . . 40.0 109.83 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.47 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 21.0 p -106.02 167.01 10.09 Favored 'General case' 0 C--O 1.195 -1.806 0 N-CA-C 107.56 -1.274 . . . . 40.0 107.56 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.02 140.45 36.22 Favored 'General case' 0 C--N 1.264 -3.125 0 O-C-N 121.32 -0.863 . . . . 40.0 109.73 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.5 m -125.4 137.47 54.01 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.318 -0.993 . . . . 40.0 108.318 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.582 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 17.7 tttp -85.1 145.76 27.49 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.834 -1.166 . . . . 40.0 109.919 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.3 pt -121.78 -33.32 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.107 -0.996 . . . . 40.0 109.63 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.647 HH21 ' CG ' ' A' ' 8' ' ' ASP . 76.7 mtt180 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.945 . . . . 40.0 108.737 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.643 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 21.8 t . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 109.123 -0.695 . . . . 40.0 109.123 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -177.57 153.79 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.094 -0.706 . . . . 40.0 109.094 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.2 p-10 -144.38 26.1 1.48 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.066 -1.021 . . . . 40.0 110.729 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.1 p -104.73 153.83 20.78 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.694 0.759 . . . . 40.0 109.779 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -56.99 -63.63 1.15 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.008 -1.057 . . . . 40.0 110.515 -179.267 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.651 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.8 OUTLIER -58.11 -41.76 84.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.481 -0.762 . . . . 40.0 109.781 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.6 -44.98 90.85 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 109.897 -1.281 . . . . 40.0 109.897 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 64.7 t -66.61 -43.41 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.485 -1.009 . . . . 40.0 108.608 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.93 -57.48 12.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.367 -0.605 . . . . 40.0 109.367 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.25 -55.63 14.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.514 -0.741 . . . . 40.0 109.039 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.654 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 38.0 t80 -52.4 -52.64 52.71 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.03 0.443 . . . . 40.0 110.268 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 18' ' ' HIS . 4.7 tt -71.42 -52.19 19.85 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.254 0.549 . . . . 40.0 110.68 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.485 ' N ' ' O ' ' A' ' 11' ' ' ALA . 56.7 mt-30 -52.85 -28.94 25.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.113 -1.617 . . . . 40.0 109.939 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.8 m -91.1 -52.51 4.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.887 -1.133 . . . . 40.0 110.682 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -97.6 12.34 33.87 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.255 -0.903 . . . . 40.0 110.525 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.569 ' N ' ' O ' ' A' ' 14' ' ' LEU . 22.5 m80 43.36 25.04 0.06 Allowed 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.528 -0.733 . . . . 40.0 110.979 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.451 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 5.4 pttp -137.14 160.58 38.57 Favored 'General case' 0 C--O 1.182 -2.467 0 O-C-N 121.397 -0.814 . . . . 40.0 109.774 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 mp -80.07 146.08 62.39 Favored Pre-proline 0 C--N 1.266 -3.045 0 O-C-N 120.879 -1.138 . . . . 40.0 108.608 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.654 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 71.2 Cg_exo -41.26 156.11 0.06 OUTLIER 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.056 2.504 . . . . 40.0 113.982 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.643 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -67.35 49.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.178 -0.951 . . . . 40.0 109.352 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.502 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -172.98 26.58 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.941 -1.099 . . . . 40.0 110.236 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -120.12 109.11 15.07 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.913 -1.115 . . . . 40.0 110.394 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.5 pt -119.02 134.1 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.959 -1.126 . . . . 40.0 107.959 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.523 ' HB ' ' CG ' ' A' ' 54' ' ' ASP . 0.7 OUTLIER -71.78 172.59 9.55 Favored 'General case' 0 N--CA 1.508 2.444 0 CA-C-O 123.677 1.704 . . . . 40.0 113.249 -175.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.565 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 14.9 mtmt -60.67 -39.31 87.92 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 106.519 -1.66 . . . . 40.0 106.519 176.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.468 ' C ' ' O ' ' A' ' 27' ' ' LYS . 2.6 m -32.24 -74.3 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.533 -0.914 . . . . 40.0 108.533 175.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.572 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.8 mp0 -65.97 -57.49 7.68 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.116 -1.439 . . . . 40.0 107.116 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.572 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -30.22 -55.01 0.18 Allowed 'General case' 0 N--CA 1.53 3.559 0 O-C-N 119.931 -1.731 . . . . 40.0 109.78 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -56.13 -66.7 0.39 Allowed 'General case' 0 N--CA 1.525 3.31 0 O-C-N 120.033 -1.667 . . . . 40.0 113.679 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.71 -32.21 59.26 Favored 'General case' 0 N--CA 1.524 3.233 0 O-C-N 121.473 -0.767 . . . . 40.0 109.751 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.03 -22.35 66.79 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.178 -1.576 . . . . 40.0 108.633 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.36 51.27 0.4 Allowed Glycine 0 N--CA 1.503 3.144 0 N-CA-C 110.049 -1.22 . . . . 40.0 110.049 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.608 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -84.67 138.96 32.37 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.18 -1.188 . . . . 40.0 108.048 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.7 t -134.81 130.01 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.788 0 CA-C-O 121.74 0.781 . . . . 40.0 110.205 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.426 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -58.23 -50.37 73.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.935 -0.478 . . . . 40.0 110.005 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 76.4 p -70.36 45.45 0.08 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.573 -0.704 . . . . 40.0 110.123 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.511 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 2.0 ttpm? -177.14 -49.24 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.857 -0.794 . . . . 40.0 108.857 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.48 59.98 8.53 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 108.213 -1.955 . . . . 40.0 108.213 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.608 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -76.69 161.18 28.73 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.483 -1.01 . . . . 40.0 110.931 -177.837 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.52 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 48.8 tp -173.73 -68.5 0.01 OUTLIER 'General case' 0 C--O 1.194 -1.838 0 O-C-N 121.233 -0.917 . . . . 40.0 110.524 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -62.24 -20.45 64.24 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.504 -1.372 . . . . 40.0 109.318 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.4 p-10 -75.98 -61.88 1.78 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.925 -0.768 . . . . 40.0 108.925 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.418 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 26.9 m -80.11 -12.68 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.582 -0.699 . . . . 40.0 109.67 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . . . -146.1 71.82 13.4 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.329 -0.857 . . . . 40.0 109.67 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -56.27 116.78 3.42 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.787 2.325 . . . . 40.0 113.375 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.87 36.67 52.14 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.757 -1.337 . . . . 40.0 109.757 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.469 ' HD3' ' HA ' ' A' ' 23' ' ' ASN . 6.8 mmtm -133.66 163.24 29.88 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 121.688 -0.889 . . . . 40.0 109.386 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 52.0 m -138.2 163.5 31.57 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.201 1.001 . . . . 40.0 111.135 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.489 HG22 HD11 ' A' ' 51' ' ' ILE . 39.0 mm -80.83 123.2 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 CA-C-N 115.208 -0.905 . . . . 40.0 110.38 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . 176.94 155.63 13.99 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.468 -1.453 . . . . 40.0 109.468 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.441 ' HA3' HG23 ' A' ' 26' ' ' THR . . . 117.36 -11.04 14.47 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.685 -1.245 . . . . 40.0 110.972 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.523 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 5.0 m-20 -72.63 -151.42 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.762 0 O-C-N 121.187 -1.184 . . . . 40.0 109.807 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -132.59 144.02 38.03 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.021 0 N-CA-C 108.256 -1.016 . . . . 40.0 108.256 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.62 ' O ' ' N ' ' A' ' 58' ' ' ASN . 15.3 t80 -112.7 90.81 3.44 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.195 -0.941 . . . . 40.0 109.157 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.652 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -59.72 38.34 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.708 0.766 . . . . 40.0 111.0 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.62 ' N ' ' O ' ' A' ' 56' ' ' PHE . 45.5 t30 34.77 37.82 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.032 -1.042 . . . . 40.0 110.964 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.652 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.4 mtm180 -70.23 38.08 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.956 -1.09 . . . . 40.0 109.85 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.657 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 12.4 mt-10 -145.47 -6.76 0.62 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.132 -0.98 . . . . 40.0 110.3 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.73 36.52 72.38 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.045 -1.622 . . . . 40.0 109.045 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.657 ' HZ1' ' CD ' ' A' ' 60' ' ' GLU . 3.5 mttp -121.4 13.75 11.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.602 -0.94 . . . . 40.0 109.692 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.422 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -138.05 143.21 38.61 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.514 -0.741 . . . . 40.0 109.584 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -61.61 123.89 13.57 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.528 2.152 . . . . 40.0 112.322 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.504 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -103.02 -177.22 26.65 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 110.115 -1.194 . . . . 40.0 110.115 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.412 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 10.8 tttt -179.01 153.93 0.65 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.385 -1.068 . . . . 40.0 108.56 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 14.0 p -73.46 56.75 0.51 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.923 -1.111 . . . . 40.0 109.024 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.37 80.44 0.03 OUTLIER Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.694 -1.362 . . . . 40.0 109.694 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.575 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -176.05 177.41 1.6 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.795 -0.826 . . . . 40.0 108.847 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.575 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 59.5 m -155.28 155.77 34.36 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.2 -0.937 . . . . 40.0 109.898 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.687 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 28.8 m95 -125.01 140.61 52.76 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.874 -0.516 . . . . 40.0 110.038 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.598 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -131.88 150.54 52.12 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.95 -1.094 . . . . 40.0 109.679 179.206 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.565 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -115.62 168.65 9.83 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.137 0.97 . . . . 40.0 111.926 -179.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.411 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . . . -164.53 139.49 5.6 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.399 0.619 . . . . 40.0 110.217 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.65 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.2 OUTLIER -61.34 153.43 26.68 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.055 0.455 . . . . 40.0 111.056 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.415 ' HA ' HD12 ' A' ' 76' ' ' ILE . 42.4 mm -135.8 146.64 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.411 -0.805 . . . . 40.0 110.2 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 55.37 71.49 0.54 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.409 0.623 . . . . 40.0 110.85 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.52 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 66.4 t80 -131.89 156.6 45.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.1 -1.0 . . . . 40.0 109.247 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' A' ' 80' ' ' SER . 21.0 p -136.87 -73.18 0.43 Allowed 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.181 0.515 . . . . 40.0 109.776 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.561 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -153.13 104.82 2.84 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.664 -0.648 . . . . 40.0 109.885 -178.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.454 ' N ' ' OH ' ' A' ' 78' ' ' TYR . . . 160.1 -100.36 0.19 Allowed Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.936 -1.266 . . . . 40.0 109.936 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.465 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 35.6 t80 -143.3 -169.95 3.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.738 -0.86 . . . . 40.0 109.541 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.634 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.5 mtm180 -71.65 -156.5 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.925 0.869 . . . . 40.0 110.423 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.467 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 12.9 p30 -166.17 -150.06 0.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.079 -1.082 . . . . 40.0 108.079 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 100' ' ' THR . 71.5 p -102.87 -8.91 20.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.742 -1.224 . . . . 40.0 109.467 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.674 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -85.73 113.27 21.78 Favored 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 121.788 0.804 . . . . 40.0 111.812 -179.245 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.803 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.09 149.66 46.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.878 -1.139 . . . . 40.0 110.625 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 7.5 tt -116.56 138.8 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.988 0.899 . . . . 40.0 109.853 179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.41 ' CD2' ' HZ ' ' A' ' 106' ' ' PHE . 3.1 mm? -117.82 126.2 51.97 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.541 -0.911 . . . . 40.0 108.541 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.686 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -119.79 129.32 54.4 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.876 -0.787 . . . . 40.0 108.876 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.687 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.5 p -93.13 158.31 15.83 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.285 1.041 . . . . 40.0 112.538 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.0 p -69.07 -17.11 63.83 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.345 -0.983 . . . . 40.0 108.345 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.477 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -86.72 9.01 20.17 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.5 -0.88 . . . . 40.0 109.428 179.714 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.46 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.29 26.77 0.54 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.517 -0.739 . . . . 40.0 110.175 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.3 mt -96.21 137.64 34.99 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.304 -0.872 . . . . 40.0 108.894 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.457 HG23 HD12 ' A' ' 96' ' ' ILE . 42.1 mm -111.99 121.18 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.508 -0.745 . . . . 40.0 110.589 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.407 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.4 m-85 -122.93 144.71 49.05 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 120.307 -0.557 . . . . 40.0 109.534 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.674 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 5.2 tptp -133.78 145.14 49.52 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.193 -0.942 . . . . 40.0 110.723 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.52 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.4 t -125.21 167.32 15.01 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.738 -0.838 . . . . 40.0 108.738 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.416 ' O ' ' OG ' ' A' ' 85' ' ' SER . 55.8 p -140.62 -9.05 1.08 Allowed 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.416 -0.803 . . . . 40.0 109.76 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.1 p30 -107.23 13.74 26.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.126 -0.984 . . . . 40.0 110.107 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 84.02 62.8 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.244 0.545 . . . . 40.0 109.982 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.634 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 32.6 m-85 70.88 -22.05 0.19 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.582 -0.699 . . . . 40.0 111.076 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.462 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.5 mt-30 -44.57 -74.21 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.1 -1.0 . . . . 40.0 110.125 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.48 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 21.1 p -105.14 164.2 12.0 Favored 'General case' 0 C--O 1.198 -1.652 0 N-CA-C 107.78 -1.193 . . . . 40.0 107.78 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.41 ' HZ ' ' CD2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -138.27 139.01 38.99 Favored 'General case' 0 C--N 1.269 -2.9 0 O-C-N 121.45 -0.781 . . . . 40.0 110.07 -179.442 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 37.5 m -125.27 137.23 54.08 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.497 -0.927 . . . . 40.0 108.497 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.642 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 16.3 tttp -83.52 146.23 28.47 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.877 -1.139 . . . . 40.0 109.559 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.2 pt -122.29 -33.99 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 C-N-CA 119.65 -0.82 . . . . 40.0 109.153 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.651 HH21 ' CG ' ' A' ' 8' ' ' ASP . 73.6 mtt180 . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 118.266 -0.873 . . . . 40.0 109.102 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.647 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 10.4 t . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.218 0.533 . . . . 40.0 109.942 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -175.73 151.05 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 108.992 -0.744 . . . . 40.0 108.992 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -141.88 23.13 2.09 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 120.866 -1.146 . . . . 40.0 110.738 -177.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 11.7 p -105.16 153.38 21.61 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.634 0.73 . . . . 40.0 110.239 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.476 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -56.42 -62.97 1.36 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.968 -1.083 . . . . 40.0 111.354 -179.283 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.623 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.7 OUTLIER -58.88 -41.56 87.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.062 -1.024 . . . . 40.0 109.639 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.43 -46.18 73.68 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.093 -1.203 . . . . 40.0 110.093 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.8 t -67.95 -42.79 85.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 O-C-N 121.69 -0.888 . . . . 40.0 108.66 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -59.74 -61.07 2.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.457 -0.777 . . . . 40.0 109.549 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.29 -56.73 6.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.574 -0.704 . . . . 40.0 109.465 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.743 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 41.3 t80 -51.44 -53.18 39.64 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 116.153 -0.476 . . . . 40.0 110.758 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' A' ' 18' ' ' HIS . 1.8 tt -72.27 -51.08 22.51 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 121.165 0.507 . . . . 40.0 110.732 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.464 ' N ' ' O ' ' A' ' 11' ' ' ALA . 66.3 mt-30 -52.06 -26.39 10.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.107 -1.621 . . . . 40.0 110.549 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.3 m -93.44 -47.84 6.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.53 -1.356 . . . . 40.0 111.449 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.46 ' O ' ' N ' ' A' ' 19' ' ' LYS . 90.5 m-85 -104.01 19.11 20.66 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.933 -1.104 . . . . 40.0 109.673 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.426 ' N ' ' O ' ' A' ' 14' ' ' LEU . 32.8 m80 40.66 25.58 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.717 0 O-C-N 121.035 -1.041 . . . . 40.0 110.863 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.495 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 3.8 pttp -137.34 157.49 46.49 Favored 'General case' 0 C--O 1.185 -2.311 0 CA-C-O 121.809 0.814 . . . . 40.0 110.466 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.48 146.11 65.03 Favored Pre-proline 0 C--N 1.271 -2.827 0 N-CA-C 108.534 -0.913 . . . . 40.0 108.534 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.743 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 88.3 Cg_exo -40.46 155.97 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.369 2.713 . . . . 40.0 114.217 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.647 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -67.22 48.44 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.897 0.856 . . . . 40.0 109.84 -179.226 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -173.13 25.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.981 -1.074 . . . . 40.0 110.52 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -118.27 109.26 16.11 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.193 -1.003 . . . . 40.0 110.07 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.429 HG22 HD12 ' A' ' 25' ' ' ILE . 11.5 pt -118.33 133.98 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.78 -1.193 . . . . 40.0 107.78 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.512 ' OG1' ' OG ' ' A' ' 28' ' ' SER . 0.6 OUTLIER -69.38 174.96 4.31 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 124.158 1.933 . . . . 40.0 112.559 -177.403 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.535 ' HB3' ' NE2' ' A' ' 31' ' ' GLN . 17.8 mtmt -64.28 -36.7 84.94 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.704 -1.591 . . . . 40.0 106.704 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.512 ' OG ' ' OG1' ' A' ' 26' ' ' THR . 4.4 m -35.95 -70.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.049 0.928 . . . . 40.0 109.674 175.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.507 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.2 mp0 -66.49 -52.42 46.25 Favored 'General case' 0 C--O 1.204 -1.295 0 CA-C-N 114.319 -1.31 . . . . 40.0 108.47 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.507 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -42.64 -50.66 5.41 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 119.988 -1.695 . . . . 40.0 109.352 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.535 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 32.9 mt-30 -56.28 -63.94 1.02 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.389 -0.82 . . . . 40.0 111.083 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.91 -22.87 67.06 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.017 -1.052 . . . . 40.0 109.887 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.8 tp -68.15 -23.5 64.88 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.994 -1.066 . . . . 40.0 108.178 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.04 53.4 0.26 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.419 -1.072 . . . . 40.0 110.419 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.584 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -87.81 140.15 29.8 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.263 -1.139 . . . . 40.0 109.456 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.9 t -134.65 130.73 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.041 0 O-C-N 121.685 -0.634 . . . . 40.0 109.807 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.427 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -59.57 -48.95 79.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.726 -0.609 . . . . 40.0 109.588 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.3 p -70.12 46.89 0.08 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.44 -0.787 . . . . 40.0 110.01 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.531 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.7 ttpm? -179.12 -51.72 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.076 -0.713 . . . . 40.0 109.076 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.28 60.53 7.4 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 108.58 -1.808 . . . . 40.0 108.58 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.584 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -76.24 159.83 30.24 Favored 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.749 -0.854 . . . . 40.0 111.063 -178.043 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.607 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 63.9 tp -172.64 -69.89 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.751 -0.78 . . . . 40.0 110.249 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.46 -19.93 58.17 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.924 -1.11 . . . . 40.0 109.556 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 4.5 p-10 -77.02 -61.91 1.82 Allowed 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.696 -0.853 . . . . 40.0 108.696 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.429 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 22.4 m -79.08 -11.58 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 109.356 -0.609 . . . . 40.0 109.356 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -149.8 74.69 9.36 Favored Pre-proline 0 N--CA 1.49 1.546 0 CA-C-O 122.259 1.028 . . . . 40.0 109.977 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.9 117.8 4.58 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 124.044 3.163 . . . . 40.0 113.106 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.429 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 73.69 40.08 46.85 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.867 -1.693 . . . . 40.0 108.867 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.429 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 6.7 mmtm -136.04 169.59 17.36 Favored 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 121.884 0.85 . . . . 40.0 110.571 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.6 m -144.85 160.7 40.87 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.713 -1.242 . . . . 40.0 111.856 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.448 HG22 HD11 ' A' ' 51' ' ' ILE . 11.4 mm -80.61 125.78 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-N 115.167 -0.924 . . . . 40.0 110.502 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.95 157.29 15.17 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.543 -1.423 . . . . 40.0 109.543 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.467 ' C ' HG21 ' A' ' 26' ' ' THR . . . 116.03 -9.02 18.48 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.539 -1.315 . . . . 40.0 110.169 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.444 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 5.1 m-20 -74.53 -151.9 0.03 OUTLIER 'General case' 0 C--O 1.196 -1.716 0 O-C-N 120.417 -1.637 . . . . 40.0 109.242 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.74 143.93 38.88 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.829 0 N-CA-C 107.878 -1.156 . . . . 40.0 107.878 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.653 ' O ' ' N ' ' A' ' 58' ' ' ASN . 12.6 t80 -112.14 89.79 3.16 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.952 -0.699 . . . . 40.0 109.247 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.646 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.8 p -58.83 38.39 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.821 0.82 . . . . 40.0 110.803 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.653 ' N ' ' O ' ' A' ' 56' ' ' PHE . 44.1 t30 33.84 38.19 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.237 -0.914 . . . . 40.0 110.708 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.646 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.2 mtm180 -68.89 35.68 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.67 -1.268 . . . . 40.0 110.163 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.63 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 14.5 mt-10 -145.35 -2.56 0.77 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.748 -1.22 . . . . 40.0 110.225 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.25 38.59 57.1 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.436 -1.466 . . . . 40.0 109.436 -178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.63 ' HZ1' ' CD ' ' A' ' 60' ' ' GLU . 5.5 mttp -121.21 12.82 11.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.373 -1.075 . . . . 40.0 109.334 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.453 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.5 mt -137.89 144.4 43.91 Favored Pre-proline 0 N--CA 1.496 1.834 0 CA-C-O 121.395 0.617 . . . . 40.0 109.467 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.83 123.2 12.19 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.536 2.157 . . . . 40.0 112.657 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.522 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.85 -177.98 26.79 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.054 -1.218 . . . . 40.0 110.054 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.421 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 8.8 tttt -177.66 153.15 0.85 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.026 -1.101 . . . . 40.0 108.026 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.6 p -72.25 53.03 0.27 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.833 -1.167 . . . . 40.0 109.395 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.97 80.13 0.03 OUTLIER Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.923 -1.271 . . . . 40.0 109.923 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.576 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -173.55 178.84 2.22 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.696 -0.885 . . . . 40.0 108.833 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.576 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 100.0 m -155.61 155.17 32.82 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.361 -0.935 . . . . 40.0 110.199 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.686 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 30.5 m95 -124.77 139.84 53.48 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.247 0.546 . . . . 40.0 110.064 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.586 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.91 148.92 52.74 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 120.756 -1.215 . . . . 40.0 109.436 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.442 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -115.01 168.47 9.89 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 122.181 0.991 . . . . 40.0 111.79 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -162.96 138.95 7.09 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.593 0.711 . . . . 40.0 111.121 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.669 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.3 OUTLIER -61.08 154.52 22.7 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.509 -0.744 . . . . 40.0 110.804 -179.654 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.401 ' HA ' HD12 ' A' ' 76' ' ' ILE . 40.1 mm -137.61 144.09 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 119.796 -0.762 . . . . 40.0 110.607 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 58.7 70.09 0.68 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.574 -0.704 . . . . 40.0 110.884 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.607 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 66.1 t80 -131.9 157.8 43.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.222 -0.924 . . . . 40.0 109.928 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.588 ' OG1' ' N ' ' A' ' 80' ' ' SER . 22.1 p -139.41 -70.15 0.41 Allowed 'General case' 0 N--CA 1.511 2.621 0 O-C-N 121.73 -0.606 . . . . 40.0 109.501 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.588 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.9 OUTLIER -154.42 105.76 2.69 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.737 -0.468 . . . . 40.0 109.737 -178.696 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.7 -103.93 0.23 Allowed Glycine 0 N--CA 1.498 2.774 0 C-N-CA 119.585 -1.293 . . . . 40.0 110.091 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 43.9 t80 -139.96 -166.66 2.13 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.086 -0.709 . . . . 40.0 109.086 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.633 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.4 mtm180 -73.95 -154.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.133 -0.979 . . . . 40.0 110.413 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.49 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 11.7 p30 -167.87 -150.99 0.1 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.08 -1.082 . . . . 40.0 108.08 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 100' ' ' THR . 80.6 p -102.98 -6.92 21.89 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.904 -1.123 . . . . 40.0 109.452 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.669 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -88.14 113.92 24.24 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 121.737 0.779 . . . . 40.0 111.47 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.807 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.22 149.78 44.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.979 -1.076 . . . . 40.0 110.675 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.1 tt -116.8 139.79 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 122.126 0.965 . . . . 40.0 109.865 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.95 126.02 51.54 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.792 -0.818 . . . . 40.0 108.792 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.674 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.78 129.15 55.09 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.882 -0.784 . . . . 40.0 108.882 179.664 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.686 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 5.0 p -94.15 159.41 15.16 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 122.344 1.069 . . . . 40.0 112.219 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.3 p -69.91 -16.16 63.18 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.427 -0.953 . . . . 40.0 108.427 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.475 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -88.11 8.99 24.21 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.129 -0.628 . . . . 40.0 109.512 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.449 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.69 26.52 0.49 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.94 -0.475 . . . . 40.0 110.055 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.5 mt -95.55 137.08 35.11 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.305 -0.872 . . . . 40.0 109.499 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.424 HG23 HD12 ' A' ' 96' ' ' ILE . 39.7 mm -111.51 119.25 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.846 -0.533 . . . . 40.0 110.411 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.405 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.6 m-85 -121.96 144.3 48.96 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 109.688 -0.486 . . . . 40.0 109.688 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.669 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 4.7 tptp -133.77 144.45 49.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.188 -0.945 . . . . 40.0 110.591 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.588 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.8 t -123.57 166.03 16.14 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.673 -0.862 . . . . 40.0 108.673 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.401 ' O ' ' OG ' ' A' ' 85' ' ' SER . 41.6 p -139.51 -10.84 1.21 Allowed 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.441 -0.787 . . . . 40.0 109.536 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.2 p30 -107.56 13.87 26.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.01 -1.056 . . . . 40.0 110.508 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 84.27 61.24 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.669 -0.644 . . . . 40.0 110.275 178.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.633 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 27.6 m-85 71.71 -21.16 0.22 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.497 -0.752 . . . . 40.0 110.972 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.454 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.7 mt-30 -44.38 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.119 -0.988 . . . . 40.0 109.88 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.454 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 22.7 p -105.29 168.95 8.74 Favored 'General case' 0 C--O 1.196 -1.721 0 N-CA-C 107.702 -1.221 . . . . 40.0 107.702 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.82 139.68 32.78 Favored 'General case' 0 C--N 1.267 -2.994 0 O-C-N 121.411 -0.806 . . . . 40.0 109.706 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.5 m -125.43 136.33 53.29 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.922 -1.14 . . . . 40.0 107.922 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.647 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 18.8 tttp -85.37 145.9 27.26 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.971 -1.081 . . . . 40.0 109.823 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.1 pt -121.44 -32.14 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 120.95 -1.094 . . . . 40.0 109.651 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.647 ' C ' ' HZ3' ' A' ' 108' ' ' LYS . 80.6 mtt180 . . . . . 0 N--CA 1.486 1.328 0 O-C-N 121.165 -0.959 . . . . 40.0 108.971 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.614 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 15.1 t . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.119 -0.697 . . . . 40.0 109.119 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -178.57 152.26 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.884 -0.784 . . . . 40.0 108.884 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -143.26 24.24 1.79 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.939 -1.101 . . . . 40.0 110.687 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.5 p -105.57 152.98 22.4 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.594 0.712 . . . . 40.0 110.169 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -55.36 -64.56 0.8 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.985 -1.072 . . . . 40.0 110.981 -179.038 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.619 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.52 -41.86 81.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.025 -1.047 . . . . 40.0 110.035 -179.007 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.38 -45.46 75.29 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.759 -1.336 . . . . 40.0 109.759 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 77.5 t -68.08 -42.68 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.792 -0.828 . . . . 40.0 109.276 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.89 -57.96 10.47 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.592 -0.892 . . . . 40.0 108.592 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.8 -56.64 9.57 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.116 -0.698 . . . . 40.0 109.116 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.72 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 40.3 t80 -51.69 -52.8 45.46 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.134 0.492 . . . . 40.0 110.525 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 18' ' ' HIS . 1.6 tt -72.55 -51.9 17.93 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.813 -0.554 . . . . 40.0 111.166 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 11' ' ' ALA . 63.9 mt-30 -50.92 -27.79 8.31 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.292 -1.505 . . . . 40.0 110.617 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 m -93.0 -49.79 5.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.901 -1.125 . . . . 40.0 111.395 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 19' ' ' LYS . 87.9 m-85 -100.16 16.55 23.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.989 -1.069 . . . . 40.0 109.585 -178.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 14' ' ' LEU . 16.9 m80 39.75 26.56 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.472 -0.767 . . . . 40.0 110.733 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 17' ' ' TYR . 3.8 pttp -137.01 159.8 40.82 Favored 'General case' 0 C--O 1.185 -2.336 0 CA-C-O 121.977 0.894 . . . . 40.0 110.617 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.95 145.33 61.26 Favored Pre-proline 0 C--N 1.268 -2.971 0 O-C-N 121.071 -1.018 . . . . 40.0 108.402 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.72 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 86.7 Cg_exo -39.29 155.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 123.43 2.753 . . . . 40.0 114.358 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.614 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -68.2 51.34 0.07 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.075 -1.015 . . . . 40.0 109.379 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -175.71 27.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 40.0 110.51 179.089 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -119.65 109.33 15.53 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.494 -1.379 . . . . 40.0 109.973 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.456 HG22 HD12 ' A' ' 25' ' ' ILE . 20.4 pt -117.85 132.27 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.135 -1.061 . . . . 40.0 108.135 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.501 HG21 ' C ' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -69.59 173.94 5.53 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 123.787 1.756 . . . . 40.0 113.244 -177.591 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.493 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 17.4 mtmt -63.53 -37.46 87.4 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.802 -1.555 . . . . 40.0 106.802 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.453 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 5.6 m -37.09 -70.87 0.08 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 122.184 0.992 . . . . 40.0 109.371 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.511 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.5 mp0 -65.35 -57.27 8.8 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.131 -1.433 . . . . 40.0 107.131 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.511 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -37.21 -51.67 1.03 Allowed 'General case' 0 N--CA 1.511 2.579 0 O-C-N 120.685 -1.259 . . . . 40.0 109.176 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -57.34 -63.95 1.05 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.437 -1.414 . . . . 40.0 111.485 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.42 -22.41 66.15 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 120.398 -1.439 . . . . 40.0 110.066 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 59.0 tp -68.64 -26.08 65.15 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.414 -1.328 . . . . 40.0 107.414 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 124.26 47.15 0.24 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.991 -0.844 . . . . 40.0 110.991 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.604 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.36 143.39 32.22 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.865 -1.373 . . . . 40.0 109.7 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.22 128.73 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 O-C-N 121.472 -0.767 . . . . 40.0 109.612 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -58.27 -49.96 75.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.778 -0.576 . . . . 40.0 109.602 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.6 p -70.07 47.21 0.08 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.356 -0.84 . . . . 40.0 109.967 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.567 ' HZ1' ' CG ' ' A' ' 41' ' ' ASN . 1.1 ttpm? -179.32 -50.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.022 -0.733 . . . . 40.0 109.022 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.56 60.03 8.85 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 108.26 -1.936 . . . . 40.0 108.26 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.604 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -75.82 162.45 28.15 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.593 -0.946 . . . . 40.0 111.007 -177.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.497 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 43.7 tp -174.12 -70.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.748 -0.781 . . . . 40.0 110.274 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.94 -21.21 63.21 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.906 -1.121 . . . . 40.0 109.571 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.0 p-10 -74.19 -62.8 1.39 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.711 -0.848 . . . . 40.0 108.711 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.439 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 16.1 m -79.35 -11.62 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.568 -0.531 . . . . 40.0 109.568 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -148.56 72.25 10.72 Favored Pre-proline 0 N--CA 1.486 1.34 0 CA-C-O 121.883 0.849 . . . . 40.0 109.449 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.8 118.18 5.01 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.994 2.463 . . . . 40.0 113.923 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.51 36.71 48.48 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.272 -1.531 . . . . 40.0 109.272 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -134.37 163.95 28.52 Favored 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.614 0.721 . . . . 40.0 109.864 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.6 m -138.97 163.75 31.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 40.0 111.173 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 51' ' ' ILE . 13.0 mm -81.45 126.98 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-N 115.548 -0.751 . . . . 40.0 110.43 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.28 157.46 15.88 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.492 -1.443 . . . . 40.0 109.492 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.501 ' C ' HG21 ' A' ' 26' ' ' THR . . . 117.5 -10.34 14.53 Favored Glycine 0 N--CA 1.499 2.895 0 C-N-CA 118.945 -1.598 . . . . 40.0 110.369 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.496 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 4.6 m-20 -75.29 -151.62 0.03 OUTLIER 'General case' 0 C--O 1.197 -1.675 0 O-C-N 120.948 -1.325 . . . . 40.0 109.847 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.1 142.16 44.22 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.944 0 CA-C-N 114.86 -1.064 . . . . 40.0 108.665 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.624 ' O ' ' N ' ' A' ' 58' ' ' ASN . 15.1 t80 -111.4 90.66 3.4 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.875 -0.787 . . . . 40.0 108.875 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.647 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -59.63 38.56 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.605 0.717 . . . . 40.0 110.823 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' A' ' 56' ' ' PHE . 43.5 t30 33.82 38.07 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.012 -1.055 . . . . 40.0 111.33 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.647 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.5 mtm180 -69.03 34.66 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.951 -1.093 . . . . 40.0 110.483 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.642 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 15.5 mt-10 -144.1 -2.86 0.88 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.13 -0.981 . . . . 40.0 110.285 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.26 38.02 56.08 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.418 -1.473 . . . . 40.0 109.418 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.642 ' HZ1' ' CD ' ' A' ' 60' ' ' GLU . 4.9 mttp -120.89 13.29 11.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.593 -0.946 . . . . 40.0 109.295 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.461 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -138.7 142.98 36.0 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.705 -0.622 . . . . 40.0 109.616 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -60.69 123.32 12.76 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.499 2.133 . . . . 40.0 112.629 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.496 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.96 -177.63 26.69 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.935 -1.266 . . . . 40.0 109.935 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.1 tttt -178.94 153.05 0.61 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.041 -1.096 . . . . 40.0 108.041 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.8 p -71.84 54.95 0.27 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.885 -1.134 . . . . 40.0 109.239 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.31 79.64 0.03 OUTLIER Glycine 0 N--CA 1.5 2.92 0 N-CA-C 110.137 -1.185 . . . . 40.0 110.137 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.579 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.92 179.06 1.69 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.694 -0.886 . . . . 40.0 109.082 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.579 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 99.9 m -155.81 154.77 31.87 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.405 -0.918 . . . . 40.0 109.8 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.676 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 29.9 m95 -124.02 140.6 52.81 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.723 -0.473 . . . . 40.0 109.723 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.602 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.81 149.49 52.43 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.837 -1.164 . . . . 40.0 109.574 179.55 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.493 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -114.33 168.15 10.09 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.068 -1.02 . . . . 40.0 112.185 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.15 136.72 4.97 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.544 -0.723 . . . . 40.0 110.798 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.656 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.2 OUTLIER -59.21 154.49 16.11 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 120.881 0.372 . . . . 40.0 111.102 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 38.0 mm -137.8 146.06 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.682 -0.807 . . . . 40.0 110.456 178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 57.64 69.96 0.69 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.316 0.579 . . . . 40.0 110.534 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.483 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 68.6 t80 -131.01 155.9 46.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.082 -1.011 . . . . 40.0 110.045 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 80' ' ' SER . 23.9 p -137.23 -72.66 0.43 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.822 -0.549 . . . . 40.0 109.557 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.572 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.9 OUTLIER -153.05 106.14 2.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 122.071 -0.393 . . . . 40.0 110.132 -179.084 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.8 -105.11 0.25 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.706 -1.357 . . . . 40.0 109.706 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 41.5 t80 -138.81 -166.05 1.94 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.006 -0.702 . . . . 40.0 109.175 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.644 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.6 mtm180 -74.21 -154.69 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.265 -0.897 . . . . 40.0 110.008 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.597 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 8.1 p30 -167.02 -150.79 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.178 -1.045 . . . . 40.0 108.178 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 100' ' ' THR . 59.4 p -102.5 -8.14 21.3 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 120.823 -1.173 . . . . 40.0 109.155 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.668 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.13 114.29 23.6 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-O 121.832 0.825 . . . . 40.0 111.456 -179.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.819 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.01 150.53 45.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.916 -1.115 . . . . 40.0 110.959 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.0 tt -116.92 140.43 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 122.304 1.049 . . . . 40.0 110.01 178.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.409 ' CD2' ' HZ ' ' A' ' 106' ' ' PHE . 3.0 mm? -119.33 125.19 48.46 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.349 -0.982 . . . . 40.0 108.349 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.677 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -119.16 129.88 55.24 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.913 -0.773 . . . . 40.0 108.913 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.676 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.1 p -94.91 159.47 15.02 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.438 1.113 . . . . 40.0 112.96 -178.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.1 p -69.58 -16.92 63.5 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.097 -1.075 . . . . 40.0 108.097 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.473 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -87.81 9.26 22.4 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.658 -0.817 . . . . 40.0 109.556 179.632 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.468 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.98 26.95 0.58 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.581 -0.699 . . . . 40.0 110.249 179.451 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.8 mt -96.22 136.25 36.93 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.424 -0.798 . . . . 40.0 109.164 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.441 HG23 HD12 ' A' ' 96' ' ' ILE . 39.8 mm -110.8 120.43 61.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.505 -0.747 . . . . 40.0 110.554 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -123.03 144.56 49.19 Favored 'General case' 0 N--CA 1.504 2.265 0 C-N-CA 120.467 -0.493 . . . . 40.0 109.804 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.668 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 6.0 tptp -133.71 144.31 49.04 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.592 -0.693 . . . . 40.0 110.722 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.56 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.7 t -124.21 166.47 15.79 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.632 -0.877 . . . . 40.0 108.632 177.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.416 ' O ' ' OG ' ' A' ' 85' ' ' SER . 40.4 p -140.33 -8.35 1.14 Allowed 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.314 -0.866 . . . . 40.0 109.702 178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.1 p30 -108.67 13.03 25.42 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.058 -1.026 . . . . 40.0 110.06 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 84.56 62.44 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.318 0.58 . . . . 40.0 110.34 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.644 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 27.1 m-85 71.23 -21.92 0.2 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.459 -0.776 . . . . 40.0 110.868 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.461 ' H ' ' C ' ' A' ' 102' ' ' ALA . 2.0 mt-30 -44.18 -74.28 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.333 -0.855 . . . . 40.0 109.69 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.459 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 25.3 p -105.53 166.58 10.34 Favored 'General case' 0 C--O 1.194 -1.82 0 N-CA-C 107.82 -1.178 . . . . 40.0 107.82 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.409 ' HZ ' ' CD2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -139.42 138.82 36.82 Favored 'General case' 0 C--N 1.27 -2.87 0 O-C-N 121.441 -0.787 . . . . 40.0 109.973 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.2 m -124.17 136.73 54.4 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.182 -1.044 . . . . 40.0 108.182 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.606 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 19.0 tttp -85.64 146.32 26.91 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.704 -1.247 . . . . 40.0 109.616 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.5 pt -121.67 -34.08 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.244 -0.91 . . . . 40.0 109.476 179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.619 HH21 ' CG ' ' A' ' 8' ' ' ASP . 78.2 mtt180 . . . . . 0 N--CA 1.488 1.452 0 O-C-N 121.197 -0.939 . . . . 40.0 108.875 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.632 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 18.5 t . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.471 -0.566 . . . . 40.0 109.471 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 tt -175.74 153.7 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.909 -0.775 . . . . 40.0 108.909 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -143.95 25.88 1.57 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.8 -1.188 . . . . 40.0 110.506 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.7 p -105.3 153.61 21.38 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.469 0.652 . . . . 40.0 109.638 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.49 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -56.97 -64.0 1.02 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.115 -0.991 . . . . 40.0 110.817 -178.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.641 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.39 -42.01 81.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.379 -0.826 . . . . 40.0 109.705 -179.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.68 -45.95 76.57 Favored Glycine 0 N--CA 1.503 3.101 0 N-CA-C 109.968 -1.253 . . . . 40.0 109.968 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.7 t -66.95 -42.6 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.767 -0.843 . . . . 40.0 108.933 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.88 -58.4 8.59 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.842 -0.799 . . . . 40.0 108.842 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.07 -56.2 9.78 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.843 -0.799 . . . . 40.0 108.843 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.683 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 35.7 t80 -52.92 -51.81 59.99 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 116.084 -0.507 . . . . 40.0 110.673 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 18' ' ' HIS . 5.1 tt -72.28 -51.4 21.02 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.575 -0.703 . . . . 40.0 110.942 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 11' ' ' ALA . 54.9 mt-30 -52.9 -28.26 22.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.271 -1.518 . . . . 40.0 110.285 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.1 m -92.96 -51.25 5.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.085 -1.009 . . . . 40.0 110.825 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -98.17 10.3 40.87 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.994 -1.066 . . . . 40.0 110.205 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.573 ' N ' ' O ' ' A' ' 14' ' ' LEU . 20.1 m80 44.56 23.73 0.08 Allowed 'General case' 0 N--CA 1.52 3.067 0 O-C-N 121.42 -0.8 . . . . 40.0 110.879 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.5 pttp -135.62 160.94 36.93 Favored 'General case' 0 C--O 1.182 -2.496 0 O-C-N 121.399 -0.813 . . . . 40.0 109.566 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mp -80.47 147.0 62.68 Favored Pre-proline 0 C--N 1.268 -2.964 0 N-CA-C 108.26 -1.015 . . . . 40.0 108.26 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.683 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 83.7 Cg_exo -42.28 157.49 0.07 OUTLIER 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 123.26 2.64 . . . . 40.0 113.633 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.632 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -66.86 49.1 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.049 -1.032 . . . . 40.0 109.871 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.486 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -172.14 24.92 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.925 -1.109 . . . . 40.0 110.139 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -117.52 106.74 13.47 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.508 -1.37 . . . . 40.0 110.63 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.4 pt -116.47 133.92 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.061 -1.024 . . . . 40.0 108.37 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.472 ' OG1' ' CB ' ' A' ' 28' ' ' SER . 0.1 OUTLIER -69.09 172.38 6.86 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-O 123.588 1.661 . . . . 40.0 112.96 -177.491 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.488 ' HB3' ' NE2' ' A' ' 31' ' ' GLN . 12.8 mtmt -62.65 -38.78 91.64 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 105.483 -2.043 . . . . 40.0 105.483 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.472 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 11.4 m -34.75 -71.68 0.06 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.103 -0.953 . . . . 40.0 108.792 175.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.55 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.1 mp0 -66.25 -59.5 3.67 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 118.509 -1.276 . . . . 40.0 107.578 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.55 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -31.43 -55.52 0.26 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 119.503 1.047 . . . . 40.0 110.445 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.488 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 25.9 mt-30 -58.0 -63.59 1.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.497 -1.377 . . . . 40.0 111.109 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.29 -27.05 63.71 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.732 -1.23 . . . . 40.0 110.621 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.7 tp -68.56 -22.52 64.48 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 108.485 -0.932 . . . . 40.0 108.485 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.42 48.99 0.25 Allowed Glycine 0 N--CA 1.496 2.687 0 C-N-CA 120.948 -0.644 . . . . 40.0 111.686 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.609 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -85.7 137.9 32.5 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.115 -1.226 . . . . 40.0 110.194 179.45 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.4 t -134.37 132.12 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.093 0 O-C-N 121.394 -0.816 . . . . 40.0 110.412 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.429 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -59.26 -48.92 79.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.708 -0.62 . . . . 40.0 109.487 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.7 p -69.71 45.75 0.07 Allowed 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 121.635 0.731 . . . . 40.0 110.527 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.47 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.6 ttpm? -178.3 -51.42 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.121 -0.696 . . . . 40.0 109.121 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.6 59.84 8.68 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 108.221 -1.952 . . . . 40.0 108.221 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.609 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -76.51 160.6 29.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.661 -0.906 . . . . 40.0 111.32 -177.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.516 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 61.8 tp -174.77 -68.67 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.913 -1.117 . . . . 40.0 110.911 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.29 -20.31 58.6 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.49 -1.381 . . . . 40.0 109.573 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 2.6 p-10 -75.95 -64.8 1.01 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.712 -0.847 . . . . 40.0 108.712 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.469 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 30.3 m -77.18 -12.68 14.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 109.415 -0.587 . . . . 40.0 109.415 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -145.6 72.08 14.04 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.56 -0.713 . . . . 40.0 110.086 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -56.91 116.79 3.45 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.73 2.287 . . . . 40.0 114.976 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.38 37.33 47.79 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.344 -1.503 . . . . 40.0 109.344 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.478 ' HD3' ' HA ' ' A' ' 23' ' ' ASN . 7.1 mmtt -132.6 171.03 14.35 Favored 'General case' 0 N--CA 1.508 2.446 0 CA-C-O 122.078 0.942 . . . . 40.0 110.226 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.3 m -145.69 162.06 38.44 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.884 -1.135 . . . . 40.0 111.501 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.408 HG22 HD11 ' A' ' 51' ' ' ILE . 18.8 mm -81.81 123.84 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-N 115.401 -0.818 . . . . 40.0 110.881 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.46 155.86 13.53 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.109 -1.596 . . . . 40.0 109.109 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 120.44 -12.19 10.36 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.278 -1.439 . . . . 40.0 110.402 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.45 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 5.0 m-20 -74.1 -154.22 0.03 OUTLIER 'General case' 0 C--O 1.193 -1.911 0 O-C-N 121.182 -1.187 . . . . 40.0 110.308 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 mp -128.57 142.74 43.11 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.868 0 CA-C-N 115.476 -0.784 . . . . 40.0 109.084 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.633 ' O ' ' N ' ' A' ' 58' ' ' ASN . 12.7 t80 -111.08 90.18 3.26 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.333 -0.855 . . . . 40.0 109.169 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.633 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -59.45 38.78 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 122.023 0.916 . . . . 40.0 110.842 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.633 ' N ' ' O ' ' A' ' 56' ' ' PHE . 45.7 t30 34.14 38.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.193 -0.942 . . . . 40.0 110.618 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.633 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 11.2 mtm180 -69.89 37.97 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.765 -1.209 . . . . 40.0 109.992 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.634 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 13.0 mt-10 -146.14 -6.92 0.56 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.038 -1.039 . . . . 40.0 109.968 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.31 37.53 74.03 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 109.424 -1.471 . . . . 40.0 109.424 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.634 ' HZ1' ' CD ' ' A' ' 60' ' ' GLU . 4.5 mttp -121.11 12.35 11.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.802 -0.822 . . . . 40.0 109.3 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.408 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -136.89 142.53 38.95 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.681 -0.637 . . . . 40.0 109.455 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -61.91 122.7 11.35 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.597 2.198 . . . . 40.0 112.27 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.489 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.05 -178.02 27.82 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.033 -1.227 . . . . 40.0 110.033 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.5 tttt -177.76 154.14 0.91 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.42 -1.047 . . . . 40.0 108.267 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.5 p -72.05 53.79 0.27 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.981 -1.074 . . . . 40.0 109.183 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.42 79.61 0.03 OUTLIER Glycine 0 N--CA 1.498 2.806 0 N-CA-C 110.017 -1.233 . . . . 40.0 110.017 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.574 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.14 178.53 2.08 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.734 -0.863 . . . . 40.0 108.991 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.574 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 98.9 m -155.42 155.53 33.74 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.202 -0.936 . . . . 40.0 109.823 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.672 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 29.1 m95 -125.07 140.64 52.72 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.834 -0.542 . . . . 40.0 109.636 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.593 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -131.35 147.32 52.56 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.105 -0.997 . . . . 40.0 110.162 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.39 168.64 9.38 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 122.466 1.127 . . . . 40.0 112.352 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.94 136.54 3.57 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.668 -0.645 . . . . 40.0 111.039 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.658 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.3 OUTLIER -58.58 154.51 14.1 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.016 0.436 . . . . 40.0 110.832 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.3 mm -137.57 146.18 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.477 -0.764 . . . . 40.0 109.733 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 56.44 70.94 0.6 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.491 0.662 . . . . 40.0 110.948 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.516 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 68.8 t80 -132.04 156.08 46.92 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.993 -1.067 . . . . 40.0 109.903 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.557 ' OG1' ' N ' ' A' ' 80' ' ' SER . 23.6 p -136.27 -73.92 0.44 Allowed 'General case' 0 N--CA 1.509 2.479 0 CA-C-O 121.284 0.564 . . . . 40.0 110.059 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.557 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -152.23 105.91 3.1 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.078 -0.712 . . . . 40.0 109.078 -178.815 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.84 -105.6 0.27 Allowed Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.417 -1.373 . . . . 40.0 110.28 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.474 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 40.0 t80 -138.36 -166.09 1.93 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.987 -0.745 . . . . 40.0 108.987 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.639 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.2 mtm180 -75.12 -155.92 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.045 -1.034 . . . . 40.0 110.343 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.541 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 10.8 p30 -165.33 -150.37 0.13 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.978 -1.119 . . . . 40.0 107.978 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 100' ' ' THR . 82.6 p -103.58 -8.15 20.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.78 -1.2 . . . . 40.0 109.152 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.665 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -86.0 113.37 22.04 Favored 'General case' 0 N--CA 1.507 2.414 0 CA-C-O 121.79 0.805 . . . . 40.0 111.713 -179.167 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.81 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.63 150.38 46.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.033 . . . . 40.0 110.988 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.9 tt -116.73 141.56 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 122.107 0.956 . . . . 40.0 109.847 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -121.37 123.99 43.45 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.944 -1.132 . . . . 40.0 107.944 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.687 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.09 129.5 55.58 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.918 0.866 . . . . 40.0 108.783 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.672 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 3.8 p -94.14 158.63 15.52 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 122.228 1.013 . . . . 40.0 112.445 -177.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.7 p -69.82 -15.87 63.18 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.443 -0.947 . . . . 40.0 108.443 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.482 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -88.02 8.2 27.65 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.61 -0.836 . . . . 40.0 109.423 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.463 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 79.36 26.07 0.42 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.675 -0.64 . . . . 40.0 110.344 179.699 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.1 mt -95.75 138.84 32.83 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.451 -0.781 . . . . 40.0 109.18 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.436 HG23 HD12 ' A' ' 96' ' ' ILE . 40.4 mm -112.91 120.21 62.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.71 -0.619 . . . . 40.0 110.426 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.429 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.4 m-85 -122.03 144.49 48.87 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 109.296 -0.631 . . . . 40.0 109.296 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.665 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 3.3 tptp -133.17 146.14 51.26 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.367 -0.933 . . . . 40.0 110.965 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.523 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.6 t -125.63 166.6 16.44 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 109.141 -0.689 . . . . 40.0 109.141 177.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.403 ' O ' ' OG ' ' A' ' 85' ' ' SER . 55.5 p -139.97 -9.69 1.17 Allowed 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.327 -0.858 . . . . 40.0 109.585 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.509 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.1 p30 -108.09 15.99 23.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.195 -0.941 . . . . 40.0 110.417 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 83.01 60.7 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.86 -0.525 . . . . 40.0 110.689 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.639 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 27.5 m-85 71.35 -20.46 0.23 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.546 -0.721 . . . . 40.0 110.847 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.459 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.6 mt-30 -44.92 -73.4 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.044 -1.035 . . . . 40.0 109.877 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.443 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 23.8 p -105.86 164.79 11.67 Favored 'General case' 0 C--O 1.195 -1.813 0 N-CA-C 107.791 -1.189 . . . . 40.0 107.791 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.95 138.2 37.11 Favored 'General case' 0 C--N 1.269 -2.915 0 O-C-N 121.306 -0.872 . . . . 40.0 109.989 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 53.3 m -124.12 137.42 54.56 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.119 -1.067 . . . . 40.0 108.119 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.629 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 18.4 tttp -84.64 145.18 28.14 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.906 -1.121 . . . . 40.0 109.601 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.4 pt -120.53 -34.68 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.175 -0.953 . . . . 40.0 109.262 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.641 HH21 ' CG ' ' A' ' 8' ' ' ASP . 79.6 mtt180 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 40.0 108.86 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.63 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 19.8 t . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 109.045 -0.724 . . . . 40.0 109.045 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 tt -174.34 154.07 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.9 -0.778 . . . . 40.0 108.9 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -144.22 26.12 1.51 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.016 -1.053 . . . . 40.0 110.593 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.0 p -104.0 153.83 20.38 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.566 0.698 . . . . 40.0 109.609 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -57.11 -63.49 1.2 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.839 -1.163 . . . . 40.0 110.511 -179.217 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.643 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.9 OUTLIER -57.31 -41.93 80.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.096 -1.002 . . . . 40.0 109.655 -179.476 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.35 -44.96 84.86 Favored Glycine 0 N--CA 1.503 3.11 0 N-CA-C 110.243 -1.143 . . . . 40.0 110.243 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 67.3 t -67.28 -42.99 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.523 -0.986 . . . . 40.0 108.828 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.478 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.88 -59.13 5.87 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.974 -0.75 . . . . 40.0 108.974 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.23 -56.79 7.08 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.913 -0.773 . . . . 40.0 108.913 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.676 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 34.2 t80 -52.15 -53.01 48.24 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 116.116 -0.493 . . . . 40.0 110.61 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.588 ' O ' ' N ' ' A' ' 18' ' ' HIS . 4.4 tt -71.67 -51.21 24.23 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.301 0.572 . . . . 40.0 110.851 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.478 ' N ' ' O ' ' A' ' 11' ' ' ALA . 58.6 mt-30 -53.57 -28.58 32.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.233 -1.542 . . . . 40.0 110.178 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.6 m -91.46 -52.63 4.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.805 -1.184 . . . . 40.0 110.524 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -97.68 12.26 34.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.279 -0.888 . . . . 40.0 110.576 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.588 ' N ' ' O ' ' A' ' 14' ' ' LEU . 23.7 m80 42.7 25.64 0.05 Allowed 'General case' 0 N--CA 1.512 2.643 0 O-C-N 121.237 -0.914 . . . . 40.0 111.151 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 pttp -137.0 160.9 37.56 Favored 'General case' 0 C--O 1.185 -2.329 0 O-C-N 121.44 -0.787 . . . . 40.0 109.559 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.4 mp -80.3 145.57 60.22 Favored Pre-proline 0 C--N 1.265 -3.101 0 O-C-N 120.744 -1.223 . . . . 40.0 108.764 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.676 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 72.6 Cg_exo -40.99 155.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.831 2.354 . . . . 40.0 113.417 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.63 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -65.61 49.97 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.05 -1.031 . . . . 40.0 109.356 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -171.91 26.21 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.703 -1.248 . . . . 40.0 110.639 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -119.82 108.39 14.32 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.789 -1.194 . . . . 40.0 109.674 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.6 pt -119.66 128.86 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.483 1.135 . . . . 40.0 108.612 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.508 ' HB ' ' CG ' ' A' ' 54' ' ' ASP . 0.4 OUTLIER -63.78 169.34 4.18 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-O 123.561 1.648 . . . . 40.0 114.091 -176.264 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.484 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 12.8 mtmt -58.51 -42.45 87.68 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 104.676 -2.342 . . . . 40.0 104.676 176.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.508 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 7.7 m -32.35 -72.97 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 116.293 -0.412 . . . . 40.0 110.261 176.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.485 ' O ' ' C ' ' A' ' 30' ' ' ALA . 3.1 mp0 -64.02 -54.86 27.71 Favored 'General case' 0 C--O 1.193 -1.909 0 N-CA-C 106.558 -1.645 . . . . 40.0 106.558 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -36.11 -55.2 0.78 Allowed 'General case' 0 N--CA 1.514 2.753 0 O-C-N 120.591 -1.318 . . . . 40.0 110.412 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.401 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 38.7 mt-30 -56.35 -67.6 0.29 Allowed 'General case' 0 N--CA 1.507 2.425 0 O-C-N 120.681 -1.262 . . . . 40.0 111.088 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.14 -26.86 61.23 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 119.93 -1.731 . . . . 40.0 110.58 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.4 tp -67.17 -21.56 65.8 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.36 -0.978 . . . . 40.0 108.36 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.59 40.45 0.53 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.851 -0.9 . . . . 40.0 110.851 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.574 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -77.68 139.97 39.51 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.435 -1.627 . . . . 40.0 109.521 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.2 t -136.44 131.27 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.607 0 O-C-N 121.74 -0.6 . . . . 40.0 109.896 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -58.45 -50.13 74.81 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 116.612 -0.267 . . . . 40.0 110.386 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.5 p -69.98 46.23 0.08 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.427 -0.796 . . . . 40.0 110.232 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.494 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 2.3 ttpm? -178.33 -51.91 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.989 -0.745 . . . . 40.0 108.989 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.1 61.83 5.73 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 108.412 -1.875 . . . . 40.0 108.412 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.574 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -78.92 161.25 26.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.607 -0.937 . . . . 40.0 110.101 -178.347 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.477 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 56.2 tp -173.56 -67.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.676 -0.81 . . . . 40.0 110.515 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.26 -19.29 65.29 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 120.571 -1.331 . . . . 40.0 109.973 -178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 5.9 p-10 -75.41 -63.41 1.29 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.857 -0.794 . . . . 40.0 108.857 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.419 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 35.2 m -78.13 -15.85 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.715 -0.616 . . . . 40.0 109.654 178.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -142.74 72.89 19.66 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 40.0 109.622 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -56.91 117.62 4.34 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.819 2.346 . . . . 40.0 113.28 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.85 35.97 48.86 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.996 -1.242 . . . . 40.0 109.996 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.45 ' HD3' ' HA ' ' A' ' 23' ' ' ASN . 7.0 mmtt -133.48 162.63 31.35 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 121.899 -0.765 . . . . 40.0 109.86 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.3 m -138.01 165.83 25.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.095 -1.003 . . . . 40.0 111.244 -177.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.438 HG22 HD11 ' A' ' 51' ' ' ILE . 15.5 mm -83.26 124.72 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.54 0.686 . . . . 40.0 111.144 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.81 157.82 17.23 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 119.539 -1.315 . . . . 40.0 110.417 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.16 -7.66 18.77 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.653 -1.379 . . . . 40.0 109.653 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.508 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 6.8 m-20 -74.31 -153.83 0.03 OUTLIER 'General case' 0 C--O 1.189 -2.106 0 O-C-N 121.375 -1.073 . . . . 40.0 110.194 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -131.68 141.29 46.07 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.027 0 N-CA-C 108.355 -0.98 . . . . 40.0 108.355 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.618 ' O ' ' N ' ' A' ' 58' ' ' ASN . 14.4 t80 -110.69 90.94 3.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 40.0 108.772 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.656 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.6 p -60.27 39.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.625 -0.672 . . . . 40.0 110.858 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.618 ' N ' ' O ' ' A' ' 56' ' ' PHE . 47.5 t30 34.35 38.19 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.104 -0.998 . . . . 40.0 111.051 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.656 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 11.4 mtm180 -71.25 38.92 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.027 -1.046 . . . . 40.0 109.847 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.659 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 11.7 mt-10 -146.24 -6.34 0.56 Allowed 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.441 -0.787 . . . . 40.0 110.195 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.28 36.48 62.65 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 109.129 -1.588 . . . . 40.0 109.129 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.659 ' HZ1' ' CD ' ' A' ' 60' ' ' GLU . 3.5 mttp -120.67 12.58 11.47 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.717 -0.872 . . . . 40.0 109.652 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.437 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.4 mt -137.54 144.41 44.87 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.451 -0.781 . . . . 40.0 109.394 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -62.5 124.75 14.77 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.441 2.094 . . . . 40.0 112.674 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.499 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.22 -178.29 27.57 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 110.054 -1.218 . . . . 40.0 110.054 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.423 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 10.3 tttt -178.03 153.15 0.78 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.272 -1.134 . . . . 40.0 108.625 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.5 p -73.09 55.3 0.42 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.755 -1.215 . . . . 40.0 109.099 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 148.28 78.94 0.03 OUTLIER Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.477 -1.449 . . . . 40.0 109.477 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.552 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -173.66 175.93 2.84 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.759 -0.848 . . . . 40.0 108.95 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.552 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 87.6 m -154.44 155.25 34.62 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.135 -0.978 . . . . 40.0 110.062 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.697 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 30.2 m95 -124.68 140.71 52.68 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 121.267 0.556 . . . . 40.0 110.246 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.596 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -131.63 149.83 52.36 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.881 -1.137 . . . . 40.0 110.216 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.484 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -113.35 167.76 10.3 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.321 1.057 . . . . 40.0 111.91 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.67 137.85 4.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.754 -0.591 . . . . 40.0 110.378 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.667 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.2 OUTLIER -59.82 153.69 20.13 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.959 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.41 HD13 ' HB ' ' A' ' 88' ' ' ILE . 42.7 mm -136.18 144.8 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.419 -0.801 . . . . 40.0 110.04 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 56.28 70.82 0.61 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.486 0.66 . . . . 40.0 110.598 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.479 ' OH ' ' N ' ' A' ' 81' ' ' GLY . 62.4 t80 -130.73 155.49 46.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.132 -0.98 . . . . 40.0 109.34 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.574 ' OG1' ' N ' ' A' ' 80' ' ' SER . 24.0 p -134.96 -73.46 0.47 Allowed 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.63 0.729 . . . . 40.0 110.064 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.574 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -153.46 105.69 2.86 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.03 -0.729 . . . . 40.0 109.03 -178.499 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.479 ' N ' ' OH ' ' A' ' 78' ' ' TYR . . . 159.13 -102.35 0.21 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.733 -1.347 . . . . 40.0 109.733 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 35.4 t80 -140.81 -167.55 2.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.638 -0.919 . . . . 40.0 109.895 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.639 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.3 mtm180 -74.19 -157.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.179 -0.95 . . . . 40.0 110.147 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.566 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 11.4 p30 -164.59 -149.25 0.12 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.939 -1.134 . . . . 40.0 107.939 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 64.1 p -103.94 -9.07 19.18 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.809 -1.182 . . . . 40.0 109.409 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.652 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -85.67 113.77 22.13 Favored 'General case' 0 N--CA 1.509 2.481 0 CA-C-O 121.787 0.803 . . . . 40.0 111.688 -179.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.806 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.43 150.22 46.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.986 -1.071 . . . . 40.0 110.617 179.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.41 ' HB ' HD13 ' A' ' 76' ' ' ILE . 7.3 tt -116.4 140.78 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-O 122.131 0.967 . . . . 40.0 109.833 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.422 ' CD2' ' HZ ' ' A' ' 106' ' ' PHE . 3.0 mm? -119.24 125.99 50.44 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.361 -0.978 . . . . 40.0 108.361 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.666 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -119.89 129.4 54.35 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.824 -0.806 . . . . 40.0 108.824 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.697 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 2.9 p -94.1 157.8 15.91 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 122.297 1.046 . . . . 40.0 112.448 -178.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.7 p -68.41 -17.49 64.23 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.559 -0.904 . . . . 40.0 108.559 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.485 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -85.82 8.54 19.66 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.567 -0.853 . . . . 40.0 109.482 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.466 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.9 25.39 0.5 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.611 -0.68 . . . . 40.0 110.496 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.5 mt -95.71 138.02 33.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.135 -0.978 . . . . 40.0 109.108 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.458 HG23 HD12 ' A' ' 96' ' ' ILE . 43.1 mm -112.04 121.16 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.587 -0.696 . . . . 40.0 110.417 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.41 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.5 m-85 -122.98 144.95 48.9 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 120.245 -0.582 . . . . 40.0 109.496 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.652 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 5.3 tptp -133.7 145.71 50.14 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.083 -1.011 . . . . 40.0 110.84 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.474 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.2 t -125.89 168.36 13.98 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.761 -0.829 . . . . 40.0 108.761 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 71.2 p -141.79 -8.15 0.95 Allowed 'General case' 0 N--CA 1.51 2.544 0 O-C-N 121.21 -0.931 . . . . 40.0 109.717 178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.514 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.2 p30 -108.81 16.63 22.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.125 -0.984 . . . . 40.0 110.104 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 81.85 61.18 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.221 0.534 . . . . 40.0 110.217 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.639 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 31.5 m-85 71.41 -20.43 0.23 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.577 -0.702 . . . . 40.0 110.87 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.451 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.6 mt-30 -45.2 -74.34 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.024 -1.047 . . . . 40.0 110.001 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.488 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 23.6 p -104.59 164.02 12.05 Favored 'General case' 0 C--O 1.194 -1.829 0 O-C-N 120.901 -1.124 . . . . 40.0 108.115 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.422 ' HZ ' ' CD2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -137.9 139.68 39.95 Favored 'General case' 0 C--N 1.273 -2.753 0 O-C-N 121.351 -0.843 . . . . 40.0 109.932 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 30.5 m -126.73 137.01 53.19 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.156 -1.053 . . . . 40.0 108.156 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.632 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 14.9 tttp -83.87 146.05 28.29 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.837 -1.164 . . . . 40.0 109.679 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.5 pt -121.75 -33.77 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.283 -0.885 . . . . 40.0 109.043 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.643 HH21 ' CG ' ' A' ' 8' ' ' ASP . 72.2 mtt180 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 118.173 -0.918 . . . . 40.0 108.993 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.658 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 17.6 t . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 109.389 -0.596 . . . . 40.0 109.389 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 tt -176.4 152.64 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.27 -0.894 . . . . 40.0 109.169 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -142.71 24.16 1.89 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.805 -1.185 . . . . 40.0 111.215 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 10.9 p -105.74 153.16 22.25 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.679 0.752 . . . . 40.0 110.172 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -55.96 -63.11 1.29 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.036 -1.04 . . . . 40.0 111.052 -178.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.631 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -58.56 -41.08 84.81 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.506 -0.746 . . . . 40.0 109.745 -179.35 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.35 -45.14 89.39 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.712 -1.355 . . . . 40.0 109.712 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.1 t -67.39 -43.68 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.578 -0.954 . . . . 40.0 108.787 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -59.94 -59.15 5.88 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.947 -0.76 . . . . 40.0 108.947 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.24 -56.74 8.37 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.951 -0.759 . . . . 40.0 108.951 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.68 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 39.9 t80 -52.3 -51.96 55.63 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.048 0.451 . . . . 40.0 110.441 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 18' ' ' HIS . 2.2 tt -72.04 -52.58 16.24 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.64 -0.663 . . . . 40.0 111.056 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.472 ' N ' ' O ' ' A' ' 11' ' ' ALA . 63.7 mt-30 -51.59 -27.25 10.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.23 -1.544 . . . . 40.0 110.721 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 m -92.35 -49.84 5.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.585 -1.322 . . . . 40.0 111.347 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 19' ' ' LYS . 92.7 m-85 -100.85 16.0 26.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.845 -1.159 . . . . 40.0 110.114 -177.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 14' ' ' LEU . 25.1 m80 41.43 24.25 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.8 -0.563 . . . . 40.0 110.976 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 17' ' ' TYR . 3.6 pttp -135.48 158.78 43.51 Favored 'General case' 0 C--O 1.178 -2.7 0 O-C-N 121.177 -0.952 . . . . 40.0 110.771 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mp -79.25 144.28 62.13 Favored Pre-proline 0 C--N 1.271 -2.847 0 O-C-N 120.9 -1.125 . . . . 40.0 108.88 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.68 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 81.8 Cg_exo -38.73 155.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.003 0 C-N-CA 123.803 3.002 . . . . 40.0 114.433 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.658 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -67.61 50.11 0.05 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.283 1.039 . . . . 40.0 109.253 -179.51 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -173.86 26.24 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.129 -0.982 . . . . 40.0 110.552 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -120.21 111.92 18.42 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.294 -1.504 . . . . 40.0 110.122 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.414 HG22 HD12 ' A' ' 25' ' ' ILE . 23.0 pt -118.28 138.22 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.248 -1.019 . . . . 40.0 108.248 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.53 ' OG1' ' OG ' ' A' ' 28' ' ' SER . 0.6 OUTLIER -72.4 168.93 17.42 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 123.372 1.558 . . . . 40.0 113.357 -178.283 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.477 ' O ' ' C ' ' A' ' 28' ' ' SER . 24.3 mtmt -60.66 -39.38 88.14 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 105.801 -1.925 . . . . 40.0 105.801 176.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.53 ' OG ' ' OG1' ' A' ' 26' ' ' THR . 1.1 m -36.37 -70.86 0.08 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.749 -0.834 . . . . 40.0 108.749 176.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.56 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.7 mp0 -64.22 -55.43 21.69 Favored 'General case' 0 C--O 1.201 -1.473 0 N-CA-C 106.098 -1.815 . . . . 40.0 106.098 -176.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.56 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -35.44 -51.87 0.62 Allowed 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 118.562 -1.255 . . . . 40.0 109.573 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -55.45 -68.43 0.2 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.992 -1.067 . . . . 40.0 111.67 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.37 -24.31 54.54 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.263 -0.898 . . . . 40.0 111.141 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.7 tp -69.88 -21.2 63.35 Favored 'General case' 0 N--CA 1.509 2.475 0 N-CA-C 106.878 -1.527 . . . . 40.0 106.878 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.7 43.61 0.53 Allowed Glycine 0 N--CA 1.504 3.184 0 N-CA-C 111.523 -0.631 . . . . 40.0 111.523 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.54 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -77.88 138.97 39.2 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.725 -1.456 . . . . 40.0 109.531 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.9 t -135.7 130.33 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.685 0 O-C-N 121.154 -0.966 . . . . 40.0 109.302 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.48 -46.74 86.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.832 -0.543 . . . . 40.0 110.014 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.5 p -71.45 44.01 0.09 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.431 0.634 . . . . 40.0 110.644 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.585 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 ttpm? -177.43 -50.5 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.495 -0.753 . . . . 40.0 109.174 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.18 59.26 9.24 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 108.934 -1.666 . . . . 40.0 108.934 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.585 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.82 160.87 30.14 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 121.453 -1.028 . . . . 40.0 110.641 -177.846 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.569 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 57.1 tp -173.32 -69.5 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.999 -1.063 . . . . 40.0 110.385 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.07 -23.0 63.43 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 120.947 -1.096 . . . . 40.0 110.028 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.4 p-10 -73.28 -64.89 0.89 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.702 0.763 . . . . 40.0 109.218 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.463 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 28.7 m -76.78 -15.17 14.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 109.205 -0.665 . . . . 40.0 109.205 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.487 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . . . -144.22 71.34 16.29 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.501 -0.749 . . . . 40.0 110.16 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.04 117.16 3.8 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 123.375 2.717 . . . . 40.0 113.788 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.61 37.73 52.13 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.167 -1.573 . . . . 40.0 109.167 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.498 ' HD3' ' HA ' ' A' ' 23' ' ' ASN . 8.5 mmtm -135.2 162.3 32.92 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 108.856 -0.794 . . . . 40.0 108.856 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 65.7 m -138.22 166.55 23.9 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.326 1.06 . . . . 40.0 110.594 -177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.473 HG22 HD11 ' A' ' 51' ' ' ILE . 18.7 mm -84.1 124.11 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-N 115.876 -0.602 . . . . 40.0 111.508 -179.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 178.08 159.67 23.18 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.506 -1.438 . . . . 40.0 109.506 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.75 -7.17 19.94 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.623 -1.275 . . . . 40.0 110.92 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.437 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 5.2 m-20 -76.02 -152.26 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.381 -1.658 . . . . 40.0 110.072 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.7 mp -131.12 143.85 39.54 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.016 0 N-CA-C 108.327 -0.99 . . . . 40.0 108.327 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.636 ' O ' ' N ' ' A' ' 58' ' ' ASN . 13.7 t80 -113.51 90.97 3.48 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.217 -0.927 . . . . 40.0 108.78 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.653 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.6 p -59.07 38.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.705 0.764 . . . . 40.0 110.735 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.636 ' N ' ' O ' ' A' ' 56' ' ' PHE . 43.5 t30 34.67 38.57 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.293 -0.88 . . . . 40.0 110.671 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.653 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.8 mtm180 -69.91 36.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -0.94 . . . . 40.0 110.483 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.659 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 14.6 mt-10 -145.36 -4.82 0.68 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.135 -0.978 . . . . 40.0 110.332 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.65 36.97 66.32 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 109.635 -1.386 . . . . 40.0 109.635 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.659 ' HZ1' ' CD ' ' A' ' 60' ' ' GLU . 5.1 mttp -120.36 12.3 11.65 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.575 -0.956 . . . . 40.0 109.502 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.412 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -136.4 142.93 41.35 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.564 -0.71 . . . . 40.0 109.36 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -61.75 122.72 11.41 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.392 2.061 . . . . 40.0 112.344 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.489 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -101.18 -178.27 28.92 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 110.535 -1.026 . . . . 40.0 110.535 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.406 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 8.9 tttt -177.6 152.75 0.83 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.138 -1.213 . . . . 40.0 108.267 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.4 p -72.07 53.62 0.27 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.841 -1.162 . . . . 40.0 109.258 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.401 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 151.26 80.34 0.03 OUTLIER Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.826 -1.31 . . . . 40.0 109.826 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.559 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.96 177.31 2.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.533 -0.981 . . . . 40.0 109.037 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.559 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 90.1 m -154.75 154.92 33.59 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.124 -0.985 . . . . 40.0 110.043 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.693 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 30.0 m95 -124.14 139.86 53.52 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.384 0.612 . . . . 40.0 109.671 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.609 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.52 149.83 52.01 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 120.794 -1.191 . . . . 40.0 109.897 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.454 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -116.19 167.69 10.78 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.068 -1.02 . . . . 40.0 112.006 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -162.9 138.57 6.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.653 -0.654 . . . . 40.0 111.351 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.679 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.2 OUTLIER -59.6 154.22 18.12 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.656 -0.652 . . . . 40.0 110.934 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.428 ' HA ' HD12 ' A' ' 76' ' ' ILE . 42.7 mm -137.43 145.87 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.499 -0.75 . . . . 40.0 110.394 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 57.38 70.08 0.68 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.483 0.659 . . . . 40.0 110.524 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.569 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 70.2 t80 -131.86 155.65 47.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.039 -1.038 . . . . 40.0 110.112 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.609 ' OG1' ' N ' ' A' ' 80' ' ' SER . 19.2 p -136.64 -73.34 0.44 Allowed 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.124 0.488 . . . . 40.0 110.202 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.609 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -153.01 106.47 3.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.554 -0.716 . . . . 40.0 109.416 -178.466 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.93 -104.32 0.24 Allowed Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.747 -1.341 . . . . 40.0 109.747 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.481 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 47.2 t80 -139.94 -167.01 2.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 122.013 -0.698 . . . . 40.0 109.382 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.638 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.1 mtm180 -73.12 -154.34 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.166 -0.959 . . . . 40.0 110.075 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.555 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 11.6 p30 -168.05 -150.24 0.1 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.262 -1.014 . . . . 40.0 108.262 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 100' ' ' THR . 71.6 p -103.3 -8.0 20.66 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.64 -1.288 . . . . 40.0 109.313 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.671 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.6 114.15 23.95 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-O 122.063 0.935 . . . . 40.0 111.473 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.803 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.28 151.0 47.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.871 -1.143 . . . . 40.0 110.426 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.7 tt -117.99 136.71 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.794 0.807 . . . . 40.0 109.825 178.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.409 ' CD2' ' HZ ' ' A' ' 106' ' ' PHE . 3.1 mm? -115.84 125.16 52.3 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.798 -0.815 . . . . 40.0 108.798 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.682 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.94 129.53 55.22 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.077 0.942 . . . . 40.0 108.997 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.693 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 3.7 p -94.65 158.9 15.32 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 122.41 1.1 . . . . 40.0 112.504 -177.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.7 p -68.59 -18.14 64.27 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.234 -1.025 . . . . 40.0 108.234 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.496 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -86.32 9.17 18.66 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.666 -0.646 . . . . 40.0 109.647 179.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.462 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.76 26.48 0.64 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.661 -0.649 . . . . 40.0 110.361 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.9 mt -95.99 137.47 35.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.118 -0.989 . . . . 40.0 109.093 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.425 HG23 HD12 ' A' ' 96' ' ' ILE . 40.2 mm -111.77 119.15 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.634 -0.666 . . . . 40.0 110.564 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.429 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 8.0 m-85 -121.83 144.32 48.9 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.357 -0.537 . . . . 40.0 109.766 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.671 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 4.8 tptp -133.25 144.5 49.8 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.372 -0.83 . . . . 40.0 110.849 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.6 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.9 t -123.12 166.69 14.76 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 108.84 -0.8 . . . . 40.0 108.84 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.408 ' O ' ' OG ' ' A' ' 85' ' ' SER . 45.0 p -140.29 -10.31 1.1 Allowed 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.556 -0.715 . . . . 40.0 109.672 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.1 p30 -107.75 12.7 27.15 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.007 -1.058 . . . . 40.0 110.203 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 84.97 61.82 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.404 0.621 . . . . 40.0 110.305 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.638 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 23.2 m-85 71.62 -21.9 0.21 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.446 -0.784 . . . . 40.0 110.812 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.457 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.9 mt-30 -44.37 -73.41 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.091 -1.006 . . . . 40.0 109.932 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.461 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 22.0 p -106.07 166.4 10.53 Favored 'General case' 0 C--O 1.193 -1.9 0 N-CA-C 107.763 -1.199 . . . . 40.0 107.763 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.409 ' HZ ' ' CD2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -140.06 139.16 35.86 Favored 'General case' 0 C--N 1.27 -2.887 0 O-C-N 121.065 -1.022 . . . . 40.0 109.779 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.1 m -124.65 136.35 53.85 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.355 -0.98 . . . . 40.0 108.355 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.621 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 19.3 tttp -84.95 145.54 27.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.779 -1.201 . . . . 40.0 109.652 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.8 pt -120.71 -34.42 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.884 -1.135 . . . . 40.0 109.318 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.631 HH21 ' CG ' ' A' ' 8' ' ' ASP . 78.7 mtt180 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.081 -1.012 . . . . 40.0 108.769 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.628 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 17.0 t . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.319 -0.623 . . . . 40.0 109.319 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -178.27 151.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.393 -0.817 . . . . 40.0 109.587 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -142.53 23.96 1.93 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.16 -0.963 . . . . 40.0 111.684 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.6 p -105.85 153.98 21.17 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.981 0.896 . . . . 40.0 110.456 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.498 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -56.39 -64.48 0.85 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.617 -1.302 . . . . 40.0 110.833 -179.288 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.616 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -56.84 -41.43 77.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.05 -1.032 . . . . 40.0 110.034 -179.294 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.21 -44.99 84.17 Favored Glycine 0 N--CA 1.504 3.181 0 N-CA-C 110.164 -1.174 . . . . 40.0 110.164 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 69.5 t -68.77 -42.49 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.587 -0.949 . . . . 40.0 108.798 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.473 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.35 -59.38 5.49 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.489 -0.93 . . . . 40.0 108.489 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.23 -56.77 8.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.55 -0.719 . . . . 40.0 109.334 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.694 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 40.8 t80 -52.74 -51.41 60.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.915 -0.491 . . . . 40.0 110.353 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 18' ' ' HIS . 4.0 tt -72.36 -51.4 20.71 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.7 -0.625 . . . . 40.0 110.945 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.473 ' N ' ' O ' ' A' ' 11' ' ' ALA . 57.3 mt-30 -52.39 -28.36 19.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.051 -1.655 . . . . 40.0 110.129 179.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 m -91.53 -51.28 5.34 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.781 -1.2 . . . . 40.0 111.249 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -99.04 12.8 34.96 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.29 -0.881 . . . . 40.0 110.258 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 14' ' ' LEU . 20.7 m80 42.47 25.67 0.05 OUTLIER 'General case' 0 N--CA 1.516 2.856 0 O-C-N 121.477 -0.764 . . . . 40.0 110.92 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.9 pttp -136.63 158.61 44.03 Favored 'General case' 0 C--O 1.184 -2.367 0 CA-C-O 121.916 0.865 . . . . 40.0 110.188 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mp -78.31 147.83 73.12 Favored Pre-proline 0 C--N 1.265 -3.093 0 O-C-N 120.659 -1.275 . . . . 40.0 108.684 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.694 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 83.3 Cg_exo -41.47 156.09 0.07 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 123.272 2.648 . . . . 40.0 114.102 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.628 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -67.07 49.49 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.124 0.964 . . . . 40.0 109.48 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -173.67 26.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.902 . . . . 40.0 110.701 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -118.19 109.75 16.74 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.76 -1.213 . . . . 40.0 110.487 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.4 pt -119.07 132.88 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.169 -1.049 . . . . 40.0 108.169 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.485 HG21 ' C ' ' A' ' 53' ' ' GLY . 0.4 OUTLIER -69.48 173.35 6.03 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-O 124.24 1.972 . . . . 40.0 113.443 -177.395 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.633 ' HB3' ' NE2' ' A' ' 31' ' ' GLN . 14.6 mtmt -62.53 -40.12 95.75 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.266 -1.753 . . . . 40.0 106.266 177.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.48 ' C ' ' O ' ' A' ' 27' ' ' LYS . 2.9 m -32.97 -74.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 123.028 1.394 . . . . 40.0 109.666 174.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.501 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.4 mp0 -63.13 -56.47 16.49 Favored 'General case' 0 C--O 1.2 -1.509 0 CA-C-N 114.392 -1.277 . . . . 40.0 108.041 -177.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -38.26 -51.64 1.48 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.956 -1.09 . . . . 40.0 109.918 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.633 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 24.1 mt-30 -56.85 -64.63 0.81 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.676 -1.265 . . . . 40.0 110.351 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.47 -25.29 64.29 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.113 -0.992 . . . . 40.0 109.471 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.1 tp -65.66 -24.52 67.04 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.729 -0.841 . . . . 40.0 108.729 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.11 48.22 0.29 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.243 -1.143 . . . . 40.0 110.243 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.579 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -85.72 137.47 32.79 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.461 -1.023 . . . . 40.0 109.906 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.5 t -134.16 131.41 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.705 0 O-C-N 121.49 -0.756 . . . . 40.0 109.956 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -58.64 -47.92 82.77 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.743 -0.836 . . . . 40.0 108.743 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.1 p -69.87 43.64 0.06 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.627 -0.67 . . . . 40.0 110.907 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.505 ' HZ1' ' CG ' ' A' ' 41' ' ' ASN . 1.1 ttpm? -176.8 -49.83 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.314 -0.866 . . . . 40.0 109.13 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.17 59.7 9.11 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 108.349 -1.9 . . . . 40.0 108.349 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.579 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -76.57 159.84 29.96 Favored 'General case' 0 C--N 1.29 -2.004 0 O-C-N 121.654 -0.909 . . . . 40.0 110.833 -177.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.549 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 56.1 tp -173.92 -68.32 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.53 -0.868 . . . . 40.0 111.04 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -60.64 -22.08 63.44 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.812 -1.18 . . . . 40.0 109.36 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.5 p-10 -74.64 -62.3 1.58 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.13 -0.693 . . . . 40.0 109.13 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.422 ' H ' HG23 ' A' ' 45' ' ' VAL . 26.4 m -78.56 -13.52 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 N-CA-C 109.122 -0.696 . . . . 40.0 109.122 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -147.12 72.57 12.14 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.637 -0.664 . . . . 40.0 110.058 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -56.7 118.58 5.45 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 123.178 2.586 . . . . 40.0 113.911 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.37 39.64 56.69 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.69 -1.364 . . . . 40.0 109.69 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.422 ' NZ ' ' HB3' ' A' ' 23' ' ' ASN . 7.2 mmtm -134.39 168.89 18.09 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.859 0.838 . . . . 40.0 109.829 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.7 m -144.39 160.83 40.4 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 120.827 -1.171 . . . . 40.0 111.381 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.436 HG22 HD11 ' A' ' 51' ' ' ILE . 17.3 mm -81.25 123.04 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-N 115.437 -0.801 . . . . 40.0 110.557 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . 177.16 154.56 12.2 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.555 -1.418 . . . . 40.0 109.555 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.485 ' C ' HG21 ' A' ' 26' ' ' THR . . . 120.54 -13.55 10.08 Favored Glycine 0 N--CA 1.497 2.713 0 C-N-CA 119.162 -1.494 . . . . 40.0 111.236 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.476 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 4.3 m-20 -71.41 -152.0 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.747 0 O-C-N 121.202 -1.176 . . . . 40.0 109.781 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.37 142.63 42.84 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 CA-C-N 115.256 -0.884 . . . . 40.0 109.236 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.652 ' O ' ' N ' ' A' ' 58' ' ' ASN . 11.1 t80 -111.17 89.76 3.14 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.347 -0.845 . . . . 40.0 109.696 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.669 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.9 p -58.71 38.38 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.921 0.867 . . . . 40.0 110.774 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.652 ' N ' ' O ' ' A' ' 56' ' ' PHE . 40.8 t30 33.66 40.01 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.275 -0.89 . . . . 40.0 110.484 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.669 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 11.4 mtm180 -70.85 37.23 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.957 -1.089 . . . . 40.0 110.056 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.635 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 14.1 mt-10 -146.6 -1.05 0.72 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.998 -1.064 . . . . 40.0 110.29 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 51.11 39.42 41.65 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.681 -1.368 . . . . 40.0 109.681 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.635 ' HZ1' ' CD ' ' A' ' 60' ' ' GLU . 3.5 mttp -121.68 12.34 10.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.657 -0.908 . . . . 40.0 109.366 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.456 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.5 mt -137.33 143.62 42.18 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.66 -0.65 . . . . 40.0 109.541 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.38 122.68 11.46 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.296 1.997 . . . . 40.0 112.137 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.5 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.98 -177.29 26.69 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.866 -1.293 . . . . 40.0 109.866 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -177.94 154.73 0.92 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 107.871 -1.159 . . . . 40.0 107.871 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.2 p -73.2 55.47 0.44 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.995 -1.066 . . . . 40.0 109.172 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.98 81.4 0.04 OUTLIER Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.753 -1.339 . . . . 40.0 109.753 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.559 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.31 178.29 2.06 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.493 -1.004 . . . . 40.0 108.713 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.559 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 92.4 m -155.24 153.01 29.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.017 -1.052 . . . . 40.0 109.921 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.696 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 28.8 m95 -122.7 140.38 52.93 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.194 0.521 . . . . 40.0 110.006 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.587 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -131.42 147.11 52.53 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 120.96 -1.087 . . . . 40.0 110.392 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.84 168.2 9.76 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.979 -1.076 . . . . 40.0 112.278 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.402 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . . . -163.76 139.75 6.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.241 -0.912 . . . . 40.0 110.225 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.662 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.2 OUTLIER -61.29 154.71 23.0 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 120.976 0.417 . . . . 40.0 110.576 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.409 ' CD1' ' HB ' ' A' ' 88' ' ' ILE . 32.6 mm -138.11 146.01 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.587 -0.696 . . . . 40.0 110.325 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 56.4 71.05 0.59 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.582 0.706 . . . . 40.0 110.839 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.549 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 67.7 t80 -132.45 156.66 46.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 40.0 109.471 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.596 ' OG1' ' N ' ' A' ' 80' ' ' SER . 21.4 p -137.97 -72.44 0.42 Allowed 'General case' 0 N--CA 1.511 2.614 0 CA-C-O 121.44 0.638 . . . . 40.0 109.491 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.596 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.7 OUTLIER -152.99 105.69 2.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.653 -0.654 . . . . 40.0 109.57 -178.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.06 -103.96 0.23 Allowed Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.467 -1.349 . . . . 40.0 110.156 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 49.2 t80 -142.16 -167.55 2.5 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.53 -0.915 . . . . 40.0 108.53 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.659 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.3 mtm180 -72.9 -156.48 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.04 -1.038 . . . . 40.0 110.398 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.501 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 10.1 p30 -165.67 -149.38 0.11 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.132 -1.062 . . . . 40.0 108.132 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.402 ' H ' ' HB2' ' A' ' 84' ' ' ASN . 60.3 p -104.14 -7.46 20.16 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 120.804 -1.185 . . . . 40.0 109.252 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.689 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.97 113.09 23.28 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-O 121.898 0.856 . . . . 40.0 111.642 -179.263 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.81 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.44 150.06 46.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.055 -1.028 . . . . 40.0 110.391 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.409 ' HB ' ' CD1' ' A' ' 76' ' ' ILE . 5.1 tt -116.69 141.51 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 122.404 1.097 . . . . 40.0 109.777 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.41 ' CD2' ' HZ ' ' A' ' 106' ' ' PHE . 2.8 mm? -121.02 124.42 44.8 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.294 -1.002 . . . . 40.0 108.294 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.679 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.15 129.38 55.49 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.82 0.819 . . . . 40.0 108.816 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.696 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.2 p -93.56 159.99 14.99 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 122.322 1.058 . . . . 40.0 112.467 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.4 p -70.04 -18.11 63.28 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.241 -1.022 . . . . 40.0 108.241 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.457 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -86.15 8.69 19.96 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.052 -0.659 . . . . 40.0 109.498 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.447 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.88 26.79 0.6 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.497 -0.752 . . . . 40.0 109.955 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 27.1 mt -94.94 137.2 34.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.121 -0.987 . . . . 40.0 108.471 178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.406 HG23 HD12 ' A' ' 96' ' ' ILE . 37.2 mm -112.15 119.84 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.533 -0.73 . . . . 40.0 110.338 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -122.2 144.74 48.78 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.935 -0.706 . . . . 40.0 109.663 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.689 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 3.7 tptp -133.66 145.04 49.59 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.109 -0.995 . . . . 40.0 110.87 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.521 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.5 t -124.01 167.12 14.6 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 109.02 -0.733 . . . . 40.0 109.02 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 38.7 p -140.47 -9.43 1.09 Allowed 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.213 -0.93 . . . . 40.0 109.922 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.514 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.2 p30 -108.16 13.27 26.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 40.0 109.997 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 84.36 62.08 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.263 0.554 . . . . 40.0 110.308 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.659 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 22.7 m-85 70.61 -20.64 0.2 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.722 -0.611 . . . . 40.0 110.864 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.467 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.7 mt-30 -44.07 -73.7 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.162 -0.961 . . . . 40.0 109.472 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.433 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 22.0 p -106.25 167.88 9.52 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 107.316 -1.364 . . . . 40.0 107.316 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.41 ' HZ ' ' CD2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -140.32 140.12 35.57 Favored 'General case' 0 C--N 1.268 -2.966 0 O-C-N 121.645 -0.66 . . . . 40.0 109.866 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.2 m -125.14 135.75 52.94 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.267 -1.012 . . . . 40.0 108.267 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.62 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 19.3 tttp -84.56 145.91 27.82 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.801 -1.187 . . . . 40.0 109.619 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.1 pt -121.03 -35.01 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.445 -0.785 . . . . 40.0 109.476 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.62 ' C ' ' HZ3' ' A' ' 108' ' ' LYS . 78.9 mtt180 . . . . . 0 N--CA 1.488 1.474 0 O-C-N 121.169 -0.957 . . . . 40.0 109.091 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.607 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 12.8 t . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 109.786 -0.45 . . . . 40.0 109.786 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -175.01 153.55 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 109.375 -0.602 . . . . 40.0 109.375 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -144.58 24.68 1.54 Allowed 'General case' 0 N--CA 1.484 1.23 0 O-C-N 120.853 -1.154 . . . . 40.0 110.36 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 14.9 p -105.95 152.34 23.45 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.792 0.806 . . . . 40.0 109.541 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -55.24 -65.1 0.65 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.987 -1.071 . . . . 40.0 110.922 -178.829 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.594 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.7 OUTLIER -56.71 -41.75 77.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.344 -0.847 . . . . 40.0 110.304 -179.286 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.96 -44.87 87.8 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.255 -1.538 . . . . 40.0 109.255 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 72.1 t -67.48 -42.42 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.837 -0.801 . . . . 40.0 108.879 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -61.65 -57.66 11.14 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.553 -0.717 . . . . 40.0 109.212 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.25 -56.64 8.71 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.615 0.722 . . . . 40.0 109.186 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.673 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 41.7 t80 -53.31 -52.49 58.96 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.147 0.499 . . . . 40.0 110.677 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 18' ' ' HIS . 1.2 tt -71.98 -51.61 21.07 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.594 -0.692 . . . . 40.0 110.132 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 11' ' ' ALA . 63.1 mt-30 -51.25 -29.43 14.46 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.278 -1.514 . . . . 40.0 110.273 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m -90.04 -50.77 5.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.841 -1.162 . . . . 40.0 111.627 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 19' ' ' LYS . 87.7 m-85 -99.88 14.81 29.14 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.386 -0.821 . . . . 40.0 109.874 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 14' ' ' LEU . 19.9 m80 41.82 24.01 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.532 0 CA-C-O 121.407 0.622 . . . . 40.0 111.141 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 17' ' ' TYR . 4.4 pttp -134.31 158.66 43.22 Favored 'General case' 0 C--O 1.184 -2.373 0 O-C-N 121.305 -0.872 . . . . 40.0 109.939 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.28 145.06 63.55 Favored Pre-proline 0 C--N 1.263 -3.173 0 O-C-N 120.945 -1.097 . . . . 40.0 109.554 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.673 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 82.3 Cg_exo -37.94 155.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.512 2.578 0 C-N-CA 123.473 2.782 . . . . 40.0 114.7 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.607 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -67.73 50.37 0.05 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.138 -0.976 . . . . 40.0 108.964 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -174.94 24.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 118.952 -1.099 . . . . 40.0 110.764 -179.42 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -118.26 109.78 16.74 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.981 0.896 . . . . 40.0 110.332 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.462 HG22 HD12 ' A' ' 25' ' ' ILE . 12.5 pt -118.47 134.13 63.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.931 -1.137 . . . . 40.0 107.931 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.511 ' OG1' ' CB ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -70.32 173.43 6.81 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 124.092 1.901 . . . . 40.0 113.371 -177.339 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.492 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 16.8 mtmt -63.29 -35.83 81.67 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 106.648 -1.612 . . . . 40.0 106.648 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.511 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 5.1 m -37.54 -70.24 0.1 Allowed 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 122.28 1.038 . . . . 40.0 108.962 175.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.476 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.2 mp0 -68.1 -50.0 57.62 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.988 -1.115 . . . . 40.0 107.988 -178.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.476 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -43.18 -49.4 6.49 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.263 -1.375 . . . . 40.0 108.888 177.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.4 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 34.3 mt-30 -59.68 -62.08 2.14 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.275 -0.891 . . . . 40.0 111.454 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.01 -24.15 66.87 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.219 -0.925 . . . . 40.0 109.118 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.2 tp -68.1 -21.57 64.95 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.236 -0.986 . . . . 40.0 108.596 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.35 43.75 0.46 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.266 -1.133 . . . . 40.0 110.266 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.542 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -80.96 143.22 32.74 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.034 -1.274 . . . . 40.0 109.38 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.9 t -140.99 131.54 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.755 0 O-C-N 120.969 -1.082 . . . . 40.0 109.217 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -58.25 -48.78 79.36 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.913 -0.492 . . . . 40.0 110.342 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.3 p -70.82 45.63 0.09 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.158 -0.963 . . . . 40.0 110.263 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.438 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 ttpm? -177.07 -51.43 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.892 -0.781 . . . . 40.0 108.892 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.7 58.93 10.18 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 108.202 -1.959 . . . . 40.0 108.202 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.542 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -75.56 159.52 31.16 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.77 -0.841 . . . . 40.0 110.288 -177.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.514 ' N ' ' OD1' ' A' ' 44' ' ' ASP . 59.4 tp -173.76 -66.75 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.232 -0.987 . . . . 40.0 110.538 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.68 -19.91 62.86 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.03 -1.044 . . . . 40.0 109.935 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.7 p-10 -78.11 -61.34 2.03 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.681 -0.859 . . . . 40.0 108.681 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.1 m -78.74 -10.17 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.412 0 O-C-N 121.644 -0.66 . . . . 40.0 110.088 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.434 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . . . -150.37 71.54 9.15 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.393 -0.817 . . . . 40.0 109.838 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.96 117.5 4.2 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 123.649 2.899 . . . . 40.0 113.135 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.81 37.89 43.54 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.081 -1.208 . . . . 40.0 110.081 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 46' ' ' ALA . 7.3 mmtm -134.99 173.6 11.54 Favored 'General case' 0 N--CA 1.511 2.585 0 CA-C-O 121.72 0.771 . . . . 40.0 110.537 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.424 ' HG ' ' C ' ' A' ' 49' ' ' LYS . 67.0 m -147.54 162.76 38.42 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.954 -1.091 . . . . 40.0 112.013 -176.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 51' ' ' ILE . 8.6 mm -82.72 124.23 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 115.26 -0.882 . . . . 40.0 110.643 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.55 157.56 17.15 Favored Glycine 0 N--CA 1.5 2.927 0 N-CA-C 109.64 -1.384 . . . . 40.0 109.64 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.422 ' HA3' HG23 ' A' ' 26' ' ' THR . . . 117.63 -9.83 14.5 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 118.938 -1.601 . . . . 40.0 110.107 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.438 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 5.3 m-20 -75.69 -151.97 0.04 OUTLIER 'General case' 0 C--O 1.193 -1.897 0 O-C-N 120.8 -1.412 . . . . 40.0 109.853 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.4 mp -130.68 142.39 43.8 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 CA-C-N 115.102 -0.954 . . . . 40.0 108.679 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.613 ' O ' ' N ' ' A' ' 58' ' ' ASN . 12.9 t80 -110.3 90.96 3.47 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.095 -0.706 . . . . 40.0 109.095 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.659 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.9 p -60.3 38.74 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.457 -0.777 . . . . 40.0 110.705 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.613 ' N ' ' O ' ' A' ' 56' ' ' PHE . 45.6 t30 33.89 38.95 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.13 -0.981 . . . . 40.0 110.721 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.659 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.5 mtm180 -69.34 35.52 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.119 -0.988 . . . . 40.0 110.086 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.657 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 15.1 mt-10 -144.86 -3.74 0.77 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.052 -1.03 . . . . 40.0 110.348 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.16 37.91 60.09 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.275 -1.53 . . . . 40.0 109.275 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.657 ' HZ1' ' CD ' ' A' ' 60' ' ' GLU . 5.0 mttp -120.32 11.66 11.54 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.537 -0.978 . . . . 40.0 109.778 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.438 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -136.88 143.98 44.72 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 109.389 -0.597 . . . . 40.0 109.389 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.83 124.64 14.91 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.605 2.203 . . . . 40.0 112.267 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.503 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -104.33 -178.75 25.1 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.076 -1.21 . . . . 40.0 110.076 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.417 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 9.5 tttt -177.16 152.57 0.89 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.363 -1.08 . . . . 40.0 108.435 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.6 p -71.3 53.41 0.19 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.304 -1.497 . . . . 40.0 109.438 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.48 80.16 0.03 OUTLIER Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.084 -1.206 . . . . 40.0 110.084 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.577 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -175.36 178.83 1.6 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.706 -0.879 . . . . 40.0 108.864 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.577 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 87.1 m -155.52 155.98 34.38 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.331 -0.947 . . . . 40.0 109.83 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.676 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 27.5 m95 -124.91 140.01 53.31 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.78 -0.452 . . . . 40.0 109.78 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.606 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.64 149.55 52.25 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.738 -1.226 . . . . 40.0 109.685 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.492 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -115.79 168.82 9.71 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 122.283 1.04 . . . . 40.0 112.304 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.13 138.5 4.66 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.846 -0.615 . . . . 40.0 111.11 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.661 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.4 OUTLIER -60.41 154.79 19.64 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.453 0.644 . . . . 40.0 111.091 179.495 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 76' ' ' ILE . 40.2 mm -137.82 145.19 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 119.962 -0.695 . . . . 40.0 110.596 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 57.83 68.4 0.85 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.738 -0.601 . . . . 40.0 110.697 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.48 ' CG ' ' N ' ' A' ' 79' ' ' THR . 61.0 t80 -129.84 157.2 42.9 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.097 -1.002 . . . . 40.0 109.867 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.541 ' OG1' ' N ' ' A' ' 80' ' ' SER . 24.2 p -137.31 -71.07 0.44 Allowed 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.517 -0.739 . . . . 40.0 109.718 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.541 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.9 OUTLIER -153.68 107.15 2.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.6 -0.687 . . . . 40.0 109.388 -178.344 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.28 -107.22 0.31 Allowed Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.667 -1.254 . . . . 40.0 110.191 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.477 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 41.6 t80 -137.29 -166.73 1.98 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.772 -0.84 . . . . 40.0 109.355 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.664 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.8 mtm180 -73.99 -155.5 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.805 -1.184 . . . . 40.0 109.643 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -166.52 -150.75 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.888 -1.153 . . . . 40.0 107.888 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 100' ' ' THR . 60.1 p -102.32 -7.49 22.02 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.004 -1.06 . . . . 40.0 109.539 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.679 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.67 113.88 23.76 Favored 'General case' 0 N--CA 1.509 2.505 0 CA-C-O 121.89 0.852 . . . . 40.0 111.552 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.803 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.35 148.55 43.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.951 -1.093 . . . . 40.0 110.84 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 5.5 tt -114.72 140.06 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-O 122.144 0.973 . . . . 40.0 110.158 178.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.415 ' CD2' ' HZ ' ' A' ' 106' ' ' PHE . 3.1 mm? -118.77 125.13 48.92 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.609 -0.886 . . . . 40.0 108.609 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.672 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -119.52 129.41 54.68 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.594 0.711 . . . . 40.0 109.203 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.676 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.7 p -93.93 160.14 14.86 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.668 1.223 . . . . 40.0 112.797 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.1 p -69.92 -17.03 63.31 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.138 -1.06 . . . . 40.0 108.138 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.467 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -88.19 10.03 20.87 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 119.773 -0.771 . . . . 40.0 109.686 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.458 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.6 27.36 0.62 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.765 -0.585 . . . . 40.0 110.259 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.0 mt -96.48 136.93 36.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.273 -0.892 . . . . 40.0 109.061 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.455 HG23 HD12 ' A' ' 96' ' ' ILE . 41.1 mm -111.72 119.95 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.772 -0.58 . . . . 40.0 110.649 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.402 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.7 m-85 -122.91 144.57 49.14 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 120.524 -0.47 . . . . 40.0 109.934 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.679 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 4.2 tptp -134.29 145.02 48.68 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.042 -1.036 . . . . 40.0 110.593 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.577 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.6 t -123.37 166.9 14.54 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.567 -0.901 . . . . 40.0 108.567 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.411 ' O ' ' OG ' ' A' ' 85' ' ' SER . 35.8 p -139.73 -10.29 1.19 Allowed 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.03 -1.044 . . . . 40.0 109.723 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.563 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.1 p30 -107.13 10.78 30.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.25 -0.907 . . . . 40.0 110.259 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.563 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 86.68 63.06 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.346 0.593 . . . . 40.0 110.494 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.664 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 24.4 m-85 70.61 -23.23 0.17 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.369 -0.832 . . . . 40.0 110.883 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.469 ' H ' ' C ' ' A' ' 102' ' ' ALA . 2.0 mt-30 -43.4 -73.45 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.293 -0.879 . . . . 40.0 109.97 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.444 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 24.8 p -106.18 167.53 9.75 Favored 'General case' 0 C--O 1.196 -1.756 0 N-CA-C 107.718 -1.215 . . . . 40.0 107.718 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.415 ' HZ ' ' CD2' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -140.93 139.16 34.27 Favored 'General case' 0 C--N 1.268 -2.942 0 O-C-N 121.51 -0.744 . . . . 40.0 109.836 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.7 m -124.48 135.98 53.65 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.143 -1.058 . . . . 40.0 108.143 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.632 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 18.1 tttp -84.64 145.57 27.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.903 -1.123 . . . . 40.0 109.656 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.6 pt -121.35 -34.42 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.157 -0.964 . . . . 40.0 109.528 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.632 ' C ' ' HZ3' ' A' ' 108' ' ' LYS . 76.3 mtt180 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 118.176 -0.916 . . . . 40.0 108.969 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.636 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 17.9 t . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 108.992 -0.744 . . . . 40.0 108.992 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -175.9 153.79 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.066 -0.716 . . . . 40.0 109.066 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -144.43 26.05 1.48 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.109 -0.994 . . . . 40.0 110.688 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.2 p -104.26 151.94 22.81 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 121.463 0.649 . . . . 40.0 109.473 -179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -55.25 -64.16 0.93 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.716 -1.24 . . . . 40.0 110.734 -179.191 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.605 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.7 OUTLIER -57.03 -41.83 79.32 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.193 -0.942 . . . . 40.0 110.107 -179.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.4 -45.28 84.18 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.702 -1.359 . . . . 40.0 109.702 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 71.1 t -67.09 -43.36 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 121.674 -0.898 . . . . 40.0 108.824 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.43 -58.79 6.99 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.283 -0.636 . . . . 40.0 109.283 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.56 -56.47 9.8 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.118 -0.989 . . . . 40.0 109.358 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.697 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 39.0 t80 -51.49 -53.07 41.19 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.942 -0.572 . . . . 40.0 110.418 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 18' ' ' HIS . 1.9 tt -72.74 -50.1 26.79 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.336 0.589 . . . . 40.0 110.982 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 11' ' ' ALA . 63.3 mt-30 -53.17 -28.27 25.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.059 -1.65 . . . . 40.0 109.925 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.9 m -91.61 -51.14 5.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.014 -1.054 . . . . 40.0 110.763 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.416 ' O ' ' N ' ' A' ' 19' ' ' LYS . 84.9 m-85 -99.11 14.03 30.79 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.268 -0.895 . . . . 40.0 110.427 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.544 ' N ' ' O ' ' A' ' 14' ' ' LEU . 20.9 m80 41.95 25.01 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 O-C-N 121.565 -0.71 . . . . 40.0 111.023 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 17' ' ' TYR . 4.1 pttp -134.89 158.65 43.71 Favored 'General case' 0 C--O 1.185 -2.3 0 O-C-N 121.2 -0.937 . . . . 40.0 109.967 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mp -79.35 146.03 65.44 Favored Pre-proline 0 C--N 1.269 -2.905 0 N-CA-C 107.961 -1.126 . . . . 40.0 107.961 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.697 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 82.2 Cg_exo -39.34 157.72 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 123.213 2.608 . . . . 40.0 114.6 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.636 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.8 OUTLIER -69.47 51.26 0.1 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.817 -1.177 . . . . 40.0 109.62 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.447 ' HA ' ' HD3' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -175.92 26.71 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.026 -1.047 . . . . 40.0 110.149 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -119.59 109.72 16.02 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.498 -1.376 . . . . 40.0 111.045 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.0 pt -116.85 134.94 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.441 -0.904 . . . . 40.0 108.704 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.484 ' OG1' ' OG ' ' A' ' 28' ' ' SER . 0.3 OUTLIER -69.51 169.98 11.5 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 123.756 1.741 . . . . 40.0 113.269 -177.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.471 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 23.1 mtmt -62.34 -37.87 87.31 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 105.96 -1.867 . . . . 40.0 105.96 177.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.484 ' OG ' ' OG1' ' A' ' 26' ' ' THR . 1.1 m -37.69 -70.84 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.667 -0.864 . . . . 40.0 108.667 176.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.545 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.5 mp0 -63.34 -57.62 9.79 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 106.823 -1.547 . . . . 40.0 106.823 -177.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.545 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -33.31 -52.03 0.36 Allowed 'General case' 0 N--CA 1.509 2.525 0 C-N-CA 119.165 -1.014 . . . . 40.0 109.251 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -56.52 -67.06 0.34 Allowed 'General case' 0 N--CA 1.516 2.864 0 O-C-N 120.906 -1.121 . . . . 40.0 111.524 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.4 -21.64 62.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.746 -1.221 . . . . 40.0 110.494 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.5 tp -70.54 -24.47 62.81 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.349 -1.352 . . . . 40.0 107.349 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.7 48.15 0.28 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.6 -1.0 . . . . 40.0 110.6 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.595 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.14 142.31 33.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.009 -1.289 . . . . 40.0 108.633 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.7 t -136.47 128.24 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 N-CA-C 108.439 -0.948 . . . . 40.0 108.439 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -59.12 -48.58 81.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.776 -0.577 . . . . 40.0 109.531 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.7 p -70.83 46.95 0.1 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.028 -1.045 . . . . 40.0 109.899 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.563 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -178.6 -50.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.916 -0.772 . . . . 40.0 108.916 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.39 59.8 8.85 Favored Glycine 0 N--CA 1.503 3.146 0 N-CA-C 108.593 -1.803 . . . . 40.0 108.593 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.595 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -76.6 160.56 29.32 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.344 -1.092 . . . . 40.0 111.59 -177.293 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.516 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 45.5 tp -172.46 -70.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.451 -0.9 . . . . 40.0 110.529 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -59.98 -21.45 61.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.852 -1.155 . . . . 40.0 109.77 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 5.0 p-10 -75.87 -62.64 1.52 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.185 -0.672 . . . . 40.0 109.185 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.414 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 15.8 m -77.76 -13.28 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 109.063 -0.718 . . . . 40.0 109.063 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.459 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -147.74 72.92 11.54 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 121.34 -0.85 . . . . 40.0 110.148 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.68 118.04 4.81 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.01 2.474 . . . . 40.0 113.959 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.441 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 75.16 36.48 45.64 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.25 -1.54 . . . . 40.0 109.25 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 23' ' ' ASN . 7.3 mmtm -135.5 163.55 29.82 Favored 'General case' 0 N--CA 1.511 2.586 0 CA-C-O 121.739 0.781 . . . . 40.0 110.364 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.5 m -138.56 166.57 23.99 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 122.12 0.962 . . . . 40.0 111.325 -176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.474 HG22 HD11 ' A' ' 51' ' ' ILE . 10.3 mm -83.98 121.66 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 115.344 -0.843 . . . . 40.0 111.689 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 178.27 155.24 13.86 Favored Glycine 0 N--CA 1.502 3.097 0 C-N-CA 119.847 -1.168 . . . . 40.0 110.604 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.7 -7.87 12.04 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.342 -1.409 . . . . 40.0 110.217 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.415 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 4.5 m-20 -75.65 -150.79 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.088 -1.242 . . . . 40.0 109.824 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -132.36 143.33 40.23 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.882 0 CA-C-N 115.067 -0.969 . . . . 40.0 108.848 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.644 ' O ' ' N ' ' A' ' 58' ' ' ASN . 14.9 t80 -112.04 89.68 3.13 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.488 -0.93 . . . . 40.0 108.488 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.667 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.8 p -59.23 37.57 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.597 0.713 . . . . 40.0 110.611 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.644 ' N ' ' O ' ' A' ' 56' ' ' PHE . 44.2 t30 34.42 39.18 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.066 -1.021 . . . . 40.0 110.656 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.667 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.8 mtm180 -70.02 35.54 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.731 -1.231 . . . . 40.0 110.45 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.623 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 14.8 mt-10 -144.91 -1.85 0.84 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.033 -1.042 . . . . 40.0 109.943 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.58 37.84 50.91 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.662 -1.375 . . . . 40.0 109.662 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.623 ' HZ1' ' CD ' ' A' ' 60' ' ' GLU . 4.3 mttp -119.89 12.36 12.04 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.458 -1.025 . . . . 40.0 109.407 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.464 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -137.54 143.85 42.55 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.702 -0.624 . . . . 40.0 109.646 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.54 123.74 13.32 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.505 2.137 . . . . 40.0 112.466 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.515 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -103.43 -177.81 26.16 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.205 -1.158 . . . . 40.0 110.205 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.408 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 8.4 tttt -178.12 154.09 0.84 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 108.024 -1.102 . . . . 40.0 108.024 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.4 p -73.29 56.04 0.47 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.774 -1.204 . . . . 40.0 109.041 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.16 81.76 0.04 OUTLIER Glycine 0 N--CA 1.498 2.815 0 N-CA-C 109.899 -1.28 . . . . 40.0 109.899 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.57 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -177.34 178.18 1.11 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.544 -0.974 . . . . 40.0 108.874 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.57 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 92.8 m -154.97 155.12 33.65 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.219 -0.926 . . . . 40.0 109.945 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.695 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 29.7 m95 -123.36 139.45 54.02 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.708 -0.479 . . . . 40.0 109.708 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.564 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.26 149.02 52.14 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.705 -1.247 . . . . 40.0 109.713 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.471 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -114.52 169.94 8.68 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.897 -1.127 . . . . 40.0 112.331 -179.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.99 137.24 3.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.745 -0.597 . . . . 40.0 110.958 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.656 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.3 OUTLIER -59.14 154.54 15.76 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 120.917 0.389 . . . . 40.0 110.896 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.405 HD13 ' HB ' ' A' ' 88' ' ' ILE . 41.6 mm -137.09 144.33 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.323 -0.861 . . . . 40.0 110.294 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 57.77 71.05 0.6 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.527 -0.733 . . . . 40.0 110.58 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.516 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 69.2 t80 -131.67 155.06 48.27 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.866 -1.146 . . . . 40.0 109.804 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.596 ' OG1' ' N ' ' A' ' 80' ' ' SER . 27.2 p -135.79 -73.05 0.45 Allowed 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.618 -0.676 . . . . 40.0 110.138 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.596 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -153.65 102.32 2.54 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.481 -0.562 . . . . 40.0 109.481 -177.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 164.01 -103.08 0.21 Allowed Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.855 -1.164 . . . . 40.0 110.397 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.486 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 45.8 t80 -141.3 -166.95 2.29 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.842 -0.799 . . . . 40.0 108.955 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.649 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.9 mtm180 -73.45 -154.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 40.0 110.429 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.588 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 9.4 p30 -167.58 -150.91 0.11 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.333 -0.988 . . . . 40.0 108.333 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 100' ' ' THR . 82.5 p -102.82 -8.06 21.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.799 -1.188 . . . . 40.0 109.309 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.691 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.25 113.67 23.19 Favored 'General case' 0 N--CA 1.509 2.48 0 CA-C-O 121.794 0.807 . . . . 40.0 111.483 -179.537 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.8 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.73 150.79 46.53 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.852 -1.155 . . . . 40.0 110.551 179.606 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.405 ' HB ' HD13 ' A' ' 76' ' ' ILE . 4.9 tt -116.93 141.02 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.511 -0.743 . . . . 40.0 109.908 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.54 124.95 47.67 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.574 -0.899 . . . . 40.0 108.574 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.677 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.66 129.53 55.35 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.873 0.844 . . . . 40.0 108.776 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.695 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.9 p -94.69 159.66 14.97 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 122.581 1.181 . . . . 40.0 112.413 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.6 p -69.42 -17.81 63.69 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.117 -1.068 . . . . 40.0 108.117 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.471 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -87.06 10.06 17.75 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.778 -0.769 . . . . 40.0 109.736 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.453 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.66 26.54 0.65 Allowed 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.62 -0.675 . . . . 40.0 110.259 179.253 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.5 mt -95.69 135.55 37.24 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.362 -0.837 . . . . 40.0 109.092 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.478 HG23 HD12 ' A' ' 96' ' ' ILE . 38.6 mm -110.96 119.02 58.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-O 121.389 0.614 . . . . 40.0 110.722 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -122.28 144.88 48.72 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 120.276 -0.57 . . . . 40.0 109.637 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.691 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 4.8 tptp -133.83 144.42 48.95 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.19 -0.943 . . . . 40.0 110.644 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.576 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.7 t -123.17 166.7 14.77 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 108.688 -0.856 . . . . 40.0 108.688 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.429 ' O ' ' OG ' ' A' ' 85' ' ' SER . 40.7 p -140.08 -9.82 1.15 Allowed 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.277 -0.889 . . . . 40.0 109.66 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.529 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.2 p30 -108.47 14.01 25.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 40.0 110.261 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 84.41 61.92 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.13 0.491 . . . . 40.0 110.329 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.649 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 24.6 m-85 70.73 -21.64 0.19 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.494 -0.754 . . . . 40.0 110.881 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.466 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.2 mt-30 -43.72 -72.55 0.06 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.088 -1.007 . . . . 40.0 109.599 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.419 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 26.4 p -107.41 169.44 8.58 Favored 'General case' 0 C--O 1.193 -1.9 0 N-CA-C 108.048 -1.093 . . . . 40.0 108.048 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.42 140.13 33.57 Favored 'General case' 0 C--N 1.272 -2.794 0 O-C-N 121.355 -0.84 . . . . 40.0 110.114 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 46.4 m -125.31 135.51 52.55 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.551 -0.907 . . . . 40.0 108.551 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.677 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 21.7 tttp -84.46 145.08 28.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.759 -1.213 . . . . 40.0 109.879 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 14.1 pt -120.32 -34.72 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.172 -0.955 . . . . 40.0 109.527 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.677 ' C ' ' HZ3' ' A' ' 108' ' ' LYS . 78.3 mtt180 . . . . . 0 N--CA 1.487 1.378 0 O-C-N 121.186 -0.946 . . . . 40.0 108.638 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.648 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 20.7 t . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 109.294 -0.632 . . . . 40.0 109.294 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 tt -177.1 152.4 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 108.981 -0.748 . . . . 40.0 108.981 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -144.29 25.78 1.52 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.733 -1.229 . . . . 40.0 110.604 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.4 p -105.38 152.82 22.49 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.528 0.68 . . . . 40.0 110.057 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.48 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -56.29 -62.74 1.51 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.459 -1.401 . . . . 40.0 111.482 -179.198 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.647 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -59.1 -40.83 86.54 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.976 -1.077 . . . . 40.0 109.738 -179.345 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.45 -44.88 85.3 Favored Glycine 0 N--CA 1.507 3.377 0 N-CA-C 109.682 -1.367 . . . . 40.0 109.682 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 70.5 t -67.55 -43.48 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.805 -0.821 . . . . 40.0 108.976 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.88 -56.48 20.64 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.967 -0.753 . . . . 40.0 108.967 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.04 -56.02 14.63 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.89 -0.782 . . . . 40.0 108.89 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.656 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 38.7 t80 -53.02 -51.78 60.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 122.017 -0.427 . . . . 40.0 110.87 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 18' ' ' HIS . 3.9 tt -71.89 -51.06 24.14 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 121.414 0.626 . . . . 40.0 110.43 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 11' ' ' ALA . 58.8 mt-30 -53.22 -28.77 28.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 119.983 -1.698 . . . . 40.0 110.316 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.3 m -92.31 -50.18 5.78 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.612 -1.305 . . . . 40.0 110.964 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.401 ' O ' ' N ' ' A' ' 19' ' ' LYS . 86.5 m-85 -99.28 12.47 36.15 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.89 -1.131 . . . . 40.0 110.308 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.569 ' N ' ' O ' ' A' ' 14' ' ' LEU . 23.5 m80 42.6 24.2 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.916 0 CA-C-O 121.484 0.659 . . . . 40.0 111.226 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 17' ' ' TYR . 5.1 pttp -135.98 156.57 48.54 Favored 'General case' 0 C--O 1.183 -2.413 0 CA-C-O 121.646 0.736 . . . . 40.0 109.804 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mp -77.62 145.63 71.6 Favored Pre-proline 0 C--N 1.268 -2.976 0 O-C-N 120.899 -1.126 . . . . 40.0 109.71 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.656 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 88.9 Cg_exo -40.33 155.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 123.267 2.645 . . . . 40.0 113.922 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.648 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -66.06 49.19 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.15 0.976 . . . . 40.0 109.376 -179.016 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -173.92 26.99 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.189 -0.944 . . . . 40.0 110.687 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -119.59 108.26 14.27 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.523 -1.361 . . . . 40.0 109.628 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.7 pt -116.94 132.11 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 C-N-CA 119.436 -0.905 . . . . 40.0 108.89 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.566 ' OG1' ' CB ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -67.17 172.02 5.1 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 123.609 1.671 . . . . 40.0 113.536 -177.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.501 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 19.5 mtmt -63.36 -35.99 82.23 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 106.458 -1.682 . . . . 40.0 106.458 176.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.566 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 5.1 m -35.56 -71.7 0.07 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 123.57 1.652 . . . . 40.0 109.222 175.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.504 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.1 mp0 -65.53 -56.18 13.76 Favored 'General case' 0 C--O 1.192 -1.93 0 N-CA-C 107.488 -1.301 . . . . 40.0 107.488 -177.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.504 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -37.26 -50.29 0.99 Allowed 'General case' 0 N--CA 1.517 2.914 0 O-C-N 120.574 -1.329 . . . . 40.0 110.647 178.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -58.93 -62.04 2.18 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.382 -1.449 . . . . 40.0 110.848 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.81 -25.98 67.83 Favored 'General case' 0 N--CA 1.512 2.662 0 O-C-N 120.679 -1.263 . . . . 40.0 110.027 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.0 tp -65.02 -25.33 67.8 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.178 -1.045 . . . . 40.0 108.178 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.33 46.2 0.33 Allowed Glycine 0 N--CA 1.502 3.068 0 N-CA-C 110.244 -1.142 . . . . 40.0 110.244 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.476 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -80.54 139.85 36.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.969 -1.312 . . . . 40.0 109.422 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.7 t -136.09 130.15 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.241 0 CA-C-O 121.6 0.714 . . . . 40.0 109.576 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -57.47 -48.18 79.87 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.298 -0.63 . . . . 40.0 109.298 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.2 p -69.7 44.85 0.06 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.33 -0.856 . . . . 40.0 110.704 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.529 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.5 ttpm? -178.48 -51.99 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.203 -0.936 . . . . 40.0 109.066 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.43 62.68 4.89 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 108.788 -1.725 . . . . 40.0 108.788 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.529 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -78.78 160.1 27.57 Favored 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.495 -1.003 . . . . 40.0 111.024 -177.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.561 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 52.0 tp -173.67 -69.4 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.479 -0.763 . . . . 40.0 110.544 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -61.37 -21.76 64.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.731 -1.231 . . . . 40.0 109.31 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 4.8 p-10 -74.16 -62.8 1.39 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.221 -0.659 . . . . 40.0 109.221 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.418 ' H ' HG23 ' A' ' 45' ' ' VAL . 29.8 m -80.4 -10.04 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.914 -0.491 . . . . 40.0 110.298 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -148.21 72.23 11.06 Favored Pre-proline 0 N--CA 1.489 1.487 0 CA-C-O 121.489 0.662 . . . . 40.0 109.518 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -55.35 115.53 2.51 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 123.779 2.986 . . . . 40.0 113.381 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.72 38.2 57.06 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.992 -1.243 . . . . 40.0 109.992 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.446 ' HD3' ' HA ' ' A' ' 23' ' ' ASN . 6.3 mmtt -133.12 163.3 29.57 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.795 -0.827 . . . . 40.0 110.008 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.2 m -139.13 161.1 38.23 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 122.432 1.11 . . . . 40.0 110.84 -176.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.437 HG22 HD11 ' A' ' 51' ' ' ILE . 19.6 mm -79.93 124.78 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 114.619 -1.173 . . . . 40.0 110.721 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.24 156.12 13.22 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 119.529 -1.319 . . . . 40.0 109.967 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.29 -10.73 13.06 Favored Glycine 0 N--CA 1.502 3.091 0 C-N-CA 119.531 -1.319 . . . . 40.0 110.163 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.443 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 4.9 m-20 -72.62 -151.15 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.538 -1.566 . . . . 40.0 109.68 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.4 mp -132.72 141.0 46.18 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 CA-C-N 115.132 -0.94 . . . . 40.0 109.304 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.634 ' C ' ' H ' ' A' ' 58' ' ' ASN . 11.7 t80 -109.28 91.76 3.77 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.295 -0.878 . . . . 40.0 109.198 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.624 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.5 p -60.27 38.21 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.92 0.867 . . . . 40.0 110.625 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.634 ' H ' ' C ' ' A' ' 56' ' ' PHE . 44.8 t30 33.97 39.27 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.407 -0.808 . . . . 40.0 110.659 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.624 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.3 mtm180 -70.37 36.3 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.516 -1.365 . . . . 40.0 110.348 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.652 ' CD ' ' HZ1' ' A' ' 62' ' ' LYS . 15.1 mt-10 -145.17 -2.76 0.78 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.347 -0.845 . . . . 40.0 109.954 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.29 37.95 56.09 Favored Glycine 0 N--CA 1.502 3.098 0 N-CA-C 109.579 -1.409 . . . . 40.0 109.579 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.652 ' HZ1' ' CD ' ' A' ' 60' ' ' GLU . 5.8 mttp -120.1 11.46 11.66 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.267 -1.137 . . . . 40.0 109.505 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.4 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.5 mt -136.38 144.26 46.88 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.64 -0.663 . . . . 40.0 109.498 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.53 123.8 13.04 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.188 1.925 . . . . 40.0 112.527 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.505 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.67 -175.84 27.05 Favored Glycine 0 N--CA 1.5 2.901 0 N-CA-C 110.235 -1.146 . . . . 40.0 110.235 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 68' ' ' GLY . 9.0 tttt -179.12 152.17 0.54 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.065 -1.256 . . . . 40.0 107.791 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.6 p -70.87 53.53 0.16 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.643 -1.286 . . . . 40.0 109.106 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 66' ' ' LYS . . . 150.89 80.98 0.03 OUTLIER Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.277 -1.129 . . . . 40.0 110.277 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.553 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.67 177.97 1.99 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.735 -0.862 . . . . 40.0 108.799 179.105 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.553 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 96.7 m -154.36 155.16 34.56 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.254 -0.904 . . . . 40.0 110.039 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.718 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 31.8 m95 -124.99 138.92 54.21 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.982 -0.449 . . . . 40.0 109.893 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.547 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.68 147.71 52.38 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.028 -1.045 . . . . 40.0 109.88 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.501 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -113.24 168.74 9.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.679 -1.263 . . . . 40.0 111.9 -179.379 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.45 139.56 5.71 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.799 0.809 . . . . 40.0 111.063 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.685 ' CG ' HH21 ' A' ' 87' ' ' ARG . 0.2 OUTLIER -60.51 154.83 19.88 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.85 -0.531 . . . . 40.0 111.275 179.641 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 33.9 mm -138.14 145.4 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.513 -0.742 . . . . 40.0 109.946 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 56.77 70.69 0.63 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.499 0.666 . . . . 40.0 110.782 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.561 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 65.6 t80 -132.29 154.9 49.21 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.917 -1.114 . . . . 40.0 109.436 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.574 ' OG1' ' N ' ' A' ' 80' ' ' SER . 22.9 p -136.17 -72.16 0.45 Allowed 'General case' 0 N--CA 1.507 2.385 0 CA-C-O 121.214 0.531 . . . . 40.0 109.934 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.574 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.5 OUTLIER -153.4 103.67 2.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.387 -0.821 . . . . 40.0 109.299 -178.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 163.42 -106.19 0.27 Allowed Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.608 -1.282 . . . . 40.0 110.212 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.469 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 52.4 t80 -138.21 -165.16 1.75 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.789 -0.819 . . . . 40.0 108.789 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.647 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.1 mtm180 -75.72 -155.84 0.06 Allowed 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.335 -1.478 . . . . 40.0 109.961 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.547 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 9.5 p30 -165.13 -149.18 0.12 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.217 -1.031 . . . . 40.0 108.217 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 82.7 p -104.21 -7.58 20.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.709 -1.244 . . . . 40.0 108.929 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.639 ' CG ' ' HZ2' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -87.6 113.42 23.27 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-O 121.878 0.846 . . . . 40.0 111.71 -179.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.811 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.55 150.61 46.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.879 -1.138 . . . . 40.0 110.519 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 6.7 tt -117.3 139.26 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-O 122.831 1.301 . . . . 40.0 110.028 178.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.86 124.44 47.16 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.421 -0.955 . . . . 40.0 108.421 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.678 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.54 129.5 55.39 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.846 0.831 . . . . 40.0 109.125 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.718 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.5 p -93.35 159.21 15.36 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 122.268 1.032 . . . . 40.0 112.221 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.8 p -69.23 -18.41 63.88 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.805 -1.183 . . . . 40.0 107.805 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.485 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -86.05 9.4 17.3 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.189 -0.604 . . . . 40.0 109.629 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.447 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.12 26.72 0.72 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.503 -0.748 . . . . 40.0 110.3 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.8 mt -96.29 134.99 38.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.398 -0.814 . . . . 40.0 109.156 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.412 HG23 HD12 ' A' ' 96' ' ' ILE . 39.2 mm -109.52 120.66 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.438 -0.788 . . . . 40.0 110.452 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -122.95 144.18 49.41 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 109.239 -0.652 . . . . 40.0 109.239 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.639 ' HZ2' ' CG ' ' A' ' 86' ' ' ASP . 4.7 tptp -133.89 144.84 49.13 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 119.569 -0.852 . . . . 40.0 110.979 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.535 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.8 t -122.95 166.74 14.58 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 108.939 -0.764 . . . . 40.0 108.939 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 40.7 p -140.3 -9.0 1.13 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.36 -0.837 . . . . 40.0 109.626 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.506 ' O ' ' CB ' ' A' ' 102' ' ' ALA . 1.2 p30 -108.58 14.63 24.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.958 -1.089 . . . . 40.0 110.285 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 101' ' ' ASP . . . 83.45 61.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.21 0.528 . . . . 40.0 110.539 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.647 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 28.5 m-85 71.23 -20.83 0.21 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.59 -0.694 . . . . 40.0 110.651 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.464 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.7 mt-30 -44.83 -74.13 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.074 -1.016 . . . . 40.0 109.83 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.47 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 21.0 p -106.02 167.01 10.09 Favored 'General case' 0 C--O 1.195 -1.806 0 N-CA-C 107.56 -1.274 . . . . 40.0 107.56 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.02 140.45 36.22 Favored 'General case' 0 C--N 1.264 -3.125 0 O-C-N 121.32 -0.863 . . . . 40.0 109.73 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.5 m -125.4 137.47 54.01 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.318 -0.993 . . . . 40.0 108.318 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.582 ' HZ3' ' C ' ' A' ' 110' ' ' ARG . 17.7 tttp -85.1 145.76 27.49 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.834 -1.166 . . . . 40.0 109.919 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.3 pt -121.78 -33.32 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.107 -0.996 . . . . 40.0 109.63 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.647 HH21 ' CG ' ' A' ' 8' ' ' ASP . 76.7 mtt180 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.945 . . . . 40.0 108.737 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.643 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 21.8 t . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 109.123 -0.695 . . . . 40.0 109.123 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -177.57 153.79 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.094 -0.706 . . . . 40.0 109.094 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.2 p-10 -144.38 26.1 1.48 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.066 -1.021 . . . . 40.0 110.729 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 10' ' ' VAL . 18.1 p -104.73 153.83 20.78 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.694 0.759 . . . . 40.0 109.779 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.48 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -56.99 -63.63 1.15 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.008 -1.057 . . . . 40.0 110.515 -179.267 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.652 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.8 OUTLIER -58.11 -41.76 84.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.481 -0.762 . . . . 40.0 109.781 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.6 -44.98 90.85 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 109.897 -1.281 . . . . 40.0 109.897 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.578 HG22 ' HG2' ' A' ' 21' ' ' PRO . 64.7 t -66.61 -43.41 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.485 -1.009 . . . . 40.0 108.608 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.93 -57.48 12.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.367 -0.605 . . . . 40.0 109.367 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.25 -55.63 14.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.514 -0.741 . . . . 40.0 109.039 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.708 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 38.0 t80 -52.4 -52.64 52.71 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.03 0.443 . . . . 40.0 110.268 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 18' ' ' HIS . 4.7 tt -71.42 -52.19 19.85 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.254 0.549 . . . . 40.0 110.68 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 11' ' ' ALA . 56.7 mt-30 -52.85 -28.94 25.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.113 -1.617 . . . . 40.0 109.939 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.8 m -91.1 -52.51 4.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.887 -1.133 . . . . 40.0 110.682 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -97.6 12.34 33.87 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.255 -0.903 . . . . 40.0 110.525 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.569 ' N ' ' O ' ' A' ' 14' ' ' LEU . 22.5 m80 43.36 25.04 0.06 Allowed 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.528 -0.733 . . . . 40.0 110.979 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.416 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 5.4 pttp -137.14 160.58 38.57 Favored 'General case' 0 C--O 1.182 -2.467 0 O-C-N 121.397 -0.814 . . . . 40.0 109.774 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 mp -80.07 146.08 62.39 Favored Pre-proline 0 C--N 1.266 -3.045 0 O-C-N 120.879 -1.138 . . . . 40.0 108.608 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.708 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 71.2 Cg_exo -41.26 156.11 0.06 OUTLIER 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.056 2.504 . . . . 40.0 113.982 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.643 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -67.35 49.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.178 -0.951 . . . . 40.0 109.352 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.513 ' HA ' ' HD3' ' A' ' 49' ' ' LYS . 0.8 OUTLIER -172.98 26.58 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.941 -1.099 . . . . 40.0 110.236 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.435 ' OH ' ' O ' ' A' ' 75' ' ' ASP . 4.3 m-85 -120.12 109.11 15.07 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.913 -1.115 . . . . 40.0 110.394 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 25' ' ' ILE . 16.5 pt -119.02 134.1 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.959 -1.126 . . . . 40.0 107.959 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.824 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.7 OUTLIER -71.78 172.59 9.55 Favored 'General case' 0 N--CA 1.508 2.444 0 CA-C-O 123.677 1.704 . . . . 40.0 113.249 -175.763 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.565 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 14.9 mtmt -60.67 -39.31 87.92 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 106.519 -1.66 . . . . 40.0 106.519 176.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.468 ' C ' ' O ' ' A' ' 27' ' ' LYS . 2.6 m -32.24 -74.3 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.533 -0.914 . . . . 40.0 108.533 175.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.572 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.8 mp0 -65.97 -57.49 7.68 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.116 -1.439 . . . . 40.0 107.116 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.572 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -30.22 -55.01 0.18 Allowed 'General case' 0 N--CA 1.53 3.559 0 O-C-N 119.931 -1.731 . . . . 40.0 109.78 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -56.13 -66.7 0.39 Allowed 'General case' 0 N--CA 1.525 3.31 0 O-C-N 120.033 -1.667 . . . . 40.0 113.679 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.71 -32.21 59.26 Favored 'General case' 0 N--CA 1.524 3.233 0 O-C-N 121.473 -0.767 . . . . 40.0 109.751 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.03 -22.35 66.79 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.178 -1.576 . . . . 40.0 108.633 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.36 51.27 0.4 Allowed Glycine 0 N--CA 1.503 3.144 0 N-CA-C 110.049 -1.22 . . . . 40.0 110.049 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.608 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -84.67 138.96 32.37 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.18 -1.188 . . . . 40.0 108.048 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.7 t -134.81 130.01 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.788 0 CA-C-O 121.74 0.781 . . . . 40.0 110.205 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -58.23 -50.37 73.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.935 -0.478 . . . . 40.0 110.005 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 76.4 p -70.36 45.45 0.08 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.573 -0.704 . . . . 40.0 110.123 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.595 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 2.0 ttpm? -177.14 -49.24 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.857 -0.794 . . . . 40.0 108.857 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.48 59.98 8.53 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 108.213 -1.955 . . . . 40.0 108.213 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.608 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -76.69 161.18 28.73 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.483 -1.01 . . . . 40.0 110.931 -177.837 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.846 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 48.8 tp -173.73 -68.5 0.01 OUTLIER 'General case' 0 C--O 1.194 -1.838 0 O-C-N 121.233 -0.917 . . . . 40.0 110.524 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -62.24 -20.45 64.24 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.504 -1.372 . . . . 40.0 109.318 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.4 p-10 -75.98 -61.88 1.78 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.925 -0.768 . . . . 40.0 108.925 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.9 m -80.11 -12.68 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.582 -0.699 . . . . 40.0 109.67 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -146.1 71.82 13.4 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.329 -0.857 . . . . 40.0 109.67 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -56.27 116.78 3.42 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.787 2.325 . . . . 40.0 113.375 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.87 36.67 52.14 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.757 -1.337 . . . . 40.0 109.757 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.58 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 6.8 mmtm -133.66 163.24 29.88 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 121.688 -0.889 . . . . 40.0 109.386 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.414 ' HG ' ' HD2' ' A' ' 78' ' ' TYR . 52.0 m -138.2 163.5 31.57 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.201 1.001 . . . . 40.0 111.135 -176.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.0 mm -80.83 123.2 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 CA-C-N 115.208 -0.905 . . . . 40.0 110.38 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . 176.94 155.63 13.99 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.468 -1.453 . . . . 40.0 109.468 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.824 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 117.36 -11.04 14.47 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.685 -1.245 . . . . 40.0 110.972 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.529 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 5.0 m-20 -72.63 -151.42 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.762 0 O-C-N 121.187 -1.184 . . . . 40.0 109.807 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -132.59 144.02 38.03 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.021 0 N-CA-C 108.256 -1.016 . . . . 40.0 108.256 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.62 ' O ' ' N ' ' A' ' 58' ' ' ASN . 15.3 t80 -112.7 90.81 3.44 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.195 -0.941 . . . . 40.0 109.157 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.652 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -59.72 38.34 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.708 0.766 . . . . 40.0 111.0 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.62 ' N ' ' O ' ' A' ' 56' ' ' PHE . 45.5 t30 34.77 37.82 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.032 -1.042 . . . . 40.0 110.964 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.652 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.4 mtm180 -70.23 38.08 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.956 -1.09 . . . . 40.0 109.85 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.608 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 12.4 mt-10 -145.47 -6.76 0.62 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.132 -0.98 . . . . 40.0 110.3 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.73 36.52 72.38 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.045 -1.622 . . . . 40.0 109.045 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.608 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 3.5 mttp -121.4 13.75 11.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.602 -0.94 . . . . 40.0 109.692 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.434 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -138.05 143.21 38.61 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.514 -0.741 . . . . 40.0 109.584 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -61.61 123.89 13.57 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.528 2.152 . . . . 40.0 112.322 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.53 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -103.02 -177.22 26.65 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 110.115 -1.194 . . . . 40.0 110.115 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.432 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 10.8 tttt -179.01 153.93 0.65 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.385 -1.068 . . . . 40.0 108.56 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 67' ' ' SER . 14.0 p -73.46 56.75 0.51 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.923 -1.111 . . . . 40.0 109.024 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.37 80.44 0.03 OUTLIER Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.694 -1.362 . . . . 40.0 109.694 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.575 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -176.05 177.41 1.6 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.795 -0.826 . . . . 40.0 108.847 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.575 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 59.5 m -155.28 155.77 34.36 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.2 -0.937 . . . . 40.0 109.898 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.706 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 28.8 m95 -125.01 140.61 52.76 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.874 -0.516 . . . . 40.0 110.038 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.626 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -131.88 150.54 52.12 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.95 -1.094 . . . . 40.0 109.679 179.206 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.565 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -115.62 168.65 9.83 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.137 0.97 . . . . 40.0 111.926 -179.372 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.436 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . . . -164.53 139.49 5.6 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.399 0.619 . . . . 40.0 110.217 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.722 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -61.34 153.43 26.68 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.055 0.455 . . . . 40.0 111.056 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.78 HD11 ' CG2' ' A' ' 88' ' ' ILE . 42.4 mm -135.8 146.64 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.411 -0.805 . . . . 40.0 110.2 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 55.37 71.49 0.54 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.409 0.623 . . . . 40.0 110.85 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.846 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 66.4 t80 -131.89 156.6 45.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.1 -1.0 . . . . 40.0 109.247 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' A' ' 80' ' ' SER . 21.0 p -136.87 -73.18 0.43 Allowed 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.181 0.515 . . . . 40.0 109.776 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.567 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -153.13 104.82 2.84 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.664 -0.648 . . . . 40.0 109.885 -178.503 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.456 ' N ' ' OH ' ' A' ' 78' ' ' TYR . . . 160.1 -100.36 0.19 Allowed Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.936 -1.266 . . . . 40.0 109.936 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.465 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 35.6 t80 -143.3 -169.95 3.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.738 -0.86 . . . . 40.0 109.541 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.634 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.5 mtm180 -71.65 -156.5 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.925 0.869 . . . . 40.0 110.423 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.467 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 12.9 p30 -166.17 -150.06 0.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.079 -1.082 . . . . 40.0 108.079 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' A' ' 100' ' ' THR . 71.5 p -102.87 -8.91 20.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.742 -1.224 . . . . 40.0 109.467 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.478 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -85.73 113.27 21.78 Favored 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 121.788 0.804 . . . . 40.0 111.812 -179.245 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.853 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.09 149.66 46.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.878 -1.139 . . . . 40.0 110.625 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.78 ' CG2' HD11 ' A' ' 76' ' ' ILE . 7.5 tt -116.56 138.8 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.988 0.899 . . . . 40.0 109.853 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.544 HD13 ' O ' ' A' ' 72' ' ' ARG . 3.1 mm? -117.82 126.2 51.97 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.541 -0.911 . . . . 40.0 108.541 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.686 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -119.79 129.32 54.4 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.876 -0.787 . . . . 40.0 108.876 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.706 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.5 p -93.13 158.31 15.83 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.285 1.041 . . . . 40.0 112.538 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.0 p -69.07 -17.11 63.83 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.345 -0.983 . . . . 40.0 108.345 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.481 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -86.72 9.01 20.17 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.5 -0.88 . . . . 40.0 109.428 179.714 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.46 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.29 26.77 0.54 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.517 -0.739 . . . . 40.0 110.175 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.3 mt -96.21 137.64 34.99 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.304 -0.872 . . . . 40.0 108.894 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.508 ' CG2' HD11 ' A' ' 109' ' ' ILE . 42.1 mm -111.99 121.18 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.508 -0.745 . . . . 40.0 110.589 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.41 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.4 m-85 -122.93 144.71 49.05 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 120.307 -0.557 . . . . 40.0 109.534 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.478 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 5.2 tptp -133.78 145.14 49.52 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.193 -0.942 . . . . 40.0 110.723 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.533 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.4 t -125.21 167.32 15.01 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.738 -0.838 . . . . 40.0 108.738 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.515 ' O ' ' OG ' ' A' ' 85' ' ' SER . 55.8 p -140.62 -9.05 1.08 Allowed 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.416 -0.803 . . . . 40.0 109.76 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.688 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -107.23 13.74 26.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.126 -0.984 . . . . 40.0 110.107 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 84.02 62.8 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.244 0.545 . . . . 40.0 109.982 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.634 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 32.6 m-85 70.88 -22.05 0.19 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.582 -0.699 . . . . 40.0 111.076 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.425 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.5 mt-30 -44.57 -74.21 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.1 -1.0 . . . . 40.0 110.125 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.529 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 21.1 p -105.14 164.2 12.0 Favored 'General case' 0 C--O 1.198 -1.652 0 N-CA-C 107.78 -1.193 . . . . 40.0 107.78 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.537 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -138.27 139.01 38.99 Favored 'General case' 0 C--N 1.269 -2.9 0 O-C-N 121.45 -0.781 . . . . 40.0 110.07 -179.442 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 37.5 m -125.27 137.23 54.08 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.497 -0.927 . . . . 40.0 108.497 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.522 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 16.3 tttp -83.52 146.23 28.47 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.877 -1.139 . . . . 40.0 109.559 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.508 HD11 ' CG2' ' A' ' 96' ' ' ILE . 15.2 pt -122.29 -33.99 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 C-N-CA 119.65 -0.82 . . . . 40.0 109.153 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.652 HH21 ' CG ' ' A' ' 8' ' ' ASP . 73.6 mtt180 . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 118.266 -0.873 . . . . 40.0 109.102 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.647 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 10.4 t . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.218 0.533 . . . . 40.0 109.942 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -175.73 151.05 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 108.992 -0.744 . . . . 40.0 108.992 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -141.88 23.13 2.09 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 120.866 -1.146 . . . . 40.0 110.738 -177.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 10' ' ' VAL . 11.7 p -105.16 153.38 21.61 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.634 0.73 . . . . 40.0 110.239 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.533 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -56.42 -62.97 1.36 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.968 -1.083 . . . . 40.0 111.354 -179.283 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.621 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.7 OUTLIER -58.88 -41.56 87.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.062 -1.024 . . . . 40.0 109.639 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.43 -46.18 73.68 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.093 -1.203 . . . . 40.0 110.093 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.53 HG22 ' HG2' ' A' ' 21' ' ' PRO . 79.8 t -67.95 -42.79 85.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 O-C-N 121.69 -0.888 . . . . 40.0 108.66 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -59.74 -61.07 2.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.457 -0.777 . . . . 40.0 109.549 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.29 -56.73 6.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.574 -0.704 . . . . 40.0 109.465 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.776 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 41.3 t80 -51.44 -53.18 39.64 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 116.153 -0.476 . . . . 40.0 110.758 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' A' ' 18' ' ' HIS . 1.8 tt -72.27 -51.08 22.51 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 121.165 0.507 . . . . 40.0 110.732 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 11' ' ' ALA . 66.3 mt-30 -52.06 -26.39 10.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.107 -1.621 . . . . 40.0 110.549 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.3 m -93.44 -47.84 6.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.53 -1.356 . . . . 40.0 111.449 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.46 ' O ' ' N ' ' A' ' 19' ' ' LYS . 90.5 m-85 -104.01 19.11 20.66 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.933 -1.104 . . . . 40.0 109.673 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.426 ' N ' ' O ' ' A' ' 14' ' ' LEU . 32.8 m80 40.66 25.58 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.717 0 O-C-N 121.035 -1.041 . . . . 40.0 110.863 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.472 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 3.8 pttp -137.34 157.49 46.49 Favored 'General case' 0 C--O 1.185 -2.311 0 CA-C-O 121.809 0.814 . . . . 40.0 110.466 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.48 146.11 65.03 Favored Pre-proline 0 C--N 1.271 -2.827 0 N-CA-C 108.534 -0.913 . . . . 40.0 108.534 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.776 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 88.3 Cg_exo -40.46 155.97 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.369 2.713 . . . . 40.0 114.217 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.647 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -67.22 48.44 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.897 0.856 . . . . 40.0 109.84 -179.226 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -173.13 25.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.981 -1.074 . . . . 40.0 110.52 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -118.27 109.26 16.11 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.193 -1.003 . . . . 40.0 110.07 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 25' ' ' ILE . 11.5 pt -118.33 133.98 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.78 -1.193 . . . . 40.0 107.78 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.829 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -69.38 174.96 4.31 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 124.158 1.933 . . . . 40.0 112.559 -177.403 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.555 ' HB3' ' NE2' ' A' ' 31' ' ' GLN . 17.8 mtmt -64.28 -36.7 84.94 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.704 -1.591 . . . . 40.0 106.704 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.512 ' OG ' ' OG1' ' A' ' 26' ' ' THR . 4.4 m -35.95 -70.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.049 0.928 . . . . 40.0 109.674 175.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.507 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.2 mp0 -66.49 -52.42 46.25 Favored 'General case' 0 C--O 1.204 -1.295 0 CA-C-N 114.319 -1.31 . . . . 40.0 108.47 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.507 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -42.64 -50.66 5.41 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 119.988 -1.695 . . . . 40.0 109.352 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.555 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 32.9 mt-30 -56.28 -63.94 1.02 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.389 -0.82 . . . . 40.0 111.083 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.91 -22.87 67.06 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.017 -1.052 . . . . 40.0 109.887 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.8 tp -68.15 -23.5 64.88 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.994 -1.066 . . . . 40.0 108.178 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.04 53.4 0.26 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.419 -1.072 . . . . 40.0 110.419 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.584 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -87.81 140.15 29.8 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.263 -1.139 . . . . 40.0 109.456 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.9 t -134.65 130.73 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.041 0 O-C-N 121.685 -0.634 . . . . 40.0 109.807 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -59.57 -48.95 79.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.726 -0.609 . . . . 40.0 109.588 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.3 p -70.12 46.89 0.08 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.44 -0.787 . . . . 40.0 110.01 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.61 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.7 ttpm? -179.12 -51.72 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.076 -0.713 . . . . 40.0 109.076 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.28 60.53 7.4 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 108.58 -1.808 . . . . 40.0 108.58 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.61 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -76.24 159.83 30.24 Favored 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.749 -0.854 . . . . 40.0 111.063 -178.043 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.874 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 63.9 tp -172.64 -69.89 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.751 -0.78 . . . . 40.0 110.249 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.579 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.46 -19.93 58.17 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.924 -1.11 . . . . 40.0 109.556 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 4.5 p-10 -77.02 -61.91 1.82 Allowed 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.696 -0.853 . . . . 40.0 108.696 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.4 m -79.08 -11.58 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 109.356 -0.609 . . . . 40.0 109.356 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -149.8 74.69 9.36 Favored Pre-proline 0 N--CA 1.49 1.546 0 CA-C-O 122.259 1.028 . . . . 40.0 109.977 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.9 117.8 4.58 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 124.044 3.163 . . . . 40.0 113.106 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.69 40.08 46.85 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.867 -1.693 . . . . 40.0 108.867 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.45 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 6.7 mmtm -136.04 169.59 17.36 Favored 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 121.884 0.85 . . . . 40.0 110.571 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.6 m -144.85 160.7 40.87 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.713 -1.242 . . . . 40.0 111.856 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.4 mm -80.61 125.78 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-N 115.167 -0.924 . . . . 40.0 110.502 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.95 157.29 15.17 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.543 -1.423 . . . . 40.0 109.543 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.829 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 116.03 -9.02 18.48 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.539 -1.315 . . . . 40.0 110.169 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.446 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 5.1 m-20 -74.53 -151.9 0.03 OUTLIER 'General case' 0 C--O 1.196 -1.716 0 O-C-N 120.417 -1.637 . . . . 40.0 109.242 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.74 143.93 38.88 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.829 0 N-CA-C 107.878 -1.156 . . . . 40.0 107.878 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.653 ' O ' ' N ' ' A' ' 58' ' ' ASN . 12.6 t80 -112.14 89.79 3.16 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.952 -0.699 . . . . 40.0 109.247 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.666 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.8 p -58.83 38.39 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.821 0.82 . . . . 40.0 110.803 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.653 ' N ' ' O ' ' A' ' 56' ' ' PHE . 44.1 t30 33.84 38.19 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.237 -0.914 . . . . 40.0 110.708 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.666 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.2 mtm180 -68.89 35.68 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.67 -1.268 . . . . 40.0 110.163 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.608 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 14.5 mt-10 -145.35 -2.56 0.77 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.748 -1.22 . . . . 40.0 110.225 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.25 38.59 57.1 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.436 -1.466 . . . . 40.0 109.436 -178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.608 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 5.5 mttp -121.21 12.82 11.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.373 -1.075 . . . . 40.0 109.334 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.463 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.5 mt -137.89 144.4 43.91 Favored Pre-proline 0 N--CA 1.496 1.834 0 CA-C-O 121.395 0.617 . . . . 40.0 109.467 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.83 123.2 12.19 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.536 2.157 . . . . 40.0 112.657 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.547 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.85 -177.98 26.79 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.054 -1.218 . . . . 40.0 110.054 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.468 ' NZ ' ' O ' ' A' ' 68' ' ' GLY . 8.8 tttt -177.66 153.15 0.85 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.026 -1.101 . . . . 40.0 108.026 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.6 p -72.25 53.03 0.27 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.833 -1.167 . . . . 40.0 109.395 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.468 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 150.97 80.13 0.03 OUTLIER Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.923 -1.271 . . . . 40.0 109.923 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.576 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -173.55 178.84 2.22 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.696 -0.885 . . . . 40.0 108.833 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.576 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 100.0 m -155.61 155.17 32.82 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.361 -0.935 . . . . 40.0 110.199 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.706 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 30.5 m95 -124.77 139.84 53.48 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.247 0.546 . . . . 40.0 110.064 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.623 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.91 148.92 52.74 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 120.756 -1.215 . . . . 40.0 109.436 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.505 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -115.01 168.47 9.89 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 122.181 0.991 . . . . 40.0 111.79 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -162.96 138.95 7.09 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.593 0.711 . . . . 40.0 111.121 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.718 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -61.08 154.52 22.7 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.509 -0.744 . . . . 40.0 110.804 -179.654 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.718 HD13 ' O ' ' A' ' 75' ' ' ASP . 40.1 mm -137.61 144.09 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 119.796 -0.762 . . . . 40.0 110.607 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 58.7 70.09 0.68 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.574 -0.704 . . . . 40.0 110.884 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.874 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 66.1 t80 -131.9 157.8 43.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.222 -0.924 . . . . 40.0 109.928 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.588 ' OG1' ' N ' ' A' ' 80' ' ' SER . 22.1 p -139.41 -70.15 0.41 Allowed 'General case' 0 N--CA 1.511 2.621 0 O-C-N 121.73 -0.606 . . . . 40.0 109.501 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.588 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.9 OUTLIER -154.42 105.76 2.69 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.737 -0.468 . . . . 40.0 109.737 -178.696 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.7 -103.93 0.23 Allowed Glycine 0 N--CA 1.498 2.774 0 C-N-CA 119.585 -1.293 . . . . 40.0 110.091 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 43.9 t80 -139.96 -166.66 2.13 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.086 -0.709 . . . . 40.0 109.086 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.633 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.4 mtm180 -73.95 -154.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.133 -0.979 . . . . 40.0 110.413 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.49 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 11.7 p30 -167.87 -150.99 0.1 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.08 -1.082 . . . . 40.0 108.08 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.6 p -102.98 -6.92 21.89 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.904 -1.123 . . . . 40.0 109.452 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.512 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -88.14 113.92 24.24 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 121.737 0.779 . . . . 40.0 111.47 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.859 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.22 149.78 44.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.979 -1.076 . . . . 40.0 110.675 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.653 ' CG2' HD11 ' A' ' 76' ' ' ILE . 6.1 tt -116.8 139.79 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 122.126 0.965 . . . . 40.0 109.865 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 72' ' ' ARG . 2.9 mm? -117.95 126.02 51.54 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.792 -0.818 . . . . 40.0 108.792 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.674 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.78 129.15 55.09 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.882 -0.784 . . . . 40.0 108.882 179.664 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.706 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 5.0 p -94.15 159.41 15.16 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 122.344 1.069 . . . . 40.0 112.219 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.3 p -69.91 -16.16 63.18 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.427 -0.953 . . . . 40.0 108.427 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.478 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -88.11 8.99 24.21 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.129 -0.628 . . . . 40.0 109.512 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.449 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.69 26.52 0.49 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.94 -0.475 . . . . 40.0 110.055 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.406 HD12 HH21 ' A' ' 69' ' ' ARG . 22.5 mt -95.55 137.08 35.11 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.305 -0.872 . . . . 40.0 109.499 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.483 ' CG2' HD11 ' A' ' 109' ' ' ILE . 39.7 mm -111.51 119.25 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.846 -0.533 . . . . 40.0 110.411 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.409 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.6 m-85 -121.96 144.3 48.96 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 109.688 -0.486 . . . . 40.0 109.688 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.512 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 4.7 tptp -133.77 144.45 49.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.188 -0.945 . . . . 40.0 110.591 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.601 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.8 t -123.57 166.03 16.14 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.673 -0.862 . . . . 40.0 108.673 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.6 p -139.51 -10.84 1.21 Allowed 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.441 -0.787 . . . . 40.0 109.536 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.691 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -107.56 13.87 26.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.01 -1.056 . . . . 40.0 110.508 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 84.27 61.24 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.669 -0.644 . . . . 40.0 110.275 178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.633 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 27.6 m-85 71.71 -21.16 0.22 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.497 -0.752 . . . . 40.0 110.972 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.413 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.7 mt-30 -44.38 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.119 -0.988 . . . . 40.0 109.88 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.497 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 22.7 p -105.29 168.95 8.74 Favored 'General case' 0 C--O 1.196 -1.721 0 N-CA-C 107.702 -1.221 . . . . 40.0 107.702 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.549 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -141.82 139.68 32.78 Favored 'General case' 0 C--N 1.267 -2.994 0 O-C-N 121.411 -0.806 . . . . 40.0 109.706 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.5 m -125.43 136.33 53.29 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.922 -1.14 . . . . 40.0 107.922 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.618 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 18.8 tttp -85.37 145.9 27.26 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.971 -1.081 . . . . 40.0 109.823 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.483 HD11 ' CG2' ' A' ' 96' ' ' ILE . 14.1 pt -121.44 -32.14 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 120.95 -1.094 . . . . 40.0 109.651 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.621 HH21 ' CG ' ' A' ' 8' ' ' ASP . 80.6 mtt180 . . . . . 0 N--CA 1.486 1.328 0 O-C-N 121.165 -0.959 . . . . 40.0 108.971 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.614 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 15.1 t . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.119 -0.697 . . . . 40.0 109.119 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -178.57 152.26 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.884 -0.784 . . . . 40.0 108.884 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -143.26 24.24 1.79 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.939 -1.101 . . . . 40.0 110.687 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 10' ' ' VAL . 16.5 p -105.57 152.98 22.4 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.594 0.712 . . . . 40.0 110.169 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.481 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -55.36 -64.56 0.8 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.985 -1.072 . . . . 40.0 110.981 -179.038 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.618 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.52 -41.86 81.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.025 -1.047 . . . . 40.0 110.035 -179.007 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.38 -45.46 75.29 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.759 -1.336 . . . . 40.0 109.759 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.585 HG22 ' HG2' ' A' ' 21' ' ' PRO . 77.5 t -68.08 -42.68 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.792 -0.828 . . . . 40.0 109.276 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.89 -57.96 10.47 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.592 -0.892 . . . . 40.0 108.592 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.8 -56.64 9.57 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.116 -0.698 . . . . 40.0 109.116 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.788 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 40.3 t80 -51.69 -52.8 45.46 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.134 0.492 . . . . 40.0 110.525 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 18' ' ' HIS . 1.6 tt -72.55 -51.9 17.93 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.813 -0.554 . . . . 40.0 111.166 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 11' ' ' ALA . 63.9 mt-30 -50.92 -27.79 8.31 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.292 -1.505 . . . . 40.0 110.617 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 m -93.0 -49.79 5.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.901 -1.125 . . . . 40.0 111.395 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 19' ' ' LYS . 87.9 m-85 -100.16 16.55 23.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.989 -1.069 . . . . 40.0 109.585 -178.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 14' ' ' LEU . 16.9 m80 39.75 26.56 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.472 -0.767 . . . . 40.0 110.733 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 17' ' ' TYR . 3.8 pttp -137.01 159.8 40.82 Favored 'General case' 0 C--O 1.185 -2.336 0 CA-C-O 121.977 0.894 . . . . 40.0 110.617 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.95 145.33 61.26 Favored Pre-proline 0 C--N 1.268 -2.971 0 O-C-N 121.071 -1.018 . . . . 40.0 108.402 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.788 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 86.7 Cg_exo -39.29 155.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 123.43 2.753 . . . . 40.0 114.358 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.614 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -68.2 51.34 0.07 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.075 -1.015 . . . . 40.0 109.379 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -175.71 27.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 40.0 110.51 179.089 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -119.65 109.33 15.53 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.494 -1.379 . . . . 40.0 109.973 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 20.4 pt -117.85 132.27 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.135 -1.061 . . . . 40.0 108.135 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.86 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -69.59 173.94 5.53 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 123.787 1.756 . . . . 40.0 113.244 -177.591 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.455 ' HE2' ' OD1' ' A' ' 54' ' ' ASP . 17.4 mtmt -63.53 -37.46 87.4 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.802 -1.555 . . . . 40.0 106.802 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.453 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 5.6 m -37.09 -70.87 0.08 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 122.184 0.992 . . . . 40.0 109.371 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.511 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.5 mp0 -65.35 -57.27 8.8 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.131 -1.433 . . . . 40.0 107.131 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.511 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -37.21 -51.67 1.03 Allowed 'General case' 0 N--CA 1.511 2.579 0 O-C-N 120.685 -1.259 . . . . 40.0 109.176 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -57.34 -63.95 1.05 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.437 -1.414 . . . . 40.0 111.485 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.42 -22.41 66.15 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 120.398 -1.439 . . . . 40.0 110.066 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.425 HD21 ' HB ' ' A' ' 45' ' ' VAL . 59.0 tp -68.64 -26.08 65.15 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.414 -1.328 . . . . 40.0 107.414 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 124.26 47.15 0.24 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.991 -0.844 . . . . 40.0 110.991 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.604 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.36 143.39 32.22 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.865 -1.373 . . . . 40.0 109.7 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.22 128.73 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 O-C-N 121.472 -0.767 . . . . 40.0 109.612 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -58.27 -49.96 75.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.778 -0.576 . . . . 40.0 109.602 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.6 p -70.07 47.21 0.08 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.356 -0.84 . . . . 40.0 109.967 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.599 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -179.32 -50.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.022 -0.733 . . . . 40.0 109.022 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.56 60.03 8.85 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 108.26 -1.936 . . . . 40.0 108.26 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.604 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -75.82 162.45 28.15 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.593 -0.946 . . . . 40.0 111.007 -177.852 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.769 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 43.7 tp -174.12 -70.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.748 -0.781 . . . . 40.0 110.274 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.547 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.94 -21.21 63.21 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.906 -1.121 . . . . 40.0 109.571 -178.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.0 p-10 -74.19 -62.8 1.39 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.711 -0.848 . . . . 40.0 108.711 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.425 ' HB ' HD21 ' A' ' 33' ' ' LEU . 16.1 m -79.35 -11.62 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.568 -0.531 . . . . 40.0 109.568 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.48 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -148.56 72.25 10.72 Favored Pre-proline 0 N--CA 1.486 1.34 0 CA-C-O 121.883 0.849 . . . . 40.0 109.449 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.8 118.18 5.01 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.994 2.463 . . . . 40.0 113.923 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.51 36.71 48.48 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.272 -1.531 . . . . 40.0 109.272 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.48 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 7.0 mmtm -134.37 163.95 28.52 Favored 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.614 0.721 . . . . 40.0 109.864 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.424 ' HA ' HD21 ' A' ' 42' ' ' LEU . 70.6 m -138.97 163.75 31.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 40.0 111.173 -176.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 13.0 mm -81.45 126.98 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-N 115.548 -0.751 . . . . 40.0 110.43 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.28 157.46 15.88 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.492 -1.443 . . . . 40.0 109.492 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.86 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 117.5 -10.34 14.53 Favored Glycine 0 N--CA 1.499 2.895 0 C-N-CA 118.945 -1.598 . . . . 40.0 110.369 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.495 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 4.6 m-20 -75.29 -151.62 0.03 OUTLIER 'General case' 0 C--O 1.197 -1.675 0 O-C-N 120.948 -1.325 . . . . 40.0 109.847 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.1 142.16 44.22 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.944 0 CA-C-N 114.86 -1.064 . . . . 40.0 108.665 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.624 ' O ' ' N ' ' A' ' 58' ' ' ASN . 15.1 t80 -111.4 90.66 3.4 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.875 -0.787 . . . . 40.0 108.875 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.647 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -59.63 38.56 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.605 0.717 . . . . 40.0 110.823 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' A' ' 56' ' ' PHE . 43.5 t30 33.82 38.07 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.012 -1.055 . . . . 40.0 111.33 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.647 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.5 mtm180 -69.03 34.66 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.951 -1.093 . . . . 40.0 110.483 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.614 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 15.5 mt-10 -144.1 -2.86 0.88 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.13 -0.981 . . . . 40.0 110.285 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.26 38.02 56.08 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.418 -1.473 . . . . 40.0 109.418 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.614 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 4.9 mttp -120.89 13.29 11.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.593 -0.946 . . . . 40.0 109.295 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.474 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -138.7 142.98 36.0 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.705 -0.622 . . . . 40.0 109.616 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -60.69 123.32 12.76 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.499 2.133 . . . . 40.0 112.629 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.52 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.96 -177.63 26.69 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.935 -1.266 . . . . 40.0 109.935 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.411 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 10.1 tttt -178.94 153.05 0.61 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.041 -1.096 . . . . 40.0 108.041 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.8 p -71.84 54.95 0.27 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.885 -1.134 . . . . 40.0 109.239 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.31 79.64 0.03 OUTLIER Glycine 0 N--CA 1.5 2.92 0 N-CA-C 110.137 -1.185 . . . . 40.0 110.137 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.579 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.92 179.06 1.69 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.694 -0.886 . . . . 40.0 109.082 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.579 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 99.9 m -155.81 154.77 31.87 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.405 -0.918 . . . . 40.0 109.8 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.696 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 29.9 m95 -124.02 140.6 52.81 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.723 -0.473 . . . . 40.0 109.723 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.634 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.81 149.49 52.43 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.837 -1.164 . . . . 40.0 109.574 179.55 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.535 ' O ' ' OH ' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -114.33 168.15 10.09 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.068 -1.02 . . . . 40.0 112.185 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.15 136.72 4.97 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.544 -0.723 . . . . 40.0 110.798 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.76 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -59.21 154.49 16.11 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 120.881 0.372 . . . . 40.0 111.102 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.76 HD13 ' O ' ' A' ' 75' ' ' ASP . 38.0 mm -137.8 146.06 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.682 -0.807 . . . . 40.0 110.456 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 57.64 69.96 0.69 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.316 0.579 . . . . 40.0 110.534 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.769 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 68.6 t80 -131.01 155.9 46.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.082 -1.011 . . . . 40.0 110.045 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 80' ' ' SER . 23.9 p -137.23 -72.66 0.43 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.822 -0.549 . . . . 40.0 109.557 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.572 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.9 OUTLIER -153.05 106.14 2.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 122.071 -0.393 . . . . 40.0 110.132 -179.084 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.8 -105.11 0.25 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.706 -1.357 . . . . 40.0 109.706 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 41.5 t80 -138.81 -166.05 1.94 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.006 -0.702 . . . . 40.0 109.175 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.644 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.6 mtm180 -74.21 -154.69 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.265 -0.897 . . . . 40.0 110.008 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.597 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 8.1 p30 -167.02 -150.79 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.178 -1.045 . . . . 40.0 108.178 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.531 ' OG ' ' O ' ' A' ' 100' ' ' THR . 59.4 p -102.5 -8.14 21.3 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 120.823 -1.173 . . . . 40.0 109.155 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.501 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.13 114.29 23.6 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-O 121.832 0.825 . . . . 40.0 111.456 -179.501 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.876 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.01 150.53 45.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.916 -1.115 . . . . 40.0 110.959 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.703 ' CG2' HD11 ' A' ' 76' ' ' ILE . 5.0 tt -116.92 140.43 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 122.304 1.049 . . . . 40.0 110.01 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 72' ' ' ARG . 3.0 mm? -119.33 125.19 48.46 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.349 -0.982 . . . . 40.0 108.349 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.677 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -119.16 129.88 55.24 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.913 -0.773 . . . . 40.0 108.913 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.696 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.1 p -94.91 159.47 15.02 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.438 1.113 . . . . 40.0 112.96 -178.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.1 p -69.58 -16.92 63.5 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.097 -1.075 . . . . 40.0 108.097 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.478 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -87.81 9.26 22.4 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.658 -0.817 . . . . 40.0 109.556 179.632 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.468 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.98 26.95 0.58 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.581 -0.699 . . . . 40.0 110.249 179.451 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.8 mt -96.22 136.25 36.93 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.424 -0.798 . . . . 40.0 109.164 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.494 ' CG2' HD11 ' A' ' 109' ' ' ILE . 39.8 mm -110.8 120.43 61.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.505 -0.747 . . . . 40.0 110.554 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.403 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.6 m-85 -123.03 144.56 49.19 Favored 'General case' 0 N--CA 1.504 2.265 0 C-N-CA 120.467 -0.493 . . . . 40.0 109.804 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.501 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 6.0 tptp -133.71 144.31 49.04 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.592 -0.693 . . . . 40.0 110.722 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.571 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.7 t -124.21 166.47 15.79 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.632 -0.877 . . . . 40.0 108.632 177.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.531 ' O ' ' OG ' ' A' ' 85' ' ' SER . 40.4 p -140.33 -8.35 1.14 Allowed 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.314 -0.866 . . . . 40.0 109.702 178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.688 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -108.67 13.03 25.42 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.058 -1.026 . . . . 40.0 110.06 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 84.56 62.44 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.318 0.58 . . . . 40.0 110.34 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.644 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 27.1 m-85 71.23 -21.92 0.2 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.459 -0.776 . . . . 40.0 110.868 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.421 ' H ' ' C ' ' A' ' 102' ' ' ALA . 2.0 mt-30 -44.18 -74.28 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.333 -0.855 . . . . 40.0 109.69 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.507 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 25.3 p -105.53 166.58 10.34 Favored 'General case' 0 C--O 1.194 -1.82 0 N-CA-C 107.82 -1.178 . . . . 40.0 107.82 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.534 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -139.42 138.82 36.82 Favored 'General case' 0 C--N 1.27 -2.87 0 O-C-N 121.441 -0.787 . . . . 40.0 109.973 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.2 m -124.17 136.73 54.4 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.182 -1.044 . . . . 40.0 108.182 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.544 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 19.0 tttp -85.64 146.32 26.91 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.704 -1.247 . . . . 40.0 109.616 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.494 HD11 ' CG2' ' A' ' 96' ' ' ILE . 13.5 pt -121.67 -34.08 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.244 -0.91 . . . . 40.0 109.476 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.618 HH21 ' CG ' ' A' ' 8' ' ' ASP . 78.2 mtt180 . . . . . 0 N--CA 1.488 1.452 0 O-C-N 121.197 -0.939 . . . . 40.0 108.875 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.632 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 18.5 t . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.471 -0.566 . . . . 40.0 109.471 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 tt -175.74 153.7 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.909 -0.775 . . . . 40.0 108.909 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -143.95 25.88 1.57 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.8 -1.188 . . . . 40.0 110.506 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 10' ' ' VAL . 15.7 p -105.3 153.61 21.38 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.469 0.652 . . . . 40.0 109.638 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.506 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -56.97 -64.0 1.02 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.115 -0.991 . . . . 40.0 110.817 -178.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.641 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.39 -42.01 81.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.379 -0.826 . . . . 40.0 109.705 -179.719 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.68 -45.95 76.57 Favored Glycine 0 N--CA 1.503 3.101 0 N-CA-C 109.968 -1.253 . . . . 40.0 109.968 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.533 HG22 ' HG2' ' A' ' 21' ' ' PRO . 69.7 t -66.95 -42.6 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.767 -0.843 . . . . 40.0 108.933 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.88 -58.4 8.59 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.842 -0.799 . . . . 40.0 108.842 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.07 -56.2 9.78 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.843 -0.799 . . . . 40.0 108.843 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.725 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 35.7 t80 -52.92 -51.81 59.99 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 116.084 -0.507 . . . . 40.0 110.673 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 18' ' ' HIS . 5.1 tt -72.28 -51.4 21.02 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.575 -0.703 . . . . 40.0 110.942 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 11' ' ' ALA . 54.9 mt-30 -52.9 -28.26 22.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.271 -1.518 . . . . 40.0 110.285 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.1 m -92.96 -51.25 5.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.085 -1.009 . . . . 40.0 110.825 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -98.17 10.3 40.87 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.994 -1.066 . . . . 40.0 110.205 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.573 ' N ' ' O ' ' A' ' 14' ' ' LEU . 20.1 m80 44.56 23.73 0.08 Allowed 'General case' 0 N--CA 1.52 3.067 0 O-C-N 121.42 -0.8 . . . . 40.0 110.879 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.5 pttp -135.62 160.94 36.93 Favored 'General case' 0 C--O 1.182 -2.496 0 O-C-N 121.399 -0.813 . . . . 40.0 109.566 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 24' ' ' TYR . 4.4 mp -80.47 147.0 62.68 Favored Pre-proline 0 C--N 1.268 -2.964 0 N-CA-C 108.26 -1.015 . . . . 40.0 108.26 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.725 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 83.7 Cg_exo -42.28 157.49 0.07 OUTLIER 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 123.26 2.64 . . . . 40.0 113.633 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.632 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -66.86 49.1 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.049 -1.032 . . . . 40.0 109.871 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.526 ' HA ' ' HD3' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -172.14 24.92 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.925 -1.109 . . . . 40.0 110.139 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.408 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 4.0 m-85 -117.52 106.74 13.47 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.508 -1.37 . . . . 40.0 110.63 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.4 pt -116.47 133.92 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.061 -1.024 . . . . 40.0 108.37 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.772 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -69.09 172.38 6.86 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-O 123.588 1.661 . . . . 40.0 112.96 -177.491 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.508 ' HB3' ' NE2' ' A' ' 31' ' ' GLN . 12.8 mtmt -62.65 -38.78 91.64 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 105.483 -2.043 . . . . 40.0 105.483 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.472 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 11.4 m -34.75 -71.68 0.06 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.103 -0.953 . . . . 40.0 108.792 175.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.55 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.1 mp0 -66.25 -59.5 3.67 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 118.509 -1.276 . . . . 40.0 107.578 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.55 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -31.43 -55.52 0.26 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 119.503 1.047 . . . . 40.0 110.445 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.508 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 25.9 mt-30 -58.0 -63.59 1.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.497 -1.377 . . . . 40.0 111.109 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.29 -27.05 63.71 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.732 -1.23 . . . . 40.0 110.621 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.7 tp -68.56 -22.52 64.48 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 108.485 -0.932 . . . . 40.0 108.485 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.42 48.99 0.25 Allowed Glycine 0 N--CA 1.496 2.687 0 C-N-CA 120.948 -0.644 . . . . 40.0 111.686 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.609 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -85.7 137.9 32.5 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.115 -1.226 . . . . 40.0 110.194 179.45 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.4 t -134.37 132.12 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.093 0 O-C-N 121.394 -0.816 . . . . 40.0 110.412 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.411 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -59.26 -48.92 79.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.708 -0.62 . . . . 40.0 109.487 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.7 p -69.71 45.75 0.07 Allowed 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 121.635 0.731 . . . . 40.0 110.527 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.507 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.6 ttpm? -178.3 -51.42 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.121 -0.696 . . . . 40.0 109.121 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.6 59.84 8.68 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 108.221 -1.952 . . . . 40.0 108.221 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.609 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -76.51 160.6 29.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.661 -0.906 . . . . 40.0 111.32 -177.68 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.797 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 61.8 tp -174.77 -68.67 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.913 -1.117 . . . . 40.0 110.911 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.631 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.29 -20.31 58.6 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.49 -1.381 . . . . 40.0 109.573 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 2.6 p-10 -75.95 -64.8 1.01 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.712 -0.847 . . . . 40.0 108.712 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.43 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 30.3 m -77.18 -12.68 14.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 109.415 -0.587 . . . . 40.0 109.415 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -145.6 72.08 14.04 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.56 -0.713 . . . . 40.0 110.086 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -56.91 116.79 3.45 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.73 2.287 . . . . 40.0 114.976 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.38 37.33 47.79 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.344 -1.503 . . . . 40.0 109.344 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.526 ' HD3' ' HA ' ' A' ' 23' ' ' ASN . 7.1 mmtt -132.6 171.03 14.35 Favored 'General case' 0 N--CA 1.508 2.446 0 CA-C-O 122.078 0.942 . . . . 40.0 110.226 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.3 m -145.69 162.06 38.44 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.884 -1.135 . . . . 40.0 111.501 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.8 mm -81.81 123.84 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-N 115.401 -0.818 . . . . 40.0 110.881 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.46 155.86 13.53 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.109 -1.596 . . . . 40.0 109.109 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.772 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 120.44 -12.19 10.36 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.278 -1.439 . . . . 40.0 110.402 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.455 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 5.0 m-20 -74.1 -154.22 0.03 OUTLIER 'General case' 0 C--O 1.193 -1.911 0 O-C-N 121.182 -1.187 . . . . 40.0 110.308 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 mp -128.57 142.74 43.11 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.868 0 CA-C-N 115.476 -0.784 . . . . 40.0 109.084 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.633 ' O ' ' N ' ' A' ' 58' ' ' ASN . 12.7 t80 -111.08 90.18 3.26 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.333 -0.855 . . . . 40.0 109.169 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.633 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -59.45 38.78 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 122.023 0.916 . . . . 40.0 110.842 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.633 ' N ' ' O ' ' A' ' 56' ' ' PHE . 45.7 t30 34.14 38.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.193 -0.942 . . . . 40.0 110.618 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.633 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 11.2 mtm180 -69.89 37.97 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.765 -1.209 . . . . 40.0 109.992 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.601 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 13.0 mt-10 -146.14 -6.92 0.56 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.038 -1.039 . . . . 40.0 109.968 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.31 37.53 74.03 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 109.424 -1.471 . . . . 40.0 109.424 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.601 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 4.5 mttp -121.11 12.35 11.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.802 -0.822 . . . . 40.0 109.3 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.42 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -136.89 142.53 38.95 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.681 -0.637 . . . . 40.0 109.455 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -61.91 122.7 11.35 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.597 2.198 . . . . 40.0 112.27 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.514 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.05 -178.02 27.82 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.033 -1.227 . . . . 40.0 110.033 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 9.5 tttt -177.76 154.14 0.91 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.42 -1.047 . . . . 40.0 108.267 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.5 p -72.05 53.79 0.27 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.981 -1.074 . . . . 40.0 109.183 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.42 79.61 0.03 OUTLIER Glycine 0 N--CA 1.498 2.806 0 N-CA-C 110.017 -1.233 . . . . 40.0 110.017 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.574 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.14 178.53 2.08 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.734 -0.863 . . . . 40.0 108.991 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.574 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 98.9 m -155.42 155.53 33.74 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.202 -0.936 . . . . 40.0 109.823 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.694 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 29.1 m95 -125.07 140.64 52.72 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.834 -0.542 . . . . 40.0 109.636 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.622 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -131.35 147.32 52.56 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.105 -0.997 . . . . 40.0 110.162 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.464 ' O ' ' OH ' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -111.39 168.64 9.38 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 122.466 1.127 . . . . 40.0 112.352 -179.485 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.94 136.54 3.57 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.668 -0.645 . . . . 40.0 111.039 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.708 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -58.58 154.51 14.1 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.016 0.436 . . . . 40.0 110.832 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.712 HD11 ' CG2' ' A' ' 88' ' ' ILE . 43.3 mm -137.57 146.18 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.477 -0.764 . . . . 40.0 109.733 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 56.44 70.94 0.6 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.491 0.662 . . . . 40.0 110.948 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.797 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 68.8 t80 -132.04 156.08 46.92 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.993 -1.067 . . . . 40.0 109.903 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 80' ' ' SER . 23.6 p -136.27 -73.92 0.44 Allowed 'General case' 0 N--CA 1.509 2.479 0 CA-C-O 121.284 0.564 . . . . 40.0 110.059 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.631 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -152.23 105.91 3.1 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.078 -0.712 . . . . 40.0 109.078 -178.815 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.405 ' N ' ' OH ' ' A' ' 78' ' ' TYR . . . 160.84 -105.6 0.27 Allowed Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.417 -1.373 . . . . 40.0 110.28 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.474 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 40.0 t80 -138.36 -166.09 1.93 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.987 -0.745 . . . . 40.0 108.987 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.639 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.2 mtm180 -75.12 -155.92 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.045 -1.034 . . . . 40.0 110.343 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.541 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 10.8 p30 -165.33 -150.37 0.13 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.978 -1.119 . . . . 40.0 107.978 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' A' ' 100' ' ' THR . 82.6 p -103.58 -8.15 20.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.78 -1.2 . . . . 40.0 109.152 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.501 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -86.0 113.37 22.04 Favored 'General case' 0 N--CA 1.507 2.414 0 CA-C-O 121.79 0.805 . . . . 40.0 111.713 -179.167 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.86 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.63 150.38 46.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.033 . . . . 40.0 110.988 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.712 ' CG2' HD11 ' A' ' 76' ' ' ILE . 6.9 tt -116.73 141.56 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 122.107 0.956 . . . . 40.0 109.847 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.542 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.8 mm? -121.37 123.99 43.45 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.944 -1.132 . . . . 40.0 107.944 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.687 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.09 129.5 55.58 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.918 0.866 . . . . 40.0 108.783 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.694 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 3.8 p -94.14 158.63 15.52 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 122.228 1.013 . . . . 40.0 112.445 -177.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.7 p -69.82 -15.87 63.18 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.443 -0.947 . . . . 40.0 108.443 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.488 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -88.02 8.2 27.65 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.61 -0.836 . . . . 40.0 109.423 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.463 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 79.36 26.07 0.42 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.675 -0.64 . . . . 40.0 110.344 179.699 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.1 mt -95.75 138.84 32.83 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.451 -0.781 . . . . 40.0 109.18 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.484 ' CG2' HD11 ' A' ' 109' ' ' ILE . 40.4 mm -112.91 120.21 62.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.71 -0.619 . . . . 40.0 110.426 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.433 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.4 m-85 -122.03 144.49 48.87 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 109.296 -0.631 . . . . 40.0 109.296 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.501 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 3.3 tptp -133.17 146.14 51.26 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.367 -0.933 . . . . 40.0 110.965 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.533 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.6 t -125.63 166.6 16.44 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 109.141 -0.689 . . . . 40.0 109.141 177.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.515 ' O ' ' OG ' ' A' ' 85' ' ' SER . 55.5 p -139.97 -9.69 1.17 Allowed 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.327 -0.858 . . . . 40.0 109.585 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.662 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -108.09 15.99 23.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.195 -0.941 . . . . 40.0 110.417 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 83.01 60.7 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.86 -0.525 . . . . 40.0 110.689 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.639 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 27.5 m-85 71.35 -20.46 0.23 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.546 -0.721 . . . . 40.0 110.847 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.424 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.6 mt-30 -44.92 -73.4 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.044 -1.035 . . . . 40.0 109.877 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.492 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 23.8 p -105.86 164.79 11.67 Favored 'General case' 0 C--O 1.195 -1.813 0 N-CA-C 107.791 -1.189 . . . . 40.0 107.791 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.542 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -138.95 138.2 37.11 Favored 'General case' 0 C--N 1.269 -2.915 0 O-C-N 121.306 -0.872 . . . . 40.0 109.989 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 53.3 m -124.12 137.42 54.56 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.119 -1.067 . . . . 40.0 108.119 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.61 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 18.4 tttp -84.64 145.18 28.14 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.906 -1.121 . . . . 40.0 109.601 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.484 HD11 ' CG2' ' A' ' 96' ' ' ILE . 15.4 pt -120.53 -34.68 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.175 -0.953 . . . . 40.0 109.262 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.641 HH21 ' CG ' ' A' ' 8' ' ' ASP . 79.6 mtt180 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 40.0 108.86 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.63 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 19.8 t . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 109.045 -0.724 . . . . 40.0 109.045 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 tt -174.34 154.07 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.9 -0.778 . . . . 40.0 108.9 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -144.22 26.12 1.51 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.016 -1.053 . . . . 40.0 110.593 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 10' ' ' VAL . 18.0 p -104.0 153.83 20.38 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.566 0.698 . . . . 40.0 109.609 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.475 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -57.11 -63.49 1.2 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.839 -1.163 . . . . 40.0 110.511 -179.217 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.643 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.9 OUTLIER -57.31 -41.93 80.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.096 -1.002 . . . . 40.0 109.655 -179.476 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.35 -44.96 84.86 Favored Glycine 0 N--CA 1.503 3.11 0 N-CA-C 110.243 -1.143 . . . . 40.0 110.243 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.573 HG22 ' HG2' ' A' ' 21' ' ' PRO . 67.3 t -67.28 -42.99 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.523 -0.986 . . . . 40.0 108.828 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.508 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.88 -59.13 5.87 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.974 -0.75 . . . . 40.0 108.974 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.23 -56.79 7.08 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.913 -0.773 . . . . 40.0 108.913 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.72 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 34.2 t80 -52.15 -53.01 48.24 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 116.116 -0.493 . . . . 40.0 110.61 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.588 ' O ' ' N ' ' A' ' 18' ' ' HIS . 4.4 tt -71.67 -51.21 24.23 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.301 0.572 . . . . 40.0 110.851 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 11' ' ' ALA . 58.6 mt-30 -53.57 -28.58 32.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.233 -1.542 . . . . 40.0 110.178 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.6 m -91.46 -52.63 4.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.805 -1.184 . . . . 40.0 110.524 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -97.68 12.26 34.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.279 -0.888 . . . . 40.0 110.576 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.588 ' N ' ' O ' ' A' ' 14' ' ' LEU . 23.7 m80 42.7 25.64 0.05 Allowed 'General case' 0 N--CA 1.512 2.643 0 O-C-N 121.237 -0.914 . . . . 40.0 111.151 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 pttp -137.0 160.9 37.56 Favored 'General case' 0 C--O 1.185 -2.329 0 O-C-N 121.44 -0.787 . . . . 40.0 109.559 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 24' ' ' TYR . 3.4 mp -80.3 145.57 60.22 Favored Pre-proline 0 C--N 1.265 -3.101 0 O-C-N 120.744 -1.223 . . . . 40.0 108.764 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.72 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 72.6 Cg_exo -40.99 155.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.831 2.354 . . . . 40.0 113.417 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.63 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -65.61 49.97 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.05 -1.031 . . . . 40.0 109.356 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -171.91 26.21 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.703 -1.248 . . . . 40.0 110.639 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.423 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 5.4 m-85 -119.82 108.39 14.32 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.789 -1.194 . . . . 40.0 109.674 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 25' ' ' ILE . 21.6 pt -119.66 128.86 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.483 1.135 . . . . 40.0 108.612 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.715 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.4 OUTLIER -63.78 169.34 4.18 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-O 123.561 1.648 . . . . 40.0 114.091 -176.264 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.53 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 12.8 mtmt -58.51 -42.45 87.68 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 104.676 -2.342 . . . . 40.0 104.676 176.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.508 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 7.7 m -32.35 -72.97 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 116.293 -0.412 . . . . 40.0 110.261 176.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.485 ' O ' ' C ' ' A' ' 30' ' ' ALA . 3.1 mp0 -64.02 -54.86 27.71 Favored 'General case' 0 C--O 1.193 -1.909 0 N-CA-C 106.558 -1.645 . . . . 40.0 106.558 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -36.11 -55.2 0.78 Allowed 'General case' 0 N--CA 1.514 2.753 0 O-C-N 120.591 -1.318 . . . . 40.0 110.412 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.423 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 38.7 mt-30 -56.35 -67.6 0.29 Allowed 'General case' 0 N--CA 1.507 2.425 0 O-C-N 120.681 -1.262 . . . . 40.0 111.088 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.14 -26.86 61.23 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 119.93 -1.731 . . . . 40.0 110.58 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.4 tp -67.17 -21.56 65.8 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.36 -0.978 . . . . 40.0 108.36 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.59 40.45 0.53 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.851 -0.9 . . . . 40.0 110.851 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.574 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -77.68 139.97 39.51 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.435 -1.627 . . . . 40.0 109.521 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.2 t -136.44 131.27 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.607 0 O-C-N 121.74 -0.6 . . . . 40.0 109.896 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.404 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -58.45 -50.13 74.81 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 116.612 -0.267 . . . . 40.0 110.386 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.5 p -69.98 46.23 0.08 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.427 -0.796 . . . . 40.0 110.232 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.599 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 2.3 ttpm? -178.33 -51.91 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.989 -0.745 . . . . 40.0 108.989 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.1 61.83 5.73 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 108.412 -1.875 . . . . 40.0 108.412 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.599 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -78.92 161.25 26.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.607 -0.937 . . . . 40.0 110.101 -178.347 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.786 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 56.2 tp -173.56 -67.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.676 -0.81 . . . . 40.0 110.515 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.611 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -64.26 -19.29 65.29 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 120.571 -1.331 . . . . 40.0 109.973 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 5.9 p-10 -75.41 -63.41 1.29 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.857 -0.794 . . . . 40.0 108.857 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.2 m -78.13 -15.85 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.715 -0.616 . . . . 40.0 109.654 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.518 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -142.74 72.89 19.66 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 40.0 109.622 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -56.91 117.62 4.34 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.819 2.346 . . . . 40.0 113.28 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.85 35.97 48.86 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.996 -1.242 . . . . 40.0 109.996 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.518 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 7.0 mmtt -133.48 162.63 31.35 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 121.899 -0.765 . . . . 40.0 109.86 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.42 ' HA ' HD21 ' A' ' 42' ' ' LEU . 70.3 m -138.01 165.83 25.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.095 -1.003 . . . . 40.0 111.244 -177.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 mm -83.26 124.72 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.54 0.686 . . . . 40.0 111.144 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.81 157.82 17.23 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 119.539 -1.315 . . . . 40.0 110.417 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.715 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 116.16 -7.66 18.77 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.653 -1.379 . . . . 40.0 109.653 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.515 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 6.8 m-20 -74.31 -153.83 0.03 OUTLIER 'General case' 0 C--O 1.189 -2.106 0 O-C-N 121.375 -1.073 . . . . 40.0 110.194 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -131.68 141.29 46.07 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.027 0 N-CA-C 108.355 -0.98 . . . . 40.0 108.355 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.618 ' O ' ' N ' ' A' ' 58' ' ' ASN . 14.4 t80 -110.69 90.94 3.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 40.0 108.772 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.656 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.6 p -60.27 39.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.625 -0.672 . . . . 40.0 110.858 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.618 ' N ' ' O ' ' A' ' 56' ' ' PHE . 47.5 t30 34.35 38.19 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.104 -0.998 . . . . 40.0 111.051 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.656 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 11.4 mtm180 -71.25 38.92 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.027 -1.046 . . . . 40.0 109.847 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.608 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 11.7 mt-10 -146.24 -6.34 0.56 Allowed 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.441 -0.787 . . . . 40.0 110.195 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.28 36.48 62.65 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 109.129 -1.588 . . . . 40.0 109.129 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.667 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 3.5 mttp -120.67 12.58 11.47 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.717 -0.872 . . . . 40.0 109.652 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.452 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.4 mt -137.54 144.41 44.87 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.451 -0.781 . . . . 40.0 109.394 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -62.5 124.75 14.77 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.441 2.094 . . . . 40.0 112.674 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.524 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.22 -178.29 27.57 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 110.054 -1.218 . . . . 40.0 110.054 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.489 ' NZ ' ' O ' ' A' ' 68' ' ' GLY . 10.3 tttt -178.03 153.15 0.78 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.272 -1.134 . . . . 40.0 108.625 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.468 ' O ' ' OG ' ' A' ' 67' ' ' SER . 8.5 p -73.09 55.3 0.42 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.755 -1.215 . . . . 40.0 109.099 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.489 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 148.28 78.94 0.03 OUTLIER Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.477 -1.449 . . . . 40.0 109.477 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.552 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -173.66 175.93 2.84 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.759 -0.848 . . . . 40.0 108.95 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.552 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 87.6 m -154.44 155.25 34.62 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.135 -0.978 . . . . 40.0 110.062 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.718 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 30.2 m95 -124.68 140.71 52.68 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 121.267 0.556 . . . . 40.0 110.246 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.624 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -131.63 149.83 52.36 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.881 -1.137 . . . . 40.0 110.216 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.53 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -113.35 167.76 10.3 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.321 1.057 . . . . 40.0 111.91 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.67 137.85 4.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.754 -0.591 . . . . 40.0 110.378 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.751 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -59.82 153.69 20.13 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.959 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.78 HD11 ' CG2' ' A' ' 88' ' ' ILE . 42.7 mm -136.18 144.8 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.419 -0.801 . . . . 40.0 110.04 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 56.28 70.82 0.61 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.486 0.66 . . . . 40.0 110.598 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.786 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 62.4 t80 -130.73 155.49 46.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.132 -0.98 . . . . 40.0 109.34 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.577 ' OG1' ' N ' ' A' ' 80' ' ' SER . 24.0 p -134.96 -73.46 0.47 Allowed 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.63 0.729 . . . . 40.0 110.064 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.611 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -153.46 105.69 2.86 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.03 -0.729 . . . . 40.0 109.03 -178.499 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.479 ' N ' ' OH ' ' A' ' 78' ' ' TYR . . . 159.13 -102.35 0.21 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.733 -1.347 . . . . 40.0 109.733 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 35.4 t80 -140.81 -167.55 2.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.638 -0.919 . . . . 40.0 109.895 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.639 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.3 mtm180 -74.19 -157.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.179 -0.95 . . . . 40.0 110.147 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.566 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 11.4 p30 -164.59 -149.25 0.12 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.939 -1.134 . . . . 40.0 107.939 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 100' ' ' THR . 64.1 p -103.94 -9.07 19.18 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.809 -1.182 . . . . 40.0 109.409 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.479 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -85.67 113.77 22.13 Favored 'General case' 0 N--CA 1.509 2.481 0 CA-C-O 121.787 0.803 . . . . 40.0 111.688 -179.389 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.856 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.43 150.22 46.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.986 -1.071 . . . . 40.0 110.617 179.556 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.78 ' CG2' HD11 ' A' ' 76' ' ' ILE . 7.3 tt -116.4 140.78 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-O 122.131 0.967 . . . . 40.0 109.833 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.581 HD13 ' O ' ' A' ' 72' ' ' ARG . 3.0 mm? -119.24 125.99 50.44 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.361 -0.978 . . . . 40.0 108.361 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.666 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -119.89 129.4 54.35 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.824 -0.806 . . . . 40.0 108.824 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.718 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 2.9 p -94.1 157.8 15.91 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 122.297 1.046 . . . . 40.0 112.448 -178.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.7 p -68.41 -17.49 64.23 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.559 -0.904 . . . . 40.0 108.559 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.491 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -85.82 8.54 19.66 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.567 -0.853 . . . . 40.0 109.482 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.466 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.9 25.39 0.5 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.611 -0.68 . . . . 40.0 110.496 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.5 mt -95.71 138.02 33.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.135 -0.978 . . . . 40.0 109.108 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.479 ' CG2' HD11 ' A' ' 109' ' ' ILE . 43.1 mm -112.04 121.16 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.587 -0.696 . . . . 40.0 110.417 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.414 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.5 m-85 -122.98 144.95 48.9 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 120.245 -0.582 . . . . 40.0 109.496 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.479 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 5.3 tptp -133.7 145.71 50.14 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.083 -1.011 . . . . 40.0 110.84 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.484 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.2 t -125.89 168.36 13.98 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.761 -0.829 . . . . 40.0 108.761 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.496 ' O ' ' OG ' ' A' ' 85' ' ' SER . 71.2 p -141.79 -8.15 0.95 Allowed 'General case' 0 N--CA 1.51 2.544 0 O-C-N 121.21 -0.931 . . . . 40.0 109.717 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.677 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -108.81 16.63 22.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.125 -0.984 . . . . 40.0 110.104 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 81.85 61.18 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.221 0.534 . . . . 40.0 110.217 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.667 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 31.5 m-85 71.41 -20.43 0.23 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.577 -0.702 . . . . 40.0 110.87 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.413 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.6 mt-30 -45.2 -74.34 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.024 -1.047 . . . . 40.0 110.001 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.536 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 23.6 p -104.59 164.02 12.05 Favored 'General case' 0 C--O 1.194 -1.829 0 O-C-N 120.901 -1.124 . . . . 40.0 108.115 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.573 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -137.9 139.68 39.95 Favored 'General case' 0 C--N 1.273 -2.753 0 O-C-N 121.351 -0.843 . . . . 40.0 109.932 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 30.5 m -126.73 137.01 53.19 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.156 -1.053 . . . . 40.0 108.156 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.6 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 14.9 tttp -83.87 146.05 28.29 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.837 -1.164 . . . . 40.0 109.679 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.479 HD11 ' CG2' ' A' ' 96' ' ' ILE . 14.5 pt -121.75 -33.77 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.283 -0.885 . . . . 40.0 109.043 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.643 HH21 ' CG ' ' A' ' 8' ' ' ASP . 72.2 mtt180 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 118.173 -0.918 . . . . 40.0 108.993 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.658 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 17.6 t . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 109.389 -0.596 . . . . 40.0 109.389 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 tt -176.4 152.64 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.27 -0.894 . . . . 40.0 109.169 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -142.71 24.16 1.89 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.805 -1.185 . . . . 40.0 111.215 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 10' ' ' VAL . 10.9 p -105.74 153.16 22.25 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.679 0.752 . . . . 40.0 110.172 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.491 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -55.96 -63.11 1.29 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.036 -1.04 . . . . 40.0 111.052 -178.927 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.631 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -58.56 -41.08 84.81 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.506 -0.746 . . . . 40.0 109.745 -179.35 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.35 -45.14 89.39 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.712 -1.355 . . . . 40.0 109.712 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.54 HG22 ' HG2' ' A' ' 21' ' ' PRO . 71.1 t -67.39 -43.68 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.578 -0.954 . . . . 40.0 108.787 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.508 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -59.94 -59.15 5.88 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.947 -0.76 . . . . 40.0 108.947 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.24 -56.74 8.37 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.951 -0.759 . . . . 40.0 108.951 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.733 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 39.9 t80 -52.3 -51.96 55.63 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.048 0.451 . . . . 40.0 110.441 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 18' ' ' HIS . 2.2 tt -72.04 -52.58 16.24 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.64 -0.663 . . . . 40.0 111.056 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 11' ' ' ALA . 63.7 mt-30 -51.59 -27.25 10.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.23 -1.544 . . . . 40.0 110.721 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 m -92.35 -49.84 5.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.585 -1.322 . . . . 40.0 111.347 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 19' ' ' LYS . 92.7 m-85 -100.85 16.0 26.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.845 -1.159 . . . . 40.0 110.114 -177.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 14' ' ' LEU . 25.1 m80 41.43 24.25 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.8 -0.563 . . . . 40.0 110.976 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 17' ' ' TYR . 3.6 pttp -135.48 158.78 43.51 Favored 'General case' 0 C--O 1.178 -2.7 0 O-C-N 121.177 -0.952 . . . . 40.0 110.771 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mp -79.25 144.28 62.13 Favored Pre-proline 0 C--N 1.271 -2.847 0 O-C-N 120.9 -1.125 . . . . 40.0 108.88 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.733 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 81.8 Cg_exo -38.73 155.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.003 0 C-N-CA 123.803 3.002 . . . . 40.0 114.433 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.658 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -67.61 50.11 0.05 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.283 1.039 . . . . 40.0 109.253 -179.51 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.531 ' HA ' ' HD3' ' A' ' 49' ' ' LYS . 0.8 OUTLIER -173.86 26.24 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.129 -0.982 . . . . 40.0 110.552 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -120.21 111.92 18.42 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.294 -1.504 . . . . 40.0 110.122 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.428 HG21 HD13 ' A' ' 25' ' ' ILE . 23.0 pt -118.28 138.22 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.248 -1.019 . . . . 40.0 108.248 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.769 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -72.4 168.93 17.42 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 123.372 1.558 . . . . 40.0 113.357 -178.283 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.509 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 24.3 mtmt -60.66 -39.38 88.14 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 105.801 -1.925 . . . . 40.0 105.801 176.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.53 ' OG ' ' OG1' ' A' ' 26' ' ' THR . 1.1 m -36.37 -70.86 0.08 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.749 -0.834 . . . . 40.0 108.749 176.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.56 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.7 mp0 -64.22 -55.43 21.69 Favored 'General case' 0 C--O 1.201 -1.473 0 N-CA-C 106.098 -1.815 . . . . 40.0 106.098 -176.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.56 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -35.44 -51.87 0.62 Allowed 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 118.562 -1.255 . . . . 40.0 109.573 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -55.45 -68.43 0.2 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.992 -1.067 . . . . 40.0 111.67 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.37 -24.31 54.54 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.263 -0.898 . . . . 40.0 111.141 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.7 tp -69.88 -21.2 63.35 Favored 'General case' 0 N--CA 1.509 2.475 0 N-CA-C 106.878 -1.527 . . . . 40.0 106.878 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.7 43.61 0.53 Allowed Glycine 0 N--CA 1.504 3.184 0 N-CA-C 111.523 -0.631 . . . . 40.0 111.523 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.54 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -77.88 138.97 39.2 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.725 -1.456 . . . . 40.0 109.531 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.9 t -135.7 130.33 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.685 0 O-C-N 121.154 -0.966 . . . . 40.0 109.302 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.48 -46.74 86.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.832 -0.543 . . . . 40.0 110.014 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.5 p -71.45 44.01 0.09 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.431 0.634 . . . . 40.0 110.644 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.585 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 ttpm? -177.43 -50.5 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.495 -0.753 . . . . 40.0 109.174 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.18 59.26 9.24 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 108.934 -1.666 . . . . 40.0 108.934 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.585 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.82 160.87 30.14 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 121.453 -1.028 . . . . 40.0 110.641 -177.846 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.872 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 57.1 tp -173.32 -69.5 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.999 -1.063 . . . . 40.0 110.385 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.554 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.07 -23.0 63.43 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 120.947 -1.096 . . . . 40.0 110.028 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.4 p-10 -73.28 -64.89 0.89 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.702 0.763 . . . . 40.0 109.218 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.431 HG13 ' OD2' ' A' ' 44' ' ' ASP . 28.7 m -76.78 -15.17 14.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 109.205 -0.665 . . . . 40.0 109.205 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.584 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -144.22 71.34 16.29 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.501 -0.749 . . . . 40.0 110.16 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.04 117.16 3.8 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 123.375 2.717 . . . . 40.0 113.788 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.61 37.73 52.13 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.167 -1.573 . . . . 40.0 109.167 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.584 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 8.5 mmtm -135.2 162.3 32.92 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 108.856 -0.794 . . . . 40.0 108.856 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.448 ' HA ' HD21 ' A' ' 42' ' ' LEU . 65.7 m -138.22 166.55 23.9 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.326 1.06 . . . . 40.0 110.594 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 18.7 mm -84.1 124.11 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-N 115.876 -0.602 . . . . 40.0 111.508 -179.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 178.08 159.67 23.18 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.506 -1.438 . . . . 40.0 109.506 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.769 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 115.75 -7.17 19.94 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.623 -1.275 . . . . 40.0 110.92 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.441 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 5.2 m-20 -76.02 -152.26 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.381 -1.658 . . . . 40.0 110.072 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.7 mp -131.12 143.85 39.54 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.016 0 N-CA-C 108.327 -0.99 . . . . 40.0 108.327 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.636 ' O ' ' N ' ' A' ' 58' ' ' ASN . 13.7 t80 -113.51 90.97 3.48 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.217 -0.927 . . . . 40.0 108.78 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.653 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.6 p -59.07 38.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.705 0.764 . . . . 40.0 110.735 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.636 ' N ' ' O ' ' A' ' 56' ' ' PHE . 43.5 t30 34.67 38.57 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.293 -0.88 . . . . 40.0 110.671 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.653 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.8 mtm180 -69.91 36.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -0.94 . . . . 40.0 110.483 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.608 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 14.6 mt-10 -145.36 -4.82 0.68 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.135 -0.978 . . . . 40.0 110.332 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.65 36.97 66.32 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 109.635 -1.386 . . . . 40.0 109.635 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.608 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 5.1 mttp -120.36 12.3 11.65 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.575 -0.956 . . . . 40.0 109.502 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.422 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -136.4 142.93 41.35 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.564 -0.71 . . . . 40.0 109.36 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -61.75 122.72 11.41 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.392 2.061 . . . . 40.0 112.344 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.513 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -101.18 -178.27 28.92 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 110.535 -1.026 . . . . 40.0 110.535 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 8.9 tttt -177.6 152.75 0.83 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.138 -1.213 . . . . 40.0 108.267 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.4 p -72.07 53.62 0.27 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.841 -1.162 . . . . 40.0 109.258 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.401 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 151.26 80.34 0.03 OUTLIER Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.826 -1.31 . . . . 40.0 109.826 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.559 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.96 177.31 2.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.533 -0.981 . . . . 40.0 109.037 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.559 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 90.1 m -154.75 154.92 33.59 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.124 -0.985 . . . . 40.0 110.043 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.713 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 30.0 m95 -124.14 139.86 53.52 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.384 0.612 . . . . 40.0 109.671 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.638 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.52 149.83 52.01 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 120.794 -1.191 . . . . 40.0 109.897 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.509 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -116.19 167.69 10.78 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.068 -1.02 . . . . 40.0 112.006 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -162.9 138.57 6.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.653 -0.654 . . . . 40.0 111.351 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.741 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -59.6 154.22 18.12 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.656 -0.652 . . . . 40.0 110.934 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.741 HD13 ' O ' ' A' ' 75' ' ' ASP . 42.7 mm -137.43 145.87 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.499 -0.75 . . . . 40.0 110.394 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 57.38 70.08 0.68 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.483 0.659 . . . . 40.0 110.524 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.872 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 70.2 t80 -131.86 155.65 47.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.039 -1.038 . . . . 40.0 110.112 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.609 ' OG1' ' N ' ' A' ' 80' ' ' SER . 19.2 p -136.64 -73.34 0.44 Allowed 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.124 0.488 . . . . 40.0 110.202 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.609 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -153.01 106.47 3.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.554 -0.716 . . . . 40.0 109.416 -178.466 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.93 -104.32 0.24 Allowed Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.747 -1.341 . . . . 40.0 109.747 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.481 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 47.2 t80 -139.94 -167.01 2.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 122.013 -0.698 . . . . 40.0 109.382 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.638 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.1 mtm180 -73.12 -154.34 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.166 -0.959 . . . . 40.0 110.075 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.555 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 11.6 p30 -168.05 -150.24 0.1 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.262 -1.014 . . . . 40.0 108.262 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.516 ' OG ' ' O ' ' A' ' 100' ' ' THR . 71.6 p -103.3 -8.0 20.66 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.64 -1.288 . . . . 40.0 109.313 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.521 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.6 114.15 23.95 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-O 122.063 0.935 . . . . 40.0 111.473 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.858 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.28 151.0 47.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.871 -1.143 . . . . 40.0 110.426 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.675 ' CG2' HD11 ' A' ' 76' ' ' ILE . 5.7 tt -117.99 136.71 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.794 0.807 . . . . 40.0 109.825 178.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.536 HD13 ' O ' ' A' ' 72' ' ' ARG . 3.1 mm? -115.84 125.16 52.3 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.798 -0.815 . . . . 40.0 108.798 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.682 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.94 129.53 55.22 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.077 0.942 . . . . 40.0 108.997 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.713 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 3.7 p -94.65 158.9 15.32 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 122.41 1.1 . . . . 40.0 112.504 -177.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.7 p -68.59 -18.14 64.27 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.234 -1.025 . . . . 40.0 108.234 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.502 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -86.32 9.17 18.66 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.666 -0.646 . . . . 40.0 109.647 179.83 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.462 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.76 26.48 0.64 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.661 -0.649 . . . . 40.0 110.361 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.9 mt -95.99 137.47 35.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.118 -0.989 . . . . 40.0 109.093 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.516 ' CG2' HD11 ' A' ' 109' ' ' ILE . 40.2 mm -111.77 119.15 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.634 -0.666 . . . . 40.0 110.564 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.434 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 8.0 m-85 -121.83 144.32 48.9 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.357 -0.537 . . . . 40.0 109.766 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.521 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 4.8 tptp -133.25 144.5 49.8 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.372 -0.83 . . . . 40.0 110.849 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.616 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.9 t -123.12 166.69 14.76 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 108.84 -0.8 . . . . 40.0 108.84 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.516 ' O ' ' OG ' ' A' ' 85' ' ' SER . 45.0 p -140.29 -10.31 1.1 Allowed 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.556 -0.715 . . . . 40.0 109.672 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.69 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -107.75 12.7 27.15 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.007 -1.058 . . . . 40.0 110.203 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 84.97 61.82 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.404 0.621 . . . . 40.0 110.305 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.638 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 23.2 m-85 71.62 -21.9 0.21 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.446 -0.784 . . . . 40.0 110.812 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.417 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.9 mt-30 -44.37 -73.41 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.091 -1.006 . . . . 40.0 109.932 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.512 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 22.0 p -106.07 166.4 10.53 Favored 'General case' 0 C--O 1.193 -1.9 0 N-CA-C 107.763 -1.199 . . . . 40.0 107.763 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.529 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -140.06 139.16 35.86 Favored 'General case' 0 C--N 1.27 -2.887 0 O-C-N 121.065 -1.022 . . . . 40.0 109.779 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.1 m -124.65 136.35 53.85 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.355 -0.98 . . . . 40.0 108.355 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.529 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 19.3 tttp -84.95 145.54 27.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.779 -1.201 . . . . 40.0 109.652 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.516 HD11 ' CG2' ' A' ' 96' ' ' ILE . 12.8 pt -120.71 -34.42 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.884 -1.135 . . . . 40.0 109.318 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.631 HH21 ' CG ' ' A' ' 8' ' ' ASP . 78.7 mtt180 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.081 -1.012 . . . . 40.0 108.769 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.628 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 17.0 t . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.319 -0.623 . . . . 40.0 109.319 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -178.27 151.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.393 -0.817 . . . . 40.0 109.587 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -142.53 23.96 1.93 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.16 -0.963 . . . . 40.0 111.684 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 10' ' ' VAL . 18.6 p -105.85 153.98 21.17 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.981 0.896 . . . . 40.0 110.456 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -56.39 -64.48 0.85 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.617 -1.302 . . . . 40.0 110.833 -179.288 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.615 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -56.84 -41.43 77.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.05 -1.032 . . . . 40.0 110.034 -179.294 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.21 -44.99 84.17 Favored Glycine 0 N--CA 1.504 3.181 0 N-CA-C 110.164 -1.174 . . . . 40.0 110.164 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.585 HG22 ' HG2' ' A' ' 21' ' ' PRO . 69.5 t -68.77 -42.49 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.587 -0.949 . . . . 40.0 108.798 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.35 -59.38 5.49 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.489 -0.93 . . . . 40.0 108.489 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.23 -56.77 8.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.55 -0.719 . . . . 40.0 109.334 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.75 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 40.8 t80 -52.74 -51.41 60.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.915 -0.491 . . . . 40.0 110.353 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 18' ' ' HIS . 4.0 tt -72.36 -51.4 20.71 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.7 -0.625 . . . . 40.0 110.945 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 11' ' ' ALA . 57.3 mt-30 -52.39 -28.36 19.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.051 -1.655 . . . . 40.0 110.129 179.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 m -91.53 -51.28 5.34 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.781 -1.2 . . . . 40.0 111.249 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -99.04 12.8 34.96 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.29 -0.881 . . . . 40.0 110.258 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 14' ' ' LEU . 20.7 m80 42.47 25.67 0.05 OUTLIER 'General case' 0 N--CA 1.516 2.856 0 O-C-N 121.477 -0.764 . . . . 40.0 110.92 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.9 pttp -136.63 158.61 44.03 Favored 'General case' 0 C--O 1.184 -2.367 0 CA-C-O 121.916 0.865 . . . . 40.0 110.188 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mp -78.31 147.83 73.12 Favored Pre-proline 0 C--N 1.265 -3.093 0 O-C-N 120.659 -1.275 . . . . 40.0 108.684 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.75 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 83.3 Cg_exo -41.47 156.09 0.07 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 123.272 2.648 . . . . 40.0 114.102 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.628 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -67.07 49.49 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.124 0.964 . . . . 40.0 109.48 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -173.67 26.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.902 . . . . 40.0 110.701 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -118.19 109.75 16.74 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.76 -1.213 . . . . 40.0 110.487 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 25' ' ' ILE . 15.4 pt -119.07 132.88 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.169 -1.049 . . . . 40.0 108.169 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.868 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.4 OUTLIER -69.48 173.35 6.03 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-O 124.24 1.972 . . . . 40.0 113.443 -177.395 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.651 ' HB3' ' NE2' ' A' ' 31' ' ' GLN . 14.6 mtmt -62.53 -40.12 95.75 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.266 -1.753 . . . . 40.0 106.266 177.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.511 ' OG ' ' OG1' ' A' ' 26' ' ' THR . 2.9 m -32.97 -74.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 123.028 1.394 . . . . 40.0 109.666 174.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.501 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.4 mp0 -63.13 -56.47 16.49 Favored 'General case' 0 C--O 1.2 -1.509 0 CA-C-N 114.392 -1.277 . . . . 40.0 108.041 -177.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -38.26 -51.64 1.48 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.956 -1.09 . . . . 40.0 109.918 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.651 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 24.1 mt-30 -56.85 -64.63 0.81 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.676 -1.265 . . . . 40.0 110.351 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.47 -25.29 64.29 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.113 -0.992 . . . . 40.0 109.471 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.1 tp -65.66 -24.52 67.04 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.729 -0.841 . . . . 40.0 108.729 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.11 48.22 0.29 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.243 -1.143 . . . . 40.0 110.243 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.579 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -85.72 137.47 32.79 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.461 -1.023 . . . . 40.0 109.906 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.5 t -134.16 131.41 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.705 0 O-C-N 121.49 -0.756 . . . . 40.0 109.956 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.64 -47.92 82.77 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.743 -0.836 . . . . 40.0 108.743 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.1 p -69.87 43.64 0.06 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.627 -0.67 . . . . 40.0 110.907 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.499 ' HZ3' ' CG ' ' A' ' 41' ' ' ASN . 1.1 ttpm? -176.8 -49.83 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.314 -0.866 . . . . 40.0 109.13 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.17 59.7 9.11 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 108.349 -1.9 . . . . 40.0 108.349 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.579 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -76.57 159.84 29.96 Favored 'General case' 0 C--N 1.29 -2.004 0 O-C-N 121.654 -0.909 . . . . 40.0 110.833 -177.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.816 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 56.1 tp -173.92 -68.32 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.53 -0.868 . . . . 40.0 111.04 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.6 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.64 -22.08 63.44 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.812 -1.18 . . . . 40.0 109.36 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.5 p-10 -74.64 -62.3 1.58 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.13 -0.693 . . . . 40.0 109.13 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.4 m -78.56 -13.52 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 N-CA-C 109.122 -0.696 . . . . 40.0 109.122 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -147.12 72.57 12.14 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.637 -0.664 . . . . 40.0 110.058 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -56.7 118.58 5.45 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 123.178 2.586 . . . . 40.0 113.911 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.37 39.64 56.69 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.69 -1.364 . . . . 40.0 109.69 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.445 ' NZ ' ' HB3' ' A' ' 23' ' ' ASN . 7.2 mmtm -134.39 168.89 18.09 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.859 0.838 . . . . 40.0 109.829 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.7 m -144.39 160.83 40.4 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 120.827 -1.171 . . . . 40.0 111.381 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.3 mm -81.25 123.04 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-N 115.437 -0.801 . . . . 40.0 110.557 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . 177.16 154.56 12.2 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.555 -1.418 . . . . 40.0 109.555 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.868 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 120.54 -13.55 10.08 Favored Glycine 0 N--CA 1.497 2.713 0 C-N-CA 119.162 -1.494 . . . . 40.0 111.236 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.47 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 4.3 m-20 -71.41 -152.0 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.747 0 O-C-N 121.202 -1.176 . . . . 40.0 109.781 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.37 142.63 42.84 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 CA-C-N 115.256 -0.884 . . . . 40.0 109.236 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.652 ' O ' ' N ' ' A' ' 58' ' ' ASN . 11.1 t80 -111.17 89.76 3.14 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.347 -0.845 . . . . 40.0 109.696 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.669 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.9 p -58.71 38.38 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.921 0.867 . . . . 40.0 110.774 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.652 ' N ' ' O ' ' A' ' 56' ' ' PHE . 40.8 t30 33.66 40.01 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.275 -0.89 . . . . 40.0 110.484 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.669 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 11.4 mtm180 -70.85 37.23 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.957 -1.089 . . . . 40.0 110.056 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.606 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 14.1 mt-10 -146.6 -1.05 0.72 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.998 -1.064 . . . . 40.0 110.29 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 51.11 39.42 41.65 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.681 -1.368 . . . . 40.0 109.681 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.606 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 3.5 mttp -121.68 12.34 10.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.657 -0.908 . . . . 40.0 109.366 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.47 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.5 mt -137.33 143.62 42.18 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.66 -0.65 . . . . 40.0 109.541 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.38 122.68 11.46 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.296 1.997 . . . . 40.0 112.137 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.525 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.98 -177.29 26.69 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.866 -1.293 . . . . 40.0 109.866 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.415 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 8.0 tttt -177.94 154.73 0.92 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 107.871 -1.159 . . . . 40.0 107.871 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.2 p -73.2 55.47 0.44 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.995 -1.066 . . . . 40.0 109.172 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.98 81.4 0.04 OUTLIER Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.753 -1.339 . . . . 40.0 109.753 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.559 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.31 178.29 2.06 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.493 -1.004 . . . . 40.0 108.713 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.559 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 92.4 m -155.24 153.01 29.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.017 -1.052 . . . . 40.0 109.921 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.717 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 28.8 m95 -122.7 140.38 52.93 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.194 0.521 . . . . 40.0 110.006 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.613 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -131.42 147.11 52.53 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 120.96 -1.087 . . . . 40.0 110.392 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.565 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -111.84 168.2 9.76 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.979 -1.076 . . . . 40.0 112.278 -179.461 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.431 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . . . -163.76 139.75 6.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.241 -0.912 . . . . 40.0 110.225 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.732 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -61.29 154.71 23.0 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 120.976 0.417 . . . . 40.0 110.576 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.732 HD13 ' O ' ' A' ' 75' ' ' ASP . 32.6 mm -138.11 146.01 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.587 -0.696 . . . . 40.0 110.325 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 56.4 71.05 0.59 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.582 0.706 . . . . 40.0 110.839 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.816 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 67.7 t80 -132.45 156.66 46.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 40.0 109.471 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.596 ' OG1' ' N ' ' A' ' 80' ' ' SER . 21.4 p -137.97 -72.44 0.42 Allowed 'General case' 0 N--CA 1.511 2.614 0 CA-C-O 121.44 0.638 . . . . 40.0 109.491 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.6 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -152.99 105.69 2.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.653 -0.654 . . . . 40.0 109.57 -178.85 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.06 -103.96 0.23 Allowed Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.467 -1.349 . . . . 40.0 110.156 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 49.2 t80 -142.16 -167.55 2.5 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.53 -0.915 . . . . 40.0 108.53 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.659 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.3 mtm180 -72.9 -156.48 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.04 -1.038 . . . . 40.0 110.398 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.501 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 10.1 p30 -165.67 -149.38 0.11 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.132 -1.062 . . . . 40.0 108.132 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.512 ' OG ' ' O ' ' A' ' 100' ' ' THR . 60.3 p -104.14 -7.46 20.16 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 120.804 -1.185 . . . . 40.0 109.252 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.509 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.97 113.09 23.28 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-O 121.898 0.856 . . . . 40.0 111.642 -179.263 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.86 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.44 150.06 46.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.055 -1.028 . . . . 40.0 110.391 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.675 ' CG2' HD11 ' A' ' 76' ' ' ILE . 5.1 tt -116.69 141.51 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 122.404 1.097 . . . . 40.0 109.777 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.584 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.8 mm? -121.02 124.42 44.8 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.294 -1.002 . . . . 40.0 108.294 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.679 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.15 129.38 55.49 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.82 0.819 . . . . 40.0 108.816 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.717 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.2 p -93.56 159.99 14.99 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 122.322 1.058 . . . . 40.0 112.467 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.4 p -70.04 -18.11 63.28 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.241 -1.022 . . . . 40.0 108.241 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.463 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -86.15 8.69 19.96 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.052 -0.659 . . . . 40.0 109.498 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.447 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.88 26.79 0.6 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.497 -0.752 . . . . 40.0 109.955 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.441 HD12 HH21 ' A' ' 69' ' ' ARG . 27.1 mt -94.94 137.2 34.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.121 -0.987 . . . . 40.0 108.471 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.52 ' CG2' HD11 ' A' ' 109' ' ' ILE . 37.2 mm -112.15 119.84 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.533 -0.73 . . . . 40.0 110.338 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -122.2 144.74 48.78 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.935 -0.706 . . . . 40.0 109.663 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.509 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 3.7 tptp -133.66 145.04 49.59 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.109 -0.995 . . . . 40.0 110.87 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.531 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.5 t -124.01 167.12 14.6 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 109.02 -0.733 . . . . 40.0 109.02 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.512 ' O ' ' OG ' ' A' ' 85' ' ' SER . 38.7 p -140.47 -9.43 1.09 Allowed 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.213 -0.93 . . . . 40.0 109.922 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.68 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -108.16 13.27 26.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 40.0 109.997 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 84.36 62.08 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.263 0.554 . . . . 40.0 110.308 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.659 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 22.7 m-85 70.61 -20.64 0.2 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.722 -0.611 . . . . 40.0 110.864 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.7 mt-30 -44.07 -73.7 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.162 -0.961 . . . . 40.0 109.472 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.477 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 22.0 p -106.25 167.88 9.52 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 107.316 -1.364 . . . . 40.0 107.316 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.584 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -140.32 140.12 35.57 Favored 'General case' 0 C--N 1.268 -2.966 0 O-C-N 121.645 -0.66 . . . . 40.0 109.866 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.2 m -125.14 135.75 52.94 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.267 -1.012 . . . . 40.0 108.267 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.612 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 19.3 tttp -84.56 145.91 27.82 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.801 -1.187 . . . . 40.0 109.619 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.52 HD11 ' CG2' ' A' ' 96' ' ' ILE . 15.1 pt -121.03 -35.01 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.445 -0.785 . . . . 40.0 109.476 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.615 HH21 ' CG ' ' A' ' 8' ' ' ASP . 78.9 mtt180 . . . . . 0 N--CA 1.488 1.474 0 O-C-N 121.169 -0.957 . . . . 40.0 109.091 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.607 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 12.8 t . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 109.786 -0.45 . . . . 40.0 109.786 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -175.01 153.55 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 109.375 -0.602 . . . . 40.0 109.375 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -144.58 24.68 1.54 Allowed 'General case' 0 N--CA 1.484 1.23 0 O-C-N 120.853 -1.154 . . . . 40.0 110.36 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 10' ' ' VAL . 14.9 p -105.95 152.34 23.45 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.792 0.806 . . . . 40.0 109.541 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.493 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -55.24 -65.1 0.65 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.987 -1.071 . . . . 40.0 110.922 -178.829 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.595 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.7 OUTLIER -56.71 -41.75 77.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.344 -0.847 . . . . 40.0 110.304 -179.286 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.96 -44.87 87.8 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.255 -1.538 . . . . 40.0 109.255 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.559 HG22 ' HG2' ' A' ' 21' ' ' PRO . 72.1 t -67.48 -42.42 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.837 -0.801 . . . . 40.0 108.879 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -61.65 -57.66 11.14 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.553 -0.717 . . . . 40.0 109.212 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.25 -56.64 8.71 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.615 0.722 . . . . 40.0 109.186 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.734 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 41.7 t80 -53.31 -52.49 58.96 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.147 0.499 . . . . 40.0 110.677 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 18' ' ' HIS . 1.2 tt -71.98 -51.61 21.07 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.594 -0.692 . . . . 40.0 110.132 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 11' ' ' ALA . 63.1 mt-30 -51.25 -29.43 14.46 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.278 -1.514 . . . . 40.0 110.273 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m -90.04 -50.77 5.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.841 -1.162 . . . . 40.0 111.627 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 19' ' ' LYS . 87.7 m-85 -99.88 14.81 29.14 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.386 -0.821 . . . . 40.0 109.874 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 14' ' ' LEU . 19.9 m80 41.82 24.01 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.532 0 CA-C-O 121.407 0.622 . . . . 40.0 111.141 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 17' ' ' TYR . 4.4 pttp -134.31 158.66 43.22 Favored 'General case' 0 C--O 1.184 -2.373 0 O-C-N 121.305 -0.872 . . . . 40.0 109.939 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.28 145.06 63.55 Favored Pre-proline 0 C--N 1.263 -3.173 0 O-C-N 120.945 -1.097 . . . . 40.0 109.554 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.734 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 82.3 Cg_exo -37.94 155.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.512 2.578 0 C-N-CA 123.473 2.782 . . . . 40.0 114.7 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.607 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -67.73 50.37 0.05 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.138 -0.976 . . . . 40.0 108.964 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -174.94 24.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 118.952 -1.099 . . . . 40.0 110.764 -179.42 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.411 ' OH ' ' O ' ' A' ' 75' ' ' ASP . 3.5 m-85 -118.26 109.78 16.74 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.981 0.896 . . . . 40.0 110.332 -178.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 25' ' ' ILE . 12.5 pt -118.47 134.13 63.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.931 -1.137 . . . . 40.0 107.931 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.84 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.3 OUTLIER -70.32 173.43 6.81 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 124.092 1.901 . . . . 40.0 113.371 -177.339 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HE2' ' OD1' ' A' ' 54' ' ' ASP . 16.8 mtmt -63.29 -35.83 81.67 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 106.648 -1.612 . . . . 40.0 106.648 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.511 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 5.1 m -37.54 -70.24 0.1 Allowed 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 122.28 1.038 . . . . 40.0 108.962 175.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.476 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.2 mp0 -68.1 -50.0 57.62 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.988 -1.115 . . . . 40.0 107.988 -178.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.476 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -43.18 -49.4 6.49 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.263 -1.375 . . . . 40.0 108.888 177.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.423 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 34.3 mt-30 -59.68 -62.08 2.14 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.275 -0.891 . . . . 40.0 111.454 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.01 -24.15 66.87 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.219 -0.925 . . . . 40.0 109.118 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.2 tp -68.1 -21.57 64.95 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.236 -0.986 . . . . 40.0 108.596 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.35 43.75 0.46 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.266 -1.133 . . . . 40.0 110.266 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.542 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -80.96 143.22 32.74 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.034 -1.274 . . . . 40.0 109.38 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.9 t -140.99 131.54 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.755 0 O-C-N 120.969 -1.082 . . . . 40.0 109.217 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.25 -48.78 79.36 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.913 -0.492 . . . . 40.0 110.342 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.3 p -70.82 45.63 0.09 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.158 -0.963 . . . . 40.0 110.263 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.482 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 ttpm? -177.07 -51.43 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.892 -0.781 . . . . 40.0 108.892 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.7 58.93 10.18 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 108.202 -1.959 . . . . 40.0 108.202 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.542 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -75.56 159.52 31.16 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.77 -0.841 . . . . 40.0 110.288 -177.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.733 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 59.4 tp -173.76 -66.75 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.232 -0.987 . . . . 40.0 110.538 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.62 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -61.68 -19.91 62.86 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.03 -1.044 . . . . 40.0 109.935 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.7 p-10 -78.11 -61.34 2.03 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.681 -0.859 . . . . 40.0 108.681 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.1 m -78.74 -10.17 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.412 0 O-C-N 121.644 -0.66 . . . . 40.0 110.088 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -150.37 71.54 9.15 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.393 -0.817 . . . . 40.0 109.838 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.96 117.5 4.2 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 123.649 2.899 . . . . 40.0 113.135 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.81 37.89 43.54 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.081 -1.208 . . . . 40.0 110.081 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.497 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 7.3 mmtm -134.99 173.6 11.54 Favored 'General case' 0 N--CA 1.511 2.585 0 CA-C-O 121.72 0.771 . . . . 40.0 110.537 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.0 m -147.54 162.76 38.42 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.954 -1.091 . . . . 40.0 112.013 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.6 mm -82.72 124.23 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 115.26 -0.882 . . . . 40.0 110.643 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.55 157.56 17.15 Favored Glycine 0 N--CA 1.5 2.927 0 N-CA-C 109.64 -1.384 . . . . 40.0 109.64 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.84 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 117.63 -9.83 14.5 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 118.938 -1.601 . . . . 40.0 110.107 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.458 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 5.3 m-20 -75.69 -151.97 0.04 OUTLIER 'General case' 0 C--O 1.193 -1.897 0 O-C-N 120.8 -1.412 . . . . 40.0 109.853 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.4 mp -130.68 142.39 43.8 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 CA-C-N 115.102 -0.954 . . . . 40.0 108.679 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.613 ' O ' ' N ' ' A' ' 58' ' ' ASN . 12.9 t80 -110.3 90.96 3.47 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.095 -0.706 . . . . 40.0 109.095 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.659 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.9 p -60.3 38.74 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.457 -0.777 . . . . 40.0 110.705 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.613 ' N ' ' O ' ' A' ' 56' ' ' PHE . 45.6 t30 33.89 38.95 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.13 -0.981 . . . . 40.0 110.721 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.659 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.5 mtm180 -69.34 35.52 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.119 -0.988 . . . . 40.0 110.086 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.628 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 15.1 mt-10 -144.86 -3.74 0.77 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.052 -1.03 . . . . 40.0 110.348 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.421 ' HA2' HD21 ' A' ' 58' ' ' ASN . . . 54.16 37.91 60.09 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.275 -1.53 . . . . 40.0 109.275 -178.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.628 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 5.0 mttp -120.32 11.66 11.54 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.537 -0.978 . . . . 40.0 109.778 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.453 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -136.88 143.98 44.72 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 109.389 -0.597 . . . . 40.0 109.389 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.83 124.64 14.91 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.605 2.203 . . . . 40.0 112.267 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.526 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -104.33 -178.75 25.1 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.076 -1.21 . . . . 40.0 110.076 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.438 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 9.5 tttt -177.16 152.57 0.89 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.363 -1.08 . . . . 40.0 108.435 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.6 p -71.3 53.41 0.19 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.304 -1.497 . . . . 40.0 109.438 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.48 80.16 0.03 OUTLIER Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.084 -1.206 . . . . 40.0 110.084 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.577 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -175.36 178.83 1.6 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.706 -0.879 . . . . 40.0 108.864 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.577 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 87.1 m -155.52 155.98 34.38 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.331 -0.947 . . . . 40.0 109.83 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.697 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 27.5 m95 -124.91 140.01 53.31 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.78 -0.452 . . . . 40.0 109.78 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.635 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.64 149.55 52.25 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.738 -1.226 . . . . 40.0 109.685 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.52 ' O ' ' OH ' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -115.79 168.82 9.71 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 122.283 1.04 . . . . 40.0 112.304 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.13 138.5 4.66 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.846 -0.615 . . . . 40.0 111.11 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.724 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -60.41 154.79 19.64 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.453 0.644 . . . . 40.0 111.091 179.495 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.724 HD13 ' O ' ' A' ' 75' ' ' ASP . 40.2 mm -137.82 145.19 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 119.962 -0.695 . . . . 40.0 110.596 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 57.83 68.4 0.85 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.738 -0.601 . . . . 40.0 110.697 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.733 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 61.0 t80 -129.84 157.2 42.9 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.097 -1.002 . . . . 40.0 109.867 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.541 ' OG1' ' N ' ' A' ' 80' ' ' SER . 24.2 p -137.31 -71.07 0.44 Allowed 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.517 -0.739 . . . . 40.0 109.718 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.62 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -153.68 107.15 2.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.6 -0.687 . . . . 40.0 109.388 -178.344 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.28 -107.22 0.31 Allowed Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.667 -1.254 . . . . 40.0 110.191 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.477 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 41.6 t80 -137.29 -166.73 1.98 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.772 -0.84 . . . . 40.0 109.355 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.664 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.8 mtm180 -73.99 -155.5 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.805 -1.184 . . . . 40.0 109.643 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -166.52 -150.75 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.888 -1.153 . . . . 40.0 107.888 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' A' ' 100' ' ' THR . 60.1 p -102.32 -7.49 22.02 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.004 -1.06 . . . . 40.0 109.539 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.536 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.67 113.88 23.76 Favored 'General case' 0 N--CA 1.509 2.505 0 CA-C-O 121.89 0.852 . . . . 40.0 111.552 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.857 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.35 148.55 43.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.951 -1.093 . . . . 40.0 110.84 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.662 ' CG2' HD11 ' A' ' 76' ' ' ILE . 5.5 tt -114.72 140.06 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-O 122.144 0.973 . . . . 40.0 110.158 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.541 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 3.1 mm? -118.77 125.13 48.92 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.609 -0.886 . . . . 40.0 108.609 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.672 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -119.52 129.41 54.68 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.594 0.711 . . . . 40.0 109.203 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.697 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.7 p -93.93 160.14 14.86 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.668 1.223 . . . . 40.0 112.797 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.1 p -69.92 -17.03 63.31 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.138 -1.06 . . . . 40.0 108.138 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.474 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -88.19 10.03 20.87 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 119.773 -0.771 . . . . 40.0 109.686 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.458 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.6 27.36 0.62 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.765 -0.585 . . . . 40.0 110.259 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.0 mt -96.48 136.93 36.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.273 -0.892 . . . . 40.0 109.061 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.508 ' CG2' HD11 ' A' ' 109' ' ' ILE . 41.1 mm -111.72 119.95 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.772 -0.58 . . . . 40.0 110.649 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.406 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.7 m-85 -122.91 144.57 49.14 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 120.524 -0.47 . . . . 40.0 109.934 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.536 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 4.2 tptp -134.29 145.02 48.68 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.042 -1.036 . . . . 40.0 110.593 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.593 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.6 t -123.37 166.9 14.54 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.567 -0.901 . . . . 40.0 108.567 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.517 ' O ' ' OG ' ' A' ' 85' ' ' SER . 35.8 p -139.73 -10.29 1.19 Allowed 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.03 -1.044 . . . . 40.0 109.723 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.713 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -107.13 10.78 30.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.25 -0.907 . . . . 40.0 110.259 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 86.68 63.06 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.346 0.593 . . . . 40.0 110.494 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.664 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 24.4 m-85 70.61 -23.23 0.17 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.369 -0.832 . . . . 40.0 110.883 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 102' ' ' ALA . 2.0 mt-30 -43.4 -73.45 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.293 -0.879 . . . . 40.0 109.97 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.491 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 24.8 p -106.18 167.53 9.75 Favored 'General case' 0 C--O 1.196 -1.756 0 N-CA-C 107.718 -1.215 . . . . 40.0 107.718 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.541 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -140.93 139.16 34.27 Favored 'General case' 0 C--N 1.268 -2.942 0 O-C-N 121.51 -0.744 . . . . 40.0 109.836 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.7 m -124.48 135.98 53.65 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.143 -1.058 . . . . 40.0 108.143 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.54 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 18.1 tttp -84.64 145.57 27.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.903 -1.123 . . . . 40.0 109.656 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.508 HD11 ' CG2' ' A' ' 96' ' ' ILE . 14.6 pt -121.35 -34.42 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.157 -0.964 . . . . 40.0 109.528 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.595 HH21 ' CG ' ' A' ' 8' ' ' ASP . 76.3 mtt180 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 118.176 -0.916 . . . . 40.0 108.969 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.636 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 17.9 t . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 108.992 -0.744 . . . . 40.0 108.992 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -175.9 153.79 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.066 -0.716 . . . . 40.0 109.066 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -144.43 26.05 1.48 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.109 -0.994 . . . . 40.0 110.688 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.492 ' O ' HG23 ' A' ' 10' ' ' VAL . 21.2 p -104.26 151.94 22.81 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 121.463 0.649 . . . . 40.0 109.473 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -55.25 -64.16 0.93 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.716 -1.24 . . . . 40.0 110.734 -179.191 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.604 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.7 OUTLIER -57.03 -41.83 79.32 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.193 -0.942 . . . . 40.0 110.107 -179.362 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.4 -45.28 84.18 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.702 -1.359 . . . . 40.0 109.702 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.59 HG22 ' HG2' ' A' ' 21' ' ' PRO . 71.1 t -67.09 -43.36 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 121.674 -0.898 . . . . 40.0 108.824 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.43 -58.79 6.99 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.283 -0.636 . . . . 40.0 109.283 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.56 -56.47 9.8 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.118 -0.989 . . . . 40.0 109.358 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.758 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 39.0 t80 -51.49 -53.07 41.19 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.942 -0.572 . . . . 40.0 110.418 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 18' ' ' HIS . 1.9 tt -72.74 -50.1 26.79 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.336 0.589 . . . . 40.0 110.982 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 11' ' ' ALA . 63.3 mt-30 -53.17 -28.27 25.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.059 -1.65 . . . . 40.0 109.925 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.9 m -91.61 -51.14 5.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.014 -1.054 . . . . 40.0 110.763 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.416 ' O ' ' N ' ' A' ' 19' ' ' LYS . 84.9 m-85 -99.11 14.03 30.79 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.268 -0.895 . . . . 40.0 110.427 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.544 ' N ' ' O ' ' A' ' 14' ' ' LEU . 20.9 m80 41.95 25.01 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 O-C-N 121.565 -0.71 . . . . 40.0 111.023 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 17' ' ' TYR . 4.1 pttp -134.89 158.65 43.71 Favored 'General case' 0 C--O 1.185 -2.3 0 O-C-N 121.2 -0.937 . . . . 40.0 109.967 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mp -79.35 146.03 65.44 Favored Pre-proline 0 C--N 1.269 -2.905 0 N-CA-C 107.961 -1.126 . . . . 40.0 107.961 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.758 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 82.2 Cg_exo -39.34 157.72 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 123.213 2.608 . . . . 40.0 114.6 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.636 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.8 OUTLIER -69.47 51.26 0.1 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.817 -1.177 . . . . 40.0 109.62 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.48 ' HA ' ' HD3' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -175.92 26.71 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.026 -1.047 . . . . 40.0 110.149 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -119.59 109.72 16.02 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.498 -1.376 . . . . 40.0 111.045 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.0 pt -116.85 134.94 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.441 -0.904 . . . . 40.0 108.704 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.758 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.3 OUTLIER -69.51 169.98 11.5 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 123.756 1.741 . . . . 40.0 113.269 -177.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.528 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 23.1 mtmt -62.34 -37.87 87.31 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 105.96 -1.867 . . . . 40.0 105.96 177.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.504 ' OG ' ' OG1' ' A' ' 26' ' ' THR . 1.1 m -37.69 -70.84 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.667 -0.864 . . . . 40.0 108.667 176.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.545 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.5 mp0 -63.34 -57.62 9.79 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 106.823 -1.547 . . . . 40.0 106.823 -177.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.545 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -33.31 -52.03 0.36 Allowed 'General case' 0 N--CA 1.509 2.525 0 C-N-CA 119.165 -1.014 . . . . 40.0 109.251 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -56.52 -67.06 0.34 Allowed 'General case' 0 N--CA 1.516 2.864 0 O-C-N 120.906 -1.121 . . . . 40.0 111.524 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.4 -21.64 62.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.746 -1.221 . . . . 40.0 110.494 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.516 HD21 ' HB ' ' A' ' 45' ' ' VAL . 60.5 tp -70.54 -24.47 62.81 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.349 -1.352 . . . . 40.0 107.349 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.7 48.15 0.28 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.6 -1.0 . . . . 40.0 110.6 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.595 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.14 142.31 33.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.009 -1.289 . . . . 40.0 108.633 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.7 t -136.47 128.24 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 N-CA-C 108.439 -0.948 . . . . 40.0 108.439 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.12 -48.58 81.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.776 -0.577 . . . . 40.0 109.531 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.7 p -70.83 46.95 0.1 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.028 -1.045 . . . . 40.0 109.899 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.613 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -178.6 -50.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.916 -0.772 . . . . 40.0 108.916 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.39 59.8 8.85 Favored Glycine 0 N--CA 1.503 3.146 0 N-CA-C 108.593 -1.803 . . . . 40.0 108.593 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.613 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -76.6 160.56 29.32 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.344 -1.092 . . . . 40.0 111.59 -177.293 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.835 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 45.5 tp -172.46 -70.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.451 -0.9 . . . . 40.0 110.529 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.59 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -59.98 -21.45 61.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.852 -1.155 . . . . 40.0 109.77 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 5.0 p-10 -75.87 -62.64 1.52 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.185 -0.672 . . . . 40.0 109.185 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.516 ' HB ' HD21 ' A' ' 33' ' ' LEU . 15.8 m -77.76 -13.28 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 109.063 -0.718 . . . . 40.0 109.063 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.474 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -147.74 72.92 11.54 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 121.34 -0.85 . . . . 40.0 110.148 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.68 118.04 4.81 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.01 2.474 . . . . 40.0 113.959 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.513 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 75.16 36.48 45.64 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.25 -1.54 . . . . 40.0 109.25 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.3 mmtm -135.5 163.55 29.82 Favored 'General case' 0 N--CA 1.511 2.586 0 CA-C-O 121.739 0.781 . . . . 40.0 110.364 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.483 ' HA ' HD21 ' A' ' 42' ' ' LEU . 50.5 m -138.56 166.57 23.99 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 122.12 0.962 . . . . 40.0 111.325 -176.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.402 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 10.3 mm -83.98 121.66 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 115.344 -0.843 . . . . 40.0 111.689 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 178.27 155.24 13.86 Favored Glycine 0 N--CA 1.502 3.097 0 C-N-CA 119.847 -1.168 . . . . 40.0 110.604 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.758 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 119.7 -7.87 12.04 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.342 -1.409 . . . . 40.0 110.217 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.417 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 4.5 m-20 -75.65 -150.79 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.088 -1.242 . . . . 40.0 109.824 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -132.36 143.33 40.23 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.882 0 CA-C-N 115.067 -0.969 . . . . 40.0 108.848 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.644 ' O ' ' N ' ' A' ' 58' ' ' ASN . 14.9 t80 -112.04 89.68 3.13 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.488 -0.93 . . . . 40.0 108.488 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.667 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.8 p -59.23 37.57 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.597 0.713 . . . . 40.0 110.611 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.644 ' N ' ' O ' ' A' ' 56' ' ' PHE . 44.2 t30 34.42 39.18 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.066 -1.021 . . . . 40.0 110.656 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.667 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.8 mtm180 -70.02 35.54 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.731 -1.231 . . . . 40.0 110.45 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.605 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 14.8 mt-10 -144.91 -1.85 0.84 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.033 -1.042 . . . . 40.0 109.943 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.58 37.84 50.91 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.662 -1.375 . . . . 40.0 109.662 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.605 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 4.3 mttp -119.89 12.36 12.04 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.458 -1.025 . . . . 40.0 109.407 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.479 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -137.54 143.85 42.55 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.702 -0.624 . . . . 40.0 109.646 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.54 123.74 13.32 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.505 2.137 . . . . 40.0 112.466 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.54 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -103.43 -177.81 26.16 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.205 -1.158 . . . . 40.0 110.205 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.43 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 8.4 tttt -178.12 154.09 0.84 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 108.024 -1.102 . . . . 40.0 108.024 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.4 p -73.29 56.04 0.47 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.774 -1.204 . . . . 40.0 109.041 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.16 81.76 0.04 OUTLIER Glycine 0 N--CA 1.498 2.815 0 N-CA-C 109.899 -1.28 . . . . 40.0 109.899 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.57 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -177.34 178.18 1.11 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.544 -0.974 . . . . 40.0 108.874 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.57 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 92.8 m -154.97 155.12 33.65 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.219 -0.926 . . . . 40.0 109.945 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.713 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 29.7 m95 -123.36 139.45 54.02 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.708 -0.479 . . . . 40.0 109.708 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.597 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.26 149.02 52.14 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.705 -1.247 . . . . 40.0 109.713 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.529 ' O ' ' OH ' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -114.52 169.94 8.68 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.897 -1.127 . . . . 40.0 112.331 -179.452 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.99 137.24 3.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.745 -0.597 . . . . 40.0 110.958 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.722 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -59.14 154.54 15.76 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 120.917 0.389 . . . . 40.0 110.896 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.722 HD13 ' O ' ' A' ' 75' ' ' ASP . 41.6 mm -137.09 144.33 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.323 -0.861 . . . . 40.0 110.294 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 57.77 71.05 0.6 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.527 -0.733 . . . . 40.0 110.58 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.835 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 69.2 t80 -131.67 155.06 48.27 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.866 -1.146 . . . . 40.0 109.804 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.596 ' OG1' ' N ' ' A' ' 80' ' ' SER . 27.2 p -135.79 -73.05 0.45 Allowed 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.618 -0.676 . . . . 40.0 110.138 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.596 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -153.65 102.32 2.54 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.481 -0.562 . . . . 40.0 109.481 -177.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.427 ' N ' ' OH ' ' A' ' 78' ' ' TYR . . . 164.01 -103.08 0.21 Allowed Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.855 -1.164 . . . . 40.0 110.397 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.486 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 45.8 t80 -141.3 -166.95 2.29 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.842 -0.799 . . . . 40.0 108.955 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.649 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.9 mtm180 -73.45 -154.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 40.0 110.429 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.597 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 9.4 p30 -167.58 -150.91 0.11 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.333 -0.988 . . . . 40.0 108.333 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.514 ' OG ' ' O ' ' A' ' 100' ' ' THR . 82.5 p -102.82 -8.06 21.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.799 -1.188 . . . . 40.0 109.309 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.522 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.25 113.67 23.19 Favored 'General case' 0 N--CA 1.509 2.48 0 CA-C-O 121.794 0.807 . . . . 40.0 111.483 -179.537 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.854 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.73 150.79 46.53 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.852 -1.155 . . . . 40.0 110.551 179.606 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.693 ' CG2' HD11 ' A' ' 76' ' ' ILE . 4.9 tt -116.93 141.02 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.511 -0.743 . . . . 40.0 109.908 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 72' ' ' ARG . 2.8 mm? -119.54 124.95 47.67 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.574 -0.899 . . . . 40.0 108.574 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.677 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.66 129.53 55.35 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.873 0.844 . . . . 40.0 108.776 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.713 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.9 p -94.69 159.66 14.97 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 122.581 1.181 . . . . 40.0 112.413 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.6 p -69.42 -17.81 63.69 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.117 -1.068 . . . . 40.0 108.117 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.476 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -87.06 10.06 17.75 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.778 -0.769 . . . . 40.0 109.736 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.453 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.66 26.54 0.65 Allowed 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.62 -0.675 . . . . 40.0 110.259 179.253 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.5 mt -95.69 135.55 37.24 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.362 -0.837 . . . . 40.0 109.092 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.523 ' CG2' HD11 ' A' ' 109' ' ' ILE . 38.6 mm -110.96 119.02 58.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-O 121.389 0.614 . . . . 40.0 110.722 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -122.28 144.88 48.72 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 120.276 -0.57 . . . . 40.0 109.637 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.522 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 4.8 tptp -133.83 144.42 48.95 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.19 -0.943 . . . . 40.0 110.644 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.59 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.7 t -123.17 166.7 14.77 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 108.688 -0.856 . . . . 40.0 108.688 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.514 ' O ' ' OG ' ' A' ' 85' ' ' SER . 40.7 p -140.08 -9.82 1.15 Allowed 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.277 -0.889 . . . . 40.0 109.66 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.69 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -108.47 14.01 25.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 40.0 110.261 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 84.41 61.92 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.13 0.491 . . . . 40.0 110.329 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.649 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 24.6 m-85 70.73 -21.64 0.19 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.494 -0.754 . . . . 40.0 110.881 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.426 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.2 mt-30 -43.72 -72.55 0.06 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.088 -1.007 . . . . 40.0 109.599 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.465 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 26.4 p -107.41 169.44 8.58 Favored 'General case' 0 C--O 1.193 -1.9 0 N-CA-C 108.048 -1.093 . . . . 40.0 108.048 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.546 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -141.42 140.13 33.57 Favored 'General case' 0 C--N 1.272 -2.794 0 O-C-N 121.355 -0.84 . . . . 40.0 110.114 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 46.4 m -125.31 135.51 52.55 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.551 -0.907 . . . . 40.0 108.551 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.596 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 21.7 tttp -84.46 145.08 28.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.759 -1.213 . . . . 40.0 109.879 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.523 HD11 ' CG2' ' A' ' 96' ' ' ILE . 14.1 pt -120.32 -34.72 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.172 -0.955 . . . . 40.0 109.527 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.604 HH21 ' CG ' ' A' ' 8' ' ' ASP . 78.3 mtt180 . . . . . 0 N--CA 1.487 1.378 0 O-C-N 121.186 -0.946 . . . . 40.0 108.638 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.648 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 20.7 t . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 109.294 -0.632 . . . . 40.0 109.294 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 tt -177.1 152.4 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 108.981 -0.748 . . . . 40.0 108.981 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -144.29 25.78 1.52 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.733 -1.229 . . . . 40.0 110.604 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 10' ' ' VAL . 17.4 p -105.38 152.82 22.49 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.528 0.68 . . . . 40.0 110.057 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.498 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -56.29 -62.74 1.51 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.459 -1.401 . . . . 40.0 111.482 -179.198 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.646 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -59.1 -40.83 86.54 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.976 -1.077 . . . . 40.0 109.738 -179.345 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.45 -44.88 85.3 Favored Glycine 0 N--CA 1.507 3.377 0 N-CA-C 109.682 -1.367 . . . . 40.0 109.682 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.513 HG22 ' HG2' ' A' ' 21' ' ' PRO . 70.5 t -67.55 -43.48 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.805 -0.821 . . . . 40.0 108.976 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.88 -56.48 20.64 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.967 -0.753 . . . . 40.0 108.967 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.04 -56.02 14.63 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.89 -0.782 . . . . 40.0 108.89 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.695 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 38.7 t80 -53.02 -51.78 60.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 122.017 -0.427 . . . . 40.0 110.87 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 18' ' ' HIS . 3.9 tt -71.89 -51.06 24.14 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 121.414 0.626 . . . . 40.0 110.43 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.495 ' N ' HD23 ' A' ' 14' ' ' LEU . 58.8 mt-30 -53.22 -28.77 28.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 119.983 -1.698 . . . . 40.0 110.316 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.3 m -92.31 -50.18 5.78 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.612 -1.305 . . . . 40.0 110.964 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.401 ' O ' ' N ' ' A' ' 19' ' ' LYS . 86.5 m-85 -99.28 12.47 36.15 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.89 -1.131 . . . . 40.0 110.308 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.569 ' N ' ' O ' ' A' ' 14' ' ' LEU . 23.5 m80 42.6 24.2 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.916 0 CA-C-O 121.484 0.659 . . . . 40.0 111.226 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 17' ' ' TYR . 5.1 pttp -135.98 156.57 48.54 Favored 'General case' 0 C--O 1.183 -2.413 0 CA-C-O 121.646 0.736 . . . . 40.0 109.804 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 24' ' ' TYR . 4.5 mp -77.62 145.63 71.6 Favored Pre-proline 0 C--N 1.268 -2.976 0 O-C-N 120.899 -1.126 . . . . 40.0 109.71 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.695 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 88.9 Cg_exo -40.33 155.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 123.267 2.645 . . . . 40.0 113.922 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.648 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -66.06 49.19 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.15 0.976 . . . . 40.0 109.376 -179.016 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -173.92 26.99 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.189 -0.944 . . . . 40.0 110.687 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.425 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 2.9 m-85 -119.59 108.26 14.27 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.523 -1.361 . . . . 40.0 109.628 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.7 pt -116.94 132.11 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 C-N-CA 119.436 -0.905 . . . . 40.0 108.89 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.782 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.5 OUTLIER -67.17 172.02 5.1 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 123.609 1.671 . . . . 40.0 113.536 -177.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.501 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 19.5 mtmt -63.36 -35.99 82.23 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 106.458 -1.682 . . . . 40.0 106.458 176.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.566 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 5.1 m -35.56 -71.7 0.07 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 123.57 1.652 . . . . 40.0 109.222 175.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.504 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.1 mp0 -65.53 -56.18 13.76 Favored 'General case' 0 C--O 1.192 -1.93 0 N-CA-C 107.488 -1.301 . . . . 40.0 107.488 -177.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.504 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -37.26 -50.29 0.99 Allowed 'General case' 0 N--CA 1.517 2.914 0 O-C-N 120.574 -1.329 . . . . 40.0 110.647 178.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -58.93 -62.04 2.18 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.382 -1.449 . . . . 40.0 110.848 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.81 -25.98 67.83 Favored 'General case' 0 N--CA 1.512 2.662 0 O-C-N 120.679 -1.263 . . . . 40.0 110.027 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.0 tp -65.02 -25.33 67.8 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.178 -1.045 . . . . 40.0 108.178 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.33 46.2 0.33 Allowed Glycine 0 N--CA 1.502 3.068 0 N-CA-C 110.244 -1.142 . . . . 40.0 110.244 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.476 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -80.54 139.85 36.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.969 -1.312 . . . . 40.0 109.422 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.7 t -136.09 130.15 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.241 0 CA-C-O 121.6 0.714 . . . . 40.0 109.576 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.47 -48.18 79.87 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.298 -0.63 . . . . 40.0 109.298 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.2 p -69.7 44.85 0.06 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.33 -0.856 . . . . 40.0 110.704 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.603 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.5 ttpm? -178.48 -51.99 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.203 -0.936 . . . . 40.0 109.066 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.43 62.68 4.89 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 108.788 -1.725 . . . . 40.0 108.788 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.603 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -78.78 160.1 27.57 Favored 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.495 -1.003 . . . . 40.0 111.024 -177.787 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.842 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 52.0 tp -173.67 -69.4 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.479 -0.763 . . . . 40.0 110.544 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.565 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -61.37 -21.76 64.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.731 -1.231 . . . . 40.0 109.31 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 4.8 p-10 -74.16 -62.8 1.39 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.221 -0.659 . . . . 40.0 109.221 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.8 m -80.4 -10.04 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.914 -0.491 . . . . 40.0 110.298 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.554 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -148.21 72.23 11.06 Favored Pre-proline 0 N--CA 1.489 1.487 0 CA-C-O 121.489 0.662 . . . . 40.0 109.518 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -55.35 115.53 2.51 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 123.779 2.986 . . . . 40.0 113.381 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.72 38.2 57.06 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.992 -1.243 . . . . 40.0 109.992 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.554 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 6.3 mmtt -133.12 163.3 29.57 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.795 -0.827 . . . . 40.0 110.008 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.4 ' HA ' HD21 ' A' ' 42' ' ' LEU . 67.2 m -139.13 161.1 38.23 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 122.432 1.11 . . . . 40.0 110.84 -176.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.6 mm -79.93 124.78 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 114.619 -1.173 . . . . 40.0 110.721 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.24 156.12 13.22 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 119.529 -1.319 . . . . 40.0 109.967 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.782 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 118.29 -10.73 13.06 Favored Glycine 0 N--CA 1.502 3.091 0 C-N-CA 119.531 -1.319 . . . . 40.0 110.163 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.437 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 4.9 m-20 -72.62 -151.15 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.538 -1.566 . . . . 40.0 109.68 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.4 mp -132.72 141.0 46.18 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 CA-C-N 115.132 -0.94 . . . . 40.0 109.304 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.627 ' O ' ' N ' ' A' ' 58' ' ' ASN . 11.7 t80 -109.28 91.76 3.77 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.295 -0.878 . . . . 40.0 109.198 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.624 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.5 p -60.27 38.21 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.92 0.867 . . . . 40.0 110.625 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.627 ' N ' ' O ' ' A' ' 56' ' ' PHE . 44.8 t30 33.97 39.27 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.407 -0.808 . . . . 40.0 110.659 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.624 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.3 mtm180 -70.37 36.3 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.516 -1.365 . . . . 40.0 110.348 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.614 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 15.1 mt-10 -145.17 -2.76 0.78 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.347 -0.845 . . . . 40.0 109.954 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.29 37.95 56.09 Favored Glycine 0 N--CA 1.502 3.098 0 N-CA-C 109.579 -1.409 . . . . 40.0 109.579 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.614 ' NZ ' ' OE2' ' A' ' 60' ' ' GLU . 5.8 mttp -120.1 11.46 11.66 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.267 -1.137 . . . . 40.0 109.505 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.405 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.5 mt -136.38 144.26 46.88 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.64 -0.663 . . . . 40.0 109.498 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.53 123.8 13.04 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.188 1.925 . . . . 40.0 112.527 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.531 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.67 -175.84 27.05 Favored Glycine 0 N--CA 1.5 2.901 0 N-CA-C 110.235 -1.146 . . . . 40.0 110.235 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.462 ' NZ ' ' O ' ' A' ' 68' ' ' GLY . 9.0 tttt -179.12 152.17 0.54 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.065 -1.256 . . . . 40.0 107.791 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.6 p -70.87 53.53 0.16 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.643 -1.286 . . . . 40.0 109.106 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.462 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 150.89 80.98 0.03 OUTLIER Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.277 -1.129 . . . . 40.0 110.277 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.553 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.67 177.97 1.99 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.735 -0.862 . . . . 40.0 108.799 179.105 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.553 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 96.7 m -154.36 155.16 34.56 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.254 -0.904 . . . . 40.0 110.039 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TRP . . . . . 0.741 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 31.8 m95 -124.99 138.92 54.21 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.982 -0.449 . . . . 40.0 109.893 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.581 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.68 147.71 52.38 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.028 -1.045 . . . . 40.0 109.88 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.501 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -113.24 168.74 9.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.679 -1.263 . . . . 40.0 111.9 -179.379 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.45 139.56 5.71 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.799 0.809 . . . . 40.0 111.063 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.743 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -60.51 154.83 19.88 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.85 -0.531 . . . . 40.0 111.275 179.641 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.743 HD13 ' O ' ' A' ' 75' ' ' ASP . 33.9 mm -138.14 145.4 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.513 -0.742 . . . . 40.0 109.946 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 56.77 70.69 0.63 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.499 0.666 . . . . 40.0 110.782 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.842 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 65.6 t80 -132.29 154.9 49.21 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.917 -1.114 . . . . 40.0 109.436 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.574 ' OG1' ' N ' ' A' ' 80' ' ' SER . 22.9 p -136.17 -72.16 0.45 Allowed 'General case' 0 N--CA 1.507 2.385 0 CA-C-O 121.214 0.531 . . . . 40.0 109.934 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.574 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.5 OUTLIER -153.4 103.67 2.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.387 -0.821 . . . . 40.0 109.299 -178.669 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.402 ' N ' ' OH ' ' A' ' 78' ' ' TYR . . . 163.42 -106.19 0.27 Allowed Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.608 -1.282 . . . . 40.0 110.212 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.469 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 52.4 t80 -138.21 -165.16 1.75 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.789 -0.819 . . . . 40.0 108.789 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.647 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.1 mtm180 -75.72 -155.84 0.06 Allowed 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.335 -1.478 . . . . 40.0 109.961 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASN . . . . . 0.547 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 9.5 p30 -165.13 -149.18 0.12 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.217 -1.031 . . . . 40.0 108.217 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 100' ' ' THR . 82.7 p -104.21 -7.58 20.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.709 -1.244 . . . . 40.0 108.929 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.482 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -87.6 113.42 23.27 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-O 121.878 0.846 . . . . 40.0 111.71 -179.435 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.863 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.55 150.61 46.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.879 -1.138 . . . . 40.0 110.519 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.729 ' CG2' HD11 ' A' ' 76' ' ' ILE . 6.7 tt -117.3 139.26 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-O 122.831 1.301 . . . . 40.0 110.028 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.528 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.9 mm? -118.86 124.44 47.16 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.421 -0.955 . . . . 40.0 108.421 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.678 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.54 129.5 55.39 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.846 0.831 . . . . 40.0 109.125 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.741 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.5 p -93.35 159.21 15.36 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 122.268 1.032 . . . . 40.0 112.221 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.8 p -69.23 -18.41 63.88 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.805 -1.183 . . . . 40.0 107.805 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.491 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -86.05 9.4 17.3 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.189 -0.604 . . . . 40.0 109.629 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.447 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.12 26.72 0.72 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.503 -0.748 . . . . 40.0 110.3 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.8 mt -96.29 134.99 38.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.398 -0.814 . . . . 40.0 109.156 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.558 ' CG2' HD11 ' A' ' 109' ' ' ILE . 39.2 mm -109.52 120.66 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.438 -0.788 . . . . 40.0 110.452 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -122.95 144.18 49.41 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 109.239 -0.652 . . . . 40.0 109.239 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.482 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 4.7 tptp -133.89 144.84 49.13 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 119.569 -0.852 . . . . 40.0 110.979 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.549 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.8 t -122.95 166.74 14.58 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 108.939 -0.764 . . . . 40.0 108.939 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.464 ' O ' ' OG ' ' A' ' 85' ' ' SER . 40.7 p -140.3 -9.0 1.13 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.36 -0.837 . . . . 40.0 109.626 178.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.674 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -108.58 14.63 24.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.958 -1.089 . . . . 40.0 110.285 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.674 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 83.45 61.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.21 0.528 . . . . 40.0 110.539 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.647 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 28.5 m-85 71.23 -20.83 0.21 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.59 -0.694 . . . . 40.0 110.651 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . 0.422 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.7 mt-30 -44.83 -74.13 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.074 -1.016 . . . . 40.0 109.83 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.515 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 21.0 p -106.02 167.01 10.09 Favored 'General case' 0 C--O 1.195 -1.806 0 N-CA-C 107.56 -1.274 . . . . 40.0 107.56 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.528 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -140.02 140.45 36.22 Favored 'General case' 0 C--N 1.264 -3.125 0 O-C-N 121.32 -0.863 . . . . 40.0 109.73 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.5 m -125.4 137.47 54.01 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.318 -0.993 . . . . 40.0 108.318 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.546 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 17.7 tttp -85.1 145.76 27.49 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.834 -1.166 . . . . 40.0 109.919 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.558 HD11 ' CG2' ' A' ' 96' ' ' ILE . 11.3 pt -121.78 -33.32 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.107 -0.996 . . . . 40.0 109.63 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.646 HH21 ' CG ' ' A' ' 8' ' ' ASP . 76.7 mtt180 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.945 . . . . 40.0 108.737 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.643 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 21.8 t . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 109.123 -0.695 . . . . 40.0 109.123 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -177.57 153.79 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.094 -0.706 . . . . 40.0 109.094 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.2 p-10 -144.38 26.1 1.48 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.066 -1.021 . . . . 40.0 110.729 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 10' ' ' VAL . 18.1 p -104.73 153.83 20.78 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.694 0.759 . . . . 40.0 109.779 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.48 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -56.99 -63.63 1.15 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.008 -1.057 . . . . 40.0 110.515 -179.267 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.652 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.8 OUTLIER -58.11 -41.76 84.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.481 -0.762 . . . . 40.0 109.781 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.6 -44.98 90.85 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 109.897 -1.281 . . . . 40.0 109.897 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.578 HG22 ' HG2' ' A' ' 21' ' ' PRO . 64.7 t -66.61 -43.41 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.485 -1.009 . . . . 40.0 108.608 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.93 -57.48 12.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.367 -0.605 . . . . 40.0 109.367 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.25 -55.63 14.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.514 -0.741 . . . . 40.0 109.039 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.708 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 38.0 t80 -52.4 -52.64 52.71 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.03 0.443 . . . . 40.0 110.268 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 18' ' ' HIS . 4.7 tt -71.42 -52.19 19.85 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.254 0.549 . . . . 40.0 110.68 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 11' ' ' ALA . 56.7 mt-30 -52.85 -28.94 25.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.113 -1.617 . . . . 40.0 109.939 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.8 m -91.1 -52.51 4.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.887 -1.133 . . . . 40.0 110.682 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -97.6 12.34 33.87 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.255 -0.903 . . . . 40.0 110.525 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.569 ' N ' ' O ' ' A' ' 14' ' ' LEU . 22.5 m80 43.36 25.04 0.06 Allowed 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.528 -0.733 . . . . 40.0 110.979 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.416 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 5.4 pttp -137.14 160.58 38.57 Favored 'General case' 0 C--O 1.182 -2.467 0 O-C-N 121.397 -0.814 . . . . 40.0 109.774 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 mp -80.07 146.08 62.39 Favored Pre-proline 0 C--N 1.266 -3.045 0 O-C-N 120.879 -1.138 . . . . 40.0 108.608 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.708 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 71.2 Cg_exo -41.26 156.11 0.06 OUTLIER 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.056 2.504 . . . . 40.0 113.982 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.643 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -67.35 49.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.178 -0.951 . . . . 40.0 109.352 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.513 ' HA ' ' HD3' ' A' ' 49' ' ' LYS . 0.8 OUTLIER -172.98 26.58 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.941 -1.099 . . . . 40.0 110.236 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.435 ' OH ' ' O ' ' A' ' 75' ' ' ASP . 4.3 m-85 -120.12 109.11 15.07 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.913 -1.115 . . . . 40.0 110.394 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 25' ' ' ILE . 16.5 pt -119.02 134.1 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.959 -1.126 . . . . 40.0 107.959 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.824 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.7 OUTLIER -71.78 172.59 9.55 Favored 'General case' 0 N--CA 1.508 2.444 0 CA-C-O 123.677 1.704 . . . . 40.0 113.249 -175.763 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.565 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 14.9 mtmt -60.67 -39.31 87.92 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 106.519 -1.66 . . . . 40.0 106.519 176.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.468 ' C ' ' O ' ' A' ' 27' ' ' LYS . 2.6 m -32.24 -74.3 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.533 -0.914 . . . . 40.0 108.533 175.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.572 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.8 mp0 -65.97 -57.49 7.68 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.116 -1.439 . . . . 40.0 107.116 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.572 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -30.22 -55.01 0.18 Allowed 'General case' 0 N--CA 1.53 3.559 0 O-C-N 119.931 -1.731 . . . . 40.0 109.78 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -56.13 -66.7 0.39 Allowed 'General case' 0 N--CA 1.525 3.31 0 O-C-N 120.033 -1.667 . . . . 40.0 113.679 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.71 -32.21 59.26 Favored 'General case' 0 N--CA 1.524 3.233 0 O-C-N 121.473 -0.767 . . . . 40.0 109.751 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.03 -22.35 66.79 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.178 -1.576 . . . . 40.0 108.633 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.36 51.27 0.4 Allowed Glycine 0 N--CA 1.503 3.144 0 N-CA-C 110.049 -1.22 . . . . 40.0 110.049 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.608 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -84.67 138.96 32.37 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.18 -1.188 . . . . 40.0 108.048 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.7 t -134.81 130.01 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.788 0 CA-C-O 121.74 0.781 . . . . 40.0 110.205 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -58.23 -50.37 73.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.935 -0.478 . . . . 40.0 110.005 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 76.4 p -70.36 45.45 0.08 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.573 -0.704 . . . . 40.0 110.123 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.595 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 2.0 ttpm? -177.14 -49.24 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.857 -0.794 . . . . 40.0 108.857 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.48 59.98 8.53 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 108.213 -1.955 . . . . 40.0 108.213 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.608 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -76.69 161.18 28.73 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.483 -1.01 . . . . 40.0 110.931 -177.837 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.846 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 48.8 tp -173.73 -68.5 0.01 OUTLIER 'General case' 0 C--O 1.194 -1.838 0 O-C-N 121.233 -0.917 . . . . 40.0 110.524 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -62.24 -20.45 64.24 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.504 -1.372 . . . . 40.0 109.318 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.4 p-10 -75.98 -61.88 1.78 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.925 -0.768 . . . . 40.0 108.925 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.9 m -80.11 -12.68 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.582 -0.699 . . . . 40.0 109.67 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -146.1 71.82 13.4 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.329 -0.857 . . . . 40.0 109.67 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -56.27 116.78 3.42 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.787 2.325 . . . . 40.0 113.375 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.87 36.67 52.14 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.757 -1.337 . . . . 40.0 109.757 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.58 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 6.8 mmtm -133.66 163.24 29.88 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 121.688 -0.889 . . . . 40.0 109.386 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.414 ' HG ' ' HD2' ' A' ' 78' ' ' TYR . 52.0 m -138.2 163.5 31.57 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.201 1.001 . . . . 40.0 111.135 -176.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.0 mm -80.83 123.2 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 CA-C-N 115.208 -0.905 . . . . 40.0 110.38 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . 176.94 155.63 13.99 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.468 -1.453 . . . . 40.0 109.468 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.824 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 117.36 -11.04 14.47 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.685 -1.245 . . . . 40.0 110.972 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.529 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 5.0 m-20 -72.63 -151.42 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.762 0 O-C-N 121.187 -1.184 . . . . 40.0 109.807 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -132.59 144.02 38.03 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.021 0 N-CA-C 108.256 -1.016 . . . . 40.0 108.256 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.62 ' O ' ' N ' ' A' ' 58' ' ' ASN . 15.3 t80 -112.7 90.81 3.44 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.195 -0.941 . . . . 40.0 109.157 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.652 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -59.72 38.34 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.708 0.766 . . . . 40.0 111.0 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.62 ' N ' ' O ' ' A' ' 56' ' ' PHE . 45.5 t30 34.77 37.82 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.032 -1.042 . . . . 40.0 110.964 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.652 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.4 mtm180 -70.23 38.08 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.956 -1.09 . . . . 40.0 109.85 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.608 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 12.4 mt-10 -145.47 -6.76 0.62 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.132 -0.98 . . . . 40.0 110.3 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.73 36.52 72.38 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.045 -1.622 . . . . 40.0 109.045 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.608 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 3.5 mttp -121.4 13.75 11.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.602 -0.94 . . . . 40.0 109.692 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.434 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -138.05 143.21 38.61 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.514 -0.741 . . . . 40.0 109.584 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -61.61 123.89 13.57 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.528 2.152 . . . . 40.0 112.322 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.53 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -103.02 -177.22 26.65 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 110.115 -1.194 . . . . 40.0 110.115 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.432 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 10.8 tttt -179.01 153.93 0.65 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.385 -1.068 . . . . 40.0 108.56 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 67' ' ' SER . 14.0 p -73.46 56.75 0.51 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.923 -1.111 . . . . 40.0 109.024 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.37 80.44 0.03 OUTLIER Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.694 -1.362 . . . . 40.0 109.694 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.575 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -176.05 177.41 1.6 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.795 -0.826 . . . . 40.0 108.847 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.575 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 59.5 m -155.28 155.77 34.36 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.2 -0.937 . . . . 40.0 109.898 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.706 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 28.8 m95 -125.01 140.61 52.76 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.874 -0.516 . . . . 40.0 110.038 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.626 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -131.88 150.54 52.12 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.95 -1.094 . . . . 40.0 109.679 179.206 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.565 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -115.62 168.65 9.83 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.137 0.97 . . . . 40.0 111.926 -179.372 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.436 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . . . -164.53 139.49 5.6 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.399 0.619 . . . . 40.0 110.217 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.722 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -61.34 153.43 26.68 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.055 0.455 . . . . 40.0 111.056 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.78 HD11 ' CG2' ' A' ' 88' ' ' ILE . 42.4 mm -135.8 146.64 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.411 -0.805 . . . . 40.0 110.2 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 55.37 71.49 0.54 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.409 0.623 . . . . 40.0 110.85 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.846 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 66.4 t80 -131.89 156.6 45.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.1 -1.0 . . . . 40.0 109.247 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' A' ' 80' ' ' SER . 21.0 p -136.87 -73.18 0.43 Allowed 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.181 0.515 . . . . 40.0 109.776 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.567 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -153.13 104.82 2.84 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.664 -0.648 . . . . 40.0 109.885 -178.503 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.456 ' N ' ' OH ' ' A' ' 78' ' ' TYR . . . 160.1 -100.36 0.19 Allowed Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.936 -1.266 . . . . 40.0 109.936 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.465 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 35.6 t80 -143.3 -169.95 3.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.738 -0.86 . . . . 40.0 109.541 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.634 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.5 mtm180 -71.65 -156.5 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.925 0.869 . . . . 40.0 110.423 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.467 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 12.9 p30 -166.17 -150.06 0.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.079 -1.082 . . . . 40.0 108.079 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' A' ' 100' ' ' THR . 71.5 p -102.87 -8.91 20.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.742 -1.224 . . . . 40.0 109.467 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.478 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -85.73 113.27 21.78 Favored 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 121.788 0.804 . . . . 40.0 111.812 -179.245 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.853 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.09 149.66 46.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.878 -1.139 . . . . 40.0 110.625 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.78 ' CG2' HD11 ' A' ' 76' ' ' ILE . 7.5 tt -116.56 138.8 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.988 0.899 . . . . 40.0 109.853 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.544 HD13 ' O ' ' A' ' 72' ' ' ARG . 3.1 mm? -117.82 126.2 51.97 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.541 -0.911 . . . . 40.0 108.541 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.686 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -119.79 129.32 54.4 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.876 -0.787 . . . . 40.0 108.876 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.706 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.5 p -93.13 158.31 15.83 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.285 1.041 . . . . 40.0 112.538 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.0 p -69.07 -17.11 63.83 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.345 -0.983 . . . . 40.0 108.345 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.481 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -86.72 9.01 20.17 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.5 -0.88 . . . . 40.0 109.428 179.714 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.46 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.29 26.77 0.54 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.517 -0.739 . . . . 40.0 110.175 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.3 mt -96.21 137.64 34.99 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.304 -0.872 . . . . 40.0 108.894 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.508 ' CG2' HD11 ' A' ' 109' ' ' ILE . 42.1 mm -111.99 121.18 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.508 -0.745 . . . . 40.0 110.589 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.41 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.4 m-85 -122.93 144.71 49.05 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 120.307 -0.557 . . . . 40.0 109.534 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.478 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 5.2 tptp -133.78 145.14 49.52 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.193 -0.942 . . . . 40.0 110.723 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.533 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.4 t -125.21 167.32 15.01 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.738 -0.838 . . . . 40.0 108.738 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.515 ' O ' ' OG ' ' A' ' 85' ' ' SER . 55.8 p -140.62 -9.05 1.08 Allowed 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.416 -0.803 . . . . 40.0 109.76 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.688 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -107.23 13.74 26.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.126 -0.984 . . . . 40.0 110.107 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 84.02 62.8 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.244 0.545 . . . . 40.0 109.982 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.634 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 32.6 m-85 70.88 -22.05 0.19 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.582 -0.699 . . . . 40.0 111.076 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.425 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.5 mt-30 -44.57 -74.21 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.1 -1.0 . . . . 40.0 110.125 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.529 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 21.1 p -105.14 164.2 12.0 Favored 'General case' 0 C--O 1.198 -1.652 0 N-CA-C 107.78 -1.193 . . . . 40.0 107.78 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.537 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -138.27 139.01 38.99 Favored 'General case' 0 C--N 1.269 -2.9 0 O-C-N 121.45 -0.781 . . . . 40.0 110.07 -179.442 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 37.5 m -125.27 137.23 54.08 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.497 -0.927 . . . . 40.0 108.497 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.522 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 16.3 tttp -83.52 146.23 28.47 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.877 -1.139 . . . . 40.0 109.559 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.508 HD11 ' CG2' ' A' ' 96' ' ' ILE . 15.2 pt -122.29 -33.99 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 C-N-CA 119.65 -0.82 . . . . 40.0 109.153 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.652 HH21 ' CG ' ' A' ' 8' ' ' ASP . 73.6 mtt180 . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 118.266 -0.873 . . . . 40.0 109.102 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.647 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 10.4 t . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.218 0.533 . . . . 40.0 109.942 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -175.73 151.05 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 108.992 -0.744 . . . . 40.0 108.992 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -141.88 23.13 2.09 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 120.866 -1.146 . . . . 40.0 110.738 -177.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 10' ' ' VAL . 11.7 p -105.16 153.38 21.61 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.634 0.73 . . . . 40.0 110.239 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.533 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -56.42 -62.97 1.36 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.968 -1.083 . . . . 40.0 111.354 -179.283 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.621 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.7 OUTLIER -58.88 -41.56 87.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.062 -1.024 . . . . 40.0 109.639 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.43 -46.18 73.68 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.093 -1.203 . . . . 40.0 110.093 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.53 HG22 ' HG2' ' A' ' 21' ' ' PRO . 79.8 t -67.95 -42.79 85.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 O-C-N 121.69 -0.888 . . . . 40.0 108.66 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -59.74 -61.07 2.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.457 -0.777 . . . . 40.0 109.549 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.29 -56.73 6.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.574 -0.704 . . . . 40.0 109.465 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.776 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 41.3 t80 -51.44 -53.18 39.64 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 116.153 -0.476 . . . . 40.0 110.758 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' A' ' 18' ' ' HIS . 1.8 tt -72.27 -51.08 22.51 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 121.165 0.507 . . . . 40.0 110.732 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 11' ' ' ALA . 66.3 mt-30 -52.06 -26.39 10.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.107 -1.621 . . . . 40.0 110.549 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.3 m -93.44 -47.84 6.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.53 -1.356 . . . . 40.0 111.449 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.46 ' O ' ' N ' ' A' ' 19' ' ' LYS . 90.5 m-85 -104.01 19.11 20.66 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.933 -1.104 . . . . 40.0 109.673 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.426 ' N ' ' O ' ' A' ' 14' ' ' LEU . 32.8 m80 40.66 25.58 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.717 0 O-C-N 121.035 -1.041 . . . . 40.0 110.863 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.472 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 3.8 pttp -137.34 157.49 46.49 Favored 'General case' 0 C--O 1.185 -2.311 0 CA-C-O 121.809 0.814 . . . . 40.0 110.466 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.48 146.11 65.03 Favored Pre-proline 0 C--N 1.271 -2.827 0 N-CA-C 108.534 -0.913 . . . . 40.0 108.534 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.776 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 88.3 Cg_exo -40.46 155.97 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.369 2.713 . . . . 40.0 114.217 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.647 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -67.22 48.44 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.897 0.856 . . . . 40.0 109.84 -179.226 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -173.13 25.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.981 -1.074 . . . . 40.0 110.52 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -118.27 109.26 16.11 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.193 -1.003 . . . . 40.0 110.07 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 25' ' ' ILE . 11.5 pt -118.33 133.98 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.78 -1.193 . . . . 40.0 107.78 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.829 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -69.38 174.96 4.31 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 124.158 1.933 . . . . 40.0 112.559 -177.403 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.555 ' HB3' ' NE2' ' A' ' 31' ' ' GLN . 17.8 mtmt -64.28 -36.7 84.94 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.704 -1.591 . . . . 40.0 106.704 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.512 ' OG ' ' OG1' ' A' ' 26' ' ' THR . 4.4 m -35.95 -70.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.049 0.928 . . . . 40.0 109.674 175.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.507 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.2 mp0 -66.49 -52.42 46.25 Favored 'General case' 0 C--O 1.204 -1.295 0 CA-C-N 114.319 -1.31 . . . . 40.0 108.47 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.507 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -42.64 -50.66 5.41 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 119.988 -1.695 . . . . 40.0 109.352 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.555 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 32.9 mt-30 -56.28 -63.94 1.02 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.389 -0.82 . . . . 40.0 111.083 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.91 -22.87 67.06 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.017 -1.052 . . . . 40.0 109.887 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.8 tp -68.15 -23.5 64.88 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.994 -1.066 . . . . 40.0 108.178 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.04 53.4 0.26 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.419 -1.072 . . . . 40.0 110.419 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.584 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -87.81 140.15 29.8 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.263 -1.139 . . . . 40.0 109.456 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.9 t -134.65 130.73 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.041 0 O-C-N 121.685 -0.634 . . . . 40.0 109.807 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -59.57 -48.95 79.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.726 -0.609 . . . . 40.0 109.588 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.3 p -70.12 46.89 0.08 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.44 -0.787 . . . . 40.0 110.01 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.61 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.7 ttpm? -179.12 -51.72 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.076 -0.713 . . . . 40.0 109.076 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.28 60.53 7.4 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 108.58 -1.808 . . . . 40.0 108.58 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.61 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -76.24 159.83 30.24 Favored 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.749 -0.854 . . . . 40.0 111.063 -178.043 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.874 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 63.9 tp -172.64 -69.89 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.751 -0.78 . . . . 40.0 110.249 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.579 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.46 -19.93 58.17 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.924 -1.11 . . . . 40.0 109.556 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 4.5 p-10 -77.02 -61.91 1.82 Allowed 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.696 -0.853 . . . . 40.0 108.696 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.4 m -79.08 -11.58 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 109.356 -0.609 . . . . 40.0 109.356 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -149.8 74.69 9.36 Favored Pre-proline 0 N--CA 1.49 1.546 0 CA-C-O 122.259 1.028 . . . . 40.0 109.977 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.9 117.8 4.58 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 124.044 3.163 . . . . 40.0 113.106 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.69 40.08 46.85 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.867 -1.693 . . . . 40.0 108.867 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.45 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 6.7 mmtm -136.04 169.59 17.36 Favored 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 121.884 0.85 . . . . 40.0 110.571 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.6 m -144.85 160.7 40.87 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.713 -1.242 . . . . 40.0 111.856 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.4 mm -80.61 125.78 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-N 115.167 -0.924 . . . . 40.0 110.502 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.95 157.29 15.17 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.543 -1.423 . . . . 40.0 109.543 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.829 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 116.03 -9.02 18.48 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.539 -1.315 . . . . 40.0 110.169 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.446 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 5.1 m-20 -74.53 -151.9 0.03 OUTLIER 'General case' 0 C--O 1.196 -1.716 0 O-C-N 120.417 -1.637 . . . . 40.0 109.242 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.74 143.93 38.88 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.829 0 N-CA-C 107.878 -1.156 . . . . 40.0 107.878 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.653 ' O ' ' N ' ' A' ' 58' ' ' ASN . 12.6 t80 -112.14 89.79 3.16 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.952 -0.699 . . . . 40.0 109.247 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.666 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.8 p -58.83 38.39 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.821 0.82 . . . . 40.0 110.803 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.653 ' N ' ' O ' ' A' ' 56' ' ' PHE . 44.1 t30 33.84 38.19 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.237 -0.914 . . . . 40.0 110.708 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.666 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.2 mtm180 -68.89 35.68 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.67 -1.268 . . . . 40.0 110.163 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.608 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 14.5 mt-10 -145.35 -2.56 0.77 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.748 -1.22 . . . . 40.0 110.225 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.25 38.59 57.1 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.436 -1.466 . . . . 40.0 109.436 -178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.608 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 5.5 mttp -121.21 12.82 11.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.373 -1.075 . . . . 40.0 109.334 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.463 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.5 mt -137.89 144.4 43.91 Favored Pre-proline 0 N--CA 1.496 1.834 0 CA-C-O 121.395 0.617 . . . . 40.0 109.467 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.83 123.2 12.19 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.536 2.157 . . . . 40.0 112.657 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.547 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.85 -177.98 26.79 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.054 -1.218 . . . . 40.0 110.054 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.468 ' NZ ' ' O ' ' A' ' 68' ' ' GLY . 8.8 tttt -177.66 153.15 0.85 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.026 -1.101 . . . . 40.0 108.026 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.6 p -72.25 53.03 0.27 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.833 -1.167 . . . . 40.0 109.395 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.468 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 150.97 80.13 0.03 OUTLIER Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.923 -1.271 . . . . 40.0 109.923 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.576 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -173.55 178.84 2.22 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.696 -0.885 . . . . 40.0 108.833 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.576 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 100.0 m -155.61 155.17 32.82 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.361 -0.935 . . . . 40.0 110.199 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.706 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 30.5 m95 -124.77 139.84 53.48 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.247 0.546 . . . . 40.0 110.064 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.623 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.91 148.92 52.74 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 120.756 -1.215 . . . . 40.0 109.436 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.505 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -115.01 168.47 9.89 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 122.181 0.991 . . . . 40.0 111.79 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -162.96 138.95 7.09 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.593 0.711 . . . . 40.0 111.121 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.718 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -61.08 154.52 22.7 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.509 -0.744 . . . . 40.0 110.804 -179.654 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.718 HD13 ' O ' ' A' ' 75' ' ' ASP . 40.1 mm -137.61 144.09 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 119.796 -0.762 . . . . 40.0 110.607 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 58.7 70.09 0.68 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.574 -0.704 . . . . 40.0 110.884 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.874 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 66.1 t80 -131.9 157.8 43.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.222 -0.924 . . . . 40.0 109.928 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.588 ' OG1' ' N ' ' A' ' 80' ' ' SER . 22.1 p -139.41 -70.15 0.41 Allowed 'General case' 0 N--CA 1.511 2.621 0 O-C-N 121.73 -0.606 . . . . 40.0 109.501 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.588 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.9 OUTLIER -154.42 105.76 2.69 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.737 -0.468 . . . . 40.0 109.737 -178.696 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.7 -103.93 0.23 Allowed Glycine 0 N--CA 1.498 2.774 0 C-N-CA 119.585 -1.293 . . . . 40.0 110.091 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 43.9 t80 -139.96 -166.66 2.13 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.086 -0.709 . . . . 40.0 109.086 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.633 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.4 mtm180 -73.95 -154.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.133 -0.979 . . . . 40.0 110.413 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.49 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 11.7 p30 -167.87 -150.99 0.1 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.08 -1.082 . . . . 40.0 108.08 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.6 p -102.98 -6.92 21.89 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.904 -1.123 . . . . 40.0 109.452 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.512 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -88.14 113.92 24.24 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 121.737 0.779 . . . . 40.0 111.47 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.859 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.22 149.78 44.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.979 -1.076 . . . . 40.0 110.675 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.653 ' CG2' HD11 ' A' ' 76' ' ' ILE . 6.1 tt -116.8 139.79 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 122.126 0.965 . . . . 40.0 109.865 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 72' ' ' ARG . 2.9 mm? -117.95 126.02 51.54 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.792 -0.818 . . . . 40.0 108.792 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.674 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.78 129.15 55.09 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.882 -0.784 . . . . 40.0 108.882 179.664 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.706 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 5.0 p -94.15 159.41 15.16 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 122.344 1.069 . . . . 40.0 112.219 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.3 p -69.91 -16.16 63.18 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.427 -0.953 . . . . 40.0 108.427 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.478 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -88.11 8.99 24.21 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.129 -0.628 . . . . 40.0 109.512 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.449 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.69 26.52 0.49 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.94 -0.475 . . . . 40.0 110.055 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.406 HD12 HH21 ' A' ' 69' ' ' ARG . 22.5 mt -95.55 137.08 35.11 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.305 -0.872 . . . . 40.0 109.499 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.483 ' CG2' HD11 ' A' ' 109' ' ' ILE . 39.7 mm -111.51 119.25 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.846 -0.533 . . . . 40.0 110.411 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.409 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.6 m-85 -121.96 144.3 48.96 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 109.688 -0.486 . . . . 40.0 109.688 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.512 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 4.7 tptp -133.77 144.45 49.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.188 -0.945 . . . . 40.0 110.591 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.601 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.8 t -123.57 166.03 16.14 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.673 -0.862 . . . . 40.0 108.673 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.6 p -139.51 -10.84 1.21 Allowed 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.441 -0.787 . . . . 40.0 109.536 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.691 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -107.56 13.87 26.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.01 -1.056 . . . . 40.0 110.508 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 84.27 61.24 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.669 -0.644 . . . . 40.0 110.275 178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.633 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 27.6 m-85 71.71 -21.16 0.22 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.497 -0.752 . . . . 40.0 110.972 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.413 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.7 mt-30 -44.38 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.119 -0.988 . . . . 40.0 109.88 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.497 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 22.7 p -105.29 168.95 8.74 Favored 'General case' 0 C--O 1.196 -1.721 0 N-CA-C 107.702 -1.221 . . . . 40.0 107.702 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.549 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -141.82 139.68 32.78 Favored 'General case' 0 C--N 1.267 -2.994 0 O-C-N 121.411 -0.806 . . . . 40.0 109.706 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.5 m -125.43 136.33 53.29 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.922 -1.14 . . . . 40.0 107.922 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.618 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 18.8 tttp -85.37 145.9 27.26 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.971 -1.081 . . . . 40.0 109.823 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.483 HD11 ' CG2' ' A' ' 96' ' ' ILE . 14.1 pt -121.44 -32.14 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 120.95 -1.094 . . . . 40.0 109.651 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.621 HH21 ' CG ' ' A' ' 8' ' ' ASP . 80.6 mtt180 . . . . . 0 N--CA 1.486 1.328 0 O-C-N 121.165 -0.959 . . . . 40.0 108.971 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.614 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 15.1 t . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.119 -0.697 . . . . 40.0 109.119 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -178.57 152.26 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.884 -0.784 . . . . 40.0 108.884 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -143.26 24.24 1.79 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.939 -1.101 . . . . 40.0 110.687 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 10' ' ' VAL . 16.5 p -105.57 152.98 22.4 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.594 0.712 . . . . 40.0 110.169 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.481 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -55.36 -64.56 0.8 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.985 -1.072 . . . . 40.0 110.981 -179.038 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.618 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.52 -41.86 81.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.025 -1.047 . . . . 40.0 110.035 -179.007 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.38 -45.46 75.29 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.759 -1.336 . . . . 40.0 109.759 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.585 HG22 ' HG2' ' A' ' 21' ' ' PRO . 77.5 t -68.08 -42.68 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.792 -0.828 . . . . 40.0 109.276 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.89 -57.96 10.47 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.592 -0.892 . . . . 40.0 108.592 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.8 -56.64 9.57 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.116 -0.698 . . . . 40.0 109.116 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.788 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 40.3 t80 -51.69 -52.8 45.46 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.134 0.492 . . . . 40.0 110.525 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 18' ' ' HIS . 1.6 tt -72.55 -51.9 17.93 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.813 -0.554 . . . . 40.0 111.166 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 11' ' ' ALA . 63.9 mt-30 -50.92 -27.79 8.31 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.292 -1.505 . . . . 40.0 110.617 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 m -93.0 -49.79 5.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.901 -1.125 . . . . 40.0 111.395 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 19' ' ' LYS . 87.9 m-85 -100.16 16.55 23.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.989 -1.069 . . . . 40.0 109.585 -178.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 14' ' ' LEU . 16.9 m80 39.75 26.56 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.472 -0.767 . . . . 40.0 110.733 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 17' ' ' TYR . 3.8 pttp -137.01 159.8 40.82 Favored 'General case' 0 C--O 1.185 -2.336 0 CA-C-O 121.977 0.894 . . . . 40.0 110.617 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.95 145.33 61.26 Favored Pre-proline 0 C--N 1.268 -2.971 0 O-C-N 121.071 -1.018 . . . . 40.0 108.402 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.788 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 86.7 Cg_exo -39.29 155.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 123.43 2.753 . . . . 40.0 114.358 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.614 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -68.2 51.34 0.07 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.075 -1.015 . . . . 40.0 109.379 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -175.71 27.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 40.0 110.51 179.089 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -119.65 109.33 15.53 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.494 -1.379 . . . . 40.0 109.973 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 20.4 pt -117.85 132.27 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.135 -1.061 . . . . 40.0 108.135 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.86 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -69.59 173.94 5.53 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 123.787 1.756 . . . . 40.0 113.244 -177.591 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.455 ' HE2' ' OD1' ' A' ' 54' ' ' ASP . 17.4 mtmt -63.53 -37.46 87.4 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.802 -1.555 . . . . 40.0 106.802 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.453 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 5.6 m -37.09 -70.87 0.08 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 122.184 0.992 . . . . 40.0 109.371 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.511 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.5 mp0 -65.35 -57.27 8.8 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.131 -1.433 . . . . 40.0 107.131 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.511 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -37.21 -51.67 1.03 Allowed 'General case' 0 N--CA 1.511 2.579 0 O-C-N 120.685 -1.259 . . . . 40.0 109.176 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -57.34 -63.95 1.05 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.437 -1.414 . . . . 40.0 111.485 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.42 -22.41 66.15 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 120.398 -1.439 . . . . 40.0 110.066 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.425 HD21 ' HB ' ' A' ' 45' ' ' VAL . 59.0 tp -68.64 -26.08 65.15 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.414 -1.328 . . . . 40.0 107.414 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 124.26 47.15 0.24 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.991 -0.844 . . . . 40.0 110.991 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.604 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.36 143.39 32.22 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.865 -1.373 . . . . 40.0 109.7 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.22 128.73 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 O-C-N 121.472 -0.767 . . . . 40.0 109.612 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -58.27 -49.96 75.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.778 -0.576 . . . . 40.0 109.602 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.6 p -70.07 47.21 0.08 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.356 -0.84 . . . . 40.0 109.967 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.599 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -179.32 -50.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.022 -0.733 . . . . 40.0 109.022 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.56 60.03 8.85 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 108.26 -1.936 . . . . 40.0 108.26 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.604 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -75.82 162.45 28.15 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.593 -0.946 . . . . 40.0 111.007 -177.852 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.769 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 43.7 tp -174.12 -70.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.748 -0.781 . . . . 40.0 110.274 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.547 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.94 -21.21 63.21 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.906 -1.121 . . . . 40.0 109.571 -178.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.0 p-10 -74.19 -62.8 1.39 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.711 -0.848 . . . . 40.0 108.711 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.425 ' HB ' HD21 ' A' ' 33' ' ' LEU . 16.1 m -79.35 -11.62 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.568 -0.531 . . . . 40.0 109.568 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.48 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -148.56 72.25 10.72 Favored Pre-proline 0 N--CA 1.486 1.34 0 CA-C-O 121.883 0.849 . . . . 40.0 109.449 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.8 118.18 5.01 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.994 2.463 . . . . 40.0 113.923 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.51 36.71 48.48 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.272 -1.531 . . . . 40.0 109.272 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.48 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 7.0 mmtm -134.37 163.95 28.52 Favored 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.614 0.721 . . . . 40.0 109.864 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.424 ' HA ' HD21 ' A' ' 42' ' ' LEU . 70.6 m -138.97 163.75 31.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 40.0 111.173 -176.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 13.0 mm -81.45 126.98 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-N 115.548 -0.751 . . . . 40.0 110.43 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.28 157.46 15.88 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.492 -1.443 . . . . 40.0 109.492 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.86 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 117.5 -10.34 14.53 Favored Glycine 0 N--CA 1.499 2.895 0 C-N-CA 118.945 -1.598 . . . . 40.0 110.369 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.495 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 4.6 m-20 -75.29 -151.62 0.03 OUTLIER 'General case' 0 C--O 1.197 -1.675 0 O-C-N 120.948 -1.325 . . . . 40.0 109.847 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.1 142.16 44.22 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.944 0 CA-C-N 114.86 -1.064 . . . . 40.0 108.665 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.624 ' O ' ' N ' ' A' ' 58' ' ' ASN . 15.1 t80 -111.4 90.66 3.4 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.875 -0.787 . . . . 40.0 108.875 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.647 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -59.63 38.56 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.605 0.717 . . . . 40.0 110.823 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' A' ' 56' ' ' PHE . 43.5 t30 33.82 38.07 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.012 -1.055 . . . . 40.0 111.33 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.647 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.5 mtm180 -69.03 34.66 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.951 -1.093 . . . . 40.0 110.483 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.614 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 15.5 mt-10 -144.1 -2.86 0.88 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.13 -0.981 . . . . 40.0 110.285 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.26 38.02 56.08 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.418 -1.473 . . . . 40.0 109.418 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.614 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 4.9 mttp -120.89 13.29 11.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.593 -0.946 . . . . 40.0 109.295 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.474 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -138.7 142.98 36.0 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.705 -0.622 . . . . 40.0 109.616 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -60.69 123.32 12.76 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.499 2.133 . . . . 40.0 112.629 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.52 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.96 -177.63 26.69 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.935 -1.266 . . . . 40.0 109.935 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.411 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 10.1 tttt -178.94 153.05 0.61 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.041 -1.096 . . . . 40.0 108.041 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.8 p -71.84 54.95 0.27 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.885 -1.134 . . . . 40.0 109.239 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.31 79.64 0.03 OUTLIER Glycine 0 N--CA 1.5 2.92 0 N-CA-C 110.137 -1.185 . . . . 40.0 110.137 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.579 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.92 179.06 1.69 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.694 -0.886 . . . . 40.0 109.082 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.579 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 99.9 m -155.81 154.77 31.87 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.405 -0.918 . . . . 40.0 109.8 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.696 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 29.9 m95 -124.02 140.6 52.81 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.723 -0.473 . . . . 40.0 109.723 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.634 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.81 149.49 52.43 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.837 -1.164 . . . . 40.0 109.574 179.55 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.535 ' O ' ' OH ' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -114.33 168.15 10.09 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.068 -1.02 . . . . 40.0 112.185 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.15 136.72 4.97 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.544 -0.723 . . . . 40.0 110.798 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.76 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -59.21 154.49 16.11 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 120.881 0.372 . . . . 40.0 111.102 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.76 HD13 ' O ' ' A' ' 75' ' ' ASP . 38.0 mm -137.8 146.06 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.682 -0.807 . . . . 40.0 110.456 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 57.64 69.96 0.69 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.316 0.579 . . . . 40.0 110.534 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.769 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 68.6 t80 -131.01 155.9 46.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.082 -1.011 . . . . 40.0 110.045 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 80' ' ' SER . 23.9 p -137.23 -72.66 0.43 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.822 -0.549 . . . . 40.0 109.557 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.572 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.9 OUTLIER -153.05 106.14 2.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 122.071 -0.393 . . . . 40.0 110.132 -179.084 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.8 -105.11 0.25 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.706 -1.357 . . . . 40.0 109.706 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 41.5 t80 -138.81 -166.05 1.94 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.006 -0.702 . . . . 40.0 109.175 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.644 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.6 mtm180 -74.21 -154.69 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.265 -0.897 . . . . 40.0 110.008 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.597 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 8.1 p30 -167.02 -150.79 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.178 -1.045 . . . . 40.0 108.178 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.531 ' OG ' ' O ' ' A' ' 100' ' ' THR . 59.4 p -102.5 -8.14 21.3 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 120.823 -1.173 . . . . 40.0 109.155 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.501 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.13 114.29 23.6 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-O 121.832 0.825 . . . . 40.0 111.456 -179.501 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.876 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.01 150.53 45.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.916 -1.115 . . . . 40.0 110.959 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.703 ' CG2' HD11 ' A' ' 76' ' ' ILE . 5.0 tt -116.92 140.43 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 122.304 1.049 . . . . 40.0 110.01 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 72' ' ' ARG . 3.0 mm? -119.33 125.19 48.46 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.349 -0.982 . . . . 40.0 108.349 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.677 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -119.16 129.88 55.24 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.913 -0.773 . . . . 40.0 108.913 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.696 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.1 p -94.91 159.47 15.02 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.438 1.113 . . . . 40.0 112.96 -178.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.1 p -69.58 -16.92 63.5 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.097 -1.075 . . . . 40.0 108.097 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.478 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -87.81 9.26 22.4 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.658 -0.817 . . . . 40.0 109.556 179.632 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.468 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.98 26.95 0.58 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.581 -0.699 . . . . 40.0 110.249 179.451 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.8 mt -96.22 136.25 36.93 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.424 -0.798 . . . . 40.0 109.164 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.494 ' CG2' HD11 ' A' ' 109' ' ' ILE . 39.8 mm -110.8 120.43 61.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.505 -0.747 . . . . 40.0 110.554 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.403 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.6 m-85 -123.03 144.56 49.19 Favored 'General case' 0 N--CA 1.504 2.265 0 C-N-CA 120.467 -0.493 . . . . 40.0 109.804 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.501 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 6.0 tptp -133.71 144.31 49.04 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.592 -0.693 . . . . 40.0 110.722 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.571 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.7 t -124.21 166.47 15.79 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.632 -0.877 . . . . 40.0 108.632 177.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.531 ' O ' ' OG ' ' A' ' 85' ' ' SER . 40.4 p -140.33 -8.35 1.14 Allowed 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.314 -0.866 . . . . 40.0 109.702 178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.688 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -108.67 13.03 25.42 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.058 -1.026 . . . . 40.0 110.06 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 84.56 62.44 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.318 0.58 . . . . 40.0 110.34 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.644 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 27.1 m-85 71.23 -21.92 0.2 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.459 -0.776 . . . . 40.0 110.868 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.421 ' H ' ' C ' ' A' ' 102' ' ' ALA . 2.0 mt-30 -44.18 -74.28 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.333 -0.855 . . . . 40.0 109.69 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.507 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 25.3 p -105.53 166.58 10.34 Favored 'General case' 0 C--O 1.194 -1.82 0 N-CA-C 107.82 -1.178 . . . . 40.0 107.82 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.534 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -139.42 138.82 36.82 Favored 'General case' 0 C--N 1.27 -2.87 0 O-C-N 121.441 -0.787 . . . . 40.0 109.973 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.2 m -124.17 136.73 54.4 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.182 -1.044 . . . . 40.0 108.182 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.544 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 19.0 tttp -85.64 146.32 26.91 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.704 -1.247 . . . . 40.0 109.616 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.494 HD11 ' CG2' ' A' ' 96' ' ' ILE . 13.5 pt -121.67 -34.08 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.244 -0.91 . . . . 40.0 109.476 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.618 HH21 ' CG ' ' A' ' 8' ' ' ASP . 78.2 mtt180 . . . . . 0 N--CA 1.488 1.452 0 O-C-N 121.197 -0.939 . . . . 40.0 108.875 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.632 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 18.5 t . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.471 -0.566 . . . . 40.0 109.471 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 tt -175.74 153.7 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.909 -0.775 . . . . 40.0 108.909 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -143.95 25.88 1.57 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.8 -1.188 . . . . 40.0 110.506 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 10' ' ' VAL . 15.7 p -105.3 153.61 21.38 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.469 0.652 . . . . 40.0 109.638 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.506 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -56.97 -64.0 1.02 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.115 -0.991 . . . . 40.0 110.817 -178.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.641 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.39 -42.01 81.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.379 -0.826 . . . . 40.0 109.705 -179.719 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.68 -45.95 76.57 Favored Glycine 0 N--CA 1.503 3.101 0 N-CA-C 109.968 -1.253 . . . . 40.0 109.968 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.533 HG22 ' HG2' ' A' ' 21' ' ' PRO . 69.7 t -66.95 -42.6 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.767 -0.843 . . . . 40.0 108.933 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.88 -58.4 8.59 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.842 -0.799 . . . . 40.0 108.842 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.07 -56.2 9.78 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.843 -0.799 . . . . 40.0 108.843 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.725 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 35.7 t80 -52.92 -51.81 59.99 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 116.084 -0.507 . . . . 40.0 110.673 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 18' ' ' HIS . 5.1 tt -72.28 -51.4 21.02 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.575 -0.703 . . . . 40.0 110.942 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 11' ' ' ALA . 54.9 mt-30 -52.9 -28.26 22.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.271 -1.518 . . . . 40.0 110.285 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.1 m -92.96 -51.25 5.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.085 -1.009 . . . . 40.0 110.825 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -98.17 10.3 40.87 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.994 -1.066 . . . . 40.0 110.205 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.573 ' N ' ' O ' ' A' ' 14' ' ' LEU . 20.1 m80 44.56 23.73 0.08 Allowed 'General case' 0 N--CA 1.52 3.067 0 O-C-N 121.42 -0.8 . . . . 40.0 110.879 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.5 pttp -135.62 160.94 36.93 Favored 'General case' 0 C--O 1.182 -2.496 0 O-C-N 121.399 -0.813 . . . . 40.0 109.566 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 24' ' ' TYR . 4.4 mp -80.47 147.0 62.68 Favored Pre-proline 0 C--N 1.268 -2.964 0 N-CA-C 108.26 -1.015 . . . . 40.0 108.26 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.725 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 83.7 Cg_exo -42.28 157.49 0.07 OUTLIER 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 123.26 2.64 . . . . 40.0 113.633 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.632 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -66.86 49.1 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.049 -1.032 . . . . 40.0 109.871 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.526 ' HA ' ' HD3' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -172.14 24.92 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.925 -1.109 . . . . 40.0 110.139 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.408 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 4.0 m-85 -117.52 106.74 13.47 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.508 -1.37 . . . . 40.0 110.63 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.4 pt -116.47 133.92 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.061 -1.024 . . . . 40.0 108.37 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.772 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -69.09 172.38 6.86 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-O 123.588 1.661 . . . . 40.0 112.96 -177.491 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.508 ' HB3' ' NE2' ' A' ' 31' ' ' GLN . 12.8 mtmt -62.65 -38.78 91.64 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 105.483 -2.043 . . . . 40.0 105.483 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.472 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 11.4 m -34.75 -71.68 0.06 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.103 -0.953 . . . . 40.0 108.792 175.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.55 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.1 mp0 -66.25 -59.5 3.67 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 118.509 -1.276 . . . . 40.0 107.578 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.55 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -31.43 -55.52 0.26 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 119.503 1.047 . . . . 40.0 110.445 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.508 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 25.9 mt-30 -58.0 -63.59 1.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.497 -1.377 . . . . 40.0 111.109 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.29 -27.05 63.71 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.732 -1.23 . . . . 40.0 110.621 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.7 tp -68.56 -22.52 64.48 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 108.485 -0.932 . . . . 40.0 108.485 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.42 48.99 0.25 Allowed Glycine 0 N--CA 1.496 2.687 0 C-N-CA 120.948 -0.644 . . . . 40.0 111.686 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.609 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -85.7 137.9 32.5 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.115 -1.226 . . . . 40.0 110.194 179.45 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.4 t -134.37 132.12 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.093 0 O-C-N 121.394 -0.816 . . . . 40.0 110.412 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.411 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -59.26 -48.92 79.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.708 -0.62 . . . . 40.0 109.487 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.7 p -69.71 45.75 0.07 Allowed 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 121.635 0.731 . . . . 40.0 110.527 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.507 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.6 ttpm? -178.3 -51.42 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.121 -0.696 . . . . 40.0 109.121 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.6 59.84 8.68 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 108.221 -1.952 . . . . 40.0 108.221 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.609 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -76.51 160.6 29.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.661 -0.906 . . . . 40.0 111.32 -177.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.797 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 61.8 tp -174.77 -68.67 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.913 -1.117 . . . . 40.0 110.911 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.631 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.29 -20.31 58.6 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.49 -1.381 . . . . 40.0 109.573 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 2.6 p-10 -75.95 -64.8 1.01 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.712 -0.847 . . . . 40.0 108.712 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.43 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 30.3 m -77.18 -12.68 14.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 109.415 -0.587 . . . . 40.0 109.415 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -145.6 72.08 14.04 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.56 -0.713 . . . . 40.0 110.086 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -56.91 116.79 3.45 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.73 2.287 . . . . 40.0 114.976 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.38 37.33 47.79 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.344 -1.503 . . . . 40.0 109.344 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.526 ' HD3' ' HA ' ' A' ' 23' ' ' ASN . 7.1 mmtt -132.6 171.03 14.35 Favored 'General case' 0 N--CA 1.508 2.446 0 CA-C-O 122.078 0.942 . . . . 40.0 110.226 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.3 m -145.69 162.06 38.44 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.884 -1.135 . . . . 40.0 111.501 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.8 mm -81.81 123.84 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-N 115.401 -0.818 . . . . 40.0 110.881 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.46 155.86 13.53 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.109 -1.596 . . . . 40.0 109.109 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.772 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 120.44 -12.19 10.36 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.278 -1.439 . . . . 40.0 110.402 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.455 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 5.0 m-20 -74.1 -154.22 0.03 OUTLIER 'General case' 0 C--O 1.193 -1.911 0 O-C-N 121.182 -1.187 . . . . 40.0 110.308 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 mp -128.57 142.74 43.11 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.868 0 CA-C-N 115.476 -0.784 . . . . 40.0 109.084 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.633 ' O ' ' N ' ' A' ' 58' ' ' ASN . 12.7 t80 -111.08 90.18 3.26 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.333 -0.855 . . . . 40.0 109.169 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.633 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -59.45 38.78 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 122.023 0.916 . . . . 40.0 110.842 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.633 ' N ' ' O ' ' A' ' 56' ' ' PHE . 45.7 t30 34.14 38.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.193 -0.942 . . . . 40.0 110.618 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.633 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 11.2 mtm180 -69.89 37.97 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.765 -1.209 . . . . 40.0 109.992 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.601 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 13.0 mt-10 -146.14 -6.92 0.56 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.038 -1.039 . . . . 40.0 109.968 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.31 37.53 74.03 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 109.424 -1.471 . . . . 40.0 109.424 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.601 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 4.5 mttp -121.11 12.35 11.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.802 -0.822 . . . . 40.0 109.3 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.42 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -136.89 142.53 38.95 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.681 -0.637 . . . . 40.0 109.455 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -61.91 122.7 11.35 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.597 2.198 . . . . 40.0 112.27 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.514 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.05 -178.02 27.82 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.033 -1.227 . . . . 40.0 110.033 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 9.5 tttt -177.76 154.14 0.91 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.42 -1.047 . . . . 40.0 108.267 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.5 p -72.05 53.79 0.27 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.981 -1.074 . . . . 40.0 109.183 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.42 79.61 0.03 OUTLIER Glycine 0 N--CA 1.498 2.806 0 N-CA-C 110.017 -1.233 . . . . 40.0 110.017 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.574 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.14 178.53 2.08 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.734 -0.863 . . . . 40.0 108.991 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.574 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 98.9 m -155.42 155.53 33.74 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.202 -0.936 . . . . 40.0 109.823 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.694 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 29.1 m95 -125.07 140.64 52.72 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.834 -0.542 . . . . 40.0 109.636 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.622 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -131.35 147.32 52.56 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.105 -0.997 . . . . 40.0 110.162 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.464 ' O ' ' OH ' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -111.39 168.64 9.38 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 122.466 1.127 . . . . 40.0 112.352 -179.485 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.94 136.54 3.57 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.668 -0.645 . . . . 40.0 111.039 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.708 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -58.58 154.51 14.1 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.016 0.436 . . . . 40.0 110.832 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.712 HD11 ' CG2' ' A' ' 88' ' ' ILE . 43.3 mm -137.57 146.18 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.477 -0.764 . . . . 40.0 109.733 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 56.44 70.94 0.6 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.491 0.662 . . . . 40.0 110.948 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.797 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 68.8 t80 -132.04 156.08 46.92 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.993 -1.067 . . . . 40.0 109.903 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 80' ' ' SER . 23.6 p -136.27 -73.92 0.44 Allowed 'General case' 0 N--CA 1.509 2.479 0 CA-C-O 121.284 0.564 . . . . 40.0 110.059 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.631 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -152.23 105.91 3.1 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.078 -0.712 . . . . 40.0 109.078 -178.815 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.405 ' N ' ' OH ' ' A' ' 78' ' ' TYR . . . 160.84 -105.6 0.27 Allowed Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.417 -1.373 . . . . 40.0 110.28 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.474 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 40.0 t80 -138.36 -166.09 1.93 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.987 -0.745 . . . . 40.0 108.987 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.639 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.2 mtm180 -75.12 -155.92 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.045 -1.034 . . . . 40.0 110.343 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.541 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 10.8 p30 -165.33 -150.37 0.13 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.978 -1.119 . . . . 40.0 107.978 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' A' ' 100' ' ' THR . 82.6 p -103.58 -8.15 20.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.78 -1.2 . . . . 40.0 109.152 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.501 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -86.0 113.37 22.04 Favored 'General case' 0 N--CA 1.507 2.414 0 CA-C-O 121.79 0.805 . . . . 40.0 111.713 -179.167 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.86 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.63 150.38 46.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.033 . . . . 40.0 110.988 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.712 ' CG2' HD11 ' A' ' 76' ' ' ILE . 6.9 tt -116.73 141.56 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 122.107 0.956 . . . . 40.0 109.847 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.542 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.8 mm? -121.37 123.99 43.45 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.944 -1.132 . . . . 40.0 107.944 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.687 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.09 129.5 55.58 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.918 0.866 . . . . 40.0 108.783 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.694 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 3.8 p -94.14 158.63 15.52 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 122.228 1.013 . . . . 40.0 112.445 -177.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.7 p -69.82 -15.87 63.18 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.443 -0.947 . . . . 40.0 108.443 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.488 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -88.02 8.2 27.65 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.61 -0.836 . . . . 40.0 109.423 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.463 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 79.36 26.07 0.42 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.675 -0.64 . . . . 40.0 110.344 179.699 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.1 mt -95.75 138.84 32.83 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.451 -0.781 . . . . 40.0 109.18 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.484 ' CG2' HD11 ' A' ' 109' ' ' ILE . 40.4 mm -112.91 120.21 62.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.71 -0.619 . . . . 40.0 110.426 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.433 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.4 m-85 -122.03 144.49 48.87 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 109.296 -0.631 . . . . 40.0 109.296 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.501 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 3.3 tptp -133.17 146.14 51.26 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.367 -0.933 . . . . 40.0 110.965 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.533 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.6 t -125.63 166.6 16.44 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 109.141 -0.689 . . . . 40.0 109.141 177.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.515 ' O ' ' OG ' ' A' ' 85' ' ' SER . 55.5 p -139.97 -9.69 1.17 Allowed 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.327 -0.858 . . . . 40.0 109.585 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.662 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -108.09 15.99 23.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.195 -0.941 . . . . 40.0 110.417 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 83.01 60.7 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.86 -0.525 . . . . 40.0 110.689 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.639 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 27.5 m-85 71.35 -20.46 0.23 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.546 -0.721 . . . . 40.0 110.847 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.424 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.6 mt-30 -44.92 -73.4 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.044 -1.035 . . . . 40.0 109.877 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.492 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 23.8 p -105.86 164.79 11.67 Favored 'General case' 0 C--O 1.195 -1.813 0 N-CA-C 107.791 -1.189 . . . . 40.0 107.791 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.542 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -138.95 138.2 37.11 Favored 'General case' 0 C--N 1.269 -2.915 0 O-C-N 121.306 -0.872 . . . . 40.0 109.989 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 53.3 m -124.12 137.42 54.56 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.119 -1.067 . . . . 40.0 108.119 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.61 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 18.4 tttp -84.64 145.18 28.14 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.906 -1.121 . . . . 40.0 109.601 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.484 HD11 ' CG2' ' A' ' 96' ' ' ILE . 15.4 pt -120.53 -34.68 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.175 -0.953 . . . . 40.0 109.262 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.641 HH21 ' CG ' ' A' ' 8' ' ' ASP . 79.6 mtt180 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 40.0 108.86 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.63 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 19.8 t . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 109.045 -0.724 . . . . 40.0 109.045 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 tt -174.34 154.07 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.9 -0.778 . . . . 40.0 108.9 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -144.22 26.12 1.51 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.016 -1.053 . . . . 40.0 110.593 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 10' ' ' VAL . 18.0 p -104.0 153.83 20.38 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.566 0.698 . . . . 40.0 109.609 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.475 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -57.11 -63.49 1.2 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.839 -1.163 . . . . 40.0 110.511 -179.217 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.643 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.9 OUTLIER -57.31 -41.93 80.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.096 -1.002 . . . . 40.0 109.655 -179.476 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.35 -44.96 84.86 Favored Glycine 0 N--CA 1.503 3.11 0 N-CA-C 110.243 -1.143 . . . . 40.0 110.243 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.573 HG22 ' HG2' ' A' ' 21' ' ' PRO . 67.3 t -67.28 -42.99 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.523 -0.986 . . . . 40.0 108.828 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.508 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.88 -59.13 5.87 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.974 -0.75 . . . . 40.0 108.974 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.23 -56.79 7.08 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.913 -0.773 . . . . 40.0 108.913 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.72 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 34.2 t80 -52.15 -53.01 48.24 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 116.116 -0.493 . . . . 40.0 110.61 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.588 ' O ' ' N ' ' A' ' 18' ' ' HIS . 4.4 tt -71.67 -51.21 24.23 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.301 0.572 . . . . 40.0 110.851 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 11' ' ' ALA . 58.6 mt-30 -53.57 -28.58 32.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.233 -1.542 . . . . 40.0 110.178 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.6 m -91.46 -52.63 4.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.805 -1.184 . . . . 40.0 110.524 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -97.68 12.26 34.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.279 -0.888 . . . . 40.0 110.576 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.588 ' N ' ' O ' ' A' ' 14' ' ' LEU . 23.7 m80 42.7 25.64 0.05 Allowed 'General case' 0 N--CA 1.512 2.643 0 O-C-N 121.237 -0.914 . . . . 40.0 111.151 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 pttp -137.0 160.9 37.56 Favored 'General case' 0 C--O 1.185 -2.329 0 O-C-N 121.44 -0.787 . . . . 40.0 109.559 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 24' ' ' TYR . 3.4 mp -80.3 145.57 60.22 Favored Pre-proline 0 C--N 1.265 -3.101 0 O-C-N 120.744 -1.223 . . . . 40.0 108.764 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.72 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 72.6 Cg_exo -40.99 155.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.831 2.354 . . . . 40.0 113.417 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.63 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -65.61 49.97 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.05 -1.031 . . . . 40.0 109.356 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -171.91 26.21 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.703 -1.248 . . . . 40.0 110.639 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.423 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 5.4 m-85 -119.82 108.39 14.32 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.789 -1.194 . . . . 40.0 109.674 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 25' ' ' ILE . 21.6 pt -119.66 128.86 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.483 1.135 . . . . 40.0 108.612 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.715 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.4 OUTLIER -63.78 169.34 4.18 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-O 123.561 1.648 . . . . 40.0 114.091 -176.264 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.53 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 12.8 mtmt -58.51 -42.45 87.68 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 104.676 -2.342 . . . . 40.0 104.676 176.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.508 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 7.7 m -32.35 -72.97 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 116.293 -0.412 . . . . 40.0 110.261 176.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.485 ' O ' ' C ' ' A' ' 30' ' ' ALA . 3.1 mp0 -64.02 -54.86 27.71 Favored 'General case' 0 C--O 1.193 -1.909 0 N-CA-C 106.558 -1.645 . . . . 40.0 106.558 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -36.11 -55.2 0.78 Allowed 'General case' 0 N--CA 1.514 2.753 0 O-C-N 120.591 -1.318 . . . . 40.0 110.412 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.423 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 38.7 mt-30 -56.35 -67.6 0.29 Allowed 'General case' 0 N--CA 1.507 2.425 0 O-C-N 120.681 -1.262 . . . . 40.0 111.088 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.14 -26.86 61.23 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 119.93 -1.731 . . . . 40.0 110.58 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.4 tp -67.17 -21.56 65.8 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.36 -0.978 . . . . 40.0 108.36 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.59 40.45 0.53 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.851 -0.9 . . . . 40.0 110.851 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.574 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -77.68 139.97 39.51 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.435 -1.627 . . . . 40.0 109.521 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.2 t -136.44 131.27 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.607 0 O-C-N 121.74 -0.6 . . . . 40.0 109.896 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.404 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -58.45 -50.13 74.81 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 116.612 -0.267 . . . . 40.0 110.386 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.5 p -69.98 46.23 0.08 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.427 -0.796 . . . . 40.0 110.232 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.599 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 2.3 ttpm? -178.33 -51.91 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.989 -0.745 . . . . 40.0 108.989 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.1 61.83 5.73 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 108.412 -1.875 . . . . 40.0 108.412 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.599 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -78.92 161.25 26.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.607 -0.937 . . . . 40.0 110.101 -178.347 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.786 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 56.2 tp -173.56 -67.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.676 -0.81 . . . . 40.0 110.515 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.611 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -64.26 -19.29 65.29 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 120.571 -1.331 . . . . 40.0 109.973 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 5.9 p-10 -75.41 -63.41 1.29 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.857 -0.794 . . . . 40.0 108.857 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.2 m -78.13 -15.85 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.715 -0.616 . . . . 40.0 109.654 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.518 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -142.74 72.89 19.66 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 40.0 109.622 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -56.91 117.62 4.34 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.819 2.346 . . . . 40.0 113.28 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.85 35.97 48.86 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.996 -1.242 . . . . 40.0 109.996 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.518 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 7.0 mmtt -133.48 162.63 31.35 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 121.899 -0.765 . . . . 40.0 109.86 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.42 ' HA ' HD21 ' A' ' 42' ' ' LEU . 70.3 m -138.01 165.83 25.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.095 -1.003 . . . . 40.0 111.244 -177.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 mm -83.26 124.72 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.54 0.686 . . . . 40.0 111.144 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.81 157.82 17.23 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 119.539 -1.315 . . . . 40.0 110.417 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.715 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 116.16 -7.66 18.77 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.653 -1.379 . . . . 40.0 109.653 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.515 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 6.8 m-20 -74.31 -153.83 0.03 OUTLIER 'General case' 0 C--O 1.189 -2.106 0 O-C-N 121.375 -1.073 . . . . 40.0 110.194 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -131.68 141.29 46.07 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.027 0 N-CA-C 108.355 -0.98 . . . . 40.0 108.355 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.618 ' O ' ' N ' ' A' ' 58' ' ' ASN . 14.4 t80 -110.69 90.94 3.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 40.0 108.772 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.656 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.6 p -60.27 39.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.625 -0.672 . . . . 40.0 110.858 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.618 ' N ' ' O ' ' A' ' 56' ' ' PHE . 47.5 t30 34.35 38.19 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.104 -0.998 . . . . 40.0 111.051 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.656 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 11.4 mtm180 -71.25 38.92 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.027 -1.046 . . . . 40.0 109.847 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.608 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 11.7 mt-10 -146.24 -6.34 0.56 Allowed 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.441 -0.787 . . . . 40.0 110.195 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.28 36.48 62.65 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 109.129 -1.588 . . . . 40.0 109.129 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.667 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 3.5 mttp -120.67 12.58 11.47 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.717 -0.872 . . . . 40.0 109.652 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.452 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.4 mt -137.54 144.41 44.87 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.451 -0.781 . . . . 40.0 109.394 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -62.5 124.75 14.77 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.441 2.094 . . . . 40.0 112.674 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.524 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.22 -178.29 27.57 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 110.054 -1.218 . . . . 40.0 110.054 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.489 ' NZ ' ' O ' ' A' ' 68' ' ' GLY . 10.3 tttt -178.03 153.15 0.78 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.272 -1.134 . . . . 40.0 108.625 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.468 ' O ' ' OG ' ' A' ' 67' ' ' SER . 8.5 p -73.09 55.3 0.42 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.755 -1.215 . . . . 40.0 109.099 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.489 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 148.28 78.94 0.03 OUTLIER Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.477 -1.449 . . . . 40.0 109.477 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.552 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -173.66 175.93 2.84 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.759 -0.848 . . . . 40.0 108.95 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.552 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 87.6 m -154.44 155.25 34.62 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.135 -0.978 . . . . 40.0 110.062 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.718 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 30.2 m95 -124.68 140.71 52.68 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 121.267 0.556 . . . . 40.0 110.246 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.624 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -131.63 149.83 52.36 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.881 -1.137 . . . . 40.0 110.216 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.53 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -113.35 167.76 10.3 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.321 1.057 . . . . 40.0 111.91 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.67 137.85 4.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.754 -0.591 . . . . 40.0 110.378 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.751 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -59.82 153.69 20.13 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.959 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.78 HD11 ' CG2' ' A' ' 88' ' ' ILE . 42.7 mm -136.18 144.8 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.419 -0.801 . . . . 40.0 110.04 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 56.28 70.82 0.61 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.486 0.66 . . . . 40.0 110.598 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.786 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 62.4 t80 -130.73 155.49 46.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.132 -0.98 . . . . 40.0 109.34 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.577 ' OG1' ' N ' ' A' ' 80' ' ' SER . 24.0 p -134.96 -73.46 0.47 Allowed 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.63 0.729 . . . . 40.0 110.064 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.611 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -153.46 105.69 2.86 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.03 -0.729 . . . . 40.0 109.03 -178.499 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.479 ' N ' ' OH ' ' A' ' 78' ' ' TYR . . . 159.13 -102.35 0.21 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.733 -1.347 . . . . 40.0 109.733 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 35.4 t80 -140.81 -167.55 2.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.638 -0.919 . . . . 40.0 109.895 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.639 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.3 mtm180 -74.19 -157.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.179 -0.95 . . . . 40.0 110.147 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.566 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 11.4 p30 -164.59 -149.25 0.12 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.939 -1.134 . . . . 40.0 107.939 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 100' ' ' THR . 64.1 p -103.94 -9.07 19.18 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.809 -1.182 . . . . 40.0 109.409 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.479 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -85.67 113.77 22.13 Favored 'General case' 0 N--CA 1.509 2.481 0 CA-C-O 121.787 0.803 . . . . 40.0 111.688 -179.389 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.856 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.43 150.22 46.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.986 -1.071 . . . . 40.0 110.617 179.556 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.78 ' CG2' HD11 ' A' ' 76' ' ' ILE . 7.3 tt -116.4 140.78 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-O 122.131 0.967 . . . . 40.0 109.833 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.581 HD13 ' O ' ' A' ' 72' ' ' ARG . 3.0 mm? -119.24 125.99 50.44 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.361 -0.978 . . . . 40.0 108.361 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.666 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -119.89 129.4 54.35 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.824 -0.806 . . . . 40.0 108.824 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.718 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 2.9 p -94.1 157.8 15.91 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 122.297 1.046 . . . . 40.0 112.448 -178.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.7 p -68.41 -17.49 64.23 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.559 -0.904 . . . . 40.0 108.559 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.491 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -85.82 8.54 19.66 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.567 -0.853 . . . . 40.0 109.482 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.466 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.9 25.39 0.5 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.611 -0.68 . . . . 40.0 110.496 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.5 mt -95.71 138.02 33.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.135 -0.978 . . . . 40.0 109.108 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.479 ' CG2' HD11 ' A' ' 109' ' ' ILE . 43.1 mm -112.04 121.16 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.587 -0.696 . . . . 40.0 110.417 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.414 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.5 m-85 -122.98 144.95 48.9 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 120.245 -0.582 . . . . 40.0 109.496 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.479 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 5.3 tptp -133.7 145.71 50.14 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.083 -1.011 . . . . 40.0 110.84 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.484 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.2 t -125.89 168.36 13.98 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.761 -0.829 . . . . 40.0 108.761 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.496 ' O ' ' OG ' ' A' ' 85' ' ' SER . 71.2 p -141.79 -8.15 0.95 Allowed 'General case' 0 N--CA 1.51 2.544 0 O-C-N 121.21 -0.931 . . . . 40.0 109.717 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.677 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -108.81 16.63 22.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.125 -0.984 . . . . 40.0 110.104 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 81.85 61.18 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.221 0.534 . . . . 40.0 110.217 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.667 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 31.5 m-85 71.41 -20.43 0.23 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.577 -0.702 . . . . 40.0 110.87 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.413 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.6 mt-30 -45.2 -74.34 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.024 -1.047 . . . . 40.0 110.001 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.536 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 23.6 p -104.59 164.02 12.05 Favored 'General case' 0 C--O 1.194 -1.829 0 O-C-N 120.901 -1.124 . . . . 40.0 108.115 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.573 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -137.9 139.68 39.95 Favored 'General case' 0 C--N 1.273 -2.753 0 O-C-N 121.351 -0.843 . . . . 40.0 109.932 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 30.5 m -126.73 137.01 53.19 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.156 -1.053 . . . . 40.0 108.156 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.6 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 14.9 tttp -83.87 146.05 28.29 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.837 -1.164 . . . . 40.0 109.679 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.479 HD11 ' CG2' ' A' ' 96' ' ' ILE . 14.5 pt -121.75 -33.77 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.283 -0.885 . . . . 40.0 109.043 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.643 HH21 ' CG ' ' A' ' 8' ' ' ASP . 72.2 mtt180 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 118.173 -0.918 . . . . 40.0 108.993 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.658 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 17.6 t . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 109.389 -0.596 . . . . 40.0 109.389 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 tt -176.4 152.64 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.27 -0.894 . . . . 40.0 109.169 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -142.71 24.16 1.89 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.805 -1.185 . . . . 40.0 111.215 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 10' ' ' VAL . 10.9 p -105.74 153.16 22.25 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.679 0.752 . . . . 40.0 110.172 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.491 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -55.96 -63.11 1.29 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.036 -1.04 . . . . 40.0 111.052 -178.927 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.631 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -58.56 -41.08 84.81 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.506 -0.746 . . . . 40.0 109.745 -179.35 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.35 -45.14 89.39 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.712 -1.355 . . . . 40.0 109.712 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.54 HG22 ' HG2' ' A' ' 21' ' ' PRO . 71.1 t -67.39 -43.68 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.578 -0.954 . . . . 40.0 108.787 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.508 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -59.94 -59.15 5.88 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.947 -0.76 . . . . 40.0 108.947 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.24 -56.74 8.37 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.951 -0.759 . . . . 40.0 108.951 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.733 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 39.9 t80 -52.3 -51.96 55.63 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.048 0.451 . . . . 40.0 110.441 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 18' ' ' HIS . 2.2 tt -72.04 -52.58 16.24 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.64 -0.663 . . . . 40.0 111.056 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 11' ' ' ALA . 63.7 mt-30 -51.59 -27.25 10.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.23 -1.544 . . . . 40.0 110.721 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 m -92.35 -49.84 5.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.585 -1.322 . . . . 40.0 111.347 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 19' ' ' LYS . 92.7 m-85 -100.85 16.0 26.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.845 -1.159 . . . . 40.0 110.114 -177.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 14' ' ' LEU . 25.1 m80 41.43 24.25 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.8 -0.563 . . . . 40.0 110.976 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 17' ' ' TYR . 3.6 pttp -135.48 158.78 43.51 Favored 'General case' 0 C--O 1.178 -2.7 0 O-C-N 121.177 -0.952 . . . . 40.0 110.771 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mp -79.25 144.28 62.13 Favored Pre-proline 0 C--N 1.271 -2.847 0 O-C-N 120.9 -1.125 . . . . 40.0 108.88 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.733 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 81.8 Cg_exo -38.73 155.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.003 0 C-N-CA 123.803 3.002 . . . . 40.0 114.433 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.658 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -67.61 50.11 0.05 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.283 1.039 . . . . 40.0 109.253 -179.51 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.531 ' HA ' ' HD3' ' A' ' 49' ' ' LYS . 0.8 OUTLIER -173.86 26.24 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.129 -0.982 . . . . 40.0 110.552 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -120.21 111.92 18.42 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.294 -1.504 . . . . 40.0 110.122 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.428 HG21 HD13 ' A' ' 25' ' ' ILE . 23.0 pt -118.28 138.22 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.248 -1.019 . . . . 40.0 108.248 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.769 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -72.4 168.93 17.42 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 123.372 1.558 . . . . 40.0 113.357 -178.283 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.509 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 24.3 mtmt -60.66 -39.38 88.14 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 105.801 -1.925 . . . . 40.0 105.801 176.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.53 ' OG ' ' OG1' ' A' ' 26' ' ' THR . 1.1 m -36.37 -70.86 0.08 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.749 -0.834 . . . . 40.0 108.749 176.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.56 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.7 mp0 -64.22 -55.43 21.69 Favored 'General case' 0 C--O 1.201 -1.473 0 N-CA-C 106.098 -1.815 . . . . 40.0 106.098 -176.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.56 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -35.44 -51.87 0.62 Allowed 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 118.562 -1.255 . . . . 40.0 109.573 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -55.45 -68.43 0.2 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.992 -1.067 . . . . 40.0 111.67 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.37 -24.31 54.54 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.263 -0.898 . . . . 40.0 111.141 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.7 tp -69.88 -21.2 63.35 Favored 'General case' 0 N--CA 1.509 2.475 0 N-CA-C 106.878 -1.527 . . . . 40.0 106.878 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.7 43.61 0.53 Allowed Glycine 0 N--CA 1.504 3.184 0 N-CA-C 111.523 -0.631 . . . . 40.0 111.523 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.54 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -77.88 138.97 39.2 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.725 -1.456 . . . . 40.0 109.531 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.9 t -135.7 130.33 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.685 0 O-C-N 121.154 -0.966 . . . . 40.0 109.302 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.48 -46.74 86.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.832 -0.543 . . . . 40.0 110.014 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.5 p -71.45 44.01 0.09 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.431 0.634 . . . . 40.0 110.644 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.585 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 ttpm? -177.43 -50.5 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.495 -0.753 . . . . 40.0 109.174 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.18 59.26 9.24 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 108.934 -1.666 . . . . 40.0 108.934 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.585 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.82 160.87 30.14 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 121.453 -1.028 . . . . 40.0 110.641 -177.846 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.872 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 57.1 tp -173.32 -69.5 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.999 -1.063 . . . . 40.0 110.385 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.554 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.07 -23.0 63.43 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 120.947 -1.096 . . . . 40.0 110.028 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.4 p-10 -73.28 -64.89 0.89 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.702 0.763 . . . . 40.0 109.218 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG13 ' OD2' ' A' ' 44' ' ' ASP . 28.7 m -76.78 -15.17 14.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 109.205 -0.665 . . . . 40.0 109.205 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.584 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -144.22 71.34 16.29 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.501 -0.749 . . . . 40.0 110.16 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.04 117.16 3.8 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 123.375 2.717 . . . . 40.0 113.788 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.61 37.73 52.13 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.167 -1.573 . . . . 40.0 109.167 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.584 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 8.5 mmtm -135.2 162.3 32.92 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 108.856 -0.794 . . . . 40.0 108.856 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.448 ' HA ' HD21 ' A' ' 42' ' ' LEU . 65.7 m -138.22 166.55 23.9 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.326 1.06 . . . . 40.0 110.594 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 18.7 mm -84.1 124.11 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-N 115.876 -0.602 . . . . 40.0 111.508 -179.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 178.08 159.67 23.18 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.506 -1.438 . . . . 40.0 109.506 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.769 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 115.75 -7.17 19.94 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.623 -1.275 . . . . 40.0 110.92 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.441 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 5.2 m-20 -76.02 -152.26 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.381 -1.658 . . . . 40.0 110.072 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.7 mp -131.12 143.85 39.54 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.016 0 N-CA-C 108.327 -0.99 . . . . 40.0 108.327 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.636 ' O ' ' N ' ' A' ' 58' ' ' ASN . 13.7 t80 -113.51 90.97 3.48 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.217 -0.927 . . . . 40.0 108.78 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.653 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.6 p -59.07 38.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.705 0.764 . . . . 40.0 110.735 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.636 ' N ' ' O ' ' A' ' 56' ' ' PHE . 43.5 t30 34.67 38.57 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.293 -0.88 . . . . 40.0 110.671 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.653 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.8 mtm180 -69.91 36.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -0.94 . . . . 40.0 110.483 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.608 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 14.6 mt-10 -145.36 -4.82 0.68 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.135 -0.978 . . . . 40.0 110.332 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.65 36.97 66.32 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 109.635 -1.386 . . . . 40.0 109.635 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.608 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 5.1 mttp -120.36 12.3 11.65 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.575 -0.956 . . . . 40.0 109.502 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.422 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -136.4 142.93 41.35 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.564 -0.71 . . . . 40.0 109.36 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -61.75 122.72 11.41 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.392 2.061 . . . . 40.0 112.344 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.513 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -101.18 -178.27 28.92 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 110.535 -1.026 . . . . 40.0 110.535 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 8.9 tttt -177.6 152.75 0.83 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.138 -1.213 . . . . 40.0 108.267 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.4 p -72.07 53.62 0.27 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.841 -1.162 . . . . 40.0 109.258 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.401 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 151.26 80.34 0.03 OUTLIER Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.826 -1.31 . . . . 40.0 109.826 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.559 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.96 177.31 2.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.533 -0.981 . . . . 40.0 109.037 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.559 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 90.1 m -154.75 154.92 33.59 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.124 -0.985 . . . . 40.0 110.043 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.713 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 30.0 m95 -124.14 139.86 53.52 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.384 0.612 . . . . 40.0 109.671 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.638 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.52 149.83 52.01 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 120.794 -1.191 . . . . 40.0 109.897 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.509 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -116.19 167.69 10.78 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.068 -1.02 . . . . 40.0 112.006 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -162.9 138.57 6.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.653 -0.654 . . . . 40.0 111.351 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.741 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -59.6 154.22 18.12 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.656 -0.652 . . . . 40.0 110.934 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.741 HD13 ' O ' ' A' ' 75' ' ' ASP . 42.7 mm -137.43 145.87 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.499 -0.75 . . . . 40.0 110.394 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 57.38 70.08 0.68 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.483 0.659 . . . . 40.0 110.524 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.872 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 70.2 t80 -131.86 155.65 47.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.039 -1.038 . . . . 40.0 110.112 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.609 ' OG1' ' N ' ' A' ' 80' ' ' SER . 19.2 p -136.64 -73.34 0.44 Allowed 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.124 0.488 . . . . 40.0 110.202 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.609 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -153.01 106.47 3.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.554 -0.716 . . . . 40.0 109.416 -178.466 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.93 -104.32 0.24 Allowed Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.747 -1.341 . . . . 40.0 109.747 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.481 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 47.2 t80 -139.94 -167.01 2.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 122.013 -0.698 . . . . 40.0 109.382 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.638 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.1 mtm180 -73.12 -154.34 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.166 -0.959 . . . . 40.0 110.075 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.555 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 11.6 p30 -168.05 -150.24 0.1 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.262 -1.014 . . . . 40.0 108.262 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.516 ' OG ' ' O ' ' A' ' 100' ' ' THR . 71.6 p -103.3 -8.0 20.66 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.64 -1.288 . . . . 40.0 109.313 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.521 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.6 114.15 23.95 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-O 122.063 0.935 . . . . 40.0 111.473 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.858 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.28 151.0 47.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.871 -1.143 . . . . 40.0 110.426 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.675 ' CG2' HD11 ' A' ' 76' ' ' ILE . 5.7 tt -117.99 136.71 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.794 0.807 . . . . 40.0 109.825 178.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.536 HD13 ' O ' ' A' ' 72' ' ' ARG . 3.1 mm? -115.84 125.16 52.3 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.798 -0.815 . . . . 40.0 108.798 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.682 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.94 129.53 55.22 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.077 0.942 . . . . 40.0 108.997 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.713 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 3.7 p -94.65 158.9 15.32 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 122.41 1.1 . . . . 40.0 112.504 -177.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.7 p -68.59 -18.14 64.27 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.234 -1.025 . . . . 40.0 108.234 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.502 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -86.32 9.17 18.66 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.666 -0.646 . . . . 40.0 109.647 179.83 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.462 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.76 26.48 0.64 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.661 -0.649 . . . . 40.0 110.361 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.9 mt -95.99 137.47 35.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.118 -0.989 . . . . 40.0 109.093 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.516 ' CG2' HD11 ' A' ' 109' ' ' ILE . 40.2 mm -111.77 119.15 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.634 -0.666 . . . . 40.0 110.564 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.434 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 8.0 m-85 -121.83 144.32 48.9 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.357 -0.537 . . . . 40.0 109.766 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.521 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 4.8 tptp -133.25 144.5 49.8 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.372 -0.83 . . . . 40.0 110.849 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.616 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.9 t -123.12 166.69 14.76 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 108.84 -0.8 . . . . 40.0 108.84 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.516 ' O ' ' OG ' ' A' ' 85' ' ' SER . 45.0 p -140.29 -10.31 1.1 Allowed 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.556 -0.715 . . . . 40.0 109.672 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.69 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -107.75 12.7 27.15 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.007 -1.058 . . . . 40.0 110.203 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 84.97 61.82 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.404 0.621 . . . . 40.0 110.305 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.638 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 23.2 m-85 71.62 -21.9 0.21 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.446 -0.784 . . . . 40.0 110.812 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.417 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.9 mt-30 -44.37 -73.41 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.091 -1.006 . . . . 40.0 109.932 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.512 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 22.0 p -106.07 166.4 10.53 Favored 'General case' 0 C--O 1.193 -1.9 0 N-CA-C 107.763 -1.199 . . . . 40.0 107.763 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.529 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -140.06 139.16 35.86 Favored 'General case' 0 C--N 1.27 -2.887 0 O-C-N 121.065 -1.022 . . . . 40.0 109.779 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.1 m -124.65 136.35 53.85 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.355 -0.98 . . . . 40.0 108.355 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.529 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 19.3 tttp -84.95 145.54 27.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.779 -1.201 . . . . 40.0 109.652 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.516 HD11 ' CG2' ' A' ' 96' ' ' ILE . 12.8 pt -120.71 -34.42 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.884 -1.135 . . . . 40.0 109.318 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.631 HH21 ' CG ' ' A' ' 8' ' ' ASP . 78.7 mtt180 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.081 -1.012 . . . . 40.0 108.769 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.628 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 17.0 t . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.319 -0.623 . . . . 40.0 109.319 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -178.27 151.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.393 -0.817 . . . . 40.0 109.587 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -142.53 23.96 1.93 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.16 -0.963 . . . . 40.0 111.684 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 10' ' ' VAL . 18.6 p -105.85 153.98 21.17 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.981 0.896 . . . . 40.0 110.456 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -56.39 -64.48 0.85 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.617 -1.302 . . . . 40.0 110.833 -179.288 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.615 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -56.84 -41.43 77.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.05 -1.032 . . . . 40.0 110.034 -179.294 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.21 -44.99 84.17 Favored Glycine 0 N--CA 1.504 3.181 0 N-CA-C 110.164 -1.174 . . . . 40.0 110.164 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.585 HG22 ' HG2' ' A' ' 21' ' ' PRO . 69.5 t -68.77 -42.49 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.587 -0.949 . . . . 40.0 108.798 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.35 -59.38 5.49 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.489 -0.93 . . . . 40.0 108.489 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.23 -56.77 8.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.55 -0.719 . . . . 40.0 109.334 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.75 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 40.8 t80 -52.74 -51.41 60.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.915 -0.491 . . . . 40.0 110.353 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 18' ' ' HIS . 4.0 tt -72.36 -51.4 20.71 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.7 -0.625 . . . . 40.0 110.945 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 11' ' ' ALA . 57.3 mt-30 -52.39 -28.36 19.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.051 -1.655 . . . . 40.0 110.129 179.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 m -91.53 -51.28 5.34 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.781 -1.2 . . . . 40.0 111.249 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -99.04 12.8 34.96 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.29 -0.881 . . . . 40.0 110.258 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 14' ' ' LEU . 20.7 m80 42.47 25.67 0.05 OUTLIER 'General case' 0 N--CA 1.516 2.856 0 O-C-N 121.477 -0.764 . . . . 40.0 110.92 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.9 pttp -136.63 158.61 44.03 Favored 'General case' 0 C--O 1.184 -2.367 0 CA-C-O 121.916 0.865 . . . . 40.0 110.188 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mp -78.31 147.83 73.12 Favored Pre-proline 0 C--N 1.265 -3.093 0 O-C-N 120.659 -1.275 . . . . 40.0 108.684 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.75 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 83.3 Cg_exo -41.47 156.09 0.07 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 123.272 2.648 . . . . 40.0 114.102 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.628 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -67.07 49.49 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.124 0.964 . . . . 40.0 109.48 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -173.67 26.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.902 . . . . 40.0 110.701 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -118.19 109.75 16.74 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.76 -1.213 . . . . 40.0 110.487 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 25' ' ' ILE . 15.4 pt -119.07 132.88 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.169 -1.049 . . . . 40.0 108.169 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.868 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.4 OUTLIER -69.48 173.35 6.03 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-O 124.24 1.972 . . . . 40.0 113.443 -177.395 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.651 ' HB3' ' NE2' ' A' ' 31' ' ' GLN . 14.6 mtmt -62.53 -40.12 95.75 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.266 -1.753 . . . . 40.0 106.266 177.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.511 ' OG ' ' OG1' ' A' ' 26' ' ' THR . 2.9 m -32.97 -74.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 123.028 1.394 . . . . 40.0 109.666 174.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.501 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.4 mp0 -63.13 -56.47 16.49 Favored 'General case' 0 C--O 1.2 -1.509 0 CA-C-N 114.392 -1.277 . . . . 40.0 108.041 -177.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -38.26 -51.64 1.48 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.956 -1.09 . . . . 40.0 109.918 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.651 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 24.1 mt-30 -56.85 -64.63 0.81 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.676 -1.265 . . . . 40.0 110.351 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.47 -25.29 64.29 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.113 -0.992 . . . . 40.0 109.471 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.1 tp -65.66 -24.52 67.04 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.729 -0.841 . . . . 40.0 108.729 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.11 48.22 0.29 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.243 -1.143 . . . . 40.0 110.243 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.579 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -85.72 137.47 32.79 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.461 -1.023 . . . . 40.0 109.906 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.5 t -134.16 131.41 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.705 0 O-C-N 121.49 -0.756 . . . . 40.0 109.956 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.64 -47.92 82.77 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.743 -0.836 . . . . 40.0 108.743 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.1 p -69.87 43.64 0.06 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.627 -0.67 . . . . 40.0 110.907 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.499 ' HZ3' ' CG ' ' A' ' 41' ' ' ASN . 1.1 ttpm? -176.8 -49.83 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.314 -0.866 . . . . 40.0 109.13 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.17 59.7 9.11 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 108.349 -1.9 . . . . 40.0 108.349 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.579 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -76.57 159.84 29.96 Favored 'General case' 0 C--N 1.29 -2.004 0 O-C-N 121.654 -0.909 . . . . 40.0 110.833 -177.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.816 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 56.1 tp -173.92 -68.32 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.53 -0.868 . . . . 40.0 111.04 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.6 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.64 -22.08 63.44 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.812 -1.18 . . . . 40.0 109.36 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.5 p-10 -74.64 -62.3 1.58 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.13 -0.693 . . . . 40.0 109.13 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.4 m -78.56 -13.52 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 N-CA-C 109.122 -0.696 . . . . 40.0 109.122 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -147.12 72.57 12.14 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.637 -0.664 . . . . 40.0 110.058 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -56.7 118.58 5.45 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 123.178 2.586 . . . . 40.0 113.911 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.37 39.64 56.69 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.69 -1.364 . . . . 40.0 109.69 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.445 ' NZ ' ' HB3' ' A' ' 23' ' ' ASN . 7.2 mmtm -134.39 168.89 18.09 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.859 0.838 . . . . 40.0 109.829 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.7 m -144.39 160.83 40.4 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 120.827 -1.171 . . . . 40.0 111.381 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.3 mm -81.25 123.04 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-N 115.437 -0.801 . . . . 40.0 110.557 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . 177.16 154.56 12.2 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.555 -1.418 . . . . 40.0 109.555 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.868 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 120.54 -13.55 10.08 Favored Glycine 0 N--CA 1.497 2.713 0 C-N-CA 119.162 -1.494 . . . . 40.0 111.236 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.47 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 4.3 m-20 -71.41 -152.0 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.747 0 O-C-N 121.202 -1.176 . . . . 40.0 109.781 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.37 142.63 42.84 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 CA-C-N 115.256 -0.884 . . . . 40.0 109.236 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.652 ' O ' ' N ' ' A' ' 58' ' ' ASN . 11.1 t80 -111.17 89.76 3.14 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.347 -0.845 . . . . 40.0 109.696 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.669 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.9 p -58.71 38.38 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.921 0.867 . . . . 40.0 110.774 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.652 ' N ' ' O ' ' A' ' 56' ' ' PHE . 40.8 t30 33.66 40.01 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.275 -0.89 . . . . 40.0 110.484 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.669 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 11.4 mtm180 -70.85 37.23 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.957 -1.089 . . . . 40.0 110.056 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.606 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 14.1 mt-10 -146.6 -1.05 0.72 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.998 -1.064 . . . . 40.0 110.29 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 51.11 39.42 41.65 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.681 -1.368 . . . . 40.0 109.681 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.606 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 3.5 mttp -121.68 12.34 10.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.657 -0.908 . . . . 40.0 109.366 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.47 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.5 mt -137.33 143.62 42.18 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.66 -0.65 . . . . 40.0 109.541 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.38 122.68 11.46 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.296 1.997 . . . . 40.0 112.137 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.525 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.98 -177.29 26.69 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.866 -1.293 . . . . 40.0 109.866 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.415 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 8.0 tttt -177.94 154.73 0.92 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 107.871 -1.159 . . . . 40.0 107.871 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.2 p -73.2 55.47 0.44 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.995 -1.066 . . . . 40.0 109.172 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.98 81.4 0.04 OUTLIER Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.753 -1.339 . . . . 40.0 109.753 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.559 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.31 178.29 2.06 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.493 -1.004 . . . . 40.0 108.713 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.559 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 92.4 m -155.24 153.01 29.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.017 -1.052 . . . . 40.0 109.921 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.717 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 28.8 m95 -122.7 140.38 52.93 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.194 0.521 . . . . 40.0 110.006 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.613 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -131.42 147.11 52.53 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 120.96 -1.087 . . . . 40.0 110.392 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.565 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -111.84 168.2 9.76 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.979 -1.076 . . . . 40.0 112.278 -179.461 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.431 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . . . -163.76 139.75 6.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.241 -0.912 . . . . 40.0 110.225 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.732 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -61.29 154.71 23.0 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 120.976 0.417 . . . . 40.0 110.576 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.732 HD13 ' O ' ' A' ' 75' ' ' ASP . 32.6 mm -138.11 146.01 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.587 -0.696 . . . . 40.0 110.325 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 56.4 71.05 0.59 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.582 0.706 . . . . 40.0 110.839 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.816 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 67.7 t80 -132.45 156.66 46.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 40.0 109.471 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.596 ' OG1' ' N ' ' A' ' 80' ' ' SER . 21.4 p -137.97 -72.44 0.42 Allowed 'General case' 0 N--CA 1.511 2.614 0 CA-C-O 121.44 0.638 . . . . 40.0 109.491 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.6 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -152.99 105.69 2.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.653 -0.654 . . . . 40.0 109.57 -178.85 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.06 -103.96 0.23 Allowed Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.467 -1.349 . . . . 40.0 110.156 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 49.2 t80 -142.16 -167.55 2.5 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.53 -0.915 . . . . 40.0 108.53 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.659 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.3 mtm180 -72.9 -156.48 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.04 -1.038 . . . . 40.0 110.398 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.501 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 10.1 p30 -165.67 -149.38 0.11 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.132 -1.062 . . . . 40.0 108.132 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.512 ' OG ' ' O ' ' A' ' 100' ' ' THR . 60.3 p -104.14 -7.46 20.16 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 120.804 -1.185 . . . . 40.0 109.252 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.509 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.97 113.09 23.28 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-O 121.898 0.856 . . . . 40.0 111.642 -179.263 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.86 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.44 150.06 46.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.055 -1.028 . . . . 40.0 110.391 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.675 ' CG2' HD11 ' A' ' 76' ' ' ILE . 5.1 tt -116.69 141.51 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 122.404 1.097 . . . . 40.0 109.777 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.584 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.8 mm? -121.02 124.42 44.8 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.294 -1.002 . . . . 40.0 108.294 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.679 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.15 129.38 55.49 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.82 0.819 . . . . 40.0 108.816 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.717 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.2 p -93.56 159.99 14.99 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 122.322 1.058 . . . . 40.0 112.467 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.4 p -70.04 -18.11 63.28 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.241 -1.022 . . . . 40.0 108.241 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.463 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -86.15 8.69 19.96 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.052 -0.659 . . . . 40.0 109.498 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.447 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.88 26.79 0.6 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.497 -0.752 . . . . 40.0 109.955 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.441 HD12 HH21 ' A' ' 69' ' ' ARG . 27.1 mt -94.94 137.2 34.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.121 -0.987 . . . . 40.0 108.471 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.52 ' CG2' HD11 ' A' ' 109' ' ' ILE . 37.2 mm -112.15 119.84 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.533 -0.73 . . . . 40.0 110.338 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -122.2 144.74 48.78 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.935 -0.706 . . . . 40.0 109.663 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.509 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 3.7 tptp -133.66 145.04 49.59 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.109 -0.995 . . . . 40.0 110.87 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.531 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.5 t -124.01 167.12 14.6 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 109.02 -0.733 . . . . 40.0 109.02 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.512 ' O ' ' OG ' ' A' ' 85' ' ' SER . 38.7 p -140.47 -9.43 1.09 Allowed 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.213 -0.93 . . . . 40.0 109.922 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.68 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -108.16 13.27 26.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 40.0 109.997 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 84.36 62.08 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.263 0.554 . . . . 40.0 110.308 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.659 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 22.7 m-85 70.61 -20.64 0.2 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.722 -0.611 . . . . 40.0 110.864 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.7 mt-30 -44.07 -73.7 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.162 -0.961 . . . . 40.0 109.472 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.477 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 22.0 p -106.25 167.88 9.52 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 107.316 -1.364 . . . . 40.0 107.316 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.584 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -140.32 140.12 35.57 Favored 'General case' 0 C--N 1.268 -2.966 0 O-C-N 121.645 -0.66 . . . . 40.0 109.866 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.2 m -125.14 135.75 52.94 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.267 -1.012 . . . . 40.0 108.267 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.612 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 19.3 tttp -84.56 145.91 27.82 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.801 -1.187 . . . . 40.0 109.619 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.52 HD11 ' CG2' ' A' ' 96' ' ' ILE . 15.1 pt -121.03 -35.01 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.445 -0.785 . . . . 40.0 109.476 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.615 HH21 ' CG ' ' A' ' 8' ' ' ASP . 78.9 mtt180 . . . . . 0 N--CA 1.488 1.474 0 O-C-N 121.169 -0.957 . . . . 40.0 109.091 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.607 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 12.8 t . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 109.786 -0.45 . . . . 40.0 109.786 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -175.01 153.55 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 109.375 -0.602 . . . . 40.0 109.375 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -144.58 24.68 1.54 Allowed 'General case' 0 N--CA 1.484 1.23 0 O-C-N 120.853 -1.154 . . . . 40.0 110.36 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 10' ' ' VAL . 14.9 p -105.95 152.34 23.45 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.792 0.806 . . . . 40.0 109.541 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.493 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -55.24 -65.1 0.65 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.987 -1.071 . . . . 40.0 110.922 -178.829 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.595 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.7 OUTLIER -56.71 -41.75 77.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.344 -0.847 . . . . 40.0 110.304 -179.286 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.96 -44.87 87.8 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.255 -1.538 . . . . 40.0 109.255 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.559 HG22 ' HG2' ' A' ' 21' ' ' PRO . 72.1 t -67.48 -42.42 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.837 -0.801 . . . . 40.0 108.879 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -61.65 -57.66 11.14 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.553 -0.717 . . . . 40.0 109.212 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.25 -56.64 8.71 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.615 0.722 . . . . 40.0 109.186 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.734 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 41.7 t80 -53.31 -52.49 58.96 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.147 0.499 . . . . 40.0 110.677 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 18' ' ' HIS . 1.2 tt -71.98 -51.61 21.07 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.594 -0.692 . . . . 40.0 110.132 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 11' ' ' ALA . 63.1 mt-30 -51.25 -29.43 14.46 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.278 -1.514 . . . . 40.0 110.273 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m -90.04 -50.77 5.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.841 -1.162 . . . . 40.0 111.627 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 19' ' ' LYS . 87.7 m-85 -99.88 14.81 29.14 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.386 -0.821 . . . . 40.0 109.874 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 14' ' ' LEU . 19.9 m80 41.82 24.01 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.532 0 CA-C-O 121.407 0.622 . . . . 40.0 111.141 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 17' ' ' TYR . 4.4 pttp -134.31 158.66 43.22 Favored 'General case' 0 C--O 1.184 -2.373 0 O-C-N 121.305 -0.872 . . . . 40.0 109.939 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.28 145.06 63.55 Favored Pre-proline 0 C--N 1.263 -3.173 0 O-C-N 120.945 -1.097 . . . . 40.0 109.554 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.734 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 82.3 Cg_exo -37.94 155.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.512 2.578 0 C-N-CA 123.473 2.782 . . . . 40.0 114.7 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.607 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -67.73 50.37 0.05 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.138 -0.976 . . . . 40.0 108.964 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -174.94 24.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 118.952 -1.099 . . . . 40.0 110.764 -179.42 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.411 ' OH ' ' O ' ' A' ' 75' ' ' ASP . 3.5 m-85 -118.26 109.78 16.74 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.981 0.896 . . . . 40.0 110.332 -178.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 25' ' ' ILE . 12.5 pt -118.47 134.13 63.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.931 -1.137 . . . . 40.0 107.931 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.84 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.3 OUTLIER -70.32 173.43 6.81 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 124.092 1.901 . . . . 40.0 113.371 -177.339 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HE2' ' OD1' ' A' ' 54' ' ' ASP . 16.8 mtmt -63.29 -35.83 81.67 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 106.648 -1.612 . . . . 40.0 106.648 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.511 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 5.1 m -37.54 -70.24 0.1 Allowed 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 122.28 1.038 . . . . 40.0 108.962 175.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.476 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.2 mp0 -68.1 -50.0 57.62 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.988 -1.115 . . . . 40.0 107.988 -178.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.476 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -43.18 -49.4 6.49 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.263 -1.375 . . . . 40.0 108.888 177.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.423 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 34.3 mt-30 -59.68 -62.08 2.14 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.275 -0.891 . . . . 40.0 111.454 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.01 -24.15 66.87 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.219 -0.925 . . . . 40.0 109.118 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.2 tp -68.1 -21.57 64.95 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.236 -0.986 . . . . 40.0 108.596 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.35 43.75 0.46 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.266 -1.133 . . . . 40.0 110.266 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.542 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -80.96 143.22 32.74 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.034 -1.274 . . . . 40.0 109.38 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.9 t -140.99 131.54 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.755 0 O-C-N 120.969 -1.082 . . . . 40.0 109.217 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.25 -48.78 79.36 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.913 -0.492 . . . . 40.0 110.342 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.3 p -70.82 45.63 0.09 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.158 -0.963 . . . . 40.0 110.263 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.482 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 ttpm? -177.07 -51.43 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.892 -0.781 . . . . 40.0 108.892 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.7 58.93 10.18 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 108.202 -1.959 . . . . 40.0 108.202 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.542 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -75.56 159.52 31.16 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.77 -0.841 . . . . 40.0 110.288 -177.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.733 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 59.4 tp -173.76 -66.75 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.232 -0.987 . . . . 40.0 110.538 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.62 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -61.68 -19.91 62.86 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.03 -1.044 . . . . 40.0 109.935 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.7 p-10 -78.11 -61.34 2.03 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.681 -0.859 . . . . 40.0 108.681 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.1 m -78.74 -10.17 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.412 0 O-C-N 121.644 -0.66 . . . . 40.0 110.088 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -150.37 71.54 9.15 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.393 -0.817 . . . . 40.0 109.838 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.96 117.5 4.2 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 123.649 2.899 . . . . 40.0 113.135 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.81 37.89 43.54 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.081 -1.208 . . . . 40.0 110.081 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.497 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 7.3 mmtm -134.99 173.6 11.54 Favored 'General case' 0 N--CA 1.511 2.585 0 CA-C-O 121.72 0.771 . . . . 40.0 110.537 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.0 m -147.54 162.76 38.42 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.954 -1.091 . . . . 40.0 112.013 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.6 mm -82.72 124.23 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 115.26 -0.882 . . . . 40.0 110.643 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.55 157.56 17.15 Favored Glycine 0 N--CA 1.5 2.927 0 N-CA-C 109.64 -1.384 . . . . 40.0 109.64 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.84 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 117.63 -9.83 14.5 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 118.938 -1.601 . . . . 40.0 110.107 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.458 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 5.3 m-20 -75.69 -151.97 0.04 OUTLIER 'General case' 0 C--O 1.193 -1.897 0 O-C-N 120.8 -1.412 . . . . 40.0 109.853 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.4 mp -130.68 142.39 43.8 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 CA-C-N 115.102 -0.954 . . . . 40.0 108.679 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.613 ' O ' ' N ' ' A' ' 58' ' ' ASN . 12.9 t80 -110.3 90.96 3.47 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.095 -0.706 . . . . 40.0 109.095 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.659 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.9 p -60.3 38.74 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.457 -0.777 . . . . 40.0 110.705 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.613 ' N ' ' O ' ' A' ' 56' ' ' PHE . 45.6 t30 33.89 38.95 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.13 -0.981 . . . . 40.0 110.721 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.659 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.5 mtm180 -69.34 35.52 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.119 -0.988 . . . . 40.0 110.086 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.628 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 15.1 mt-10 -144.86 -3.74 0.77 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.052 -1.03 . . . . 40.0 110.348 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.421 ' HA2' HD21 ' A' ' 58' ' ' ASN . . . 54.16 37.91 60.09 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.275 -1.53 . . . . 40.0 109.275 -178.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.628 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 5.0 mttp -120.32 11.66 11.54 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.537 -0.978 . . . . 40.0 109.778 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.453 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -136.88 143.98 44.72 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 109.389 -0.597 . . . . 40.0 109.389 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.83 124.64 14.91 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.605 2.203 . . . . 40.0 112.267 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.526 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -104.33 -178.75 25.1 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.076 -1.21 . . . . 40.0 110.076 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.438 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 9.5 tttt -177.16 152.57 0.89 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.363 -1.08 . . . . 40.0 108.435 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.6 p -71.3 53.41 0.19 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.304 -1.497 . . . . 40.0 109.438 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.48 80.16 0.03 OUTLIER Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.084 -1.206 . . . . 40.0 110.084 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.577 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -175.36 178.83 1.6 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.706 -0.879 . . . . 40.0 108.864 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.577 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 87.1 m -155.52 155.98 34.38 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.331 -0.947 . . . . 40.0 109.83 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.697 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 27.5 m95 -124.91 140.01 53.31 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.78 -0.452 . . . . 40.0 109.78 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.635 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.64 149.55 52.25 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.738 -1.226 . . . . 40.0 109.685 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.52 ' O ' ' OH ' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -115.79 168.82 9.71 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 122.283 1.04 . . . . 40.0 112.304 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.13 138.5 4.66 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.846 -0.615 . . . . 40.0 111.11 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.724 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -60.41 154.79 19.64 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.453 0.644 . . . . 40.0 111.091 179.495 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.724 HD13 ' O ' ' A' ' 75' ' ' ASP . 40.2 mm -137.82 145.19 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 119.962 -0.695 . . . . 40.0 110.596 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 57.83 68.4 0.85 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.738 -0.601 . . . . 40.0 110.697 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.733 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 61.0 t80 -129.84 157.2 42.9 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.097 -1.002 . . . . 40.0 109.867 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.541 ' OG1' ' N ' ' A' ' 80' ' ' SER . 24.2 p -137.31 -71.07 0.44 Allowed 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.517 -0.739 . . . . 40.0 109.718 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.62 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -153.68 107.15 2.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.6 -0.687 . . . . 40.0 109.388 -178.344 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.28 -107.22 0.31 Allowed Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.667 -1.254 . . . . 40.0 110.191 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.477 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 41.6 t80 -137.29 -166.73 1.98 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.772 -0.84 . . . . 40.0 109.355 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.664 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.8 mtm180 -73.99 -155.5 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.805 -1.184 . . . . 40.0 109.643 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -166.52 -150.75 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.888 -1.153 . . . . 40.0 107.888 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' A' ' 100' ' ' THR . 60.1 p -102.32 -7.49 22.02 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.004 -1.06 . . . . 40.0 109.539 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.536 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.67 113.88 23.76 Favored 'General case' 0 N--CA 1.509 2.505 0 CA-C-O 121.89 0.852 . . . . 40.0 111.552 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.857 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.35 148.55 43.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.951 -1.093 . . . . 40.0 110.84 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.662 ' CG2' HD11 ' A' ' 76' ' ' ILE . 5.5 tt -114.72 140.06 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-O 122.144 0.973 . . . . 40.0 110.158 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.541 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 3.1 mm? -118.77 125.13 48.92 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.609 -0.886 . . . . 40.0 108.609 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.672 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -119.52 129.41 54.68 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.594 0.711 . . . . 40.0 109.203 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.697 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.7 p -93.93 160.14 14.86 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.668 1.223 . . . . 40.0 112.797 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.1 p -69.92 -17.03 63.31 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.138 -1.06 . . . . 40.0 108.138 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.474 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -88.19 10.03 20.87 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 119.773 -0.771 . . . . 40.0 109.686 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.458 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.6 27.36 0.62 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.765 -0.585 . . . . 40.0 110.259 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.0 mt -96.48 136.93 36.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.273 -0.892 . . . . 40.0 109.061 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.508 ' CG2' HD11 ' A' ' 109' ' ' ILE . 41.1 mm -111.72 119.95 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.772 -0.58 . . . . 40.0 110.649 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.406 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.7 m-85 -122.91 144.57 49.14 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 120.524 -0.47 . . . . 40.0 109.934 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.536 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 4.2 tptp -134.29 145.02 48.68 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.042 -1.036 . . . . 40.0 110.593 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.593 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.6 t -123.37 166.9 14.54 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.567 -0.901 . . . . 40.0 108.567 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.517 ' O ' ' OG ' ' A' ' 85' ' ' SER . 35.8 p -139.73 -10.29 1.19 Allowed 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.03 -1.044 . . . . 40.0 109.723 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.713 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -107.13 10.78 30.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.25 -0.907 . . . . 40.0 110.259 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 86.68 63.06 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.346 0.593 . . . . 40.0 110.494 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.664 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 24.4 m-85 70.61 -23.23 0.17 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.369 -0.832 . . . . 40.0 110.883 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 102' ' ' ALA . 2.0 mt-30 -43.4 -73.45 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.293 -0.879 . . . . 40.0 109.97 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.491 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 24.8 p -106.18 167.53 9.75 Favored 'General case' 0 C--O 1.196 -1.756 0 N-CA-C 107.718 -1.215 . . . . 40.0 107.718 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.541 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -140.93 139.16 34.27 Favored 'General case' 0 C--N 1.268 -2.942 0 O-C-N 121.51 -0.744 . . . . 40.0 109.836 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.7 m -124.48 135.98 53.65 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.143 -1.058 . . . . 40.0 108.143 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.54 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 18.1 tttp -84.64 145.57 27.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.903 -1.123 . . . . 40.0 109.656 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.508 HD11 ' CG2' ' A' ' 96' ' ' ILE . 14.6 pt -121.35 -34.42 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.157 -0.964 . . . . 40.0 109.528 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.595 HH21 ' CG ' ' A' ' 8' ' ' ASP . 76.3 mtt180 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 118.176 -0.916 . . . . 40.0 108.969 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.636 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 17.9 t . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 108.992 -0.744 . . . . 40.0 108.992 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -175.9 153.79 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.066 -0.716 . . . . 40.0 109.066 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -144.43 26.05 1.48 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.109 -0.994 . . . . 40.0 110.688 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.492 ' O ' HG23 ' A' ' 10' ' ' VAL . 21.2 p -104.26 151.94 22.81 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 121.463 0.649 . . . . 40.0 109.473 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -55.25 -64.16 0.93 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.716 -1.24 . . . . 40.0 110.734 -179.191 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.604 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.7 OUTLIER -57.03 -41.83 79.32 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.193 -0.942 . . . . 40.0 110.107 -179.362 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.4 -45.28 84.18 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.702 -1.359 . . . . 40.0 109.702 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.59 HG22 ' HG2' ' A' ' 21' ' ' PRO . 71.1 t -67.09 -43.36 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 121.674 -0.898 . . . . 40.0 108.824 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.43 -58.79 6.99 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.283 -0.636 . . . . 40.0 109.283 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.56 -56.47 9.8 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.118 -0.989 . . . . 40.0 109.358 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.758 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 39.0 t80 -51.49 -53.07 41.19 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.942 -0.572 . . . . 40.0 110.418 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 18' ' ' HIS . 1.9 tt -72.74 -50.1 26.79 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.336 0.589 . . . . 40.0 110.982 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 11' ' ' ALA . 63.3 mt-30 -53.17 -28.27 25.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.059 -1.65 . . . . 40.0 109.925 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.9 m -91.61 -51.14 5.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.014 -1.054 . . . . 40.0 110.763 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.416 ' O ' ' N ' ' A' ' 19' ' ' LYS . 84.9 m-85 -99.11 14.03 30.79 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.268 -0.895 . . . . 40.0 110.427 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.544 ' N ' ' O ' ' A' ' 14' ' ' LEU . 20.9 m80 41.95 25.01 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 O-C-N 121.565 -0.71 . . . . 40.0 111.023 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 17' ' ' TYR . 4.1 pttp -134.89 158.65 43.71 Favored 'General case' 0 C--O 1.185 -2.3 0 O-C-N 121.2 -0.937 . . . . 40.0 109.967 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mp -79.35 146.03 65.44 Favored Pre-proline 0 C--N 1.269 -2.905 0 N-CA-C 107.961 -1.126 . . . . 40.0 107.961 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.758 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 82.2 Cg_exo -39.34 157.72 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 123.213 2.608 . . . . 40.0 114.6 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.636 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.8 OUTLIER -69.47 51.26 0.1 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.817 -1.177 . . . . 40.0 109.62 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.48 ' HA ' ' HD3' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -175.92 26.71 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.026 -1.047 . . . . 40.0 110.149 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -119.59 109.72 16.02 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.498 -1.376 . . . . 40.0 111.045 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.0 pt -116.85 134.94 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.441 -0.904 . . . . 40.0 108.704 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.758 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.3 OUTLIER -69.51 169.98 11.5 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 123.756 1.741 . . . . 40.0 113.269 -177.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.528 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 23.1 mtmt -62.34 -37.87 87.31 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 105.96 -1.867 . . . . 40.0 105.96 177.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.504 ' OG ' ' OG1' ' A' ' 26' ' ' THR . 1.1 m -37.69 -70.84 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.667 -0.864 . . . . 40.0 108.667 176.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.545 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.5 mp0 -63.34 -57.62 9.79 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 106.823 -1.547 . . . . 40.0 106.823 -177.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.545 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -33.31 -52.03 0.36 Allowed 'General case' 0 N--CA 1.509 2.525 0 C-N-CA 119.165 -1.014 . . . . 40.0 109.251 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -56.52 -67.06 0.34 Allowed 'General case' 0 N--CA 1.516 2.864 0 O-C-N 120.906 -1.121 . . . . 40.0 111.524 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.4 -21.64 62.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.746 -1.221 . . . . 40.0 110.494 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.516 HD21 ' HB ' ' A' ' 45' ' ' VAL . 60.5 tp -70.54 -24.47 62.81 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.349 -1.352 . . . . 40.0 107.349 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.7 48.15 0.28 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.6 -1.0 . . . . 40.0 110.6 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.595 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.14 142.31 33.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.009 -1.289 . . . . 40.0 108.633 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.7 t -136.47 128.24 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 N-CA-C 108.439 -0.948 . . . . 40.0 108.439 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.12 -48.58 81.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.776 -0.577 . . . . 40.0 109.531 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.7 p -70.83 46.95 0.1 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.028 -1.045 . . . . 40.0 109.899 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.613 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -178.6 -50.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.916 -0.772 . . . . 40.0 108.916 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.39 59.8 8.85 Favored Glycine 0 N--CA 1.503 3.146 0 N-CA-C 108.593 -1.803 . . . . 40.0 108.593 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.613 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -76.6 160.56 29.32 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.344 -1.092 . . . . 40.0 111.59 -177.293 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.835 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 45.5 tp -172.46 -70.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.451 -0.9 . . . . 40.0 110.529 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.59 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -59.98 -21.45 61.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.852 -1.155 . . . . 40.0 109.77 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 5.0 p-10 -75.87 -62.64 1.52 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.185 -0.672 . . . . 40.0 109.185 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.516 ' HB ' HD21 ' A' ' 33' ' ' LEU . 15.8 m -77.76 -13.28 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 109.063 -0.718 . . . . 40.0 109.063 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.474 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -147.74 72.92 11.54 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 121.34 -0.85 . . . . 40.0 110.148 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.68 118.04 4.81 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.01 2.474 . . . . 40.0 113.959 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.513 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 75.16 36.48 45.64 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.25 -1.54 . . . . 40.0 109.25 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.3 mmtm -135.5 163.55 29.82 Favored 'General case' 0 N--CA 1.511 2.586 0 CA-C-O 121.739 0.781 . . . . 40.0 110.364 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.483 ' HA ' HD21 ' A' ' 42' ' ' LEU . 50.5 m -138.56 166.57 23.99 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 122.12 0.962 . . . . 40.0 111.325 -176.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.402 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 10.3 mm -83.98 121.66 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 115.344 -0.843 . . . . 40.0 111.689 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 178.27 155.24 13.86 Favored Glycine 0 N--CA 1.502 3.097 0 C-N-CA 119.847 -1.168 . . . . 40.0 110.604 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.758 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 119.7 -7.87 12.04 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.342 -1.409 . . . . 40.0 110.217 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.417 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 4.5 m-20 -75.65 -150.79 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.088 -1.242 . . . . 40.0 109.824 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -132.36 143.33 40.23 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.882 0 CA-C-N 115.067 -0.969 . . . . 40.0 108.848 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.644 ' O ' ' N ' ' A' ' 58' ' ' ASN . 14.9 t80 -112.04 89.68 3.13 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.488 -0.93 . . . . 40.0 108.488 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.667 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.8 p -59.23 37.57 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.597 0.713 . . . . 40.0 110.611 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.644 ' N ' ' O ' ' A' ' 56' ' ' PHE . 44.2 t30 34.42 39.18 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.066 -1.021 . . . . 40.0 110.656 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.667 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.8 mtm180 -70.02 35.54 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.731 -1.231 . . . . 40.0 110.45 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.605 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 14.8 mt-10 -144.91 -1.85 0.84 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.033 -1.042 . . . . 40.0 109.943 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.58 37.84 50.91 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.662 -1.375 . . . . 40.0 109.662 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.605 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 4.3 mttp -119.89 12.36 12.04 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.458 -1.025 . . . . 40.0 109.407 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.479 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -137.54 143.85 42.55 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.702 -0.624 . . . . 40.0 109.646 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.54 123.74 13.32 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.505 2.137 . . . . 40.0 112.466 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.54 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -103.43 -177.81 26.16 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.205 -1.158 . . . . 40.0 110.205 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.43 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 8.4 tttt -178.12 154.09 0.84 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 108.024 -1.102 . . . . 40.0 108.024 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.4 p -73.29 56.04 0.47 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.774 -1.204 . . . . 40.0 109.041 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.16 81.76 0.04 OUTLIER Glycine 0 N--CA 1.498 2.815 0 N-CA-C 109.899 -1.28 . . . . 40.0 109.899 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.57 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -177.34 178.18 1.11 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.544 -0.974 . . . . 40.0 108.874 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.57 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 92.8 m -154.97 155.12 33.65 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.219 -0.926 . . . . 40.0 109.945 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.713 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 29.7 m95 -123.36 139.45 54.02 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.708 -0.479 . . . . 40.0 109.708 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.597 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.26 149.02 52.14 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.705 -1.247 . . . . 40.0 109.713 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.529 ' O ' ' OH ' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -114.52 169.94 8.68 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.897 -1.127 . . . . 40.0 112.331 -179.452 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.99 137.24 3.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.745 -0.597 . . . . 40.0 110.958 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.722 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -59.14 154.54 15.76 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 120.917 0.389 . . . . 40.0 110.896 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.722 HD13 ' O ' ' A' ' 75' ' ' ASP . 41.6 mm -137.09 144.33 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.323 -0.861 . . . . 40.0 110.294 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 57.77 71.05 0.6 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.527 -0.733 . . . . 40.0 110.58 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.835 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 69.2 t80 -131.67 155.06 48.27 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.866 -1.146 . . . . 40.0 109.804 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.596 ' OG1' ' N ' ' A' ' 80' ' ' SER . 27.2 p -135.79 -73.05 0.45 Allowed 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.618 -0.676 . . . . 40.0 110.138 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.596 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -153.65 102.32 2.54 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.481 -0.562 . . . . 40.0 109.481 -177.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.427 ' N ' ' OH ' ' A' ' 78' ' ' TYR . . . 164.01 -103.08 0.21 Allowed Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.855 -1.164 . . . . 40.0 110.397 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.486 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 45.8 t80 -141.3 -166.95 2.29 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.842 -0.799 . . . . 40.0 108.955 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.649 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.9 mtm180 -73.45 -154.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 40.0 110.429 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.597 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 9.4 p30 -167.58 -150.91 0.11 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.333 -0.988 . . . . 40.0 108.333 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.514 ' OG ' ' O ' ' A' ' 100' ' ' THR . 82.5 p -102.82 -8.06 21.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.799 -1.188 . . . . 40.0 109.309 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.522 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.25 113.67 23.19 Favored 'General case' 0 N--CA 1.509 2.48 0 CA-C-O 121.794 0.807 . . . . 40.0 111.483 -179.537 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.854 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.73 150.79 46.53 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.852 -1.155 . . . . 40.0 110.551 179.606 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.693 ' CG2' HD11 ' A' ' 76' ' ' ILE . 4.9 tt -116.93 141.02 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.511 -0.743 . . . . 40.0 109.908 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 72' ' ' ARG . 2.8 mm? -119.54 124.95 47.67 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.574 -0.899 . . . . 40.0 108.574 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.677 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.66 129.53 55.35 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.873 0.844 . . . . 40.0 108.776 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.713 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.9 p -94.69 159.66 14.97 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 122.581 1.181 . . . . 40.0 112.413 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.6 p -69.42 -17.81 63.69 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.117 -1.068 . . . . 40.0 108.117 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.476 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -87.06 10.06 17.75 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.778 -0.769 . . . . 40.0 109.736 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.453 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.66 26.54 0.65 Allowed 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.62 -0.675 . . . . 40.0 110.259 179.253 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.5 mt -95.69 135.55 37.24 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.362 -0.837 . . . . 40.0 109.092 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.523 ' CG2' HD11 ' A' ' 109' ' ' ILE . 38.6 mm -110.96 119.02 58.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-O 121.389 0.614 . . . . 40.0 110.722 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -122.28 144.88 48.72 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 120.276 -0.57 . . . . 40.0 109.637 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.522 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 4.8 tptp -133.83 144.42 48.95 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.19 -0.943 . . . . 40.0 110.644 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.59 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.7 t -123.17 166.7 14.77 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 108.688 -0.856 . . . . 40.0 108.688 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.514 ' O ' ' OG ' ' A' ' 85' ' ' SER . 40.7 p -140.08 -9.82 1.15 Allowed 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.277 -0.889 . . . . 40.0 109.66 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.69 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -108.47 14.01 25.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 40.0 110.261 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 84.41 61.92 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.13 0.491 . . . . 40.0 110.329 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.649 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 24.6 m-85 70.73 -21.64 0.19 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.494 -0.754 . . . . 40.0 110.881 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.426 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.2 mt-30 -43.72 -72.55 0.06 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.088 -1.007 . . . . 40.0 109.599 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.465 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 26.4 p -107.41 169.44 8.58 Favored 'General case' 0 C--O 1.193 -1.9 0 N-CA-C 108.048 -1.093 . . . . 40.0 108.048 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.546 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -141.42 140.13 33.57 Favored 'General case' 0 C--N 1.272 -2.794 0 O-C-N 121.355 -0.84 . . . . 40.0 110.114 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 46.4 m -125.31 135.51 52.55 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.551 -0.907 . . . . 40.0 108.551 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.596 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 21.7 tttp -84.46 145.08 28.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.759 -1.213 . . . . 40.0 109.879 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.523 HD11 ' CG2' ' A' ' 96' ' ' ILE . 14.1 pt -120.32 -34.72 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.172 -0.955 . . . . 40.0 109.527 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.604 HH21 ' CG ' ' A' ' 8' ' ' ASP . 78.3 mtt180 . . . . . 0 N--CA 1.487 1.378 0 O-C-N 121.186 -0.946 . . . . 40.0 108.638 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.648 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 20.7 t . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 109.294 -0.632 . . . . 40.0 109.294 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 tt -177.1 152.4 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 108.981 -0.748 . . . . 40.0 108.981 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -144.29 25.78 1.52 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.733 -1.229 . . . . 40.0 110.604 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 10' ' ' VAL . 17.4 p -105.38 152.82 22.49 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.528 0.68 . . . . 40.0 110.057 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.498 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -56.29 -62.74 1.51 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.459 -1.401 . . . . 40.0 111.482 -179.198 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.646 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -59.1 -40.83 86.54 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.976 -1.077 . . . . 40.0 109.738 -179.345 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.45 -44.88 85.3 Favored Glycine 0 N--CA 1.507 3.377 0 N-CA-C 109.682 -1.367 . . . . 40.0 109.682 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.513 HG22 ' HG2' ' A' ' 21' ' ' PRO . 70.5 t -67.55 -43.48 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.805 -0.821 . . . . 40.0 108.976 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.88 -56.48 20.64 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.967 -0.753 . . . . 40.0 108.967 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.04 -56.02 14.63 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.89 -0.782 . . . . 40.0 108.89 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.695 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 38.7 t80 -53.02 -51.78 60.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 122.017 -0.427 . . . . 40.0 110.87 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 18' ' ' HIS . 3.9 tt -71.89 -51.06 24.14 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 121.414 0.626 . . . . 40.0 110.43 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.495 ' N ' HD23 ' A' ' 14' ' ' LEU . 58.8 mt-30 -53.22 -28.77 28.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 119.983 -1.698 . . . . 40.0 110.316 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.3 m -92.31 -50.18 5.78 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.612 -1.305 . . . . 40.0 110.964 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.401 ' O ' ' N ' ' A' ' 19' ' ' LYS . 86.5 m-85 -99.28 12.47 36.15 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.89 -1.131 . . . . 40.0 110.308 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.569 ' N ' ' O ' ' A' ' 14' ' ' LEU . 23.5 m80 42.6 24.2 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.916 0 CA-C-O 121.484 0.659 . . . . 40.0 111.226 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 17' ' ' TYR . 5.1 pttp -135.98 156.57 48.54 Favored 'General case' 0 C--O 1.183 -2.413 0 CA-C-O 121.646 0.736 . . . . 40.0 109.804 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 24' ' ' TYR . 4.5 mp -77.62 145.63 71.6 Favored Pre-proline 0 C--N 1.268 -2.976 0 O-C-N 120.899 -1.126 . . . . 40.0 109.71 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.695 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 88.9 Cg_exo -40.33 155.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 123.267 2.645 . . . . 40.0 113.922 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.648 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -66.06 49.19 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.15 0.976 . . . . 40.0 109.376 -179.016 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -173.92 26.99 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.189 -0.944 . . . . 40.0 110.687 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.425 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 2.9 m-85 -119.59 108.26 14.27 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.523 -1.361 . . . . 40.0 109.628 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.7 pt -116.94 132.11 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 C-N-CA 119.436 -0.905 . . . . 40.0 108.89 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.782 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.5 OUTLIER -67.17 172.02 5.1 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 123.609 1.671 . . . . 40.0 113.536 -177.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.501 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 19.5 mtmt -63.36 -35.99 82.23 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 106.458 -1.682 . . . . 40.0 106.458 176.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.566 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 5.1 m -35.56 -71.7 0.07 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 123.57 1.652 . . . . 40.0 109.222 175.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.504 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.1 mp0 -65.53 -56.18 13.76 Favored 'General case' 0 C--O 1.192 -1.93 0 N-CA-C 107.488 -1.301 . . . . 40.0 107.488 -177.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.504 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -37.26 -50.29 0.99 Allowed 'General case' 0 N--CA 1.517 2.914 0 O-C-N 120.574 -1.329 . . . . 40.0 110.647 178.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -58.93 -62.04 2.18 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.382 -1.449 . . . . 40.0 110.848 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.81 -25.98 67.83 Favored 'General case' 0 N--CA 1.512 2.662 0 O-C-N 120.679 -1.263 . . . . 40.0 110.027 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.0 tp -65.02 -25.33 67.8 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.178 -1.045 . . . . 40.0 108.178 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.33 46.2 0.33 Allowed Glycine 0 N--CA 1.502 3.068 0 N-CA-C 110.244 -1.142 . . . . 40.0 110.244 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.476 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -80.54 139.85 36.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.969 -1.312 . . . . 40.0 109.422 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.7 t -136.09 130.15 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.241 0 CA-C-O 121.6 0.714 . . . . 40.0 109.576 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.47 -48.18 79.87 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.298 -0.63 . . . . 40.0 109.298 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.2 p -69.7 44.85 0.06 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.33 -0.856 . . . . 40.0 110.704 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.603 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.5 ttpm? -178.48 -51.99 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.203 -0.936 . . . . 40.0 109.066 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.43 62.68 4.89 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 108.788 -1.725 . . . . 40.0 108.788 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.603 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -78.78 160.1 27.57 Favored 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.495 -1.003 . . . . 40.0 111.024 -177.787 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.842 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 52.0 tp -173.67 -69.4 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.479 -0.763 . . . . 40.0 110.544 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.565 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -61.37 -21.76 64.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.731 -1.231 . . . . 40.0 109.31 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 4.8 p-10 -74.16 -62.8 1.39 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.221 -0.659 . . . . 40.0 109.221 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.8 m -80.4 -10.04 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.914 -0.491 . . . . 40.0 110.298 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.554 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -148.21 72.23 11.06 Favored Pre-proline 0 N--CA 1.489 1.487 0 CA-C-O 121.489 0.662 . . . . 40.0 109.518 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -55.35 115.53 2.51 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 123.779 2.986 . . . . 40.0 113.381 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.72 38.2 57.06 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.992 -1.243 . . . . 40.0 109.992 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.554 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 6.3 mmtt -133.12 163.3 29.57 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.795 -0.827 . . . . 40.0 110.008 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.4 ' HA ' HD21 ' A' ' 42' ' ' LEU . 67.2 m -139.13 161.1 38.23 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 122.432 1.11 . . . . 40.0 110.84 -176.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.6 mm -79.93 124.78 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 114.619 -1.173 . . . . 40.0 110.721 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.24 156.12 13.22 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 119.529 -1.319 . . . . 40.0 109.967 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.782 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 118.29 -10.73 13.06 Favored Glycine 0 N--CA 1.502 3.091 0 C-N-CA 119.531 -1.319 . . . . 40.0 110.163 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.437 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 4.9 m-20 -72.62 -151.15 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.538 -1.566 . . . . 40.0 109.68 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.4 mp -132.72 141.0 46.18 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 CA-C-N 115.132 -0.94 . . . . 40.0 109.304 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.627 ' O ' ' N ' ' A' ' 58' ' ' ASN . 11.7 t80 -109.28 91.76 3.77 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.295 -0.878 . . . . 40.0 109.198 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.624 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.5 p -60.27 38.21 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.92 0.867 . . . . 40.0 110.625 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.627 ' N ' ' O ' ' A' ' 56' ' ' PHE . 44.8 t30 33.97 39.27 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.407 -0.808 . . . . 40.0 110.659 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.624 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.3 mtm180 -70.37 36.3 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.516 -1.365 . . . . 40.0 110.348 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.614 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 15.1 mt-10 -145.17 -2.76 0.78 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.347 -0.845 . . . . 40.0 109.954 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.29 37.95 56.09 Favored Glycine 0 N--CA 1.502 3.098 0 N-CA-C 109.579 -1.409 . . . . 40.0 109.579 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.614 ' NZ ' ' OE2' ' A' ' 60' ' ' GLU . 5.8 mttp -120.1 11.46 11.66 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.267 -1.137 . . . . 40.0 109.505 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.405 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.5 mt -136.38 144.26 46.88 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.64 -0.663 . . . . 40.0 109.498 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.53 123.8 13.04 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.188 1.925 . . . . 40.0 112.527 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.531 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.67 -175.84 27.05 Favored Glycine 0 N--CA 1.5 2.901 0 N-CA-C 110.235 -1.146 . . . . 40.0 110.235 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.462 ' NZ ' ' O ' ' A' ' 68' ' ' GLY . 9.0 tttt -179.12 152.17 0.54 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.065 -1.256 . . . . 40.0 107.791 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.6 p -70.87 53.53 0.16 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.643 -1.286 . . . . 40.0 109.106 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.462 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 150.89 80.98 0.03 OUTLIER Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.277 -1.129 . . . . 40.0 110.277 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.553 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.67 177.97 1.99 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.735 -0.862 . . . . 40.0 108.799 179.105 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.553 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 96.7 m -154.36 155.16 34.56 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.254 -0.904 . . . . 40.0 110.039 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.741 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 31.8 m95 -124.99 138.92 54.21 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.982 -0.449 . . . . 40.0 109.893 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.581 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.68 147.71 52.38 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.028 -1.045 . . . . 40.0 109.88 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.501 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -113.24 168.74 9.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.679 -1.263 . . . . 40.0 111.9 -179.379 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.45 139.56 5.71 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.799 0.809 . . . . 40.0 111.063 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.743 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -60.51 154.83 19.88 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.85 -0.531 . . . . 40.0 111.275 179.641 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.743 HD13 ' O ' ' A' ' 75' ' ' ASP . 33.9 mm -138.14 145.4 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.513 -0.742 . . . . 40.0 109.946 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 56.77 70.69 0.63 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.499 0.666 . . . . 40.0 110.782 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.842 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 65.6 t80 -132.29 154.9 49.21 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.917 -1.114 . . . . 40.0 109.436 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.574 ' OG1' ' N ' ' A' ' 80' ' ' SER . 22.9 p -136.17 -72.16 0.45 Allowed 'General case' 0 N--CA 1.507 2.385 0 CA-C-O 121.214 0.531 . . . . 40.0 109.934 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.574 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.5 OUTLIER -153.4 103.67 2.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.387 -0.821 . . . . 40.0 109.299 -178.669 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.402 ' N ' ' OH ' ' A' ' 78' ' ' TYR . . . 163.42 -106.19 0.27 Allowed Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.608 -1.282 . . . . 40.0 110.212 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.469 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 52.4 t80 -138.21 -165.16 1.75 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.789 -0.819 . . . . 40.0 108.789 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.647 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.1 mtm180 -75.72 -155.84 0.06 Allowed 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.335 -1.478 . . . . 40.0 109.961 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.547 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 9.5 p30 -165.13 -149.18 0.12 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.217 -1.031 . . . . 40.0 108.217 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 100' ' ' THR . 82.7 p -104.21 -7.58 20.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.709 -1.244 . . . . 40.0 108.929 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.482 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -87.6 113.42 23.27 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-O 121.878 0.846 . . . . 40.0 111.71 -179.435 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.863 ' HG2' ' NH1' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.55 150.61 46.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.879 -1.138 . . . . 40.0 110.519 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.729 ' CG2' HD11 ' A' ' 76' ' ' ILE . 6.7 tt -117.3 139.26 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-O 122.831 1.301 . . . . 40.0 110.028 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.528 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.9 mm? -118.86 124.44 47.16 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.421 -0.955 . . . . 40.0 108.421 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.678 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.54 129.5 55.39 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.846 0.831 . . . . 40.0 109.125 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.741 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.5 p -93.35 159.21 15.36 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 122.268 1.032 . . . . 40.0 112.221 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.8 p -69.23 -18.41 63.88 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.805 -1.183 . . . . 40.0 107.805 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.491 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -86.05 9.4 17.3 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.189 -0.604 . . . . 40.0 109.629 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.447 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.12 26.72 0.72 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.503 -0.748 . . . . 40.0 110.3 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.8 mt -96.29 134.99 38.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.398 -0.814 . . . . 40.0 109.156 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.558 ' CG2' HD11 ' A' ' 109' ' ' ILE . 39.2 mm -109.52 120.66 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.438 -0.788 . . . . 40.0 110.452 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -122.95 144.18 49.41 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 109.239 -0.652 . . . . 40.0 109.239 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.482 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 4.7 tptp -133.89 144.84 49.13 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 119.569 -0.852 . . . . 40.0 110.979 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.549 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.8 t -122.95 166.74 14.58 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 108.939 -0.764 . . . . 40.0 108.939 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.464 ' O ' ' OG ' ' A' ' 85' ' ' SER . 40.7 p -140.3 -9.0 1.13 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.36 -0.837 . . . . 40.0 109.626 178.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.674 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -108.58 14.63 24.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.958 -1.089 . . . . 40.0 110.285 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.674 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 83.45 61.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.21 0.528 . . . . 40.0 110.539 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.647 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 28.5 m-85 71.23 -20.83 0.21 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.59 -0.694 . . . . 40.0 110.651 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . 0.422 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.7 mt-30 -44.83 -74.13 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.074 -1.016 . . . . 40.0 109.83 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.515 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 21.0 p -106.02 167.01 10.09 Favored 'General case' 0 C--O 1.195 -1.806 0 N-CA-C 107.56 -1.274 . . . . 40.0 107.56 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.528 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -140.02 140.45 36.22 Favored 'General case' 0 C--N 1.264 -3.125 0 O-C-N 121.32 -0.863 . . . . 40.0 109.73 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.5 m -125.4 137.47 54.01 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.318 -0.993 . . . . 40.0 108.318 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.546 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 17.7 tttp -85.1 145.76 27.49 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.834 -1.166 . . . . 40.0 109.919 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.558 HD11 ' CG2' ' A' ' 96' ' ' ILE . 11.3 pt -121.78 -33.32 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.107 -0.996 . . . . 40.0 109.63 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.646 HH21 ' CG ' ' A' ' 8' ' ' ASP . 76.7 mtt180 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.945 . . . . 40.0 108.737 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.643 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 21.8 t . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 109.123 -0.695 . . . . 40.0 109.123 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -177.57 153.79 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.094 -0.706 . . . . 40.0 109.094 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.2 p-10 -144.38 26.1 1.48 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.066 -1.021 . . . . 40.0 110.729 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 10' ' ' VAL . 18.1 p -104.73 153.83 20.78 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.694 0.759 . . . . 40.0 109.779 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.48 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -56.99 -63.63 1.15 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.008 -1.057 . . . . 40.0 110.515 -179.267 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.652 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.8 OUTLIER -58.11 -41.76 84.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.481 -0.762 . . . . 40.0 109.781 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.6 -44.98 90.85 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 109.897 -1.281 . . . . 40.0 109.897 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.578 HG22 ' HG2' ' A' ' 21' ' ' PRO . 64.7 t -66.61 -43.41 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.485 -1.009 . . . . 40.0 108.608 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.93 -57.48 12.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.367 -0.605 . . . . 40.0 109.367 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.25 -55.63 14.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.514 -0.741 . . . . 40.0 109.039 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.708 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 38.0 t80 -52.4 -52.64 52.71 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.03 0.443 . . . . 40.0 110.268 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 18' ' ' HIS . 4.7 tt -71.42 -52.19 19.85 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.254 0.549 . . . . 40.0 110.68 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 11' ' ' ALA . 56.7 mt-30 -52.85 -28.94 25.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.113 -1.617 . . . . 40.0 109.939 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.8 m -91.1 -52.51 4.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.887 -1.133 . . . . 40.0 110.682 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -97.6 12.34 33.87 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.255 -0.903 . . . . 40.0 110.525 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.569 ' N ' ' O ' ' A' ' 14' ' ' LEU . 22.5 m80 43.36 25.04 0.06 Allowed 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.528 -0.733 . . . . 40.0 110.979 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.416 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 5.4 pttp -137.14 160.58 38.57 Favored 'General case' 0 C--O 1.182 -2.467 0 O-C-N 121.397 -0.814 . . . . 40.0 109.774 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 mp -80.07 146.08 62.39 Favored Pre-proline 0 C--N 1.266 -3.045 0 O-C-N 120.879 -1.138 . . . . 40.0 108.608 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.708 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 71.2 Cg_exo -41.26 156.11 0.06 OUTLIER 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.056 2.504 . . . . 40.0 113.982 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.643 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -67.35 49.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.178 -0.951 . . . . 40.0 109.352 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.513 ' HA ' ' HD3' ' A' ' 49' ' ' LYS . 0.8 OUTLIER -172.98 26.58 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.941 -1.099 . . . . 40.0 110.236 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.435 ' OH ' ' O ' ' A' ' 75' ' ' ASP . 4.3 m-85 -120.12 109.11 15.07 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.913 -1.115 . . . . 40.0 110.394 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 25' ' ' ILE . 16.5 pt -119.02 134.1 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.959 -1.126 . . . . 40.0 107.959 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.824 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.7 OUTLIER -71.78 172.59 9.55 Favored 'General case' 0 N--CA 1.508 2.444 0 CA-C-O 123.677 1.704 . . . . 40.0 113.249 -175.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.565 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 14.9 mtmt -60.67 -39.31 87.92 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 106.519 -1.66 . . . . 40.0 106.519 176.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.468 ' C ' ' O ' ' A' ' 27' ' ' LYS . 2.6 m -32.24 -74.3 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.533 -0.914 . . . . 40.0 108.533 175.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.572 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.8 mp0 -65.97 -57.49 7.68 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.116 -1.439 . . . . 40.0 107.116 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.572 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -30.22 -55.01 0.18 Allowed 'General case' 0 N--CA 1.53 3.559 0 O-C-N 119.931 -1.731 . . . . 40.0 109.78 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -56.13 -66.7 0.39 Allowed 'General case' 0 N--CA 1.525 3.31 0 O-C-N 120.033 -1.667 . . . . 40.0 113.679 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.71 -32.21 59.26 Favored 'General case' 0 N--CA 1.524 3.233 0 O-C-N 121.473 -0.767 . . . . 40.0 109.751 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.03 -22.35 66.79 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.178 -1.576 . . . . 40.0 108.633 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.36 51.27 0.4 Allowed Glycine 0 N--CA 1.503 3.144 0 N-CA-C 110.049 -1.22 . . . . 40.0 110.049 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.608 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -84.67 138.96 32.37 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.18 -1.188 . . . . 40.0 108.048 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.7 t -134.81 130.01 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.788 0 CA-C-O 121.74 0.781 . . . . 40.0 110.205 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -58.23 -50.37 73.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.935 -0.478 . . . . 40.0 110.005 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 76.4 p -70.36 45.45 0.08 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.573 -0.704 . . . . 40.0 110.123 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.595 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 2.0 ttpm? -177.14 -49.24 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.857 -0.794 . . . . 40.0 108.857 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.48 59.98 8.53 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 108.213 -1.955 . . . . 40.0 108.213 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.608 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -76.69 161.18 28.73 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.483 -1.01 . . . . 40.0 110.931 -177.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.846 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 48.8 tp -173.73 -68.5 0.01 OUTLIER 'General case' 0 C--O 1.194 -1.838 0 O-C-N 121.233 -0.917 . . . . 40.0 110.524 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -62.24 -20.45 64.24 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.504 -1.372 . . . . 40.0 109.318 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.4 p-10 -75.98 -61.88 1.78 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.925 -0.768 . . . . 40.0 108.925 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.9 m -80.11 -12.68 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.582 -0.699 . . . . 40.0 109.67 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -146.1 71.82 13.4 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.329 -0.857 . . . . 40.0 109.67 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -56.27 116.78 3.42 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.787 2.325 . . . . 40.0 113.375 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.87 36.67 52.14 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.757 -1.337 . . . . 40.0 109.757 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.58 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 6.8 mmtm -133.66 163.24 29.88 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 121.688 -0.889 . . . . 40.0 109.386 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.414 ' HG ' ' HD2' ' A' ' 78' ' ' TYR . 52.0 m -138.2 163.5 31.57 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.201 1.001 . . . . 40.0 111.135 -176.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.0 mm -80.83 123.2 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 CA-C-N 115.208 -0.905 . . . . 40.0 110.38 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . 176.94 155.63 13.99 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.468 -1.453 . . . . 40.0 109.468 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.824 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 117.36 -11.04 14.47 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.685 -1.245 . . . . 40.0 110.972 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.529 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 5.0 m-20 -72.63 -151.42 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.762 0 O-C-N 121.187 -1.184 . . . . 40.0 109.807 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -132.59 144.02 38.03 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.021 0 N-CA-C 108.256 -1.016 . . . . 40.0 108.256 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.62 ' O ' ' N ' ' A' ' 58' ' ' ASN . 15.3 t80 -112.7 90.81 3.44 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.195 -0.941 . . . . 40.0 109.157 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.652 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -59.72 38.34 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.708 0.766 . . . . 40.0 111.0 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.62 ' N ' ' O ' ' A' ' 56' ' ' PHE . 45.5 t30 34.77 37.82 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.032 -1.042 . . . . 40.0 110.964 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.652 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.4 mtm180 -70.23 38.08 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.956 -1.09 . . . . 40.0 109.85 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.608 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 12.4 mt-10 -145.47 -6.76 0.62 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.132 -0.98 . . . . 40.0 110.3 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.73 36.52 72.38 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.045 -1.622 . . . . 40.0 109.045 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.608 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 3.5 mttp -121.4 13.75 11.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.602 -0.94 . . . . 40.0 109.692 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.434 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -138.05 143.21 38.61 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.514 -0.741 . . . . 40.0 109.584 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -61.61 123.89 13.57 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.528 2.152 . . . . 40.0 112.322 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.53 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -103.02 -177.22 26.65 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 110.115 -1.194 . . . . 40.0 110.115 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.432 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 10.8 tttt -179.01 153.93 0.65 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.385 -1.068 . . . . 40.0 108.56 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 67' ' ' SER . 14.0 p -73.46 56.75 0.51 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.923 -1.111 . . . . 40.0 109.024 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.37 80.44 0.03 OUTLIER Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.694 -1.362 . . . . 40.0 109.694 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.575 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -176.05 177.41 1.6 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.795 -0.826 . . . . 40.0 108.847 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.575 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 59.5 m -155.28 155.77 34.36 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.2 -0.937 . . . . 40.0 109.898 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.706 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 28.8 m95 -125.01 140.61 52.76 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.874 -0.516 . . . . 40.0 110.038 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.626 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -131.88 150.54 52.12 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.95 -1.094 . . . . 40.0 109.679 179.206 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.565 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -115.62 168.65 9.83 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.137 0.97 . . . . 40.0 111.926 -179.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.436 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . . . -164.53 139.49 5.6 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.399 0.619 . . . . 40.0 110.217 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.722 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -61.34 153.43 26.68 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.055 0.455 . . . . 40.0 111.056 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.78 HD11 ' CG2' ' A' ' 88' ' ' ILE . 42.4 mm -135.8 146.64 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.411 -0.805 . . . . 40.0 110.2 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 55.37 71.49 0.54 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.409 0.623 . . . . 40.0 110.85 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.846 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 66.4 t80 -131.89 156.6 45.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.1 -1.0 . . . . 40.0 109.247 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' A' ' 80' ' ' SER . 21.0 p -136.87 -73.18 0.43 Allowed 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.181 0.515 . . . . 40.0 109.776 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.567 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -153.13 104.82 2.84 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.664 -0.648 . . . . 40.0 109.885 -178.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.456 ' N ' ' OH ' ' A' ' 78' ' ' TYR . . . 160.1 -100.36 0.19 Allowed Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.936 -1.266 . . . . 40.0 109.936 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.465 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 35.6 t80 -143.3 -169.95 3.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.738 -0.86 . . . . 40.0 109.541 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.634 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.5 mtm180 -71.65 -156.5 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.925 0.869 . . . . 40.0 110.423 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.467 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 12.9 p30 -166.17 -150.06 0.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.079 -1.082 . . . . 40.0 108.079 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' A' ' 100' ' ' THR . 71.5 p -102.87 -8.91 20.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.742 -1.224 . . . . 40.0 109.467 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.478 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -85.73 113.27 21.78 Favored 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 121.788 0.804 . . . . 40.0 111.812 -179.245 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.853 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.09 149.66 46.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.878 -1.139 . . . . 40.0 110.625 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.78 ' CG2' HD11 ' A' ' 76' ' ' ILE . 7.5 tt -116.56 138.8 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.988 0.899 . . . . 40.0 109.853 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.544 HD13 ' O ' ' A' ' 72' ' ' ARG . 3.1 mm? -117.82 126.2 51.97 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.541 -0.911 . . . . 40.0 108.541 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.686 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -119.79 129.32 54.4 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.876 -0.787 . . . . 40.0 108.876 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.706 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.5 p -93.13 158.31 15.83 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.285 1.041 . . . . 40.0 112.538 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.0 p -69.07 -17.11 63.83 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.345 -0.983 . . . . 40.0 108.345 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.481 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -86.72 9.01 20.17 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.5 -0.88 . . . . 40.0 109.428 179.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.46 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.29 26.77 0.54 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.517 -0.739 . . . . 40.0 110.175 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.3 mt -96.21 137.64 34.99 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.304 -0.872 . . . . 40.0 108.894 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.508 ' CG2' HD11 ' A' ' 109' ' ' ILE . 42.1 mm -111.99 121.18 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.508 -0.745 . . . . 40.0 110.589 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.41 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.4 m-85 -122.93 144.71 49.05 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 120.307 -0.557 . . . . 40.0 109.534 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.478 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 5.2 tptp -133.78 145.14 49.52 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.193 -0.942 . . . . 40.0 110.723 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.533 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.4 t -125.21 167.32 15.01 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.738 -0.838 . . . . 40.0 108.738 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.515 ' O ' ' OG ' ' A' ' 85' ' ' SER . 55.8 p -140.62 -9.05 1.08 Allowed 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.416 -0.803 . . . . 40.0 109.76 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.688 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -107.23 13.74 26.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.126 -0.984 . . . . 40.0 110.107 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 84.02 62.8 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.244 0.545 . . . . 40.0 109.982 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.634 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 32.6 m-85 70.88 -22.05 0.19 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.582 -0.699 . . . . 40.0 111.076 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.425 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.5 mt-30 -44.57 -74.21 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.1 -1.0 . . . . 40.0 110.125 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.529 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 21.1 p -105.14 164.2 12.0 Favored 'General case' 0 C--O 1.198 -1.652 0 N-CA-C 107.78 -1.193 . . . . 40.0 107.78 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.537 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -138.27 139.01 38.99 Favored 'General case' 0 C--N 1.269 -2.9 0 O-C-N 121.45 -0.781 . . . . 40.0 110.07 -179.442 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 37.5 m -125.27 137.23 54.08 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.497 -0.927 . . . . 40.0 108.497 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.522 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 16.3 tttp -83.52 146.23 28.47 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.877 -1.139 . . . . 40.0 109.559 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.508 HD11 ' CG2' ' A' ' 96' ' ' ILE . 15.2 pt -122.29 -33.99 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 C-N-CA 119.65 -0.82 . . . . 40.0 109.153 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.652 HH21 ' CG ' ' A' ' 8' ' ' ASP . 73.6 mtt180 . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 118.266 -0.873 . . . . 40.0 109.102 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.647 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 10.4 t . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.218 0.533 . . . . 40.0 109.942 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -175.73 151.05 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 108.992 -0.744 . . . . 40.0 108.992 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -141.88 23.13 2.09 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 120.866 -1.146 . . . . 40.0 110.738 -177.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 10' ' ' VAL . 11.7 p -105.16 153.38 21.61 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.634 0.73 . . . . 40.0 110.239 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.533 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -56.42 -62.97 1.36 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.968 -1.083 . . . . 40.0 111.354 -179.283 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.621 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.7 OUTLIER -58.88 -41.56 87.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.062 -1.024 . . . . 40.0 109.639 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.43 -46.18 73.68 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.093 -1.203 . . . . 40.0 110.093 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.53 HG22 ' HG2' ' A' ' 21' ' ' PRO . 79.8 t -67.95 -42.79 85.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 O-C-N 121.69 -0.888 . . . . 40.0 108.66 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -59.74 -61.07 2.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.457 -0.777 . . . . 40.0 109.549 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.29 -56.73 6.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.574 -0.704 . . . . 40.0 109.465 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.776 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 41.3 t80 -51.44 -53.18 39.64 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 116.153 -0.476 . . . . 40.0 110.758 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' A' ' 18' ' ' HIS . 1.8 tt -72.27 -51.08 22.51 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 121.165 0.507 . . . . 40.0 110.732 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 11' ' ' ALA . 66.3 mt-30 -52.06 -26.39 10.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.107 -1.621 . . . . 40.0 110.549 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.3 m -93.44 -47.84 6.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.53 -1.356 . . . . 40.0 111.449 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.46 ' O ' ' N ' ' A' ' 19' ' ' LYS . 90.5 m-85 -104.01 19.11 20.66 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.933 -1.104 . . . . 40.0 109.673 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.426 ' N ' ' O ' ' A' ' 14' ' ' LEU . 32.8 m80 40.66 25.58 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.717 0 O-C-N 121.035 -1.041 . . . . 40.0 110.863 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.472 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 3.8 pttp -137.34 157.49 46.49 Favored 'General case' 0 C--O 1.185 -2.311 0 CA-C-O 121.809 0.814 . . . . 40.0 110.466 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.48 146.11 65.03 Favored Pre-proline 0 C--N 1.271 -2.827 0 N-CA-C 108.534 -0.913 . . . . 40.0 108.534 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.776 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 88.3 Cg_exo -40.46 155.97 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.369 2.713 . . . . 40.0 114.217 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.647 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -67.22 48.44 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.897 0.856 . . . . 40.0 109.84 -179.226 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -173.13 25.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.981 -1.074 . . . . 40.0 110.52 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -118.27 109.26 16.11 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.193 -1.003 . . . . 40.0 110.07 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 25' ' ' ILE . 11.5 pt -118.33 133.98 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.78 -1.193 . . . . 40.0 107.78 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.829 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -69.38 174.96 4.31 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 124.158 1.933 . . . . 40.0 112.559 -177.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.555 ' HB3' ' NE2' ' A' ' 31' ' ' GLN . 17.8 mtmt -64.28 -36.7 84.94 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.704 -1.591 . . . . 40.0 106.704 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.512 ' OG ' ' OG1' ' A' ' 26' ' ' THR . 4.4 m -35.95 -70.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.049 0.928 . . . . 40.0 109.674 175.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.507 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.2 mp0 -66.49 -52.42 46.25 Favored 'General case' 0 C--O 1.204 -1.295 0 CA-C-N 114.319 -1.31 . . . . 40.0 108.47 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.507 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -42.64 -50.66 5.41 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 119.988 -1.695 . . . . 40.0 109.352 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.555 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 32.9 mt-30 -56.28 -63.94 1.02 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.389 -0.82 . . . . 40.0 111.083 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.91 -22.87 67.06 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.017 -1.052 . . . . 40.0 109.887 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.8 tp -68.15 -23.5 64.88 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.994 -1.066 . . . . 40.0 108.178 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.04 53.4 0.26 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.419 -1.072 . . . . 40.0 110.419 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.584 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -87.81 140.15 29.8 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.263 -1.139 . . . . 40.0 109.456 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.9 t -134.65 130.73 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.041 0 O-C-N 121.685 -0.634 . . . . 40.0 109.807 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -59.57 -48.95 79.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.726 -0.609 . . . . 40.0 109.588 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.3 p -70.12 46.89 0.08 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.44 -0.787 . . . . 40.0 110.01 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.61 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.7 ttpm? -179.12 -51.72 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.076 -0.713 . . . . 40.0 109.076 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.28 60.53 7.4 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 108.58 -1.808 . . . . 40.0 108.58 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.61 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -76.24 159.83 30.24 Favored 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.749 -0.854 . . . . 40.0 111.063 -178.043 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.874 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 63.9 tp -172.64 -69.89 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.751 -0.78 . . . . 40.0 110.249 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.579 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.46 -19.93 58.17 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.924 -1.11 . . . . 40.0 109.556 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 4.5 p-10 -77.02 -61.91 1.82 Allowed 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.696 -0.853 . . . . 40.0 108.696 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.4 m -79.08 -11.58 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 109.356 -0.609 . . . . 40.0 109.356 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -149.8 74.69 9.36 Favored Pre-proline 0 N--CA 1.49 1.546 0 CA-C-O 122.259 1.028 . . . . 40.0 109.977 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.9 117.8 4.58 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 124.044 3.163 . . . . 40.0 113.106 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.69 40.08 46.85 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.867 -1.693 . . . . 40.0 108.867 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.45 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 6.7 mmtm -136.04 169.59 17.36 Favored 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 121.884 0.85 . . . . 40.0 110.571 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.6 m -144.85 160.7 40.87 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.713 -1.242 . . . . 40.0 111.856 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.4 mm -80.61 125.78 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-N 115.167 -0.924 . . . . 40.0 110.502 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.95 157.29 15.17 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.543 -1.423 . . . . 40.0 109.543 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.829 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 116.03 -9.02 18.48 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.539 -1.315 . . . . 40.0 110.169 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.446 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 5.1 m-20 -74.53 -151.9 0.03 OUTLIER 'General case' 0 C--O 1.196 -1.716 0 O-C-N 120.417 -1.637 . . . . 40.0 109.242 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.74 143.93 38.88 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.829 0 N-CA-C 107.878 -1.156 . . . . 40.0 107.878 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.653 ' O ' ' N ' ' A' ' 58' ' ' ASN . 12.6 t80 -112.14 89.79 3.16 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.952 -0.699 . . . . 40.0 109.247 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.666 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.8 p -58.83 38.39 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.821 0.82 . . . . 40.0 110.803 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.653 ' N ' ' O ' ' A' ' 56' ' ' PHE . 44.1 t30 33.84 38.19 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.237 -0.914 . . . . 40.0 110.708 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.666 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.2 mtm180 -68.89 35.68 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.67 -1.268 . . . . 40.0 110.163 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.608 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 14.5 mt-10 -145.35 -2.56 0.77 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.748 -1.22 . . . . 40.0 110.225 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.25 38.59 57.1 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.436 -1.466 . . . . 40.0 109.436 -178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.608 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 5.5 mttp -121.21 12.82 11.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.373 -1.075 . . . . 40.0 109.334 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.463 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.5 mt -137.89 144.4 43.91 Favored Pre-proline 0 N--CA 1.496 1.834 0 CA-C-O 121.395 0.617 . . . . 40.0 109.467 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.83 123.2 12.19 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.536 2.157 . . . . 40.0 112.657 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.547 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.85 -177.98 26.79 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.054 -1.218 . . . . 40.0 110.054 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.468 ' NZ ' ' O ' ' A' ' 68' ' ' GLY . 8.8 tttt -177.66 153.15 0.85 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.026 -1.101 . . . . 40.0 108.026 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.6 p -72.25 53.03 0.27 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.833 -1.167 . . . . 40.0 109.395 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.468 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 150.97 80.13 0.03 OUTLIER Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.923 -1.271 . . . . 40.0 109.923 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.576 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -173.55 178.84 2.22 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.696 -0.885 . . . . 40.0 108.833 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.576 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 100.0 m -155.61 155.17 32.82 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.361 -0.935 . . . . 40.0 110.199 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.706 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 30.5 m95 -124.77 139.84 53.48 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.247 0.546 . . . . 40.0 110.064 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.623 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.91 148.92 52.74 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 120.756 -1.215 . . . . 40.0 109.436 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.505 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -115.01 168.47 9.89 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 122.181 0.991 . . . . 40.0 111.79 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -162.96 138.95 7.09 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.593 0.711 . . . . 40.0 111.121 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.718 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -61.08 154.52 22.7 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.509 -0.744 . . . . 40.0 110.804 -179.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.718 HD13 ' O ' ' A' ' 75' ' ' ASP . 40.1 mm -137.61 144.09 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 119.796 -0.762 . . . . 40.0 110.607 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 58.7 70.09 0.68 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.574 -0.704 . . . . 40.0 110.884 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.874 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 66.1 t80 -131.9 157.8 43.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.222 -0.924 . . . . 40.0 109.928 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.588 ' OG1' ' N ' ' A' ' 80' ' ' SER . 22.1 p -139.41 -70.15 0.41 Allowed 'General case' 0 N--CA 1.511 2.621 0 O-C-N 121.73 -0.606 . . . . 40.0 109.501 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.588 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.9 OUTLIER -154.42 105.76 2.69 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.737 -0.468 . . . . 40.0 109.737 -178.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.7 -103.93 0.23 Allowed Glycine 0 N--CA 1.498 2.774 0 C-N-CA 119.585 -1.293 . . . . 40.0 110.091 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 43.9 t80 -139.96 -166.66 2.13 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.086 -0.709 . . . . 40.0 109.086 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.633 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.4 mtm180 -73.95 -154.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.133 -0.979 . . . . 40.0 110.413 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.49 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 11.7 p30 -167.87 -150.99 0.1 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.08 -1.082 . . . . 40.0 108.08 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.6 p -102.98 -6.92 21.89 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.904 -1.123 . . . . 40.0 109.452 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.512 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -88.14 113.92 24.24 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 121.737 0.779 . . . . 40.0 111.47 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.859 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.22 149.78 44.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.979 -1.076 . . . . 40.0 110.675 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.653 ' CG2' HD11 ' A' ' 76' ' ' ILE . 6.1 tt -116.8 139.79 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 122.126 0.965 . . . . 40.0 109.865 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 72' ' ' ARG . 2.9 mm? -117.95 126.02 51.54 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.792 -0.818 . . . . 40.0 108.792 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.674 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.78 129.15 55.09 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.882 -0.784 . . . . 40.0 108.882 179.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.706 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 5.0 p -94.15 159.41 15.16 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 122.344 1.069 . . . . 40.0 112.219 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.3 p -69.91 -16.16 63.18 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.427 -0.953 . . . . 40.0 108.427 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.478 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -88.11 8.99 24.21 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.129 -0.628 . . . . 40.0 109.512 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.449 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.69 26.52 0.49 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.94 -0.475 . . . . 40.0 110.055 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.406 HD12 HH21 ' A' ' 69' ' ' ARG . 22.5 mt -95.55 137.08 35.11 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.305 -0.872 . . . . 40.0 109.499 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.483 ' CG2' HD11 ' A' ' 109' ' ' ILE . 39.7 mm -111.51 119.25 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.846 -0.533 . . . . 40.0 110.411 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.409 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.6 m-85 -121.96 144.3 48.96 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 109.688 -0.486 . . . . 40.0 109.688 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.512 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 4.7 tptp -133.77 144.45 49.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.188 -0.945 . . . . 40.0 110.591 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.601 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.8 t -123.57 166.03 16.14 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.673 -0.862 . . . . 40.0 108.673 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.6 p -139.51 -10.84 1.21 Allowed 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.441 -0.787 . . . . 40.0 109.536 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.691 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -107.56 13.87 26.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.01 -1.056 . . . . 40.0 110.508 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 84.27 61.24 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.669 -0.644 . . . . 40.0 110.275 178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.633 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 27.6 m-85 71.71 -21.16 0.22 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.497 -0.752 . . . . 40.0 110.972 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.413 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.7 mt-30 -44.38 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.119 -0.988 . . . . 40.0 109.88 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.497 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 22.7 p -105.29 168.95 8.74 Favored 'General case' 0 C--O 1.196 -1.721 0 N-CA-C 107.702 -1.221 . . . . 40.0 107.702 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.549 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -141.82 139.68 32.78 Favored 'General case' 0 C--N 1.267 -2.994 0 O-C-N 121.411 -0.806 . . . . 40.0 109.706 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.5 m -125.43 136.33 53.29 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.922 -1.14 . . . . 40.0 107.922 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.618 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 18.8 tttp -85.37 145.9 27.26 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.971 -1.081 . . . . 40.0 109.823 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.483 HD11 ' CG2' ' A' ' 96' ' ' ILE . 14.1 pt -121.44 -32.14 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 120.95 -1.094 . . . . 40.0 109.651 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.621 HH21 ' CG ' ' A' ' 8' ' ' ASP . 80.6 mtt180 . . . . . 0 N--CA 1.486 1.328 0 O-C-N 121.165 -0.959 . . . . 40.0 108.971 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.614 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 15.1 t . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.119 -0.697 . . . . 40.0 109.119 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -178.57 152.26 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.884 -0.784 . . . . 40.0 108.884 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -143.26 24.24 1.79 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.939 -1.101 . . . . 40.0 110.687 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 10' ' ' VAL . 16.5 p -105.57 152.98 22.4 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.594 0.712 . . . . 40.0 110.169 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.481 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -55.36 -64.56 0.8 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.985 -1.072 . . . . 40.0 110.981 -179.038 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.618 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.52 -41.86 81.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.025 -1.047 . . . . 40.0 110.035 -179.007 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.38 -45.46 75.29 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.759 -1.336 . . . . 40.0 109.759 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.585 HG22 ' HG2' ' A' ' 21' ' ' PRO . 77.5 t -68.08 -42.68 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.792 -0.828 . . . . 40.0 109.276 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.89 -57.96 10.47 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.592 -0.892 . . . . 40.0 108.592 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.8 -56.64 9.57 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.116 -0.698 . . . . 40.0 109.116 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.788 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 40.3 t80 -51.69 -52.8 45.46 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.134 0.492 . . . . 40.0 110.525 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 18' ' ' HIS . 1.6 tt -72.55 -51.9 17.93 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.813 -0.554 . . . . 40.0 111.166 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 11' ' ' ALA . 63.9 mt-30 -50.92 -27.79 8.31 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.292 -1.505 . . . . 40.0 110.617 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 m -93.0 -49.79 5.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.901 -1.125 . . . . 40.0 111.395 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 19' ' ' LYS . 87.9 m-85 -100.16 16.55 23.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.989 -1.069 . . . . 40.0 109.585 -178.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 14' ' ' LEU . 16.9 m80 39.75 26.56 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.472 -0.767 . . . . 40.0 110.733 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 17' ' ' TYR . 3.8 pttp -137.01 159.8 40.82 Favored 'General case' 0 C--O 1.185 -2.336 0 CA-C-O 121.977 0.894 . . . . 40.0 110.617 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.95 145.33 61.26 Favored Pre-proline 0 C--N 1.268 -2.971 0 O-C-N 121.071 -1.018 . . . . 40.0 108.402 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.788 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 86.7 Cg_exo -39.29 155.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 123.43 2.753 . . . . 40.0 114.358 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.614 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -68.2 51.34 0.07 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.075 -1.015 . . . . 40.0 109.379 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -175.71 27.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 40.0 110.51 179.089 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -119.65 109.33 15.53 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.494 -1.379 . . . . 40.0 109.973 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 20.4 pt -117.85 132.27 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.135 -1.061 . . . . 40.0 108.135 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.86 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -69.59 173.94 5.53 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 123.787 1.756 . . . . 40.0 113.244 -177.591 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.455 ' HE2' ' OD1' ' A' ' 54' ' ' ASP . 17.4 mtmt -63.53 -37.46 87.4 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.802 -1.555 . . . . 40.0 106.802 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.453 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 5.6 m -37.09 -70.87 0.08 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 122.184 0.992 . . . . 40.0 109.371 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.511 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.5 mp0 -65.35 -57.27 8.8 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.131 -1.433 . . . . 40.0 107.131 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.511 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -37.21 -51.67 1.03 Allowed 'General case' 0 N--CA 1.511 2.579 0 O-C-N 120.685 -1.259 . . . . 40.0 109.176 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -57.34 -63.95 1.05 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.437 -1.414 . . . . 40.0 111.485 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.42 -22.41 66.15 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 120.398 -1.439 . . . . 40.0 110.066 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.425 HD21 ' HB ' ' A' ' 45' ' ' VAL . 59.0 tp -68.64 -26.08 65.15 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.414 -1.328 . . . . 40.0 107.414 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 124.26 47.15 0.24 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.991 -0.844 . . . . 40.0 110.991 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.604 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.36 143.39 32.22 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.865 -1.373 . . . . 40.0 109.7 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.22 128.73 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 O-C-N 121.472 -0.767 . . . . 40.0 109.612 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -58.27 -49.96 75.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.778 -0.576 . . . . 40.0 109.602 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.6 p -70.07 47.21 0.08 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.356 -0.84 . . . . 40.0 109.967 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.599 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -179.32 -50.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.022 -0.733 . . . . 40.0 109.022 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.56 60.03 8.85 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 108.26 -1.936 . . . . 40.0 108.26 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.604 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -75.82 162.45 28.15 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.593 -0.946 . . . . 40.0 111.007 -177.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.769 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 43.7 tp -174.12 -70.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.748 -0.781 . . . . 40.0 110.274 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.547 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.94 -21.21 63.21 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.906 -1.121 . . . . 40.0 109.571 -178.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.0 p-10 -74.19 -62.8 1.39 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.711 -0.848 . . . . 40.0 108.711 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.425 ' HB ' HD21 ' A' ' 33' ' ' LEU . 16.1 m -79.35 -11.62 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.568 -0.531 . . . . 40.0 109.568 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.48 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -148.56 72.25 10.72 Favored Pre-proline 0 N--CA 1.486 1.34 0 CA-C-O 121.883 0.849 . . . . 40.0 109.449 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.8 118.18 5.01 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.994 2.463 . . . . 40.0 113.923 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.51 36.71 48.48 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.272 -1.531 . . . . 40.0 109.272 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.48 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 7.0 mmtm -134.37 163.95 28.52 Favored 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.614 0.721 . . . . 40.0 109.864 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.424 ' HA ' HD21 ' A' ' 42' ' ' LEU . 70.6 m -138.97 163.75 31.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 40.0 111.173 -176.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 13.0 mm -81.45 126.98 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-N 115.548 -0.751 . . . . 40.0 110.43 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.28 157.46 15.88 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.492 -1.443 . . . . 40.0 109.492 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.86 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 117.5 -10.34 14.53 Favored Glycine 0 N--CA 1.499 2.895 0 C-N-CA 118.945 -1.598 . . . . 40.0 110.369 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.495 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 4.6 m-20 -75.29 -151.62 0.03 OUTLIER 'General case' 0 C--O 1.197 -1.675 0 O-C-N 120.948 -1.325 . . . . 40.0 109.847 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.1 142.16 44.22 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.944 0 CA-C-N 114.86 -1.064 . . . . 40.0 108.665 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.624 ' O ' ' N ' ' A' ' 58' ' ' ASN . 15.1 t80 -111.4 90.66 3.4 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.875 -0.787 . . . . 40.0 108.875 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.647 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -59.63 38.56 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.605 0.717 . . . . 40.0 110.823 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' A' ' 56' ' ' PHE . 43.5 t30 33.82 38.07 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.012 -1.055 . . . . 40.0 111.33 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.647 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.5 mtm180 -69.03 34.66 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.951 -1.093 . . . . 40.0 110.483 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.614 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 15.5 mt-10 -144.1 -2.86 0.88 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.13 -0.981 . . . . 40.0 110.285 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.26 38.02 56.08 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.418 -1.473 . . . . 40.0 109.418 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.614 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 4.9 mttp -120.89 13.29 11.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.593 -0.946 . . . . 40.0 109.295 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.474 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -138.7 142.98 36.0 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.705 -0.622 . . . . 40.0 109.616 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -60.69 123.32 12.76 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.499 2.133 . . . . 40.0 112.629 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.52 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.96 -177.63 26.69 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.935 -1.266 . . . . 40.0 109.935 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.411 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 10.1 tttt -178.94 153.05 0.61 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.041 -1.096 . . . . 40.0 108.041 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.8 p -71.84 54.95 0.27 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.885 -1.134 . . . . 40.0 109.239 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.31 79.64 0.03 OUTLIER Glycine 0 N--CA 1.5 2.92 0 N-CA-C 110.137 -1.185 . . . . 40.0 110.137 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.579 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.92 179.06 1.69 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.694 -0.886 . . . . 40.0 109.082 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.579 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 99.9 m -155.81 154.77 31.87 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.405 -0.918 . . . . 40.0 109.8 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.696 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 29.9 m95 -124.02 140.6 52.81 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.723 -0.473 . . . . 40.0 109.723 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.634 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.81 149.49 52.43 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.837 -1.164 . . . . 40.0 109.574 179.55 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.535 ' O ' ' OH ' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -114.33 168.15 10.09 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.068 -1.02 . . . . 40.0 112.185 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.15 136.72 4.97 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.544 -0.723 . . . . 40.0 110.798 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.76 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -59.21 154.49 16.11 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 120.881 0.372 . . . . 40.0 111.102 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.76 HD13 ' O ' ' A' ' 75' ' ' ASP . 38.0 mm -137.8 146.06 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.682 -0.807 . . . . 40.0 110.456 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 57.64 69.96 0.69 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.316 0.579 . . . . 40.0 110.534 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.769 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 68.6 t80 -131.01 155.9 46.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.082 -1.011 . . . . 40.0 110.045 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 80' ' ' SER . 23.9 p -137.23 -72.66 0.43 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.822 -0.549 . . . . 40.0 109.557 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.572 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.9 OUTLIER -153.05 106.14 2.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 122.071 -0.393 . . . . 40.0 110.132 -179.084 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.8 -105.11 0.25 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.706 -1.357 . . . . 40.0 109.706 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 41.5 t80 -138.81 -166.05 1.94 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.006 -0.702 . . . . 40.0 109.175 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.644 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.6 mtm180 -74.21 -154.69 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.265 -0.897 . . . . 40.0 110.008 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.597 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 8.1 p30 -167.02 -150.79 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.178 -1.045 . . . . 40.0 108.178 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.531 ' OG ' ' O ' ' A' ' 100' ' ' THR . 59.4 p -102.5 -8.14 21.3 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 120.823 -1.173 . . . . 40.0 109.155 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.501 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.13 114.29 23.6 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-O 121.832 0.825 . . . . 40.0 111.456 -179.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.876 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.01 150.53 45.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.916 -1.115 . . . . 40.0 110.959 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.703 ' CG2' HD11 ' A' ' 76' ' ' ILE . 5.0 tt -116.92 140.43 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 122.304 1.049 . . . . 40.0 110.01 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 72' ' ' ARG . 3.0 mm? -119.33 125.19 48.46 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.349 -0.982 . . . . 40.0 108.349 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.677 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -119.16 129.88 55.24 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.913 -0.773 . . . . 40.0 108.913 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.696 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.1 p -94.91 159.47 15.02 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.438 1.113 . . . . 40.0 112.96 -178.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.1 p -69.58 -16.92 63.5 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.097 -1.075 . . . . 40.0 108.097 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.478 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -87.81 9.26 22.4 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.658 -0.817 . . . . 40.0 109.556 179.632 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.468 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.98 26.95 0.58 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.581 -0.699 . . . . 40.0 110.249 179.451 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.8 mt -96.22 136.25 36.93 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.424 -0.798 . . . . 40.0 109.164 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.494 ' CG2' HD11 ' A' ' 109' ' ' ILE . 39.8 mm -110.8 120.43 61.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.505 -0.747 . . . . 40.0 110.554 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.403 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.6 m-85 -123.03 144.56 49.19 Favored 'General case' 0 N--CA 1.504 2.265 0 C-N-CA 120.467 -0.493 . . . . 40.0 109.804 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.501 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 6.0 tptp -133.71 144.31 49.04 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.592 -0.693 . . . . 40.0 110.722 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.571 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.7 t -124.21 166.47 15.79 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.632 -0.877 . . . . 40.0 108.632 177.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.531 ' O ' ' OG ' ' A' ' 85' ' ' SER . 40.4 p -140.33 -8.35 1.14 Allowed 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.314 -0.866 . . . . 40.0 109.702 178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.688 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -108.67 13.03 25.42 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.058 -1.026 . . . . 40.0 110.06 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 84.56 62.44 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.318 0.58 . . . . 40.0 110.34 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.644 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 27.1 m-85 71.23 -21.92 0.2 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.459 -0.776 . . . . 40.0 110.868 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.421 ' H ' ' C ' ' A' ' 102' ' ' ALA . 2.0 mt-30 -44.18 -74.28 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.333 -0.855 . . . . 40.0 109.69 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.507 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 25.3 p -105.53 166.58 10.34 Favored 'General case' 0 C--O 1.194 -1.82 0 N-CA-C 107.82 -1.178 . . . . 40.0 107.82 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.534 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -139.42 138.82 36.82 Favored 'General case' 0 C--N 1.27 -2.87 0 O-C-N 121.441 -0.787 . . . . 40.0 109.973 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.2 m -124.17 136.73 54.4 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.182 -1.044 . . . . 40.0 108.182 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.544 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 19.0 tttp -85.64 146.32 26.91 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.704 -1.247 . . . . 40.0 109.616 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.494 HD11 ' CG2' ' A' ' 96' ' ' ILE . 13.5 pt -121.67 -34.08 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.244 -0.91 . . . . 40.0 109.476 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.618 HH21 ' CG ' ' A' ' 8' ' ' ASP . 78.2 mtt180 . . . . . 0 N--CA 1.488 1.452 0 O-C-N 121.197 -0.939 . . . . 40.0 108.875 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.632 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 18.5 t . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.471 -0.566 . . . . 40.0 109.471 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 tt -175.74 153.7 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.909 -0.775 . . . . 40.0 108.909 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -143.95 25.88 1.57 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.8 -1.188 . . . . 40.0 110.506 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 10' ' ' VAL . 15.7 p -105.3 153.61 21.38 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.469 0.652 . . . . 40.0 109.638 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.506 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -56.97 -64.0 1.02 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.115 -0.991 . . . . 40.0 110.817 -178.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.641 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.39 -42.01 81.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.379 -0.826 . . . . 40.0 109.705 -179.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.68 -45.95 76.57 Favored Glycine 0 N--CA 1.503 3.101 0 N-CA-C 109.968 -1.253 . . . . 40.0 109.968 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.533 HG22 ' HG2' ' A' ' 21' ' ' PRO . 69.7 t -66.95 -42.6 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.767 -0.843 . . . . 40.0 108.933 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.88 -58.4 8.59 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.842 -0.799 . . . . 40.0 108.842 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.07 -56.2 9.78 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.843 -0.799 . . . . 40.0 108.843 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.725 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 35.7 t80 -52.92 -51.81 59.99 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 116.084 -0.507 . . . . 40.0 110.673 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 18' ' ' HIS . 5.1 tt -72.28 -51.4 21.02 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.575 -0.703 . . . . 40.0 110.942 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 11' ' ' ALA . 54.9 mt-30 -52.9 -28.26 22.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.271 -1.518 . . . . 40.0 110.285 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.1 m -92.96 -51.25 5.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.085 -1.009 . . . . 40.0 110.825 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -98.17 10.3 40.87 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.994 -1.066 . . . . 40.0 110.205 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.573 ' N ' ' O ' ' A' ' 14' ' ' LEU . 20.1 m80 44.56 23.73 0.08 Allowed 'General case' 0 N--CA 1.52 3.067 0 O-C-N 121.42 -0.8 . . . . 40.0 110.879 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.5 pttp -135.62 160.94 36.93 Favored 'General case' 0 C--O 1.182 -2.496 0 O-C-N 121.399 -0.813 . . . . 40.0 109.566 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 24' ' ' TYR . 4.4 mp -80.47 147.0 62.68 Favored Pre-proline 0 C--N 1.268 -2.964 0 N-CA-C 108.26 -1.015 . . . . 40.0 108.26 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.725 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 83.7 Cg_exo -42.28 157.49 0.07 OUTLIER 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 123.26 2.64 . . . . 40.0 113.633 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.632 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -66.86 49.1 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.049 -1.032 . . . . 40.0 109.871 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.526 ' HA ' ' HD3' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -172.14 24.92 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.925 -1.109 . . . . 40.0 110.139 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.408 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 4.0 m-85 -117.52 106.74 13.47 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.508 -1.37 . . . . 40.0 110.63 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.4 pt -116.47 133.92 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.061 -1.024 . . . . 40.0 108.37 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.772 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -69.09 172.38 6.86 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-O 123.588 1.661 . . . . 40.0 112.96 -177.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.508 ' HB3' ' NE2' ' A' ' 31' ' ' GLN . 12.8 mtmt -62.65 -38.78 91.64 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 105.483 -2.043 . . . . 40.0 105.483 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.472 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 11.4 m -34.75 -71.68 0.06 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.103 -0.953 . . . . 40.0 108.792 175.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.55 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.1 mp0 -66.25 -59.5 3.67 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 118.509 -1.276 . . . . 40.0 107.578 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.55 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -31.43 -55.52 0.26 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 119.503 1.047 . . . . 40.0 110.445 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.508 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 25.9 mt-30 -58.0 -63.59 1.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.497 -1.377 . . . . 40.0 111.109 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.29 -27.05 63.71 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.732 -1.23 . . . . 40.0 110.621 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.7 tp -68.56 -22.52 64.48 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 108.485 -0.932 . . . . 40.0 108.485 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.42 48.99 0.25 Allowed Glycine 0 N--CA 1.496 2.687 0 C-N-CA 120.948 -0.644 . . . . 40.0 111.686 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.609 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -85.7 137.9 32.5 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.115 -1.226 . . . . 40.0 110.194 179.45 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.4 t -134.37 132.12 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.093 0 O-C-N 121.394 -0.816 . . . . 40.0 110.412 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.411 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -59.26 -48.92 79.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.708 -0.62 . . . . 40.0 109.487 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.7 p -69.71 45.75 0.07 Allowed 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 121.635 0.731 . . . . 40.0 110.527 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.507 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.6 ttpm? -178.3 -51.42 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.121 -0.696 . . . . 40.0 109.121 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.6 59.84 8.68 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 108.221 -1.952 . . . . 40.0 108.221 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.609 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -76.51 160.6 29.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.661 -0.906 . . . . 40.0 111.32 -177.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.797 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 61.8 tp -174.77 -68.67 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.913 -1.117 . . . . 40.0 110.911 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.631 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.29 -20.31 58.6 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.49 -1.381 . . . . 40.0 109.573 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 2.6 p-10 -75.95 -64.8 1.01 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.712 -0.847 . . . . 40.0 108.712 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.43 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 30.3 m -77.18 -12.68 14.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 109.415 -0.587 . . . . 40.0 109.415 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -145.6 72.08 14.04 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.56 -0.713 . . . . 40.0 110.086 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -56.91 116.79 3.45 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.73 2.287 . . . . 40.0 114.976 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.38 37.33 47.79 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.344 -1.503 . . . . 40.0 109.344 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.526 ' HD3' ' HA ' ' A' ' 23' ' ' ASN . 7.1 mmtt -132.6 171.03 14.35 Favored 'General case' 0 N--CA 1.508 2.446 0 CA-C-O 122.078 0.942 . . . . 40.0 110.226 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.3 m -145.69 162.06 38.44 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.884 -1.135 . . . . 40.0 111.501 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.8 mm -81.81 123.84 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-N 115.401 -0.818 . . . . 40.0 110.881 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.46 155.86 13.53 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.109 -1.596 . . . . 40.0 109.109 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.772 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 120.44 -12.19 10.36 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.278 -1.439 . . . . 40.0 110.402 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.455 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 5.0 m-20 -74.1 -154.22 0.03 OUTLIER 'General case' 0 C--O 1.193 -1.911 0 O-C-N 121.182 -1.187 . . . . 40.0 110.308 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 mp -128.57 142.74 43.11 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.868 0 CA-C-N 115.476 -0.784 . . . . 40.0 109.084 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.633 ' O ' ' N ' ' A' ' 58' ' ' ASN . 12.7 t80 -111.08 90.18 3.26 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.333 -0.855 . . . . 40.0 109.169 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.633 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -59.45 38.78 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 122.023 0.916 . . . . 40.0 110.842 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.633 ' N ' ' O ' ' A' ' 56' ' ' PHE . 45.7 t30 34.14 38.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.193 -0.942 . . . . 40.0 110.618 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.633 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 11.2 mtm180 -69.89 37.97 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.765 -1.209 . . . . 40.0 109.992 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.601 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 13.0 mt-10 -146.14 -6.92 0.56 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.038 -1.039 . . . . 40.0 109.968 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.31 37.53 74.03 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 109.424 -1.471 . . . . 40.0 109.424 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.601 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 4.5 mttp -121.11 12.35 11.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.802 -0.822 . . . . 40.0 109.3 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.42 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -136.89 142.53 38.95 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.681 -0.637 . . . . 40.0 109.455 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -61.91 122.7 11.35 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.597 2.198 . . . . 40.0 112.27 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.514 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.05 -178.02 27.82 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.033 -1.227 . . . . 40.0 110.033 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 9.5 tttt -177.76 154.14 0.91 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.42 -1.047 . . . . 40.0 108.267 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.5 p -72.05 53.79 0.27 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.981 -1.074 . . . . 40.0 109.183 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.42 79.61 0.03 OUTLIER Glycine 0 N--CA 1.498 2.806 0 N-CA-C 110.017 -1.233 . . . . 40.0 110.017 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.574 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.14 178.53 2.08 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.734 -0.863 . . . . 40.0 108.991 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.574 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 98.9 m -155.42 155.53 33.74 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.202 -0.936 . . . . 40.0 109.823 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.694 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 29.1 m95 -125.07 140.64 52.72 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.834 -0.542 . . . . 40.0 109.636 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.622 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -131.35 147.32 52.56 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.105 -0.997 . . . . 40.0 110.162 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.464 ' O ' ' OH ' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -111.39 168.64 9.38 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 122.466 1.127 . . . . 40.0 112.352 -179.485 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.94 136.54 3.57 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.668 -0.645 . . . . 40.0 111.039 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.708 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -58.58 154.51 14.1 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.016 0.436 . . . . 40.0 110.832 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.712 HD11 ' CG2' ' A' ' 88' ' ' ILE . 43.3 mm -137.57 146.18 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.477 -0.764 . . . . 40.0 109.733 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 56.44 70.94 0.6 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.491 0.662 . . . . 40.0 110.948 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.797 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 68.8 t80 -132.04 156.08 46.92 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.993 -1.067 . . . . 40.0 109.903 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 80' ' ' SER . 23.6 p -136.27 -73.92 0.44 Allowed 'General case' 0 N--CA 1.509 2.479 0 CA-C-O 121.284 0.564 . . . . 40.0 110.059 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.631 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -152.23 105.91 3.1 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.078 -0.712 . . . . 40.0 109.078 -178.815 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.405 ' N ' ' OH ' ' A' ' 78' ' ' TYR . . . 160.84 -105.6 0.27 Allowed Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.417 -1.373 . . . . 40.0 110.28 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.474 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 40.0 t80 -138.36 -166.09 1.93 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.987 -0.745 . . . . 40.0 108.987 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.639 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.2 mtm180 -75.12 -155.92 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.045 -1.034 . . . . 40.0 110.343 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.541 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 10.8 p30 -165.33 -150.37 0.13 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.978 -1.119 . . . . 40.0 107.978 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' A' ' 100' ' ' THR . 82.6 p -103.58 -8.15 20.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.78 -1.2 . . . . 40.0 109.152 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.501 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -86.0 113.37 22.04 Favored 'General case' 0 N--CA 1.507 2.414 0 CA-C-O 121.79 0.805 . . . . 40.0 111.713 -179.167 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.86 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.63 150.38 46.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.033 . . . . 40.0 110.988 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.712 ' CG2' HD11 ' A' ' 76' ' ' ILE . 6.9 tt -116.73 141.56 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 122.107 0.956 . . . . 40.0 109.847 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.542 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.8 mm? -121.37 123.99 43.45 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.944 -1.132 . . . . 40.0 107.944 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.687 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.09 129.5 55.58 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.918 0.866 . . . . 40.0 108.783 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.694 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 3.8 p -94.14 158.63 15.52 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 122.228 1.013 . . . . 40.0 112.445 -177.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.7 p -69.82 -15.87 63.18 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.443 -0.947 . . . . 40.0 108.443 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.488 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -88.02 8.2 27.65 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.61 -0.836 . . . . 40.0 109.423 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.463 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 79.36 26.07 0.42 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.675 -0.64 . . . . 40.0 110.344 179.699 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.1 mt -95.75 138.84 32.83 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.451 -0.781 . . . . 40.0 109.18 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.484 ' CG2' HD11 ' A' ' 109' ' ' ILE . 40.4 mm -112.91 120.21 62.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.71 -0.619 . . . . 40.0 110.426 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.433 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.4 m-85 -122.03 144.49 48.87 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 109.296 -0.631 . . . . 40.0 109.296 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.501 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 3.3 tptp -133.17 146.14 51.26 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.367 -0.933 . . . . 40.0 110.965 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.533 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.6 t -125.63 166.6 16.44 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 109.141 -0.689 . . . . 40.0 109.141 177.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.515 ' O ' ' OG ' ' A' ' 85' ' ' SER . 55.5 p -139.97 -9.69 1.17 Allowed 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.327 -0.858 . . . . 40.0 109.585 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.662 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -108.09 15.99 23.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.195 -0.941 . . . . 40.0 110.417 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 83.01 60.7 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.86 -0.525 . . . . 40.0 110.689 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.639 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 27.5 m-85 71.35 -20.46 0.23 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.546 -0.721 . . . . 40.0 110.847 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.424 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.6 mt-30 -44.92 -73.4 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.044 -1.035 . . . . 40.0 109.877 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.492 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 23.8 p -105.86 164.79 11.67 Favored 'General case' 0 C--O 1.195 -1.813 0 N-CA-C 107.791 -1.189 . . . . 40.0 107.791 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.542 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -138.95 138.2 37.11 Favored 'General case' 0 C--N 1.269 -2.915 0 O-C-N 121.306 -0.872 . . . . 40.0 109.989 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 53.3 m -124.12 137.42 54.56 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.119 -1.067 . . . . 40.0 108.119 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.61 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 18.4 tttp -84.64 145.18 28.14 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.906 -1.121 . . . . 40.0 109.601 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.484 HD11 ' CG2' ' A' ' 96' ' ' ILE . 15.4 pt -120.53 -34.68 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.175 -0.953 . . . . 40.0 109.262 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.641 HH21 ' CG ' ' A' ' 8' ' ' ASP . 79.6 mtt180 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 40.0 108.86 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.63 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 19.8 t . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 109.045 -0.724 . . . . 40.0 109.045 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 tt -174.34 154.07 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.9 -0.778 . . . . 40.0 108.9 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -144.22 26.12 1.51 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.016 -1.053 . . . . 40.0 110.593 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 10' ' ' VAL . 18.0 p -104.0 153.83 20.38 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.566 0.698 . . . . 40.0 109.609 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.475 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -57.11 -63.49 1.2 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.839 -1.163 . . . . 40.0 110.511 -179.217 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.643 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.9 OUTLIER -57.31 -41.93 80.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.096 -1.002 . . . . 40.0 109.655 -179.476 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.35 -44.96 84.86 Favored Glycine 0 N--CA 1.503 3.11 0 N-CA-C 110.243 -1.143 . . . . 40.0 110.243 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.573 HG22 ' HG2' ' A' ' 21' ' ' PRO . 67.3 t -67.28 -42.99 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.523 -0.986 . . . . 40.0 108.828 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.508 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.88 -59.13 5.87 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.974 -0.75 . . . . 40.0 108.974 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.23 -56.79 7.08 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.913 -0.773 . . . . 40.0 108.913 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.72 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 34.2 t80 -52.15 -53.01 48.24 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 116.116 -0.493 . . . . 40.0 110.61 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.588 ' O ' ' N ' ' A' ' 18' ' ' HIS . 4.4 tt -71.67 -51.21 24.23 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.301 0.572 . . . . 40.0 110.851 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 11' ' ' ALA . 58.6 mt-30 -53.57 -28.58 32.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.233 -1.542 . . . . 40.0 110.178 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.6 m -91.46 -52.63 4.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.805 -1.184 . . . . 40.0 110.524 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -97.68 12.26 34.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.279 -0.888 . . . . 40.0 110.576 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.588 ' N ' ' O ' ' A' ' 14' ' ' LEU . 23.7 m80 42.7 25.64 0.05 Allowed 'General case' 0 N--CA 1.512 2.643 0 O-C-N 121.237 -0.914 . . . . 40.0 111.151 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 pttp -137.0 160.9 37.56 Favored 'General case' 0 C--O 1.185 -2.329 0 O-C-N 121.44 -0.787 . . . . 40.0 109.559 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 24' ' ' TYR . 3.4 mp -80.3 145.57 60.22 Favored Pre-proline 0 C--N 1.265 -3.101 0 O-C-N 120.744 -1.223 . . . . 40.0 108.764 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.72 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 72.6 Cg_exo -40.99 155.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.831 2.354 . . . . 40.0 113.417 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.63 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -65.61 49.97 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.05 -1.031 . . . . 40.0 109.356 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -171.91 26.21 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.703 -1.248 . . . . 40.0 110.639 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.423 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 5.4 m-85 -119.82 108.39 14.32 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.789 -1.194 . . . . 40.0 109.674 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 25' ' ' ILE . 21.6 pt -119.66 128.86 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.483 1.135 . . . . 40.0 108.612 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.715 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.4 OUTLIER -63.78 169.34 4.18 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-O 123.561 1.648 . . . . 40.0 114.091 -176.264 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.53 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 12.8 mtmt -58.51 -42.45 87.68 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 104.676 -2.342 . . . . 40.0 104.676 176.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.508 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 7.7 m -32.35 -72.97 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 116.293 -0.412 . . . . 40.0 110.261 176.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.485 ' O ' ' C ' ' A' ' 30' ' ' ALA . 3.1 mp0 -64.02 -54.86 27.71 Favored 'General case' 0 C--O 1.193 -1.909 0 N-CA-C 106.558 -1.645 . . . . 40.0 106.558 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -36.11 -55.2 0.78 Allowed 'General case' 0 N--CA 1.514 2.753 0 O-C-N 120.591 -1.318 . . . . 40.0 110.412 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.423 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 38.7 mt-30 -56.35 -67.6 0.29 Allowed 'General case' 0 N--CA 1.507 2.425 0 O-C-N 120.681 -1.262 . . . . 40.0 111.088 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.14 -26.86 61.23 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 119.93 -1.731 . . . . 40.0 110.58 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.4 tp -67.17 -21.56 65.8 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.36 -0.978 . . . . 40.0 108.36 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.59 40.45 0.53 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.851 -0.9 . . . . 40.0 110.851 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.574 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -77.68 139.97 39.51 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.435 -1.627 . . . . 40.0 109.521 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.2 t -136.44 131.27 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.607 0 O-C-N 121.74 -0.6 . . . . 40.0 109.896 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.404 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -58.45 -50.13 74.81 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 116.612 -0.267 . . . . 40.0 110.386 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.5 p -69.98 46.23 0.08 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.427 -0.796 . . . . 40.0 110.232 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.599 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 2.3 ttpm? -178.33 -51.91 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.989 -0.745 . . . . 40.0 108.989 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.1 61.83 5.73 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 108.412 -1.875 . . . . 40.0 108.412 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.599 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -78.92 161.25 26.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.607 -0.937 . . . . 40.0 110.101 -178.347 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.786 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 56.2 tp -173.56 -67.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.676 -0.81 . . . . 40.0 110.515 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.611 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -64.26 -19.29 65.29 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 120.571 -1.331 . . . . 40.0 109.973 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 5.9 p-10 -75.41 -63.41 1.29 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.857 -0.794 . . . . 40.0 108.857 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.2 m -78.13 -15.85 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.715 -0.616 . . . . 40.0 109.654 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.518 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -142.74 72.89 19.66 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 40.0 109.622 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -56.91 117.62 4.34 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.819 2.346 . . . . 40.0 113.28 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.85 35.97 48.86 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.996 -1.242 . . . . 40.0 109.996 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.518 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 7.0 mmtt -133.48 162.63 31.35 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 121.899 -0.765 . . . . 40.0 109.86 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.42 ' HA ' HD21 ' A' ' 42' ' ' LEU . 70.3 m -138.01 165.83 25.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.095 -1.003 . . . . 40.0 111.244 -177.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 mm -83.26 124.72 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.54 0.686 . . . . 40.0 111.144 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.81 157.82 17.23 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 119.539 -1.315 . . . . 40.0 110.417 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.715 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 116.16 -7.66 18.77 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.653 -1.379 . . . . 40.0 109.653 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.515 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 6.8 m-20 -74.31 -153.83 0.03 OUTLIER 'General case' 0 C--O 1.189 -2.106 0 O-C-N 121.375 -1.073 . . . . 40.0 110.194 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -131.68 141.29 46.07 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.027 0 N-CA-C 108.355 -0.98 . . . . 40.0 108.355 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.618 ' O ' ' N ' ' A' ' 58' ' ' ASN . 14.4 t80 -110.69 90.94 3.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 40.0 108.772 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.656 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.6 p -60.27 39.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.625 -0.672 . . . . 40.0 110.858 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.618 ' N ' ' O ' ' A' ' 56' ' ' PHE . 47.5 t30 34.35 38.19 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.104 -0.998 . . . . 40.0 111.051 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.656 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 11.4 mtm180 -71.25 38.92 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.027 -1.046 . . . . 40.0 109.847 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.608 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 11.7 mt-10 -146.24 -6.34 0.56 Allowed 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.441 -0.787 . . . . 40.0 110.195 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.28 36.48 62.65 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 109.129 -1.588 . . . . 40.0 109.129 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.667 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 3.5 mttp -120.67 12.58 11.47 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.717 -0.872 . . . . 40.0 109.652 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.452 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.4 mt -137.54 144.41 44.87 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.451 -0.781 . . . . 40.0 109.394 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -62.5 124.75 14.77 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.441 2.094 . . . . 40.0 112.674 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.524 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.22 -178.29 27.57 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 110.054 -1.218 . . . . 40.0 110.054 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.489 ' NZ ' ' O ' ' A' ' 68' ' ' GLY . 10.3 tttt -178.03 153.15 0.78 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.272 -1.134 . . . . 40.0 108.625 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.468 ' O ' ' OG ' ' A' ' 67' ' ' SER . 8.5 p -73.09 55.3 0.42 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.755 -1.215 . . . . 40.0 109.099 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.489 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 148.28 78.94 0.03 OUTLIER Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.477 -1.449 . . . . 40.0 109.477 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.552 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -173.66 175.93 2.84 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.759 -0.848 . . . . 40.0 108.95 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.552 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 87.6 m -154.44 155.25 34.62 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.135 -0.978 . . . . 40.0 110.062 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.718 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 30.2 m95 -124.68 140.71 52.68 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 121.267 0.556 . . . . 40.0 110.246 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.624 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -131.63 149.83 52.36 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.881 -1.137 . . . . 40.0 110.216 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.53 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -113.35 167.76 10.3 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.321 1.057 . . . . 40.0 111.91 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.67 137.85 4.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.754 -0.591 . . . . 40.0 110.378 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.751 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -59.82 153.69 20.13 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.959 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.78 HD11 ' CG2' ' A' ' 88' ' ' ILE . 42.7 mm -136.18 144.8 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.419 -0.801 . . . . 40.0 110.04 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 56.28 70.82 0.61 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.486 0.66 . . . . 40.0 110.598 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.786 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 62.4 t80 -130.73 155.49 46.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.132 -0.98 . . . . 40.0 109.34 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.577 ' OG1' ' N ' ' A' ' 80' ' ' SER . 24.0 p -134.96 -73.46 0.47 Allowed 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.63 0.729 . . . . 40.0 110.064 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.611 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -153.46 105.69 2.86 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.03 -0.729 . . . . 40.0 109.03 -178.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.479 ' N ' ' OH ' ' A' ' 78' ' ' TYR . . . 159.13 -102.35 0.21 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.733 -1.347 . . . . 40.0 109.733 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 35.4 t80 -140.81 -167.55 2.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.638 -0.919 . . . . 40.0 109.895 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.639 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.3 mtm180 -74.19 -157.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.179 -0.95 . . . . 40.0 110.147 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.566 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 11.4 p30 -164.59 -149.25 0.12 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.939 -1.134 . . . . 40.0 107.939 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 100' ' ' THR . 64.1 p -103.94 -9.07 19.18 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.809 -1.182 . . . . 40.0 109.409 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.479 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -85.67 113.77 22.13 Favored 'General case' 0 N--CA 1.509 2.481 0 CA-C-O 121.787 0.803 . . . . 40.0 111.688 -179.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.856 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.43 150.22 46.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.986 -1.071 . . . . 40.0 110.617 179.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.78 ' CG2' HD11 ' A' ' 76' ' ' ILE . 7.3 tt -116.4 140.78 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-O 122.131 0.967 . . . . 40.0 109.833 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.581 HD13 ' O ' ' A' ' 72' ' ' ARG . 3.0 mm? -119.24 125.99 50.44 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.361 -0.978 . . . . 40.0 108.361 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.666 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -119.89 129.4 54.35 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.824 -0.806 . . . . 40.0 108.824 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.718 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 2.9 p -94.1 157.8 15.91 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 122.297 1.046 . . . . 40.0 112.448 -178.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.7 p -68.41 -17.49 64.23 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.559 -0.904 . . . . 40.0 108.559 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.491 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -85.82 8.54 19.66 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.567 -0.853 . . . . 40.0 109.482 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.466 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.9 25.39 0.5 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.611 -0.68 . . . . 40.0 110.496 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.5 mt -95.71 138.02 33.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.135 -0.978 . . . . 40.0 109.108 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.479 ' CG2' HD11 ' A' ' 109' ' ' ILE . 43.1 mm -112.04 121.16 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.587 -0.696 . . . . 40.0 110.417 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.414 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.5 m-85 -122.98 144.95 48.9 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 120.245 -0.582 . . . . 40.0 109.496 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.479 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 5.3 tptp -133.7 145.71 50.14 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.083 -1.011 . . . . 40.0 110.84 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.484 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.2 t -125.89 168.36 13.98 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.761 -0.829 . . . . 40.0 108.761 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.496 ' O ' ' OG ' ' A' ' 85' ' ' SER . 71.2 p -141.79 -8.15 0.95 Allowed 'General case' 0 N--CA 1.51 2.544 0 O-C-N 121.21 -0.931 . . . . 40.0 109.717 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.677 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -108.81 16.63 22.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.125 -0.984 . . . . 40.0 110.104 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 81.85 61.18 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.221 0.534 . . . . 40.0 110.217 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.667 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 31.5 m-85 71.41 -20.43 0.23 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.577 -0.702 . . . . 40.0 110.87 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.413 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.6 mt-30 -45.2 -74.34 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.024 -1.047 . . . . 40.0 110.001 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.536 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 23.6 p -104.59 164.02 12.05 Favored 'General case' 0 C--O 1.194 -1.829 0 O-C-N 120.901 -1.124 . . . . 40.0 108.115 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.573 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -137.9 139.68 39.95 Favored 'General case' 0 C--N 1.273 -2.753 0 O-C-N 121.351 -0.843 . . . . 40.0 109.932 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 30.5 m -126.73 137.01 53.19 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.156 -1.053 . . . . 40.0 108.156 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.6 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 14.9 tttp -83.87 146.05 28.29 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.837 -1.164 . . . . 40.0 109.679 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.479 HD11 ' CG2' ' A' ' 96' ' ' ILE . 14.5 pt -121.75 -33.77 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.283 -0.885 . . . . 40.0 109.043 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.643 HH21 ' CG ' ' A' ' 8' ' ' ASP . 72.2 mtt180 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 118.173 -0.918 . . . . 40.0 108.993 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.658 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 17.6 t . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 109.389 -0.596 . . . . 40.0 109.389 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 tt -176.4 152.64 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.27 -0.894 . . . . 40.0 109.169 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -142.71 24.16 1.89 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.805 -1.185 . . . . 40.0 111.215 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 10' ' ' VAL . 10.9 p -105.74 153.16 22.25 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.679 0.752 . . . . 40.0 110.172 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.491 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -55.96 -63.11 1.29 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.036 -1.04 . . . . 40.0 111.052 -178.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.631 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -58.56 -41.08 84.81 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.506 -0.746 . . . . 40.0 109.745 -179.35 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.35 -45.14 89.39 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.712 -1.355 . . . . 40.0 109.712 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.54 HG22 ' HG2' ' A' ' 21' ' ' PRO . 71.1 t -67.39 -43.68 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.578 -0.954 . . . . 40.0 108.787 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.508 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -59.94 -59.15 5.88 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.947 -0.76 . . . . 40.0 108.947 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.24 -56.74 8.37 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.951 -0.759 . . . . 40.0 108.951 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.733 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 39.9 t80 -52.3 -51.96 55.63 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.048 0.451 . . . . 40.0 110.441 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 18' ' ' HIS . 2.2 tt -72.04 -52.58 16.24 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.64 -0.663 . . . . 40.0 111.056 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 11' ' ' ALA . 63.7 mt-30 -51.59 -27.25 10.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.23 -1.544 . . . . 40.0 110.721 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 m -92.35 -49.84 5.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.585 -1.322 . . . . 40.0 111.347 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 19' ' ' LYS . 92.7 m-85 -100.85 16.0 26.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.845 -1.159 . . . . 40.0 110.114 -177.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 14' ' ' LEU . 25.1 m80 41.43 24.25 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.8 -0.563 . . . . 40.0 110.976 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 17' ' ' TYR . 3.6 pttp -135.48 158.78 43.51 Favored 'General case' 0 C--O 1.178 -2.7 0 O-C-N 121.177 -0.952 . . . . 40.0 110.771 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mp -79.25 144.28 62.13 Favored Pre-proline 0 C--N 1.271 -2.847 0 O-C-N 120.9 -1.125 . . . . 40.0 108.88 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.733 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 81.8 Cg_exo -38.73 155.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.003 0 C-N-CA 123.803 3.002 . . . . 40.0 114.433 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.658 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -67.61 50.11 0.05 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.283 1.039 . . . . 40.0 109.253 -179.51 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.531 ' HA ' ' HD3' ' A' ' 49' ' ' LYS . 0.8 OUTLIER -173.86 26.24 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.129 -0.982 . . . . 40.0 110.552 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -120.21 111.92 18.42 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.294 -1.504 . . . . 40.0 110.122 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.428 HG21 HD13 ' A' ' 25' ' ' ILE . 23.0 pt -118.28 138.22 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.248 -1.019 . . . . 40.0 108.248 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.769 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -72.4 168.93 17.42 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 123.372 1.558 . . . . 40.0 113.357 -178.283 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.509 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 24.3 mtmt -60.66 -39.38 88.14 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 105.801 -1.925 . . . . 40.0 105.801 176.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.53 ' OG ' ' OG1' ' A' ' 26' ' ' THR . 1.1 m -36.37 -70.86 0.08 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.749 -0.834 . . . . 40.0 108.749 176.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.56 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.7 mp0 -64.22 -55.43 21.69 Favored 'General case' 0 C--O 1.201 -1.473 0 N-CA-C 106.098 -1.815 . . . . 40.0 106.098 -176.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.56 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -35.44 -51.87 0.62 Allowed 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 118.562 -1.255 . . . . 40.0 109.573 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -55.45 -68.43 0.2 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.992 -1.067 . . . . 40.0 111.67 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.37 -24.31 54.54 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.263 -0.898 . . . . 40.0 111.141 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.7 tp -69.88 -21.2 63.35 Favored 'General case' 0 N--CA 1.509 2.475 0 N-CA-C 106.878 -1.527 . . . . 40.0 106.878 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.7 43.61 0.53 Allowed Glycine 0 N--CA 1.504 3.184 0 N-CA-C 111.523 -0.631 . . . . 40.0 111.523 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.54 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -77.88 138.97 39.2 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.725 -1.456 . . . . 40.0 109.531 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.9 t -135.7 130.33 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.685 0 O-C-N 121.154 -0.966 . . . . 40.0 109.302 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.48 -46.74 86.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.832 -0.543 . . . . 40.0 110.014 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.5 p -71.45 44.01 0.09 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.431 0.634 . . . . 40.0 110.644 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.585 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 ttpm? -177.43 -50.5 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.495 -0.753 . . . . 40.0 109.174 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.18 59.26 9.24 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 108.934 -1.666 . . . . 40.0 108.934 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.585 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.82 160.87 30.14 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 121.453 -1.028 . . . . 40.0 110.641 -177.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.872 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 57.1 tp -173.32 -69.5 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.999 -1.063 . . . . 40.0 110.385 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.554 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.07 -23.0 63.43 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 120.947 -1.096 . . . . 40.0 110.028 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.4 p-10 -73.28 -64.89 0.89 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.702 0.763 . . . . 40.0 109.218 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.431 HG13 ' OD2' ' A' ' 44' ' ' ASP . 28.7 m -76.78 -15.17 14.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 109.205 -0.665 . . . . 40.0 109.205 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.584 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -144.22 71.34 16.29 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.501 -0.749 . . . . 40.0 110.16 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.04 117.16 3.8 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 123.375 2.717 . . . . 40.0 113.788 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.61 37.73 52.13 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.167 -1.573 . . . . 40.0 109.167 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.584 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 8.5 mmtm -135.2 162.3 32.92 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 108.856 -0.794 . . . . 40.0 108.856 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.448 ' HA ' HD21 ' A' ' 42' ' ' LEU . 65.7 m -138.22 166.55 23.9 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.326 1.06 . . . . 40.0 110.594 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 18.7 mm -84.1 124.11 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-N 115.876 -0.602 . . . . 40.0 111.508 -179.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 178.08 159.67 23.18 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.506 -1.438 . . . . 40.0 109.506 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.769 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 115.75 -7.17 19.94 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.623 -1.275 . . . . 40.0 110.92 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.441 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 5.2 m-20 -76.02 -152.26 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.381 -1.658 . . . . 40.0 110.072 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.7 mp -131.12 143.85 39.54 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.016 0 N-CA-C 108.327 -0.99 . . . . 40.0 108.327 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.636 ' O ' ' N ' ' A' ' 58' ' ' ASN . 13.7 t80 -113.51 90.97 3.48 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.217 -0.927 . . . . 40.0 108.78 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.653 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.6 p -59.07 38.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.705 0.764 . . . . 40.0 110.735 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.636 ' N ' ' O ' ' A' ' 56' ' ' PHE . 43.5 t30 34.67 38.57 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.293 -0.88 . . . . 40.0 110.671 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.653 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.8 mtm180 -69.91 36.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -0.94 . . . . 40.0 110.483 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.608 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 14.6 mt-10 -145.36 -4.82 0.68 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.135 -0.978 . . . . 40.0 110.332 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.65 36.97 66.32 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 109.635 -1.386 . . . . 40.0 109.635 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.608 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 5.1 mttp -120.36 12.3 11.65 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.575 -0.956 . . . . 40.0 109.502 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.422 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -136.4 142.93 41.35 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.564 -0.71 . . . . 40.0 109.36 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -61.75 122.72 11.41 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.392 2.061 . . . . 40.0 112.344 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.513 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -101.18 -178.27 28.92 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 110.535 -1.026 . . . . 40.0 110.535 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 8.9 tttt -177.6 152.75 0.83 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.138 -1.213 . . . . 40.0 108.267 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.4 p -72.07 53.62 0.27 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.841 -1.162 . . . . 40.0 109.258 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.401 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 151.26 80.34 0.03 OUTLIER Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.826 -1.31 . . . . 40.0 109.826 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.559 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.96 177.31 2.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.533 -0.981 . . . . 40.0 109.037 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.559 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 90.1 m -154.75 154.92 33.59 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.124 -0.985 . . . . 40.0 110.043 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.713 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 30.0 m95 -124.14 139.86 53.52 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.384 0.612 . . . . 40.0 109.671 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.638 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.52 149.83 52.01 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 120.794 -1.191 . . . . 40.0 109.897 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.509 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -116.19 167.69 10.78 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.068 -1.02 . . . . 40.0 112.006 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -162.9 138.57 6.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.653 -0.654 . . . . 40.0 111.351 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.741 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -59.6 154.22 18.12 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.656 -0.652 . . . . 40.0 110.934 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.741 HD13 ' O ' ' A' ' 75' ' ' ASP . 42.7 mm -137.43 145.87 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.499 -0.75 . . . . 40.0 110.394 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 57.38 70.08 0.68 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.483 0.659 . . . . 40.0 110.524 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.872 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 70.2 t80 -131.86 155.65 47.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.039 -1.038 . . . . 40.0 110.112 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.609 ' OG1' ' N ' ' A' ' 80' ' ' SER . 19.2 p -136.64 -73.34 0.44 Allowed 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.124 0.488 . . . . 40.0 110.202 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.609 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -153.01 106.47 3.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.554 -0.716 . . . . 40.0 109.416 -178.466 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.93 -104.32 0.24 Allowed Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.747 -1.341 . . . . 40.0 109.747 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.481 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 47.2 t80 -139.94 -167.01 2.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 122.013 -0.698 . . . . 40.0 109.382 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.638 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.1 mtm180 -73.12 -154.34 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.166 -0.959 . . . . 40.0 110.075 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.555 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 11.6 p30 -168.05 -150.24 0.1 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.262 -1.014 . . . . 40.0 108.262 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.516 ' OG ' ' O ' ' A' ' 100' ' ' THR . 71.6 p -103.3 -8.0 20.66 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.64 -1.288 . . . . 40.0 109.313 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.521 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.6 114.15 23.95 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-O 122.063 0.935 . . . . 40.0 111.473 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.858 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.28 151.0 47.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.871 -1.143 . . . . 40.0 110.426 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.675 ' CG2' HD11 ' A' ' 76' ' ' ILE . 5.7 tt -117.99 136.71 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.794 0.807 . . . . 40.0 109.825 178.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.536 HD13 ' O ' ' A' ' 72' ' ' ARG . 3.1 mm? -115.84 125.16 52.3 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.798 -0.815 . . . . 40.0 108.798 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.682 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.94 129.53 55.22 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.077 0.942 . . . . 40.0 108.997 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.713 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 3.7 p -94.65 158.9 15.32 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 122.41 1.1 . . . . 40.0 112.504 -177.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.7 p -68.59 -18.14 64.27 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.234 -1.025 . . . . 40.0 108.234 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.502 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -86.32 9.17 18.66 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.666 -0.646 . . . . 40.0 109.647 179.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.462 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.76 26.48 0.64 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.661 -0.649 . . . . 40.0 110.361 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.9 mt -95.99 137.47 35.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.118 -0.989 . . . . 40.0 109.093 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.516 ' CG2' HD11 ' A' ' 109' ' ' ILE . 40.2 mm -111.77 119.15 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.634 -0.666 . . . . 40.0 110.564 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.434 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 8.0 m-85 -121.83 144.32 48.9 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.357 -0.537 . . . . 40.0 109.766 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.521 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 4.8 tptp -133.25 144.5 49.8 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.372 -0.83 . . . . 40.0 110.849 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.616 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.9 t -123.12 166.69 14.76 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 108.84 -0.8 . . . . 40.0 108.84 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.516 ' O ' ' OG ' ' A' ' 85' ' ' SER . 45.0 p -140.29 -10.31 1.1 Allowed 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.556 -0.715 . . . . 40.0 109.672 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.69 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -107.75 12.7 27.15 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.007 -1.058 . . . . 40.0 110.203 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 84.97 61.82 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.404 0.621 . . . . 40.0 110.305 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.638 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 23.2 m-85 71.62 -21.9 0.21 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.446 -0.784 . . . . 40.0 110.812 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.417 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.9 mt-30 -44.37 -73.41 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.091 -1.006 . . . . 40.0 109.932 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.512 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 22.0 p -106.07 166.4 10.53 Favored 'General case' 0 C--O 1.193 -1.9 0 N-CA-C 107.763 -1.199 . . . . 40.0 107.763 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.529 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -140.06 139.16 35.86 Favored 'General case' 0 C--N 1.27 -2.887 0 O-C-N 121.065 -1.022 . . . . 40.0 109.779 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.1 m -124.65 136.35 53.85 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.355 -0.98 . . . . 40.0 108.355 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.529 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 19.3 tttp -84.95 145.54 27.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.779 -1.201 . . . . 40.0 109.652 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.516 HD11 ' CG2' ' A' ' 96' ' ' ILE . 12.8 pt -120.71 -34.42 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.884 -1.135 . . . . 40.0 109.318 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.631 HH21 ' CG ' ' A' ' 8' ' ' ASP . 78.7 mtt180 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.081 -1.012 . . . . 40.0 108.769 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.628 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 17.0 t . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.319 -0.623 . . . . 40.0 109.319 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -178.27 151.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.393 -0.817 . . . . 40.0 109.587 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -142.53 23.96 1.93 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.16 -0.963 . . . . 40.0 111.684 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 10' ' ' VAL . 18.6 p -105.85 153.98 21.17 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.981 0.896 . . . . 40.0 110.456 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -56.39 -64.48 0.85 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.617 -1.302 . . . . 40.0 110.833 -179.288 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.615 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -56.84 -41.43 77.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.05 -1.032 . . . . 40.0 110.034 -179.294 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.21 -44.99 84.17 Favored Glycine 0 N--CA 1.504 3.181 0 N-CA-C 110.164 -1.174 . . . . 40.0 110.164 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.585 HG22 ' HG2' ' A' ' 21' ' ' PRO . 69.5 t -68.77 -42.49 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.587 -0.949 . . . . 40.0 108.798 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.35 -59.38 5.49 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.489 -0.93 . . . . 40.0 108.489 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.23 -56.77 8.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.55 -0.719 . . . . 40.0 109.334 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.75 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 40.8 t80 -52.74 -51.41 60.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.915 -0.491 . . . . 40.0 110.353 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 18' ' ' HIS . 4.0 tt -72.36 -51.4 20.71 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.7 -0.625 . . . . 40.0 110.945 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 11' ' ' ALA . 57.3 mt-30 -52.39 -28.36 19.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.051 -1.655 . . . . 40.0 110.129 179.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 m -91.53 -51.28 5.34 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.781 -1.2 . . . . 40.0 111.249 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -99.04 12.8 34.96 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.29 -0.881 . . . . 40.0 110.258 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 14' ' ' LEU . 20.7 m80 42.47 25.67 0.05 OUTLIER 'General case' 0 N--CA 1.516 2.856 0 O-C-N 121.477 -0.764 . . . . 40.0 110.92 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.9 pttp -136.63 158.61 44.03 Favored 'General case' 0 C--O 1.184 -2.367 0 CA-C-O 121.916 0.865 . . . . 40.0 110.188 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mp -78.31 147.83 73.12 Favored Pre-proline 0 C--N 1.265 -3.093 0 O-C-N 120.659 -1.275 . . . . 40.0 108.684 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.75 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 83.3 Cg_exo -41.47 156.09 0.07 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 123.272 2.648 . . . . 40.0 114.102 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.628 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -67.07 49.49 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.124 0.964 . . . . 40.0 109.48 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -173.67 26.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.902 . . . . 40.0 110.701 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -118.19 109.75 16.74 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.76 -1.213 . . . . 40.0 110.487 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 25' ' ' ILE . 15.4 pt -119.07 132.88 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.169 -1.049 . . . . 40.0 108.169 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.868 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.4 OUTLIER -69.48 173.35 6.03 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-O 124.24 1.972 . . . . 40.0 113.443 -177.395 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.651 ' HB3' ' NE2' ' A' ' 31' ' ' GLN . 14.6 mtmt -62.53 -40.12 95.75 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.266 -1.753 . . . . 40.0 106.266 177.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.511 ' OG ' ' OG1' ' A' ' 26' ' ' THR . 2.9 m -32.97 -74.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 123.028 1.394 . . . . 40.0 109.666 174.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.501 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.4 mp0 -63.13 -56.47 16.49 Favored 'General case' 0 C--O 1.2 -1.509 0 CA-C-N 114.392 -1.277 . . . . 40.0 108.041 -177.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -38.26 -51.64 1.48 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.956 -1.09 . . . . 40.0 109.918 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.651 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 24.1 mt-30 -56.85 -64.63 0.81 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.676 -1.265 . . . . 40.0 110.351 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.47 -25.29 64.29 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.113 -0.992 . . . . 40.0 109.471 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.1 tp -65.66 -24.52 67.04 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.729 -0.841 . . . . 40.0 108.729 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.11 48.22 0.29 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.243 -1.143 . . . . 40.0 110.243 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.579 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -85.72 137.47 32.79 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.461 -1.023 . . . . 40.0 109.906 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.5 t -134.16 131.41 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.705 0 O-C-N 121.49 -0.756 . . . . 40.0 109.956 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.64 -47.92 82.77 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.743 -0.836 . . . . 40.0 108.743 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.1 p -69.87 43.64 0.06 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.627 -0.67 . . . . 40.0 110.907 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.499 ' HZ3' ' CG ' ' A' ' 41' ' ' ASN . 1.1 ttpm? -176.8 -49.83 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.314 -0.866 . . . . 40.0 109.13 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.17 59.7 9.11 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 108.349 -1.9 . . . . 40.0 108.349 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.579 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -76.57 159.84 29.96 Favored 'General case' 0 C--N 1.29 -2.004 0 O-C-N 121.654 -0.909 . . . . 40.0 110.833 -177.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.816 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 56.1 tp -173.92 -68.32 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.53 -0.868 . . . . 40.0 111.04 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.6 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.64 -22.08 63.44 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.812 -1.18 . . . . 40.0 109.36 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.5 p-10 -74.64 -62.3 1.58 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.13 -0.693 . . . . 40.0 109.13 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.4 m -78.56 -13.52 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 N-CA-C 109.122 -0.696 . . . . 40.0 109.122 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -147.12 72.57 12.14 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.637 -0.664 . . . . 40.0 110.058 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -56.7 118.58 5.45 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 123.178 2.586 . . . . 40.0 113.911 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.37 39.64 56.69 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.69 -1.364 . . . . 40.0 109.69 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.445 ' NZ ' ' HB3' ' A' ' 23' ' ' ASN . 7.2 mmtm -134.39 168.89 18.09 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.859 0.838 . . . . 40.0 109.829 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.7 m -144.39 160.83 40.4 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 120.827 -1.171 . . . . 40.0 111.381 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.3 mm -81.25 123.04 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-N 115.437 -0.801 . . . . 40.0 110.557 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . 177.16 154.56 12.2 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.555 -1.418 . . . . 40.0 109.555 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.868 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 120.54 -13.55 10.08 Favored Glycine 0 N--CA 1.497 2.713 0 C-N-CA 119.162 -1.494 . . . . 40.0 111.236 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.47 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 4.3 m-20 -71.41 -152.0 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.747 0 O-C-N 121.202 -1.176 . . . . 40.0 109.781 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.37 142.63 42.84 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 CA-C-N 115.256 -0.884 . . . . 40.0 109.236 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.652 ' O ' ' N ' ' A' ' 58' ' ' ASN . 11.1 t80 -111.17 89.76 3.14 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.347 -0.845 . . . . 40.0 109.696 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.669 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.9 p -58.71 38.38 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.921 0.867 . . . . 40.0 110.774 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.652 ' N ' ' O ' ' A' ' 56' ' ' PHE . 40.8 t30 33.66 40.01 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.275 -0.89 . . . . 40.0 110.484 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.669 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 11.4 mtm180 -70.85 37.23 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.957 -1.089 . . . . 40.0 110.056 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.606 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 14.1 mt-10 -146.6 -1.05 0.72 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.998 -1.064 . . . . 40.0 110.29 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 51.11 39.42 41.65 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.681 -1.368 . . . . 40.0 109.681 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.606 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 3.5 mttp -121.68 12.34 10.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.657 -0.908 . . . . 40.0 109.366 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.47 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.5 mt -137.33 143.62 42.18 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.66 -0.65 . . . . 40.0 109.541 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.38 122.68 11.46 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.296 1.997 . . . . 40.0 112.137 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.525 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.98 -177.29 26.69 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.866 -1.293 . . . . 40.0 109.866 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.415 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 8.0 tttt -177.94 154.73 0.92 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 107.871 -1.159 . . . . 40.0 107.871 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.2 p -73.2 55.47 0.44 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.995 -1.066 . . . . 40.0 109.172 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.98 81.4 0.04 OUTLIER Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.753 -1.339 . . . . 40.0 109.753 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.559 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.31 178.29 2.06 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.493 -1.004 . . . . 40.0 108.713 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.559 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 92.4 m -155.24 153.01 29.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.017 -1.052 . . . . 40.0 109.921 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.717 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 28.8 m95 -122.7 140.38 52.93 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.194 0.521 . . . . 40.0 110.006 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.613 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -131.42 147.11 52.53 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 120.96 -1.087 . . . . 40.0 110.392 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.565 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -111.84 168.2 9.76 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.979 -1.076 . . . . 40.0 112.278 -179.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.431 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . . . -163.76 139.75 6.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.241 -0.912 . . . . 40.0 110.225 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.732 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -61.29 154.71 23.0 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 120.976 0.417 . . . . 40.0 110.576 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.732 HD13 ' O ' ' A' ' 75' ' ' ASP . 32.6 mm -138.11 146.01 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.587 -0.696 . . . . 40.0 110.325 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 56.4 71.05 0.59 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.582 0.706 . . . . 40.0 110.839 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.816 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 67.7 t80 -132.45 156.66 46.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 40.0 109.471 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.596 ' OG1' ' N ' ' A' ' 80' ' ' SER . 21.4 p -137.97 -72.44 0.42 Allowed 'General case' 0 N--CA 1.511 2.614 0 CA-C-O 121.44 0.638 . . . . 40.0 109.491 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.6 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -152.99 105.69 2.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.653 -0.654 . . . . 40.0 109.57 -178.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.06 -103.96 0.23 Allowed Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.467 -1.349 . . . . 40.0 110.156 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 49.2 t80 -142.16 -167.55 2.5 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.53 -0.915 . . . . 40.0 108.53 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.659 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.3 mtm180 -72.9 -156.48 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.04 -1.038 . . . . 40.0 110.398 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.501 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 10.1 p30 -165.67 -149.38 0.11 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.132 -1.062 . . . . 40.0 108.132 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.512 ' OG ' ' O ' ' A' ' 100' ' ' THR . 60.3 p -104.14 -7.46 20.16 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 120.804 -1.185 . . . . 40.0 109.252 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.509 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.97 113.09 23.28 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-O 121.898 0.856 . . . . 40.0 111.642 -179.263 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.86 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.44 150.06 46.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.055 -1.028 . . . . 40.0 110.391 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.675 ' CG2' HD11 ' A' ' 76' ' ' ILE . 5.1 tt -116.69 141.51 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 122.404 1.097 . . . . 40.0 109.777 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.584 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.8 mm? -121.02 124.42 44.8 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.294 -1.002 . . . . 40.0 108.294 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.679 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.15 129.38 55.49 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.82 0.819 . . . . 40.0 108.816 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.717 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.2 p -93.56 159.99 14.99 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 122.322 1.058 . . . . 40.0 112.467 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.4 p -70.04 -18.11 63.28 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.241 -1.022 . . . . 40.0 108.241 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.463 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -86.15 8.69 19.96 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.052 -0.659 . . . . 40.0 109.498 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.447 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.88 26.79 0.6 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.497 -0.752 . . . . 40.0 109.955 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.441 HD12 HH21 ' A' ' 69' ' ' ARG . 27.1 mt -94.94 137.2 34.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.121 -0.987 . . . . 40.0 108.471 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.52 ' CG2' HD11 ' A' ' 109' ' ' ILE . 37.2 mm -112.15 119.84 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.533 -0.73 . . . . 40.0 110.338 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -122.2 144.74 48.78 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.935 -0.706 . . . . 40.0 109.663 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.509 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 3.7 tptp -133.66 145.04 49.59 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.109 -0.995 . . . . 40.0 110.87 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.531 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.5 t -124.01 167.12 14.6 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 109.02 -0.733 . . . . 40.0 109.02 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.512 ' O ' ' OG ' ' A' ' 85' ' ' SER . 38.7 p -140.47 -9.43 1.09 Allowed 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.213 -0.93 . . . . 40.0 109.922 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.68 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -108.16 13.27 26.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 40.0 109.997 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 84.36 62.08 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.263 0.554 . . . . 40.0 110.308 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.659 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 22.7 m-85 70.61 -20.64 0.2 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.722 -0.611 . . . . 40.0 110.864 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.7 mt-30 -44.07 -73.7 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.162 -0.961 . . . . 40.0 109.472 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.477 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 22.0 p -106.25 167.88 9.52 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 107.316 -1.364 . . . . 40.0 107.316 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.584 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -140.32 140.12 35.57 Favored 'General case' 0 C--N 1.268 -2.966 0 O-C-N 121.645 -0.66 . . . . 40.0 109.866 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.2 m -125.14 135.75 52.94 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.267 -1.012 . . . . 40.0 108.267 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.612 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 19.3 tttp -84.56 145.91 27.82 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.801 -1.187 . . . . 40.0 109.619 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.52 HD11 ' CG2' ' A' ' 96' ' ' ILE . 15.1 pt -121.03 -35.01 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.445 -0.785 . . . . 40.0 109.476 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.615 HH21 ' CG ' ' A' ' 8' ' ' ASP . 78.9 mtt180 . . . . . 0 N--CA 1.488 1.474 0 O-C-N 121.169 -0.957 . . . . 40.0 109.091 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.607 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 12.8 t . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 109.786 -0.45 . . . . 40.0 109.786 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -175.01 153.55 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 109.375 -0.602 . . . . 40.0 109.375 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -144.58 24.68 1.54 Allowed 'General case' 0 N--CA 1.484 1.23 0 O-C-N 120.853 -1.154 . . . . 40.0 110.36 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 10' ' ' VAL . 14.9 p -105.95 152.34 23.45 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.792 0.806 . . . . 40.0 109.541 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.493 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -55.24 -65.1 0.65 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.987 -1.071 . . . . 40.0 110.922 -178.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.595 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.7 OUTLIER -56.71 -41.75 77.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.344 -0.847 . . . . 40.0 110.304 -179.286 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.96 -44.87 87.8 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.255 -1.538 . . . . 40.0 109.255 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.559 HG22 ' HG2' ' A' ' 21' ' ' PRO . 72.1 t -67.48 -42.42 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.837 -0.801 . . . . 40.0 108.879 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -61.65 -57.66 11.14 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.553 -0.717 . . . . 40.0 109.212 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.25 -56.64 8.71 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.615 0.722 . . . . 40.0 109.186 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.734 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 41.7 t80 -53.31 -52.49 58.96 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.147 0.499 . . . . 40.0 110.677 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 18' ' ' HIS . 1.2 tt -71.98 -51.61 21.07 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.594 -0.692 . . . . 40.0 110.132 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 11' ' ' ALA . 63.1 mt-30 -51.25 -29.43 14.46 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.278 -1.514 . . . . 40.0 110.273 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m -90.04 -50.77 5.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.841 -1.162 . . . . 40.0 111.627 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 19' ' ' LYS . 87.7 m-85 -99.88 14.81 29.14 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.386 -0.821 . . . . 40.0 109.874 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 14' ' ' LEU . 19.9 m80 41.82 24.01 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.532 0 CA-C-O 121.407 0.622 . . . . 40.0 111.141 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 17' ' ' TYR . 4.4 pttp -134.31 158.66 43.22 Favored 'General case' 0 C--O 1.184 -2.373 0 O-C-N 121.305 -0.872 . . . . 40.0 109.939 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.28 145.06 63.55 Favored Pre-proline 0 C--N 1.263 -3.173 0 O-C-N 120.945 -1.097 . . . . 40.0 109.554 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.734 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 82.3 Cg_exo -37.94 155.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.512 2.578 0 C-N-CA 123.473 2.782 . . . . 40.0 114.7 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.607 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -67.73 50.37 0.05 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.138 -0.976 . . . . 40.0 108.964 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -174.94 24.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 118.952 -1.099 . . . . 40.0 110.764 -179.42 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.411 ' OH ' ' O ' ' A' ' 75' ' ' ASP . 3.5 m-85 -118.26 109.78 16.74 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.981 0.896 . . . . 40.0 110.332 -178.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 25' ' ' ILE . 12.5 pt -118.47 134.13 63.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.931 -1.137 . . . . 40.0 107.931 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.84 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.3 OUTLIER -70.32 173.43 6.81 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 124.092 1.901 . . . . 40.0 113.371 -177.339 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HE2' ' OD1' ' A' ' 54' ' ' ASP . 16.8 mtmt -63.29 -35.83 81.67 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 106.648 -1.612 . . . . 40.0 106.648 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.511 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 5.1 m -37.54 -70.24 0.1 Allowed 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 122.28 1.038 . . . . 40.0 108.962 175.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.476 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.2 mp0 -68.1 -50.0 57.62 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.988 -1.115 . . . . 40.0 107.988 -178.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.476 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -43.18 -49.4 6.49 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.263 -1.375 . . . . 40.0 108.888 177.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.423 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 34.3 mt-30 -59.68 -62.08 2.14 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.275 -0.891 . . . . 40.0 111.454 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.01 -24.15 66.87 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.219 -0.925 . . . . 40.0 109.118 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.2 tp -68.1 -21.57 64.95 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.236 -0.986 . . . . 40.0 108.596 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.35 43.75 0.46 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.266 -1.133 . . . . 40.0 110.266 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.542 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -80.96 143.22 32.74 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.034 -1.274 . . . . 40.0 109.38 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.9 t -140.99 131.54 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.755 0 O-C-N 120.969 -1.082 . . . . 40.0 109.217 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.25 -48.78 79.36 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.913 -0.492 . . . . 40.0 110.342 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.3 p -70.82 45.63 0.09 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.158 -0.963 . . . . 40.0 110.263 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.482 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 ttpm? -177.07 -51.43 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.892 -0.781 . . . . 40.0 108.892 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.7 58.93 10.18 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 108.202 -1.959 . . . . 40.0 108.202 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.542 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -75.56 159.52 31.16 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.77 -0.841 . . . . 40.0 110.288 -177.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.733 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 59.4 tp -173.76 -66.75 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.232 -0.987 . . . . 40.0 110.538 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.62 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -61.68 -19.91 62.86 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.03 -1.044 . . . . 40.0 109.935 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.7 p-10 -78.11 -61.34 2.03 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.681 -0.859 . . . . 40.0 108.681 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.1 m -78.74 -10.17 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.412 0 O-C-N 121.644 -0.66 . . . . 40.0 110.088 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -150.37 71.54 9.15 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.393 -0.817 . . . . 40.0 109.838 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.96 117.5 4.2 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 123.649 2.899 . . . . 40.0 113.135 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.81 37.89 43.54 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.081 -1.208 . . . . 40.0 110.081 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.497 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 7.3 mmtm -134.99 173.6 11.54 Favored 'General case' 0 N--CA 1.511 2.585 0 CA-C-O 121.72 0.771 . . . . 40.0 110.537 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.0 m -147.54 162.76 38.42 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.954 -1.091 . . . . 40.0 112.013 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.6 mm -82.72 124.23 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 115.26 -0.882 . . . . 40.0 110.643 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.55 157.56 17.15 Favored Glycine 0 N--CA 1.5 2.927 0 N-CA-C 109.64 -1.384 . . . . 40.0 109.64 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.84 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 117.63 -9.83 14.5 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 118.938 -1.601 . . . . 40.0 110.107 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.458 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 5.3 m-20 -75.69 -151.97 0.04 OUTLIER 'General case' 0 C--O 1.193 -1.897 0 O-C-N 120.8 -1.412 . . . . 40.0 109.853 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.4 mp -130.68 142.39 43.8 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 CA-C-N 115.102 -0.954 . . . . 40.0 108.679 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.613 ' O ' ' N ' ' A' ' 58' ' ' ASN . 12.9 t80 -110.3 90.96 3.47 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.095 -0.706 . . . . 40.0 109.095 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.659 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.9 p -60.3 38.74 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.457 -0.777 . . . . 40.0 110.705 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.613 ' N ' ' O ' ' A' ' 56' ' ' PHE . 45.6 t30 33.89 38.95 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.13 -0.981 . . . . 40.0 110.721 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.659 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.5 mtm180 -69.34 35.52 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.119 -0.988 . . . . 40.0 110.086 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.628 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 15.1 mt-10 -144.86 -3.74 0.77 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.052 -1.03 . . . . 40.0 110.348 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.421 ' HA2' HD21 ' A' ' 58' ' ' ASN . . . 54.16 37.91 60.09 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.275 -1.53 . . . . 40.0 109.275 -178.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.628 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 5.0 mttp -120.32 11.66 11.54 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.537 -0.978 . . . . 40.0 109.778 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.453 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -136.88 143.98 44.72 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 109.389 -0.597 . . . . 40.0 109.389 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.83 124.64 14.91 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.605 2.203 . . . . 40.0 112.267 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.526 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -104.33 -178.75 25.1 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.076 -1.21 . . . . 40.0 110.076 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.438 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 9.5 tttt -177.16 152.57 0.89 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.363 -1.08 . . . . 40.0 108.435 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.6 p -71.3 53.41 0.19 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.304 -1.497 . . . . 40.0 109.438 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.48 80.16 0.03 OUTLIER Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.084 -1.206 . . . . 40.0 110.084 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.577 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -175.36 178.83 1.6 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.706 -0.879 . . . . 40.0 108.864 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.577 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 87.1 m -155.52 155.98 34.38 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.331 -0.947 . . . . 40.0 109.83 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.697 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 27.5 m95 -124.91 140.01 53.31 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.78 -0.452 . . . . 40.0 109.78 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.635 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.64 149.55 52.25 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.738 -1.226 . . . . 40.0 109.685 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.52 ' O ' ' OH ' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -115.79 168.82 9.71 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 122.283 1.04 . . . . 40.0 112.304 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.13 138.5 4.66 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.846 -0.615 . . . . 40.0 111.11 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.724 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -60.41 154.79 19.64 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.453 0.644 . . . . 40.0 111.091 179.495 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.724 HD13 ' O ' ' A' ' 75' ' ' ASP . 40.2 mm -137.82 145.19 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 119.962 -0.695 . . . . 40.0 110.596 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 57.83 68.4 0.85 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.738 -0.601 . . . . 40.0 110.697 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.733 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 61.0 t80 -129.84 157.2 42.9 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.097 -1.002 . . . . 40.0 109.867 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.541 ' OG1' ' N ' ' A' ' 80' ' ' SER . 24.2 p -137.31 -71.07 0.44 Allowed 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.517 -0.739 . . . . 40.0 109.718 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.62 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -153.68 107.15 2.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.6 -0.687 . . . . 40.0 109.388 -178.344 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.28 -107.22 0.31 Allowed Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.667 -1.254 . . . . 40.0 110.191 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.477 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 41.6 t80 -137.29 -166.73 1.98 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.772 -0.84 . . . . 40.0 109.355 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.664 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.8 mtm180 -73.99 -155.5 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.805 -1.184 . . . . 40.0 109.643 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -166.52 -150.75 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.888 -1.153 . . . . 40.0 107.888 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' A' ' 100' ' ' THR . 60.1 p -102.32 -7.49 22.02 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.004 -1.06 . . . . 40.0 109.539 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.536 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.67 113.88 23.76 Favored 'General case' 0 N--CA 1.509 2.505 0 CA-C-O 121.89 0.852 . . . . 40.0 111.552 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.857 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.35 148.55 43.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.951 -1.093 . . . . 40.0 110.84 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.662 ' CG2' HD11 ' A' ' 76' ' ' ILE . 5.5 tt -114.72 140.06 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-O 122.144 0.973 . . . . 40.0 110.158 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.541 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 3.1 mm? -118.77 125.13 48.92 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.609 -0.886 . . . . 40.0 108.609 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.672 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -119.52 129.41 54.68 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.594 0.711 . . . . 40.0 109.203 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.697 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.7 p -93.93 160.14 14.86 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.668 1.223 . . . . 40.0 112.797 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.1 p -69.92 -17.03 63.31 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.138 -1.06 . . . . 40.0 108.138 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.474 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -88.19 10.03 20.87 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 119.773 -0.771 . . . . 40.0 109.686 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.458 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.6 27.36 0.62 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.765 -0.585 . . . . 40.0 110.259 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.0 mt -96.48 136.93 36.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.273 -0.892 . . . . 40.0 109.061 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.508 ' CG2' HD11 ' A' ' 109' ' ' ILE . 41.1 mm -111.72 119.95 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.772 -0.58 . . . . 40.0 110.649 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.406 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.7 m-85 -122.91 144.57 49.14 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 120.524 -0.47 . . . . 40.0 109.934 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.536 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 4.2 tptp -134.29 145.02 48.68 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.042 -1.036 . . . . 40.0 110.593 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.593 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.6 t -123.37 166.9 14.54 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.567 -0.901 . . . . 40.0 108.567 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.517 ' O ' ' OG ' ' A' ' 85' ' ' SER . 35.8 p -139.73 -10.29 1.19 Allowed 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.03 -1.044 . . . . 40.0 109.723 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.713 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -107.13 10.78 30.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.25 -0.907 . . . . 40.0 110.259 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 86.68 63.06 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.346 0.593 . . . . 40.0 110.494 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.664 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 24.4 m-85 70.61 -23.23 0.17 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.369 -0.832 . . . . 40.0 110.883 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 102' ' ' ALA . 2.0 mt-30 -43.4 -73.45 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.293 -0.879 . . . . 40.0 109.97 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.491 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 24.8 p -106.18 167.53 9.75 Favored 'General case' 0 C--O 1.196 -1.756 0 N-CA-C 107.718 -1.215 . . . . 40.0 107.718 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.541 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -140.93 139.16 34.27 Favored 'General case' 0 C--N 1.268 -2.942 0 O-C-N 121.51 -0.744 . . . . 40.0 109.836 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.7 m -124.48 135.98 53.65 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.143 -1.058 . . . . 40.0 108.143 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.54 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 18.1 tttp -84.64 145.57 27.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.903 -1.123 . . . . 40.0 109.656 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.508 HD11 ' CG2' ' A' ' 96' ' ' ILE . 14.6 pt -121.35 -34.42 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.157 -0.964 . . . . 40.0 109.528 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.595 HH21 ' CG ' ' A' ' 8' ' ' ASP . 76.3 mtt180 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 118.176 -0.916 . . . . 40.0 108.969 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.636 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 17.9 t . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 108.992 -0.744 . . . . 40.0 108.992 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -175.9 153.79 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.066 -0.716 . . . . 40.0 109.066 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -144.43 26.05 1.48 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.109 -0.994 . . . . 40.0 110.688 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.492 ' O ' HG23 ' A' ' 10' ' ' VAL . 21.2 p -104.26 151.94 22.81 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 121.463 0.649 . . . . 40.0 109.473 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -55.25 -64.16 0.93 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.716 -1.24 . . . . 40.0 110.734 -179.191 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.604 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.7 OUTLIER -57.03 -41.83 79.32 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.193 -0.942 . . . . 40.0 110.107 -179.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.4 -45.28 84.18 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.702 -1.359 . . . . 40.0 109.702 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.59 HG22 ' HG2' ' A' ' 21' ' ' PRO . 71.1 t -67.09 -43.36 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 121.674 -0.898 . . . . 40.0 108.824 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.43 -58.79 6.99 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.283 -0.636 . . . . 40.0 109.283 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.56 -56.47 9.8 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.118 -0.989 . . . . 40.0 109.358 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.758 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 39.0 t80 -51.49 -53.07 41.19 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.942 -0.572 . . . . 40.0 110.418 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 18' ' ' HIS . 1.9 tt -72.74 -50.1 26.79 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.336 0.589 . . . . 40.0 110.982 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 11' ' ' ALA . 63.3 mt-30 -53.17 -28.27 25.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.059 -1.65 . . . . 40.0 109.925 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.9 m -91.61 -51.14 5.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.014 -1.054 . . . . 40.0 110.763 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.416 ' O ' ' N ' ' A' ' 19' ' ' LYS . 84.9 m-85 -99.11 14.03 30.79 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.268 -0.895 . . . . 40.0 110.427 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.544 ' N ' ' O ' ' A' ' 14' ' ' LEU . 20.9 m80 41.95 25.01 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 O-C-N 121.565 -0.71 . . . . 40.0 111.023 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 17' ' ' TYR . 4.1 pttp -134.89 158.65 43.71 Favored 'General case' 0 C--O 1.185 -2.3 0 O-C-N 121.2 -0.937 . . . . 40.0 109.967 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mp -79.35 146.03 65.44 Favored Pre-proline 0 C--N 1.269 -2.905 0 N-CA-C 107.961 -1.126 . . . . 40.0 107.961 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.758 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 82.2 Cg_exo -39.34 157.72 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 123.213 2.608 . . . . 40.0 114.6 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.636 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.8 OUTLIER -69.47 51.26 0.1 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.817 -1.177 . . . . 40.0 109.62 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.48 ' HA ' ' HD3' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -175.92 26.71 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.026 -1.047 . . . . 40.0 110.149 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -119.59 109.72 16.02 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.498 -1.376 . . . . 40.0 111.045 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.0 pt -116.85 134.94 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.441 -0.904 . . . . 40.0 108.704 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.758 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.3 OUTLIER -69.51 169.98 11.5 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 123.756 1.741 . . . . 40.0 113.269 -177.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.528 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 23.1 mtmt -62.34 -37.87 87.31 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 105.96 -1.867 . . . . 40.0 105.96 177.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.504 ' OG ' ' OG1' ' A' ' 26' ' ' THR . 1.1 m -37.69 -70.84 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.667 -0.864 . . . . 40.0 108.667 176.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.545 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.5 mp0 -63.34 -57.62 9.79 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 106.823 -1.547 . . . . 40.0 106.823 -177.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.545 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -33.31 -52.03 0.36 Allowed 'General case' 0 N--CA 1.509 2.525 0 C-N-CA 119.165 -1.014 . . . . 40.0 109.251 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -56.52 -67.06 0.34 Allowed 'General case' 0 N--CA 1.516 2.864 0 O-C-N 120.906 -1.121 . . . . 40.0 111.524 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.4 -21.64 62.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.746 -1.221 . . . . 40.0 110.494 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.516 HD21 ' HB ' ' A' ' 45' ' ' VAL . 60.5 tp -70.54 -24.47 62.81 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.349 -1.352 . . . . 40.0 107.349 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.7 48.15 0.28 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.6 -1.0 . . . . 40.0 110.6 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.595 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.14 142.31 33.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.009 -1.289 . . . . 40.0 108.633 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.7 t -136.47 128.24 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 N-CA-C 108.439 -0.948 . . . . 40.0 108.439 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.12 -48.58 81.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.776 -0.577 . . . . 40.0 109.531 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.7 p -70.83 46.95 0.1 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.028 -1.045 . . . . 40.0 109.899 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.613 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -178.6 -50.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.916 -0.772 . . . . 40.0 108.916 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.39 59.8 8.85 Favored Glycine 0 N--CA 1.503 3.146 0 N-CA-C 108.593 -1.803 . . . . 40.0 108.593 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.613 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -76.6 160.56 29.32 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.344 -1.092 . . . . 40.0 111.59 -177.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.835 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 45.5 tp -172.46 -70.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.451 -0.9 . . . . 40.0 110.529 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.59 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -59.98 -21.45 61.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.852 -1.155 . . . . 40.0 109.77 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 5.0 p-10 -75.87 -62.64 1.52 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.185 -0.672 . . . . 40.0 109.185 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.516 ' HB ' HD21 ' A' ' 33' ' ' LEU . 15.8 m -77.76 -13.28 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 109.063 -0.718 . . . . 40.0 109.063 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.474 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -147.74 72.92 11.54 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 121.34 -0.85 . . . . 40.0 110.148 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.68 118.04 4.81 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.01 2.474 . . . . 40.0 113.959 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.513 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 75.16 36.48 45.64 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.25 -1.54 . . . . 40.0 109.25 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.3 mmtm -135.5 163.55 29.82 Favored 'General case' 0 N--CA 1.511 2.586 0 CA-C-O 121.739 0.781 . . . . 40.0 110.364 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.483 ' HA ' HD21 ' A' ' 42' ' ' LEU . 50.5 m -138.56 166.57 23.99 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 122.12 0.962 . . . . 40.0 111.325 -176.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.402 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 10.3 mm -83.98 121.66 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 115.344 -0.843 . . . . 40.0 111.689 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 178.27 155.24 13.86 Favored Glycine 0 N--CA 1.502 3.097 0 C-N-CA 119.847 -1.168 . . . . 40.0 110.604 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.758 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 119.7 -7.87 12.04 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.342 -1.409 . . . . 40.0 110.217 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.417 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 4.5 m-20 -75.65 -150.79 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.088 -1.242 . . . . 40.0 109.824 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -132.36 143.33 40.23 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.882 0 CA-C-N 115.067 -0.969 . . . . 40.0 108.848 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.644 ' O ' ' N ' ' A' ' 58' ' ' ASN . 14.9 t80 -112.04 89.68 3.13 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.488 -0.93 . . . . 40.0 108.488 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.667 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.8 p -59.23 37.57 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.597 0.713 . . . . 40.0 110.611 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.644 ' N ' ' O ' ' A' ' 56' ' ' PHE . 44.2 t30 34.42 39.18 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.066 -1.021 . . . . 40.0 110.656 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.667 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.8 mtm180 -70.02 35.54 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.731 -1.231 . . . . 40.0 110.45 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.605 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 14.8 mt-10 -144.91 -1.85 0.84 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.033 -1.042 . . . . 40.0 109.943 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.58 37.84 50.91 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.662 -1.375 . . . . 40.0 109.662 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.605 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 4.3 mttp -119.89 12.36 12.04 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.458 -1.025 . . . . 40.0 109.407 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.479 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -137.54 143.85 42.55 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.702 -0.624 . . . . 40.0 109.646 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.54 123.74 13.32 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.505 2.137 . . . . 40.0 112.466 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.54 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -103.43 -177.81 26.16 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.205 -1.158 . . . . 40.0 110.205 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.43 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 8.4 tttt -178.12 154.09 0.84 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 108.024 -1.102 . . . . 40.0 108.024 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.4 p -73.29 56.04 0.47 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.774 -1.204 . . . . 40.0 109.041 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.16 81.76 0.04 OUTLIER Glycine 0 N--CA 1.498 2.815 0 N-CA-C 109.899 -1.28 . . . . 40.0 109.899 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.57 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -177.34 178.18 1.11 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.544 -0.974 . . . . 40.0 108.874 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.57 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 92.8 m -154.97 155.12 33.65 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.219 -0.926 . . . . 40.0 109.945 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.713 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 29.7 m95 -123.36 139.45 54.02 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.708 -0.479 . . . . 40.0 109.708 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.597 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.26 149.02 52.14 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.705 -1.247 . . . . 40.0 109.713 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.529 ' O ' ' OH ' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -114.52 169.94 8.68 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.897 -1.127 . . . . 40.0 112.331 -179.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.99 137.24 3.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.745 -0.597 . . . . 40.0 110.958 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.722 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -59.14 154.54 15.76 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 120.917 0.389 . . . . 40.0 110.896 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.722 HD13 ' O ' ' A' ' 75' ' ' ASP . 41.6 mm -137.09 144.33 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.323 -0.861 . . . . 40.0 110.294 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 57.77 71.05 0.6 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.527 -0.733 . . . . 40.0 110.58 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.835 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 69.2 t80 -131.67 155.06 48.27 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.866 -1.146 . . . . 40.0 109.804 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.596 ' OG1' ' N ' ' A' ' 80' ' ' SER . 27.2 p -135.79 -73.05 0.45 Allowed 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.618 -0.676 . . . . 40.0 110.138 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.596 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -153.65 102.32 2.54 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.481 -0.562 . . . . 40.0 109.481 -177.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.427 ' N ' ' OH ' ' A' ' 78' ' ' TYR . . . 164.01 -103.08 0.21 Allowed Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.855 -1.164 . . . . 40.0 110.397 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.486 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 45.8 t80 -141.3 -166.95 2.29 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.842 -0.799 . . . . 40.0 108.955 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.649 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.9 mtm180 -73.45 -154.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 40.0 110.429 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.597 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 9.4 p30 -167.58 -150.91 0.11 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.333 -0.988 . . . . 40.0 108.333 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.514 ' OG ' ' O ' ' A' ' 100' ' ' THR . 82.5 p -102.82 -8.06 21.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.799 -1.188 . . . . 40.0 109.309 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.522 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.25 113.67 23.19 Favored 'General case' 0 N--CA 1.509 2.48 0 CA-C-O 121.794 0.807 . . . . 40.0 111.483 -179.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.854 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.73 150.79 46.53 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.852 -1.155 . . . . 40.0 110.551 179.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.693 ' CG2' HD11 ' A' ' 76' ' ' ILE . 4.9 tt -116.93 141.02 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.511 -0.743 . . . . 40.0 109.908 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 72' ' ' ARG . 2.8 mm? -119.54 124.95 47.67 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.574 -0.899 . . . . 40.0 108.574 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.677 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.66 129.53 55.35 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.873 0.844 . . . . 40.0 108.776 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.713 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.9 p -94.69 159.66 14.97 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 122.581 1.181 . . . . 40.0 112.413 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.6 p -69.42 -17.81 63.69 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.117 -1.068 . . . . 40.0 108.117 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.476 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -87.06 10.06 17.75 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.778 -0.769 . . . . 40.0 109.736 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.453 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.66 26.54 0.65 Allowed 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.62 -0.675 . . . . 40.0 110.259 179.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.5 mt -95.69 135.55 37.24 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.362 -0.837 . . . . 40.0 109.092 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.523 ' CG2' HD11 ' A' ' 109' ' ' ILE . 38.6 mm -110.96 119.02 58.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-O 121.389 0.614 . . . . 40.0 110.722 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -122.28 144.88 48.72 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 120.276 -0.57 . . . . 40.0 109.637 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.522 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 4.8 tptp -133.83 144.42 48.95 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.19 -0.943 . . . . 40.0 110.644 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.59 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.7 t -123.17 166.7 14.77 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 108.688 -0.856 . . . . 40.0 108.688 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.514 ' O ' ' OG ' ' A' ' 85' ' ' SER . 40.7 p -140.08 -9.82 1.15 Allowed 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.277 -0.889 . . . . 40.0 109.66 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.69 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -108.47 14.01 25.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 40.0 110.261 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 84.41 61.92 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.13 0.491 . . . . 40.0 110.329 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.649 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 24.6 m-85 70.73 -21.64 0.19 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.494 -0.754 . . . . 40.0 110.881 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.426 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.2 mt-30 -43.72 -72.55 0.06 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.088 -1.007 . . . . 40.0 109.599 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.465 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 26.4 p -107.41 169.44 8.58 Favored 'General case' 0 C--O 1.193 -1.9 0 N-CA-C 108.048 -1.093 . . . . 40.0 108.048 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.546 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -141.42 140.13 33.57 Favored 'General case' 0 C--N 1.272 -2.794 0 O-C-N 121.355 -0.84 . . . . 40.0 110.114 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 46.4 m -125.31 135.51 52.55 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.551 -0.907 . . . . 40.0 108.551 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.596 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 21.7 tttp -84.46 145.08 28.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.759 -1.213 . . . . 40.0 109.879 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.523 HD11 ' CG2' ' A' ' 96' ' ' ILE . 14.1 pt -120.32 -34.72 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.172 -0.955 . . . . 40.0 109.527 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.604 HH21 ' CG ' ' A' ' 8' ' ' ASP . 78.3 mtt180 . . . . . 0 N--CA 1.487 1.378 0 O-C-N 121.186 -0.946 . . . . 40.0 108.638 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.648 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 20.7 t . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 109.294 -0.632 . . . . 40.0 109.294 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 tt -177.1 152.4 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 108.981 -0.748 . . . . 40.0 108.981 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -144.29 25.78 1.52 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.733 -1.229 . . . . 40.0 110.604 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 10' ' ' VAL . 17.4 p -105.38 152.82 22.49 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.528 0.68 . . . . 40.0 110.057 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.498 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -56.29 -62.74 1.51 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.459 -1.401 . . . . 40.0 111.482 -179.198 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.646 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -59.1 -40.83 86.54 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.976 -1.077 . . . . 40.0 109.738 -179.345 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.45 -44.88 85.3 Favored Glycine 0 N--CA 1.507 3.377 0 N-CA-C 109.682 -1.367 . . . . 40.0 109.682 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.513 HG22 ' HG2' ' A' ' 21' ' ' PRO . 70.5 t -67.55 -43.48 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.805 -0.821 . . . . 40.0 108.976 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.88 -56.48 20.64 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.967 -0.753 . . . . 40.0 108.967 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.04 -56.02 14.63 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.89 -0.782 . . . . 40.0 108.89 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.695 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 38.7 t80 -53.02 -51.78 60.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 122.017 -0.427 . . . . 40.0 110.87 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 18' ' ' HIS . 3.9 tt -71.89 -51.06 24.14 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 121.414 0.626 . . . . 40.0 110.43 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.495 ' N ' HD23 ' A' ' 14' ' ' LEU . 58.8 mt-30 -53.22 -28.77 28.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 119.983 -1.698 . . . . 40.0 110.316 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.3 m -92.31 -50.18 5.78 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.612 -1.305 . . . . 40.0 110.964 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.401 ' O ' ' N ' ' A' ' 19' ' ' LYS . 86.5 m-85 -99.28 12.47 36.15 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.89 -1.131 . . . . 40.0 110.308 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.569 ' N ' ' O ' ' A' ' 14' ' ' LEU . 23.5 m80 42.6 24.2 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.916 0 CA-C-O 121.484 0.659 . . . . 40.0 111.226 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 17' ' ' TYR . 5.1 pttp -135.98 156.57 48.54 Favored 'General case' 0 C--O 1.183 -2.413 0 CA-C-O 121.646 0.736 . . . . 40.0 109.804 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 24' ' ' TYR . 4.5 mp -77.62 145.63 71.6 Favored Pre-proline 0 C--N 1.268 -2.976 0 O-C-N 120.899 -1.126 . . . . 40.0 109.71 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.695 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 88.9 Cg_exo -40.33 155.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 123.267 2.645 . . . . 40.0 113.922 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.648 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -66.06 49.19 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.15 0.976 . . . . 40.0 109.376 -179.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -173.92 26.99 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.189 -0.944 . . . . 40.0 110.687 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.425 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 2.9 m-85 -119.59 108.26 14.27 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.523 -1.361 . . . . 40.0 109.628 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.7 pt -116.94 132.11 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 C-N-CA 119.436 -0.905 . . . . 40.0 108.89 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.782 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.5 OUTLIER -67.17 172.02 5.1 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 123.609 1.671 . . . . 40.0 113.536 -177.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.501 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 19.5 mtmt -63.36 -35.99 82.23 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 106.458 -1.682 . . . . 40.0 106.458 176.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.566 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 5.1 m -35.56 -71.7 0.07 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 123.57 1.652 . . . . 40.0 109.222 175.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.504 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.1 mp0 -65.53 -56.18 13.76 Favored 'General case' 0 C--O 1.192 -1.93 0 N-CA-C 107.488 -1.301 . . . . 40.0 107.488 -177.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.504 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -37.26 -50.29 0.99 Allowed 'General case' 0 N--CA 1.517 2.914 0 O-C-N 120.574 -1.329 . . . . 40.0 110.647 178.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -58.93 -62.04 2.18 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.382 -1.449 . . . . 40.0 110.848 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.81 -25.98 67.83 Favored 'General case' 0 N--CA 1.512 2.662 0 O-C-N 120.679 -1.263 . . . . 40.0 110.027 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.0 tp -65.02 -25.33 67.8 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.178 -1.045 . . . . 40.0 108.178 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.33 46.2 0.33 Allowed Glycine 0 N--CA 1.502 3.068 0 N-CA-C 110.244 -1.142 . . . . 40.0 110.244 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.476 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -80.54 139.85 36.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.969 -1.312 . . . . 40.0 109.422 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.7 t -136.09 130.15 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.241 0 CA-C-O 121.6 0.714 . . . . 40.0 109.576 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.47 -48.18 79.87 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.298 -0.63 . . . . 40.0 109.298 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.2 p -69.7 44.85 0.06 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.33 -0.856 . . . . 40.0 110.704 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.603 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.5 ttpm? -178.48 -51.99 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.203 -0.936 . . . . 40.0 109.066 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.43 62.68 4.89 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 108.788 -1.725 . . . . 40.0 108.788 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.603 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -78.78 160.1 27.57 Favored 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.495 -1.003 . . . . 40.0 111.024 -177.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.842 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 52.0 tp -173.67 -69.4 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.479 -0.763 . . . . 40.0 110.544 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.565 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -61.37 -21.76 64.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.731 -1.231 . . . . 40.0 109.31 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 4.8 p-10 -74.16 -62.8 1.39 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.221 -0.659 . . . . 40.0 109.221 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.8 m -80.4 -10.04 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.914 -0.491 . . . . 40.0 110.298 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.554 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -148.21 72.23 11.06 Favored Pre-proline 0 N--CA 1.489 1.487 0 CA-C-O 121.489 0.662 . . . . 40.0 109.518 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -55.35 115.53 2.51 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 123.779 2.986 . . . . 40.0 113.381 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.72 38.2 57.06 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.992 -1.243 . . . . 40.0 109.992 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.554 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 6.3 mmtt -133.12 163.3 29.57 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.795 -0.827 . . . . 40.0 110.008 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.4 ' HA ' HD21 ' A' ' 42' ' ' LEU . 67.2 m -139.13 161.1 38.23 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 122.432 1.11 . . . . 40.0 110.84 -176.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.6 mm -79.93 124.78 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 114.619 -1.173 . . . . 40.0 110.721 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.24 156.12 13.22 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 119.529 -1.319 . . . . 40.0 109.967 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.782 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 118.29 -10.73 13.06 Favored Glycine 0 N--CA 1.502 3.091 0 C-N-CA 119.531 -1.319 . . . . 40.0 110.163 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.437 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 4.9 m-20 -72.62 -151.15 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.538 -1.566 . . . . 40.0 109.68 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.4 mp -132.72 141.0 46.18 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 CA-C-N 115.132 -0.94 . . . . 40.0 109.304 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.627 ' O ' ' N ' ' A' ' 58' ' ' ASN . 11.7 t80 -109.28 91.76 3.77 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.295 -0.878 . . . . 40.0 109.198 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.624 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.5 p -60.27 38.21 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.92 0.867 . . . . 40.0 110.625 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.627 ' N ' ' O ' ' A' ' 56' ' ' PHE . 44.8 t30 33.97 39.27 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.407 -0.808 . . . . 40.0 110.659 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.624 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.3 mtm180 -70.37 36.3 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.516 -1.365 . . . . 40.0 110.348 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.614 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 15.1 mt-10 -145.17 -2.76 0.78 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.347 -0.845 . . . . 40.0 109.954 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.29 37.95 56.09 Favored Glycine 0 N--CA 1.502 3.098 0 N-CA-C 109.579 -1.409 . . . . 40.0 109.579 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.614 ' NZ ' ' OE2' ' A' ' 60' ' ' GLU . 5.8 mttp -120.1 11.46 11.66 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.267 -1.137 . . . . 40.0 109.505 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.405 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.5 mt -136.38 144.26 46.88 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.64 -0.663 . . . . 40.0 109.498 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.53 123.8 13.04 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.188 1.925 . . . . 40.0 112.527 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.531 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.67 -175.84 27.05 Favored Glycine 0 N--CA 1.5 2.901 0 N-CA-C 110.235 -1.146 . . . . 40.0 110.235 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.462 ' NZ ' ' O ' ' A' ' 68' ' ' GLY . 9.0 tttt -179.12 152.17 0.54 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.065 -1.256 . . . . 40.0 107.791 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.6 p -70.87 53.53 0.16 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.643 -1.286 . . . . 40.0 109.106 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.462 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 150.89 80.98 0.03 OUTLIER Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.277 -1.129 . . . . 40.0 110.277 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.553 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.67 177.97 1.99 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.735 -0.862 . . . . 40.0 108.799 179.105 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.553 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 96.7 m -154.36 155.16 34.56 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.254 -0.904 . . . . 40.0 110.039 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TRP . . . . . 0.741 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 31.8 m95 -124.99 138.92 54.21 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.982 -0.449 . . . . 40.0 109.893 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.581 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.68 147.71 52.38 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.028 -1.045 . . . . 40.0 109.88 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.501 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -113.24 168.74 9.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.679 -1.263 . . . . 40.0 111.9 -179.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.45 139.56 5.71 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.799 0.809 . . . . 40.0 111.063 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.743 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -60.51 154.83 19.88 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.85 -0.531 . . . . 40.0 111.275 179.641 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.743 HD13 ' O ' ' A' ' 75' ' ' ASP . 33.9 mm -138.14 145.4 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.513 -0.742 . . . . 40.0 109.946 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 56.77 70.69 0.63 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.499 0.666 . . . . 40.0 110.782 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.842 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 65.6 t80 -132.29 154.9 49.21 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.917 -1.114 . . . . 40.0 109.436 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.574 ' OG1' ' N ' ' A' ' 80' ' ' SER . 22.9 p -136.17 -72.16 0.45 Allowed 'General case' 0 N--CA 1.507 2.385 0 CA-C-O 121.214 0.531 . . . . 40.0 109.934 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.574 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.5 OUTLIER -153.4 103.67 2.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.387 -0.821 . . . . 40.0 109.299 -178.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.402 ' N ' ' OH ' ' A' ' 78' ' ' TYR . . . 163.42 -106.19 0.27 Allowed Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.608 -1.282 . . . . 40.0 110.212 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.469 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 52.4 t80 -138.21 -165.16 1.75 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.789 -0.819 . . . . 40.0 108.789 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.647 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.1 mtm180 -75.72 -155.84 0.06 Allowed 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.335 -1.478 . . . . 40.0 109.961 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASN . . . . . 0.547 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 9.5 p30 -165.13 -149.18 0.12 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.217 -1.031 . . . . 40.0 108.217 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 100' ' ' THR . 82.7 p -104.21 -7.58 20.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.709 -1.244 . . . . 40.0 108.929 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.482 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -87.6 113.42 23.27 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-O 121.878 0.846 . . . . 40.0 111.71 -179.435 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.863 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.55 150.61 46.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.879 -1.138 . . . . 40.0 110.519 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.729 ' CG2' HD11 ' A' ' 76' ' ' ILE . 6.7 tt -117.3 139.26 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-O 122.831 1.301 . . . . 40.0 110.028 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.528 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.9 mm? -118.86 124.44 47.16 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.421 -0.955 . . . . 40.0 108.421 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.678 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.54 129.5 55.39 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.846 0.831 . . . . 40.0 109.125 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.741 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.5 p -93.35 159.21 15.36 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 122.268 1.032 . . . . 40.0 112.221 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.8 p -69.23 -18.41 63.88 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.805 -1.183 . . . . 40.0 107.805 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.491 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -86.05 9.4 17.3 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.189 -0.604 . . . . 40.0 109.629 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.447 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.12 26.72 0.72 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.503 -0.748 . . . . 40.0 110.3 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.8 mt -96.29 134.99 38.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.398 -0.814 . . . . 40.0 109.156 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.558 ' CG2' HD11 ' A' ' 109' ' ' ILE . 39.2 mm -109.52 120.66 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.438 -0.788 . . . . 40.0 110.452 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -122.95 144.18 49.41 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 109.239 -0.652 . . . . 40.0 109.239 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.482 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 4.7 tptp -133.89 144.84 49.13 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 119.569 -0.852 . . . . 40.0 110.979 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.549 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.8 t -122.95 166.74 14.58 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 108.939 -0.764 . . . . 40.0 108.939 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.464 ' O ' ' OG ' ' A' ' 85' ' ' SER . 40.7 p -140.3 -9.0 1.13 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.36 -0.837 . . . . 40.0 109.626 178.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.674 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -108.58 14.63 24.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.958 -1.089 . . . . 40.0 110.285 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.674 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 83.45 61.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.21 0.528 . . . . 40.0 110.539 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.647 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 28.5 m-85 71.23 -20.83 0.21 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.59 -0.694 . . . . 40.0 110.651 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . 0.422 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.7 mt-30 -44.83 -74.13 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.074 -1.016 . . . . 40.0 109.83 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.515 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 21.0 p -106.02 167.01 10.09 Favored 'General case' 0 C--O 1.195 -1.806 0 N-CA-C 107.56 -1.274 . . . . 40.0 107.56 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.528 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -140.02 140.45 36.22 Favored 'General case' 0 C--N 1.264 -3.125 0 O-C-N 121.32 -0.863 . . . . 40.0 109.73 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.5 m -125.4 137.47 54.01 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.318 -0.993 . . . . 40.0 108.318 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.546 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 17.7 tttp -85.1 145.76 27.49 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.834 -1.166 . . . . 40.0 109.919 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.558 HD11 ' CG2' ' A' ' 96' ' ' ILE . 11.3 pt -121.78 -33.32 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.107 -0.996 . . . . 40.0 109.63 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.646 HH21 ' CG ' ' A' ' 8' ' ' ASP . 76.7 mtt180 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.945 . . . . 40.0 108.737 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.643 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 21.8 t . . . . . 0 N--CA 1.484 1.239 0 N-CA-C 109.123 -0.695 . . . . 40.0 109.123 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -177.57 153.79 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 109.094 -0.706 . . . . 40.0 109.094 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 49.2 p-10 -144.38 26.1 1.48 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.066 -1.021 . . . . 40.0 110.729 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 10' ' ' VAL . 18.1 p -104.73 153.83 20.78 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.694 0.759 . . . . 40.0 109.779 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.48 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -56.99 -63.63 1.15 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.008 -1.057 . . . . 40.0 110.515 -179.267 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.652 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.8 OUTLIER -58.11 -41.76 84.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.481 -0.762 . . . . 40.0 109.781 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.6 -44.98 90.85 Favored Glycine 0 N--CA 1.499 2.875 0 N-CA-C 109.897 -1.281 . . . . 40.0 109.897 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.578 HG22 ' HG2' ' A' ' 21' ' ' PRO . 64.7 t -66.61 -43.41 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.485 -1.009 . . . . 40.0 108.608 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.522 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.93 -57.48 12.45 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 109.367 -0.605 . . . . 40.0 109.367 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -50.25 -55.63 14.55 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.514 -0.741 . . . . 40.0 109.039 178.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.708 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 38.0 t80 -52.4 -52.64 52.71 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.03 0.443 . . . . 40.0 110.268 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 18' ' ' HIS . 4.7 tt -71.42 -52.19 19.85 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.254 0.549 . . . . 40.0 110.68 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 11' ' ' ALA . 56.7 mt-30 -52.85 -28.94 25.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.113 -1.617 . . . . 40.0 109.939 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.8 m -91.1 -52.51 4.79 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.887 -1.133 . . . . 40.0 110.682 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -97.6 12.34 33.87 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.255 -0.903 . . . . 40.0 110.525 -178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.569 ' N ' ' O ' ' A' ' 14' ' ' LEU . 22.5 m80 43.36 25.04 0.06 Allowed 'General case' 0 N--CA 1.514 2.732 0 O-C-N 121.528 -0.733 . . . . 40.0 110.979 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.416 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 5.4 pttp -137.14 160.58 38.57 Favored 'General case' 0 C--O 1.182 -2.467 0 O-C-N 121.397 -0.814 . . . . 40.0 109.774 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.8 mp -80.07 146.08 62.39 Favored Pre-proline 0 C--N 1.266 -3.045 0 O-C-N 120.879 -1.138 . . . . 40.0 108.608 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.708 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 71.2 Cg_exo -41.26 156.11 0.06 OUTLIER 'Trans proline' 0 N--CA 1.498 1.766 0 C-N-CA 123.056 2.504 . . . . 40.0 113.982 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.643 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -67.35 49.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.178 -0.951 . . . . 40.0 109.352 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.513 ' HA ' ' HD3' ' A' ' 49' ' ' LYS . 0.8 OUTLIER -172.98 26.58 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.941 -1.099 . . . . 40.0 110.236 -179.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.435 ' OH ' ' O ' ' A' ' 75' ' ' ASP . 4.3 m-85 -120.12 109.11 15.07 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.913 -1.115 . . . . 40.0 110.394 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 25' ' ' ILE . 16.5 pt -119.02 134.1 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.959 -1.126 . . . . 40.0 107.959 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.824 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.7 OUTLIER -71.78 172.59 9.55 Favored 'General case' 0 N--CA 1.508 2.444 0 CA-C-O 123.677 1.704 . . . . 40.0 113.249 -175.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.565 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 14.9 mtmt -60.67 -39.31 87.92 Favored 'General case' 0 C--N 1.294 -1.848 0 N-CA-C 106.519 -1.66 . . . . 40.0 106.519 176.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.468 ' C ' ' O ' ' A' ' 27' ' ' LYS . 2.6 m -32.24 -74.3 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.533 -0.914 . . . . 40.0 108.533 175.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.572 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.8 mp0 -65.97 -57.49 7.68 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.116 -1.439 . . . . 40.0 107.116 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.572 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -30.22 -55.01 0.18 Allowed 'General case' 0 N--CA 1.53 3.559 0 O-C-N 119.931 -1.731 . . . . 40.0 109.78 176.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -56.13 -66.7 0.39 Allowed 'General case' 0 N--CA 1.525 3.31 0 O-C-N 120.033 -1.667 . . . . 40.0 113.679 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -54.71 -32.21 59.26 Favored 'General case' 0 N--CA 1.524 3.233 0 O-C-N 121.473 -0.767 . . . . 40.0 109.751 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.03 -22.35 66.79 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.178 -1.576 . . . . 40.0 108.633 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 116.36 51.27 0.4 Allowed Glycine 0 N--CA 1.503 3.144 0 N-CA-C 110.049 -1.22 . . . . 40.0 110.049 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.608 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -84.67 138.96 32.37 Favored 'General case' 0 N--CA 1.51 2.533 0 O-C-N 121.18 -1.188 . . . . 40.0 108.048 179.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.7 t -134.81 130.01 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.788 0 CA-C-O 121.74 0.781 . . . . 40.0 110.205 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -58.23 -50.37 73.82 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.935 -0.478 . . . . 40.0 110.005 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 76.4 p -70.36 45.45 0.08 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.573 -0.704 . . . . 40.0 110.123 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.595 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 2.0 ttpm? -177.14 -49.24 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.857 -0.794 . . . . 40.0 108.857 178.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.48 59.98 8.53 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 108.213 -1.955 . . . . 40.0 108.213 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.608 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -76.69 161.18 28.73 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.483 -1.01 . . . . 40.0 110.931 -177.837 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.846 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 48.8 tp -173.73 -68.5 0.01 OUTLIER 'General case' 0 C--O 1.194 -1.838 0 O-C-N 121.233 -0.917 . . . . 40.0 110.524 178.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.567 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -62.24 -20.45 64.24 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.504 -1.372 . . . . 40.0 109.318 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.4 p-10 -75.98 -61.88 1.78 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.925 -0.768 . . . . 40.0 108.925 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.9 m -80.11 -12.68 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.582 -0.699 . . . . 40.0 109.67 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -146.1 71.82 13.4 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.329 -0.857 . . . . 40.0 109.67 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_exo -56.27 116.78 3.42 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.787 2.325 . . . . 40.0 113.375 -178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.87 36.67 52.14 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.757 -1.337 . . . . 40.0 109.757 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.58 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 6.8 mmtm -133.66 163.24 29.88 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 121.688 -0.889 . . . . 40.0 109.386 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.414 ' HG ' ' HD2' ' A' ' 78' ' ' TYR . 52.0 m -138.2 163.5 31.57 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.201 1.001 . . . . 40.0 111.135 -176.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 39.0 mm -80.83 123.2 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.127 0 CA-C-N 115.208 -0.905 . . . . 40.0 110.38 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . 176.94 155.63 13.99 Favored Glycine 0 N--CA 1.495 2.613 0 N-CA-C 109.468 -1.453 . . . . 40.0 109.468 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.824 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 117.36 -11.04 14.47 Favored Glycine 0 N--CA 1.498 2.768 0 C-N-CA 119.685 -1.245 . . . . 40.0 110.972 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.529 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 5.0 m-20 -72.63 -151.42 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.762 0 O-C-N 121.187 -1.184 . . . . 40.0 109.807 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -132.59 144.02 38.03 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.021 0 N-CA-C 108.256 -1.016 . . . . 40.0 108.256 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.62 ' O ' ' N ' ' A' ' 58' ' ' ASN . 15.3 t80 -112.7 90.81 3.44 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.195 -0.941 . . . . 40.0 109.157 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.652 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -59.72 38.34 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 CA-C-O 121.708 0.766 . . . . 40.0 111.0 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.62 ' N ' ' O ' ' A' ' 56' ' ' PHE . 45.5 t30 34.77 37.82 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.032 -1.042 . . . . 40.0 110.964 179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.652 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.4 mtm180 -70.23 38.08 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.956 -1.09 . . . . 40.0 109.85 179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.608 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 12.4 mt-10 -145.47 -6.76 0.62 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.132 -0.98 . . . . 40.0 110.3 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.73 36.52 72.38 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 109.045 -1.622 . . . . 40.0 109.045 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.608 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 3.5 mttp -121.4 13.75 11.07 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.602 -0.94 . . . . 40.0 109.692 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.434 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -138.05 143.21 38.61 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.514 -0.741 . . . . 40.0 109.584 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -61.61 123.89 13.57 Favored 'Trans proline' 0 N--CA 1.498 1.748 0 C-N-CA 122.528 2.152 . . . . 40.0 112.322 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.53 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -103.02 -177.22 26.65 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 110.115 -1.194 . . . . 40.0 110.115 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.432 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 10.8 tttt -179.01 153.93 0.65 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.385 -1.068 . . . . 40.0 108.56 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 67' ' ' SER . 14.0 p -73.46 56.75 0.51 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.923 -1.111 . . . . 40.0 109.024 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.37 80.44 0.03 OUTLIER Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.694 -1.362 . . . . 40.0 109.694 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.575 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -176.05 177.41 1.6 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.795 -0.826 . . . . 40.0 108.847 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.575 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 59.5 m -155.28 155.77 34.36 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.2 -0.937 . . . . 40.0 109.898 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.706 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 28.8 m95 -125.01 140.61 52.76 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.874 -0.516 . . . . 40.0 110.038 -179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.626 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -131.88 150.54 52.12 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.95 -1.094 . . . . 40.0 109.679 179.206 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.565 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -115.62 168.65 9.83 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.137 0.97 . . . . 40.0 111.926 -179.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.436 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . . . -164.53 139.49 5.6 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.399 0.619 . . . . 40.0 110.217 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.722 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -61.34 153.43 26.68 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.055 0.455 . . . . 40.0 111.056 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.78 HD11 ' CG2' ' A' ' 88' ' ' ILE . 42.4 mm -135.8 146.64 29.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.411 -0.805 . . . . 40.0 110.2 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 55.37 71.49 0.54 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.409 0.623 . . . . 40.0 110.85 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.846 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 66.4 t80 -131.89 156.6 45.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.1 -1.0 . . . . 40.0 109.247 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' A' ' 80' ' ' SER . 21.0 p -136.87 -73.18 0.43 Allowed 'General case' 0 N--CA 1.503 2.188 0 CA-C-O 121.181 0.515 . . . . 40.0 109.776 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.567 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -153.13 104.82 2.84 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.664 -0.648 . . . . 40.0 109.885 -178.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.456 ' N ' ' OH ' ' A' ' 78' ' ' TYR . . . 160.1 -100.36 0.19 Allowed Glycine 0 N--CA 1.498 2.794 0 N-CA-C 109.936 -1.266 . . . . 40.0 109.936 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.465 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 35.6 t80 -143.3 -169.95 3.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.738 -0.86 . . . . 40.0 109.541 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.634 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.5 mtm180 -71.65 -156.5 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.925 0.869 . . . . 40.0 110.423 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.467 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 12.9 p30 -166.17 -150.06 0.11 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.079 -1.082 . . . . 40.0 108.079 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' A' ' 100' ' ' THR . 71.5 p -102.87 -8.91 20.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.742 -1.224 . . . . 40.0 109.467 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.478 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -85.73 113.27 21.78 Favored 'General case' 0 N--CA 1.509 2.5 0 CA-C-O 121.788 0.804 . . . . 40.0 111.812 -179.245 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.853 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.09 149.66 46.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.878 -1.139 . . . . 40.0 110.625 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.78 ' CG2' HD11 ' A' ' 76' ' ' ILE . 7.5 tt -116.56 138.8 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-O 121.988 0.899 . . . . 40.0 109.853 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.544 HD13 ' O ' ' A' ' 72' ' ' ARG . 3.1 mm? -117.82 126.2 51.97 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.541 -0.911 . . . . 40.0 108.541 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.686 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -119.79 129.32 54.4 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 108.876 -0.787 . . . . 40.0 108.876 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.706 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.5 p -93.13 158.31 15.83 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 122.285 1.041 . . . . 40.0 112.538 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.0 p -69.07 -17.11 63.83 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.345 -0.983 . . . . 40.0 108.345 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.481 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -86.72 9.01 20.17 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.5 -0.88 . . . . 40.0 109.428 179.714 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.46 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.29 26.77 0.54 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.517 -0.739 . . . . 40.0 110.175 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 21.3 mt -96.21 137.64 34.99 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.304 -0.872 . . . . 40.0 108.894 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.508 ' CG2' HD11 ' A' ' 109' ' ' ILE . 42.1 mm -111.99 121.18 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.508 -0.745 . . . . 40.0 110.589 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.41 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.4 m-85 -122.93 144.71 49.05 Favored 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 120.307 -0.557 . . . . 40.0 109.534 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.478 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 5.2 tptp -133.78 145.14 49.52 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.193 -0.942 . . . . 40.0 110.723 -178.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.533 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.4 t -125.21 167.32 15.01 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.738 -0.838 . . . . 40.0 108.738 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.515 ' O ' ' OG ' ' A' ' 85' ' ' SER . 55.8 p -140.62 -9.05 1.08 Allowed 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.416 -0.803 . . . . 40.0 109.76 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.688 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -107.23 13.74 26.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.126 -0.984 . . . . 40.0 110.107 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 84.02 62.8 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.244 0.545 . . . . 40.0 109.982 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.634 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 32.6 m-85 70.88 -22.05 0.19 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.582 -0.699 . . . . 40.0 111.076 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.425 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.5 mt-30 -44.57 -74.21 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.1 -1.0 . . . . 40.0 110.125 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.529 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 21.1 p -105.14 164.2 12.0 Favored 'General case' 0 C--O 1.198 -1.652 0 N-CA-C 107.78 -1.193 . . . . 40.0 107.78 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.537 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -138.27 139.01 38.99 Favored 'General case' 0 C--N 1.269 -2.9 0 O-C-N 121.45 -0.781 . . . . 40.0 110.07 -179.442 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 37.5 m -125.27 137.23 54.08 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.497 -0.927 . . . . 40.0 108.497 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.522 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 16.3 tttp -83.52 146.23 28.47 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.877 -1.139 . . . . 40.0 109.559 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.508 HD11 ' CG2' ' A' ' 96' ' ' ILE . 15.2 pt -122.29 -33.99 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 C-N-CA 119.65 -0.82 . . . . 40.0 109.153 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.652 HH21 ' CG ' ' A' ' 8' ' ' ASP . 73.6 mtt180 . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 118.266 -0.873 . . . . 40.0 109.102 178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.647 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 10.4 t . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 121.218 0.533 . . . . 40.0 109.942 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -175.73 151.05 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 108.992 -0.744 . . . . 40.0 108.992 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.0 p-10 -141.88 23.13 2.09 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 120.866 -1.146 . . . . 40.0 110.738 -177.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.486 ' O ' HG23 ' A' ' 10' ' ' VAL . 11.7 p -105.16 153.38 21.61 Favored 'General case' 0 N--CA 1.505 2.315 0 CA-C-O 121.634 0.73 . . . . 40.0 110.239 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.533 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.6 OUTLIER -56.42 -62.97 1.36 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.968 -1.083 . . . . 40.0 111.354 -179.283 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.621 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.7 OUTLIER -58.88 -41.56 87.42 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.062 -1.024 . . . . 40.0 109.639 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.43 -46.18 73.68 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.093 -1.203 . . . . 40.0 110.093 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.53 HG22 ' HG2' ' A' ' 21' ' ' PRO . 79.8 t -67.95 -42.79 85.85 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 O-C-N 121.69 -0.888 . . . . 40.0 108.66 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -59.74 -61.07 2.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.457 -0.777 . . . . 40.0 109.549 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.29 -56.73 6.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.574 -0.704 . . . . 40.0 109.465 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.776 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 41.3 t80 -51.44 -53.18 39.64 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 116.153 -0.476 . . . . 40.0 110.758 178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.426 ' O ' ' N ' ' A' ' 18' ' ' HIS . 1.8 tt -72.27 -51.08 22.51 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 121.165 0.507 . . . . 40.0 110.732 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 11' ' ' ALA . 66.3 mt-30 -52.06 -26.39 10.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.107 -1.621 . . . . 40.0 110.549 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.3 m -93.44 -47.84 6.68 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.53 -1.356 . . . . 40.0 111.449 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.46 ' O ' ' N ' ' A' ' 19' ' ' LYS . 90.5 m-85 -104.01 19.11 20.66 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.933 -1.104 . . . . 40.0 109.673 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.426 ' N ' ' O ' ' A' ' 14' ' ' LEU . 32.8 m80 40.66 25.58 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.717 0 O-C-N 121.035 -1.041 . . . . 40.0 110.863 178.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.472 ' NZ ' ' OH ' ' A' ' 13' ' ' TYR . 3.8 pttp -137.34 157.49 46.49 Favored 'General case' 0 C--O 1.185 -2.311 0 CA-C-O 121.809 0.814 . . . . 40.0 110.466 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.48 146.11 65.03 Favored Pre-proline 0 C--N 1.271 -2.827 0 N-CA-C 108.534 -0.913 . . . . 40.0 108.534 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.776 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 88.3 Cg_exo -40.46 155.97 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.845 0 C-N-CA 123.369 2.713 . . . . 40.0 114.217 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.647 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -67.22 48.44 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.402 0 CA-C-O 121.897 0.856 . . . . 40.0 109.84 -179.226 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.483 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -173.13 25.25 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.981 -1.074 . . . . 40.0 110.52 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -118.27 109.26 16.11 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 119.193 -1.003 . . . . 40.0 110.07 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.419 HG21 HD13 ' A' ' 25' ' ' ILE . 11.5 pt -118.33 133.98 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.78 -1.193 . . . . 40.0 107.78 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.829 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -69.38 174.96 4.31 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 124.158 1.933 . . . . 40.0 112.559 -177.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.555 ' HB3' ' NE2' ' A' ' 31' ' ' GLN . 17.8 mtmt -64.28 -36.7 84.94 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 106.704 -1.591 . . . . 40.0 106.704 176.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.512 ' OG ' ' OG1' ' A' ' 26' ' ' THR . 4.4 m -35.95 -70.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 122.049 0.928 . . . . 40.0 109.674 175.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.507 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.2 mp0 -66.49 -52.42 46.25 Favored 'General case' 0 C--O 1.204 -1.295 0 CA-C-N 114.319 -1.31 . . . . 40.0 108.47 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.507 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -42.64 -50.66 5.41 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 119.988 -1.695 . . . . 40.0 109.352 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.555 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 32.9 mt-30 -56.28 -63.94 1.02 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.389 -0.82 . . . . 40.0 111.083 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.91 -22.87 67.06 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.017 -1.052 . . . . 40.0 109.887 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.8 tp -68.15 -23.5 64.88 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.994 -1.066 . . . . 40.0 108.178 178.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.04 53.4 0.26 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.419 -1.072 . . . . 40.0 110.419 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.584 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -87.81 140.15 29.8 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.263 -1.139 . . . . 40.0 109.456 179.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.9 t -134.65 130.73 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.041 0 O-C-N 121.685 -0.634 . . . . 40.0 109.807 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -59.57 -48.95 79.64 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.726 -0.609 . . . . 40.0 109.588 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.3 p -70.12 46.89 0.08 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.44 -0.787 . . . . 40.0 110.01 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.61 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.7 ttpm? -179.12 -51.72 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.076 -0.713 . . . . 40.0 109.076 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.28 60.53 7.4 Favored Glycine 0 N--CA 1.499 2.839 0 N-CA-C 108.58 -1.808 . . . . 40.0 108.58 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.61 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -76.24 159.83 30.24 Favored 'General case' 0 C--N 1.292 -1.902 0 O-C-N 121.749 -0.854 . . . . 40.0 111.063 -178.043 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.874 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 63.9 tp -172.64 -69.89 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.751 -0.78 . . . . 40.0 110.249 178.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.579 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.46 -19.93 58.17 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.924 -1.11 . . . . 40.0 109.556 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.558 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 4.5 p-10 -77.02 -61.91 1.82 Allowed 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 108.696 -0.853 . . . . 40.0 108.696 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.4 m -79.08 -11.58 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 109.356 -0.609 . . . . 40.0 109.356 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -149.8 74.69 9.36 Favored Pre-proline 0 N--CA 1.49 1.546 0 CA-C-O 122.259 1.028 . . . . 40.0 109.977 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.9 117.8 4.58 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 124.044 3.163 . . . . 40.0 113.106 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.69 40.08 46.85 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.867 -1.693 . . . . 40.0 108.867 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.45 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 6.7 mmtm -136.04 169.59 17.36 Favored 'General case' 0 N--CA 1.507 2.415 0 CA-C-O 121.884 0.85 . . . . 40.0 110.571 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 73.6 m -144.85 160.7 40.87 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.713 -1.242 . . . . 40.0 111.856 -177.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.4 mm -80.61 125.78 39.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-N 115.167 -0.924 . . . . 40.0 110.502 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.95 157.29 15.17 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.543 -1.423 . . . . 40.0 109.543 179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.829 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 116.03 -9.02 18.48 Favored Glycine 0 N--CA 1.488 2.101 0 C-N-CA 119.539 -1.315 . . . . 40.0 110.169 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.446 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 5.1 m-20 -74.53 -151.9 0.03 OUTLIER 'General case' 0 C--O 1.196 -1.716 0 O-C-N 120.417 -1.637 . . . . 40.0 109.242 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.74 143.93 38.88 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.829 0 N-CA-C 107.878 -1.156 . . . . 40.0 107.878 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.653 ' O ' ' N ' ' A' ' 58' ' ' ASN . 12.6 t80 -112.14 89.79 3.16 Favored 'General case' 0 C--N 1.293 -1.871 0 C-N-CA 119.952 -0.699 . . . . 40.0 109.247 179.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.666 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.8 p -58.83 38.39 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.821 0.82 . . . . 40.0 110.803 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.653 ' N ' ' O ' ' A' ' 56' ' ' PHE . 44.1 t30 33.84 38.19 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.237 -0.914 . . . . 40.0 110.708 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.666 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.2 mtm180 -68.89 35.68 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.67 -1.268 . . . . 40.0 110.163 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.608 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 14.5 mt-10 -145.35 -2.56 0.77 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.748 -1.22 . . . . 40.0 110.225 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.25 38.59 57.1 Favored Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.436 -1.466 . . . . 40.0 109.436 -178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.608 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 5.5 mttp -121.21 12.82 11.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.373 -1.075 . . . . 40.0 109.334 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.463 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.5 mt -137.89 144.4 43.91 Favored Pre-proline 0 N--CA 1.496 1.834 0 CA-C-O 121.395 0.617 . . . . 40.0 109.467 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -61.83 123.2 12.19 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.536 2.157 . . . . 40.0 112.657 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.547 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.85 -177.98 26.79 Favored Glycine 0 N--CA 1.496 2.676 0 N-CA-C 110.054 -1.218 . . . . 40.0 110.054 -179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.468 ' NZ ' ' O ' ' A' ' 68' ' ' GLY . 8.8 tttt -177.66 153.15 0.85 Allowed 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.026 -1.101 . . . . 40.0 108.026 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.6 p -72.25 53.03 0.27 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.833 -1.167 . . . . 40.0 109.395 -179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.468 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 150.97 80.13 0.03 OUTLIER Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.923 -1.271 . . . . 40.0 109.923 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.576 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -173.55 178.84 2.22 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.696 -0.885 . . . . 40.0 108.833 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.576 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 100.0 m -155.61 155.17 32.82 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 119.361 -0.935 . . . . 40.0 110.199 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.706 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 30.5 m95 -124.77 139.84 53.48 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.247 0.546 . . . . 40.0 110.064 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.623 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.91 148.92 52.74 Favored 'General case' 0 N--CA 1.508 2.431 0 O-C-N 120.756 -1.215 . . . . 40.0 109.436 179.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.505 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -115.01 168.47 9.89 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 122.181 0.991 . . . . 40.0 111.79 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -162.96 138.95 7.09 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.593 0.711 . . . . 40.0 111.121 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.718 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -61.08 154.52 22.7 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.509 -0.744 . . . . 40.0 110.804 -179.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.718 HD13 ' O ' ' A' ' 75' ' ' ASP . 40.1 mm -137.61 144.09 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 C-N-CA 119.796 -0.762 . . . . 40.0 110.607 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 58.7 70.09 0.68 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.574 -0.704 . . . . 40.0 110.884 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.874 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 66.1 t80 -131.9 157.8 43.03 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.222 -0.924 . . . . 40.0 109.928 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.588 ' OG1' ' N ' ' A' ' 80' ' ' SER . 22.1 p -139.41 -70.15 0.41 Allowed 'General case' 0 N--CA 1.511 2.621 0 O-C-N 121.73 -0.606 . . . . 40.0 109.501 179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.588 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.9 OUTLIER -154.42 105.76 2.69 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.737 -0.468 . . . . 40.0 109.737 -178.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.7 -103.93 0.23 Allowed Glycine 0 N--CA 1.498 2.774 0 C-N-CA 119.585 -1.293 . . . . 40.0 110.091 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 43.9 t80 -139.96 -166.66 2.13 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 109.086 -0.709 . . . . 40.0 109.086 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.633 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.4 mtm180 -73.95 -154.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.133 -0.979 . . . . 40.0 110.413 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.49 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 11.7 p30 -167.87 -150.99 0.1 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.08 -1.082 . . . . 40.0 108.08 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.6 p -102.98 -6.92 21.89 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.904 -1.123 . . . . 40.0 109.452 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.512 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -88.14 113.92 24.24 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-O 121.737 0.779 . . . . 40.0 111.47 -179.286 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.859 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.22 149.78 44.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.979 -1.076 . . . . 40.0 110.675 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.653 ' CG2' HD11 ' A' ' 76' ' ' ILE . 6.1 tt -116.8 139.79 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-O 122.126 0.965 . . . . 40.0 109.865 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 72' ' ' ARG . 2.9 mm? -117.95 126.02 51.54 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.792 -0.818 . . . . 40.0 108.792 179.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.674 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.78 129.15 55.09 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.882 -0.784 . . . . 40.0 108.882 179.664 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.706 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 5.0 p -94.15 159.41 15.16 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 122.344 1.069 . . . . 40.0 112.219 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.3 p -69.91 -16.16 63.18 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.427 -0.953 . . . . 40.0 108.427 177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.478 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -88.11 8.99 24.21 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 120.129 -0.628 . . . . 40.0 109.512 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.449 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.69 26.52 0.49 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.94 -0.475 . . . . 40.0 110.055 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.406 HD12 HH21 ' A' ' 69' ' ' ARG . 22.5 mt -95.55 137.08 35.11 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.305 -0.872 . . . . 40.0 109.499 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.483 ' CG2' HD11 ' A' ' 109' ' ' ILE . 39.7 mm -111.51 119.25 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.846 -0.533 . . . . 40.0 110.411 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.409 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.6 m-85 -121.96 144.3 48.96 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 109.688 -0.486 . . . . 40.0 109.688 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.512 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 4.7 tptp -133.77 144.45 49.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.188 -0.945 . . . . 40.0 110.591 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.601 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.8 t -123.57 166.03 16.14 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.673 -0.862 . . . . 40.0 108.673 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.6 p -139.51 -10.84 1.21 Allowed 'General case' 0 N--CA 1.507 2.419 0 O-C-N 121.441 -0.787 . . . . 40.0 109.536 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.691 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -107.56 13.87 26.32 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.01 -1.056 . . . . 40.0 110.508 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 84.27 61.24 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.669 -0.644 . . . . 40.0 110.275 178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.633 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 27.6 m-85 71.71 -21.16 0.22 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.497 -0.752 . . . . 40.0 110.972 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.413 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.7 mt-30 -44.38 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.119 -0.988 . . . . 40.0 109.88 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.497 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 22.7 p -105.29 168.95 8.74 Favored 'General case' 0 C--O 1.196 -1.721 0 N-CA-C 107.702 -1.221 . . . . 40.0 107.702 178.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.549 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -141.82 139.68 32.78 Favored 'General case' 0 C--N 1.267 -2.994 0 O-C-N 121.411 -0.806 . . . . 40.0 109.706 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 42.5 m -125.43 136.33 53.29 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.922 -1.14 . . . . 40.0 107.922 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.618 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 18.8 tttp -85.37 145.9 27.26 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.971 -1.081 . . . . 40.0 109.823 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.483 HD11 ' CG2' ' A' ' 96' ' ' ILE . 14.1 pt -121.44 -32.14 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 120.95 -1.094 . . . . 40.0 109.651 179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.621 HH21 ' CG ' ' A' ' 8' ' ' ASP . 80.6 mtt180 . . . . . 0 N--CA 1.486 1.328 0 O-C-N 121.165 -0.959 . . . . 40.0 108.971 178.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.614 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 15.1 t . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.119 -0.697 . . . . 40.0 109.119 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -178.57 152.26 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 N-CA-C 108.884 -0.784 . . . . 40.0 108.884 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -143.26 24.24 1.79 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.939 -1.101 . . . . 40.0 110.687 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.461 ' O ' HG23 ' A' ' 10' ' ' VAL . 16.5 p -105.57 152.98 22.4 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-O 121.594 0.712 . . . . 40.0 110.169 -178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.481 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -55.36 -64.56 0.8 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.985 -1.072 . . . . 40.0 110.981 -179.038 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.618 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.52 -41.86 81.67 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.025 -1.047 . . . . 40.0 110.035 -179.007 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.38 -45.46 75.29 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.759 -1.336 . . . . 40.0 109.759 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.585 HG22 ' HG2' ' A' ' 21' ' ' PRO . 77.5 t -68.08 -42.68 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.792 -0.828 . . . . 40.0 109.276 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.89 -57.96 10.47 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.592 -0.892 . . . . 40.0 108.592 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.8 -56.64 9.57 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.116 -0.698 . . . . 40.0 109.116 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.788 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 40.3 t80 -51.69 -52.8 45.46 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.134 0.492 . . . . 40.0 110.525 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.492 ' O ' ' N ' ' A' ' 18' ' ' HIS . 1.6 tt -72.55 -51.9 17.93 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.813 -0.554 . . . . 40.0 111.166 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 11' ' ' ALA . 63.9 mt-30 -50.92 -27.79 8.31 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.292 -1.505 . . . . 40.0 110.617 178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.8 m -93.0 -49.79 5.85 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.901 -1.125 . . . . 40.0 111.395 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.452 ' O ' ' N ' ' A' ' 19' ' ' LYS . 87.9 m-85 -100.16 16.55 23.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.989 -1.069 . . . . 40.0 109.585 -178.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.492 ' N ' ' O ' ' A' ' 14' ' ' LEU . 16.9 m80 39.75 26.56 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.472 -0.767 . . . . 40.0 110.733 179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.452 ' N ' ' O ' ' A' ' 17' ' ' TYR . 3.8 pttp -137.01 159.8 40.82 Favored 'General case' 0 C--O 1.185 -2.336 0 CA-C-O 121.977 0.894 . . . . 40.0 110.617 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.95 145.33 61.26 Favored Pre-proline 0 C--N 1.268 -2.971 0 O-C-N 121.071 -1.018 . . . . 40.0 108.402 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.788 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 86.7 Cg_exo -39.29 155.59 0.04 OUTLIER 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 123.43 2.753 . . . . 40.0 114.358 -179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.614 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.6 OUTLIER -68.2 51.34 0.07 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.075 -1.015 . . . . 40.0 109.379 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.501 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -175.71 27.42 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.297 -0.877 . . . . 40.0 110.51 179.089 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -119.65 109.33 15.53 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 120.494 -1.379 . . . . 40.0 109.973 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 51' ' ' ILE . 20.4 pt -117.85 132.27 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.135 -1.061 . . . . 40.0 108.135 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.86 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -69.59 173.94 5.53 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-O 123.787 1.756 . . . . 40.0 113.244 -177.591 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.455 ' HE2' ' OD1' ' A' ' 54' ' ' ASP . 17.4 mtmt -63.53 -37.46 87.4 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 106.802 -1.555 . . . . 40.0 106.802 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.453 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 5.6 m -37.09 -70.87 0.08 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 122.184 0.992 . . . . 40.0 109.371 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.511 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.5 mp0 -65.35 -57.27 8.8 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.131 -1.433 . . . . 40.0 107.131 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.511 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -37.21 -51.67 1.03 Allowed 'General case' 0 N--CA 1.511 2.579 0 O-C-N 120.685 -1.259 . . . . 40.0 109.176 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -57.34 -63.95 1.05 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.437 -1.414 . . . . 40.0 111.485 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.42 -22.41 66.15 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 120.398 -1.439 . . . . 40.0 110.066 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.425 HD21 ' HB ' ' A' ' 45' ' ' VAL . 59.0 tp -68.64 -26.08 65.15 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.414 -1.328 . . . . 40.0 107.414 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 124.26 47.15 0.24 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.991 -0.844 . . . . 40.0 110.991 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.604 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.36 143.39 32.22 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.865 -1.373 . . . . 40.0 109.7 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.0 t -137.22 128.73 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 O-C-N 121.472 -0.767 . . . . 40.0 109.612 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 39' ' ' LYS . . . -58.27 -49.96 75.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.778 -0.576 . . . . 40.0 109.602 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 79.6 p -70.07 47.21 0.08 Allowed 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.356 -0.84 . . . . 40.0 109.967 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.599 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -179.32 -50.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.022 -0.733 . . . . 40.0 109.022 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 61.56 60.03 8.85 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 108.26 -1.936 . . . . 40.0 108.26 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.604 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -75.82 162.45 28.15 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.593 -0.946 . . . . 40.0 111.007 -177.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.769 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 43.7 tp -174.12 -70.5 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.748 -0.781 . . . . 40.0 110.274 179.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.547 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.94 -21.21 63.21 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.906 -1.121 . . . . 40.0 109.571 -178.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.0 p-10 -74.19 -62.8 1.39 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.711 -0.848 . . . . 40.0 108.711 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.425 ' HB ' HD21 ' A' ' 33' ' ' LEU . 16.1 m -79.35 -11.62 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 109.568 -0.531 . . . . 40.0 109.568 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.48 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -148.56 72.25 10.72 Favored Pre-proline 0 N--CA 1.486 1.34 0 CA-C-O 121.883 0.849 . . . . 40.0 109.449 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.8 118.18 5.01 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.994 2.463 . . . . 40.0 113.923 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.51 36.71 48.48 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.272 -1.531 . . . . 40.0 109.272 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.48 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 7.0 mmtm -134.37 163.95 28.52 Favored 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 121.614 0.721 . . . . 40.0 109.864 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.424 ' HA ' HD21 ' A' ' 42' ' ' LEU . 70.6 m -138.97 163.75 31.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.246 -0.909 . . . . 40.0 111.173 -176.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 13.0 mm -81.45 126.98 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-N 115.548 -0.751 . . . . 40.0 110.43 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.28 157.46 15.88 Favored Glycine 0 N--CA 1.498 2.803 0 N-CA-C 109.492 -1.443 . . . . 40.0 109.492 178.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.86 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 117.5 -10.34 14.53 Favored Glycine 0 N--CA 1.499 2.895 0 C-N-CA 118.945 -1.598 . . . . 40.0 110.369 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.495 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 4.6 m-20 -75.29 -151.62 0.03 OUTLIER 'General case' 0 C--O 1.197 -1.675 0 O-C-N 120.948 -1.325 . . . . 40.0 109.847 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.1 142.16 44.22 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.944 0 CA-C-N 114.86 -1.064 . . . . 40.0 108.665 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.624 ' O ' ' N ' ' A' ' 58' ' ' ASN . 15.1 t80 -111.4 90.66 3.4 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 108.875 -0.787 . . . . 40.0 108.875 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.647 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -59.63 38.56 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 CA-C-O 121.605 0.717 . . . . 40.0 110.823 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.624 ' N ' ' O ' ' A' ' 56' ' ' PHE . 43.5 t30 33.82 38.07 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.012 -1.055 . . . . 40.0 111.33 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.647 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.5 mtm180 -69.03 34.66 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.951 -1.093 . . . . 40.0 110.483 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.614 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 15.5 mt-10 -144.1 -2.86 0.88 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.13 -0.981 . . . . 40.0 110.285 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.26 38.02 56.08 Favored Glycine 0 N--CA 1.497 2.745 0 N-CA-C 109.418 -1.473 . . . . 40.0 109.418 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.614 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 4.9 mttp -120.89 13.29 11.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.593 -0.946 . . . . 40.0 109.295 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.474 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -138.7 142.98 36.0 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.705 -0.622 . . . . 40.0 109.616 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -60.69 123.32 12.76 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.499 2.133 . . . . 40.0 112.629 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.52 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.96 -177.63 26.69 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.935 -1.266 . . . . 40.0 109.935 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.411 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 10.1 tttt -178.94 153.05 0.61 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.041 -1.096 . . . . 40.0 108.041 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.8 p -71.84 54.95 0.27 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.885 -1.134 . . . . 40.0 109.239 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.31 79.64 0.03 OUTLIER Glycine 0 N--CA 1.5 2.92 0 N-CA-C 110.137 -1.185 . . . . 40.0 110.137 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.579 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.92 179.06 1.69 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.694 -0.886 . . . . 40.0 109.082 179.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.579 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 99.9 m -155.81 154.77 31.87 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.405 -0.918 . . . . 40.0 109.8 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.696 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 29.9 m95 -124.02 140.6 52.81 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.723 -0.473 . . . . 40.0 109.723 -179.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.634 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.81 149.49 52.43 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 120.837 -1.164 . . . . 40.0 109.574 179.55 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.535 ' O ' ' OH ' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -114.33 168.15 10.09 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.068 -1.02 . . . . 40.0 112.185 -179.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.15 136.72 4.97 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.544 -0.723 . . . . 40.0 110.798 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.76 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -59.21 154.49 16.11 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 120.881 0.372 . . . . 40.0 111.102 179.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.76 HD13 ' O ' ' A' ' 75' ' ' ASP . 38.0 mm -137.8 146.06 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 C-N-CA 119.682 -0.807 . . . . 40.0 110.456 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 57.64 69.96 0.69 Allowed 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.316 0.579 . . . . 40.0 110.534 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.769 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 68.6 t80 -131.01 155.9 46.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.082 -1.011 . . . . 40.0 110.045 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 80' ' ' SER . 23.9 p -137.23 -72.66 0.43 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.822 -0.549 . . . . 40.0 109.557 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.572 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.9 OUTLIER -153.05 106.14 2.99 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 122.071 -0.393 . . . . 40.0 110.132 -179.084 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 160.8 -105.11 0.25 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.706 -1.357 . . . . 40.0 109.706 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 41.5 t80 -138.81 -166.05 1.94 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 122.006 -0.702 . . . . 40.0 109.175 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.644 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.6 mtm180 -74.21 -154.69 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.265 -0.897 . . . . 40.0 110.008 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.597 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 8.1 p30 -167.02 -150.79 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.178 -1.045 . . . . 40.0 108.178 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.531 ' OG ' ' O ' ' A' ' 100' ' ' THR . 59.4 p -102.5 -8.14 21.3 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 120.823 -1.173 . . . . 40.0 109.155 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.501 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.13 114.29 23.6 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-O 121.832 0.825 . . . . 40.0 111.456 -179.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.876 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.01 150.53 45.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.916 -1.115 . . . . 40.0 110.959 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.703 ' CG2' HD11 ' A' ' 76' ' ' ILE . 5.0 tt -116.92 140.43 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-O 122.304 1.049 . . . . 40.0 110.01 178.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 72' ' ' ARG . 3.0 mm? -119.33 125.19 48.46 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.349 -0.982 . . . . 40.0 108.349 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.677 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -119.16 129.88 55.24 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.913 -0.773 . . . . 40.0 108.913 -179.491 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.696 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.1 p -94.91 159.47 15.02 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 122.438 1.113 . . . . 40.0 112.96 -178.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.1 p -69.58 -16.92 63.5 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.097 -1.075 . . . . 40.0 108.097 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.478 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -87.81 9.26 22.4 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.658 -0.817 . . . . 40.0 109.556 179.632 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.468 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.98 26.95 0.58 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.581 -0.699 . . . . 40.0 110.249 179.451 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.8 mt -96.22 136.25 36.93 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.424 -0.798 . . . . 40.0 109.164 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.494 ' CG2' HD11 ' A' ' 109' ' ' ILE . 39.8 mm -110.8 120.43 61.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.505 -0.747 . . . . 40.0 110.554 -178.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.403 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.6 m-85 -123.03 144.56 49.19 Favored 'General case' 0 N--CA 1.504 2.265 0 C-N-CA 120.467 -0.493 . . . . 40.0 109.804 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.501 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 6.0 tptp -133.71 144.31 49.04 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 121.592 -0.693 . . . . 40.0 110.722 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.571 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.7 t -124.21 166.47 15.79 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.632 -0.877 . . . . 40.0 108.632 177.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.531 ' O ' ' OG ' ' A' ' 85' ' ' SER . 40.4 p -140.33 -8.35 1.14 Allowed 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.314 -0.866 . . . . 40.0 109.702 178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.688 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -108.67 13.03 25.42 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.058 -1.026 . . . . 40.0 110.06 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 84.56 62.44 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.318 0.58 . . . . 40.0 110.34 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.644 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 27.1 m-85 71.23 -21.92 0.2 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.459 -0.776 . . . . 40.0 110.868 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.421 ' H ' ' C ' ' A' ' 102' ' ' ALA . 2.0 mt-30 -44.18 -74.28 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.47 0 O-C-N 121.333 -0.855 . . . . 40.0 109.69 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.507 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 25.3 p -105.53 166.58 10.34 Favored 'General case' 0 C--O 1.194 -1.82 0 N-CA-C 107.82 -1.178 . . . . 40.0 107.82 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.534 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -139.42 138.82 36.82 Favored 'General case' 0 C--N 1.27 -2.87 0 O-C-N 121.441 -0.787 . . . . 40.0 109.973 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 41.2 m -124.17 136.73 54.4 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.182 -1.044 . . . . 40.0 108.182 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.544 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 19.0 tttp -85.64 146.32 26.91 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.704 -1.247 . . . . 40.0 109.616 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.494 HD11 ' CG2' ' A' ' 96' ' ' ILE . 13.5 pt -121.67 -34.08 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.244 -0.91 . . . . 40.0 109.476 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.618 HH21 ' CG ' ' A' ' 8' ' ' ASP . 78.2 mtt180 . . . . . 0 N--CA 1.488 1.452 0 O-C-N 121.197 -0.939 . . . . 40.0 108.875 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.632 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 18.5 t . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.471 -0.566 . . . . 40.0 109.471 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 tt -175.74 153.7 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 108.909 -0.775 . . . . 40.0 108.909 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -143.95 25.88 1.57 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.8 -1.188 . . . . 40.0 110.506 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 10' ' ' VAL . 15.7 p -105.3 153.61 21.38 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.469 0.652 . . . . 40.0 109.638 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.506 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -56.97 -64.0 1.02 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.115 -0.991 . . . . 40.0 110.817 -178.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.641 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -57.39 -42.01 81.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.379 -0.826 . . . . 40.0 109.705 -179.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -54.68 -45.95 76.57 Favored Glycine 0 N--CA 1.503 3.101 0 N-CA-C 109.968 -1.253 . . . . 40.0 109.968 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.533 HG22 ' HG2' ' A' ' 21' ' ' PRO . 69.7 t -66.95 -42.6 89.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.767 -0.843 . . . . 40.0 108.933 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.88 -58.4 8.59 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.842 -0.799 . . . . 40.0 108.842 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.07 -56.2 9.78 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.843 -0.799 . . . . 40.0 108.843 178.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.725 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 35.7 t80 -52.92 -51.81 59.99 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 116.084 -0.507 . . . . 40.0 110.673 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.573 ' O ' ' N ' ' A' ' 18' ' ' HIS . 5.1 tt -72.28 -51.4 21.02 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.575 -0.703 . . . . 40.0 110.942 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.509 ' N ' ' O ' ' A' ' 11' ' ' ALA . 54.9 mt-30 -52.9 -28.26 22.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.271 -1.518 . . . . 40.0 110.285 179.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.1 m -92.96 -51.25 5.15 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.085 -1.009 . . . . 40.0 110.825 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -98.17 10.3 40.87 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.994 -1.066 . . . . 40.0 110.205 -178.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.573 ' N ' ' O ' ' A' ' 14' ' ' LEU . 20.1 m80 44.56 23.73 0.08 Allowed 'General case' 0 N--CA 1.52 3.067 0 O-C-N 121.42 -0.8 . . . . 40.0 110.879 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.5 pttp -135.62 160.94 36.93 Favored 'General case' 0 C--O 1.182 -2.496 0 O-C-N 121.399 -0.813 . . . . 40.0 109.566 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 24' ' ' TYR . 4.4 mp -80.47 147.0 62.68 Favored Pre-proline 0 C--N 1.268 -2.964 0 N-CA-C 108.26 -1.015 . . . . 40.0 108.26 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.725 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 83.7 Cg_exo -42.28 157.49 0.07 OUTLIER 'Trans proline' 0 N--CA 1.503 2.084 0 C-N-CA 123.26 2.64 . . . . 40.0 113.633 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.632 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -66.86 49.1 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.049 -1.032 . . . . 40.0 109.871 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.526 ' HA ' ' HD3' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -172.14 24.92 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.925 -1.109 . . . . 40.0 110.139 179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.408 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 4.0 m-85 -117.52 106.74 13.47 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 120.508 -1.37 . . . . 40.0 110.63 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 28.4 pt -116.47 133.92 61.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.061 -1.024 . . . . 40.0 108.37 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.772 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.1 OUTLIER -69.09 172.38 6.86 Favored 'General case' 0 C--N 1.283 -2.295 0 CA-C-O 123.588 1.661 . . . . 40.0 112.96 -177.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.508 ' HB3' ' NE2' ' A' ' 31' ' ' GLN . 12.8 mtmt -62.65 -38.78 91.64 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 105.483 -2.043 . . . . 40.0 105.483 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.472 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 11.4 m -34.75 -71.68 0.06 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 115.103 -0.953 . . . . 40.0 108.792 175.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.55 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.1 mp0 -66.25 -59.5 3.67 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 118.509 -1.276 . . . . 40.0 107.578 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.55 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -31.43 -55.52 0.26 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 119.503 1.047 . . . . 40.0 110.445 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.508 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 25.9 mt-30 -58.0 -63.59 1.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.497 -1.377 . . . . 40.0 111.109 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.29 -27.05 63.71 Favored 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.732 -1.23 . . . . 40.0 110.621 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.7 tp -68.56 -22.52 64.48 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 108.485 -0.932 . . . . 40.0 108.485 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 122.42 48.99 0.25 Allowed Glycine 0 N--CA 1.496 2.687 0 C-N-CA 120.948 -0.644 . . . . 40.0 111.686 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.609 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -85.7 137.9 32.5 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.115 -1.226 . . . . 40.0 110.194 179.45 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.4 t -134.37 132.12 54.99 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.093 0 O-C-N 121.394 -0.816 . . . . 40.0 110.412 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.411 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -59.26 -48.92 79.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.708 -0.62 . . . . 40.0 109.487 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.7 p -69.71 45.75 0.07 Allowed 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 121.635 0.731 . . . . 40.0 110.527 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.507 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.6 ttpm? -178.3 -51.42 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 109.121 -0.696 . . . . 40.0 109.121 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.6 59.84 8.68 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 108.221 -1.952 . . . . 40.0 108.221 -178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.609 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -76.51 160.6 29.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.661 -0.906 . . . . 40.0 111.32 -177.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.797 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 61.8 tp -174.77 -68.67 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.913 -1.117 . . . . 40.0 110.911 178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.631 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.29 -20.31 58.6 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.49 -1.381 . . . . 40.0 109.573 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 2.6 p-10 -75.95 -64.8 1.01 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.712 -0.847 . . . . 40.0 108.712 -179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.43 ' H ' ' CG ' ' A' ' 44' ' ' ASP . 30.3 m -77.18 -12.68 14.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 109.415 -0.587 . . . . 40.0 109.415 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.47 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -145.6 72.08 14.04 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.56 -0.713 . . . . 40.0 110.086 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_exo -56.91 116.79 3.45 Favored 'Trans proline' 0 N--CA 1.499 1.846 0 C-N-CA 122.73 2.287 . . . . 40.0 114.976 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.38 37.33 47.79 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.344 -1.503 . . . . 40.0 109.344 178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.526 ' HD3' ' HA ' ' A' ' 23' ' ' ASN . 7.1 mmtt -132.6 171.03 14.35 Favored 'General case' 0 N--CA 1.508 2.446 0 CA-C-O 122.078 0.942 . . . . 40.0 110.226 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 69.3 m -145.69 162.06 38.44 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.884 -1.135 . . . . 40.0 111.501 -176.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 18.8 mm -81.81 123.84 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 CA-C-N 115.401 -0.818 . . . . 40.0 110.881 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.46 155.86 13.53 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.109 -1.596 . . . . 40.0 109.109 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.772 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 120.44 -12.19 10.36 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 119.278 -1.439 . . . . 40.0 110.402 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.455 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 5.0 m-20 -74.1 -154.22 0.03 OUTLIER 'General case' 0 C--O 1.193 -1.911 0 O-C-N 121.182 -1.187 . . . . 40.0 110.308 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.8 mp -128.57 142.74 43.11 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.868 0 CA-C-N 115.476 -0.784 . . . . 40.0 109.084 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.633 ' O ' ' N ' ' A' ' 58' ' ' ASN . 12.7 t80 -111.08 90.18 3.26 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.333 -0.855 . . . . 40.0 109.169 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.633 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.7 p -59.45 38.78 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 122.023 0.916 . . . . 40.0 110.842 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.633 ' N ' ' O ' ' A' ' 56' ' ' PHE . 45.7 t30 34.14 38.43 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.193 -0.942 . . . . 40.0 110.618 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.633 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 11.2 mtm180 -69.89 37.97 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.765 -1.209 . . . . 40.0 109.992 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.601 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 13.0 mt-10 -146.14 -6.92 0.56 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.038 -1.039 . . . . 40.0 109.968 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 56.31 37.53 74.03 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 109.424 -1.471 . . . . 40.0 109.424 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.601 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 4.5 mttp -121.11 12.35 11.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.802 -0.822 . . . . 40.0 109.3 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.42 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -136.89 142.53 38.95 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.681 -0.637 . . . . 40.0 109.455 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -61.91 122.7 11.35 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.597 2.198 . . . . 40.0 112.27 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.514 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.05 -178.02 27.82 Favored Glycine 0 N--CA 1.497 2.758 0 N-CA-C 110.033 -1.227 . . . . 40.0 110.033 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.402 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 9.5 tttt -177.76 154.14 0.91 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.42 -1.047 . . . . 40.0 108.267 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 42.5 p -72.05 53.79 0.27 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.981 -1.074 . . . . 40.0 109.183 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 150.42 79.61 0.03 OUTLIER Glycine 0 N--CA 1.498 2.806 0 N-CA-C 110.017 -1.233 . . . . 40.0 110.017 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.574 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.14 178.53 2.08 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.734 -0.863 . . . . 40.0 108.991 179.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.574 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 98.9 m -155.42 155.53 33.74 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.202 -0.936 . . . . 40.0 109.823 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.694 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 29.1 m95 -125.07 140.64 52.72 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.834 -0.542 . . . . 40.0 109.636 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.622 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -131.35 147.32 52.56 Favored 'General case' 0 N--CA 1.506 2.343 0 O-C-N 121.105 -0.997 . . . . 40.0 110.162 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.464 ' O ' ' OH ' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -111.39 168.64 9.38 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 122.466 1.127 . . . . 40.0 112.352 -179.485 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.94 136.54 3.57 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.668 -0.645 . . . . 40.0 111.039 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.708 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -58.58 154.51 14.1 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.016 0.436 . . . . 40.0 110.832 179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.712 HD11 ' CG2' ' A' ' 88' ' ' ILE . 43.3 mm -137.57 146.18 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.477 -0.764 . . . . 40.0 109.733 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 56.44 70.94 0.6 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.491 0.662 . . . . 40.0 110.948 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.797 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 68.8 t80 -132.04 156.08 46.92 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.993 -1.067 . . . . 40.0 109.903 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.597 ' OG1' ' N ' ' A' ' 80' ' ' SER . 23.6 p -136.27 -73.92 0.44 Allowed 'General case' 0 N--CA 1.509 2.479 0 CA-C-O 121.284 0.564 . . . . 40.0 110.059 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.631 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -152.23 105.91 3.1 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 109.078 -0.712 . . . . 40.0 109.078 -178.815 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.405 ' N ' ' OH ' ' A' ' 78' ' ' TYR . . . 160.84 -105.6 0.27 Allowed Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.417 -1.373 . . . . 40.0 110.28 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.474 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 40.0 t80 -138.36 -166.09 1.93 Allowed 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 108.987 -0.745 . . . . 40.0 108.987 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.639 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.2 mtm180 -75.12 -155.92 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.045 -1.034 . . . . 40.0 110.343 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.541 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 10.8 p30 -165.33 -150.37 0.13 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.978 -1.119 . . . . 40.0 107.978 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' A' ' 100' ' ' THR . 82.6 p -103.58 -8.15 20.24 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.78 -1.2 . . . . 40.0 109.152 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.501 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -86.0 113.37 22.04 Favored 'General case' 0 N--CA 1.507 2.414 0 CA-C-O 121.79 0.805 . . . . 40.0 111.713 -179.167 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.86 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.63 150.38 46.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.033 . . . . 40.0 110.988 179.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.712 ' CG2' HD11 ' A' ' 76' ' ' ILE . 6.9 tt -116.73 141.56 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 122.107 0.956 . . . . 40.0 109.847 178.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.542 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.8 mm? -121.37 123.99 43.45 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.944 -1.132 . . . . 40.0 107.944 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.687 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.09 129.5 55.58 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.918 0.866 . . . . 40.0 108.783 -179.714 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.694 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 3.8 p -94.14 158.63 15.52 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 122.228 1.013 . . . . 40.0 112.445 -177.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.7 p -69.82 -15.87 63.18 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.443 -0.947 . . . . 40.0 108.443 178.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.488 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -88.02 8.2 27.65 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.61 -0.836 . . . . 40.0 109.423 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.463 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 79.36 26.07 0.42 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.675 -0.64 . . . . 40.0 110.344 179.699 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.1 mt -95.75 138.84 32.83 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.451 -0.781 . . . . 40.0 109.18 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.484 ' CG2' HD11 ' A' ' 109' ' ' ILE . 40.4 mm -112.91 120.21 62.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 O-C-N 121.71 -0.619 . . . . 40.0 110.426 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.433 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.4 m-85 -122.03 144.49 48.87 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 109.296 -0.631 . . . . 40.0 109.296 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.501 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 3.3 tptp -133.17 146.14 51.26 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 119.367 -0.933 . . . . 40.0 110.965 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.533 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.6 t -125.63 166.6 16.44 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 109.141 -0.689 . . . . 40.0 109.141 177.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.515 ' O ' ' OG ' ' A' ' 85' ' ' SER . 55.5 p -139.97 -9.69 1.17 Allowed 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.327 -0.858 . . . . 40.0 109.585 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.662 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -108.09 15.99 23.75 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.195 -0.941 . . . . 40.0 110.417 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.662 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 83.01 60.7 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.86 -0.525 . . . . 40.0 110.689 179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.639 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 27.5 m-85 71.35 -20.46 0.23 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.546 -0.721 . . . . 40.0 110.847 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.424 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.6 mt-30 -44.92 -73.4 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.044 -1.035 . . . . 40.0 109.877 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.492 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 23.8 p -105.86 164.79 11.67 Favored 'General case' 0 C--O 1.195 -1.813 0 N-CA-C 107.791 -1.189 . . . . 40.0 107.791 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.542 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -138.95 138.2 37.11 Favored 'General case' 0 C--N 1.269 -2.915 0 O-C-N 121.306 -0.872 . . . . 40.0 109.989 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 53.3 m -124.12 137.42 54.56 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.119 -1.067 . . . . 40.0 108.119 177.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.61 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 18.4 tttp -84.64 145.18 28.14 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 120.906 -1.121 . . . . 40.0 109.601 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.484 HD11 ' CG2' ' A' ' 96' ' ' ILE . 15.4 pt -120.53 -34.68 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.175 -0.953 . . . . 40.0 109.262 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.641 HH21 ' CG ' ' A' ' 8' ' ' ASP . 79.6 mtt180 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.172 -0.955 . . . . 40.0 108.86 178.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.63 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 19.8 t . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 109.045 -0.724 . . . . 40.0 109.045 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 tt -174.34 154.07 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 N-CA-C 108.9 -0.778 . . . . 40.0 108.9 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.9 p-10 -144.22 26.12 1.51 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.016 -1.053 . . . . 40.0 110.593 -178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 10' ' ' VAL . 18.0 p -104.0 153.83 20.38 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.566 0.698 . . . . 40.0 109.609 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.475 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.4 OUTLIER -57.11 -63.49 1.2 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 120.839 -1.163 . . . . 40.0 110.511 -179.217 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.643 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.9 OUTLIER -57.31 -41.93 80.85 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.096 -1.002 . . . . 40.0 109.655 -179.476 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.35 -44.96 84.86 Favored Glycine 0 N--CA 1.503 3.11 0 N-CA-C 110.243 -1.143 . . . . 40.0 110.243 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.573 HG22 ' HG2' ' A' ' 21' ' ' PRO . 67.3 t -67.28 -42.99 88.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.523 -0.986 . . . . 40.0 108.828 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.508 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.88 -59.13 5.87 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.974 -0.75 . . . . 40.0 108.974 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.23 -56.79 7.08 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.913 -0.773 . . . . 40.0 108.913 178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.72 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 34.2 t80 -52.15 -53.01 48.24 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 116.116 -0.493 . . . . 40.0 110.61 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.588 ' O ' ' N ' ' A' ' 18' ' ' HIS . 4.4 tt -71.67 -51.21 24.23 Favored 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.301 0.572 . . . . 40.0 110.851 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 11' ' ' ALA . 58.6 mt-30 -53.57 -28.58 32.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.233 -1.542 . . . . 40.0 110.178 178.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.6 m -91.46 -52.63 4.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.805 -1.184 . . . . 40.0 110.524 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -97.68 12.26 34.28 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.279 -0.888 . . . . 40.0 110.576 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.588 ' N ' ' O ' ' A' ' 14' ' ' LEU . 23.7 m80 42.7 25.64 0.05 Allowed 'General case' 0 N--CA 1.512 2.643 0 O-C-N 121.237 -0.914 . . . . 40.0 111.151 178.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 pttp -137.0 160.9 37.56 Favored 'General case' 0 C--O 1.185 -2.329 0 O-C-N 121.44 -0.787 . . . . 40.0 109.559 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.423 ' HB3' ' HB2' ' A' ' 24' ' ' TYR . 3.4 mp -80.3 145.57 60.22 Favored Pre-proline 0 C--N 1.265 -3.101 0 O-C-N 120.744 -1.223 . . . . 40.0 108.764 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.72 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 72.6 Cg_exo -40.99 155.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.831 2.354 . . . . 40.0 113.417 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.63 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.2 OUTLIER -65.61 49.97 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.05 -1.031 . . . . 40.0 109.356 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -171.91 26.21 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.703 -1.248 . . . . 40.0 110.639 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.423 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 5.4 m-85 -119.82 108.39 14.32 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.789 -1.194 . . . . 40.0 109.674 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.413 HG21 HD13 ' A' ' 25' ' ' ILE . 21.6 pt -119.66 128.86 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.483 1.135 . . . . 40.0 108.612 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.715 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.4 OUTLIER -63.78 169.34 4.18 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-O 123.561 1.648 . . . . 40.0 114.091 -176.264 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.53 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 12.8 mtmt -58.51 -42.45 87.68 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 104.676 -2.342 . . . . 40.0 104.676 176.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.508 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 7.7 m -32.35 -72.97 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 CA-C-N 116.293 -0.412 . . . . 40.0 110.261 176.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.485 ' O ' ' C ' ' A' ' 30' ' ' ALA . 3.1 mp0 -64.02 -54.86 27.71 Favored 'General case' 0 C--O 1.193 -1.909 0 N-CA-C 106.558 -1.645 . . . . 40.0 106.558 -178.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.485 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -36.11 -55.2 0.78 Allowed 'General case' 0 N--CA 1.514 2.753 0 O-C-N 120.591 -1.318 . . . . 40.0 110.412 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.423 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 38.7 mt-30 -56.35 -67.6 0.29 Allowed 'General case' 0 N--CA 1.507 2.425 0 O-C-N 120.681 -1.262 . . . . 40.0 111.088 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.14 -26.86 61.23 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 119.93 -1.731 . . . . 40.0 110.58 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 38.4 tp -67.17 -21.56 65.8 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 108.36 -0.978 . . . . 40.0 108.36 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.59 40.45 0.53 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.851 -0.9 . . . . 40.0 110.851 178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.574 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -77.68 139.97 39.51 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.435 -1.627 . . . . 40.0 109.521 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 72.2 t -136.44 131.27 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.607 0 O-C-N 121.74 -0.6 . . . . 40.0 109.896 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.404 ' C ' ' H ' ' A' ' 39' ' ' LYS . . . -58.45 -50.13 74.81 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 116.612 -0.267 . . . . 40.0 110.386 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 80.5 p -69.98 46.23 0.08 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.427 -0.796 . . . . 40.0 110.232 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.599 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 2.3 ttpm? -178.33 -51.91 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.989 -0.745 . . . . 40.0 108.989 179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.1 61.83 5.73 Favored Glycine 0 N--CA 1.499 2.858 0 N-CA-C 108.412 -1.875 . . . . 40.0 108.412 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.599 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -78.92 161.25 26.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.607 -0.937 . . . . 40.0 110.101 -178.347 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.786 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 56.2 tp -173.56 -67.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.676 -0.81 . . . . 40.0 110.515 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.611 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -64.26 -19.29 65.29 Favored 'General case' 0 N--CA 1.505 2.315 0 O-C-N 120.571 -1.331 . . . . 40.0 109.973 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 5.9 p-10 -75.41 -63.41 1.29 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.857 -0.794 . . . . 40.0 108.857 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.2 m -78.13 -15.85 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.715 -0.616 . . . . 40.0 109.654 178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.518 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -142.74 72.89 19.66 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.255 -0.903 . . . . 40.0 109.622 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -56.91 117.62 4.34 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.819 2.346 . . . . 40.0 113.28 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.85 35.97 48.86 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.996 -1.242 . . . . 40.0 109.996 178.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.518 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 7.0 mmtt -133.48 162.63 31.35 Favored 'General case' 0 N--CA 1.51 2.528 0 O-C-N 121.899 -0.765 . . . . 40.0 109.86 -178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.42 ' HA ' HD21 ' A' ' 42' ' ' LEU . 70.3 m -138.01 165.83 25.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.095 -1.003 . . . . 40.0 111.244 -177.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 15.5 mm -83.26 124.72 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.54 0.686 . . . . 40.0 111.144 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.81 157.82 17.23 Favored Glycine 0 N--CA 1.499 2.84 0 C-N-CA 119.539 -1.315 . . . . 40.0 110.417 178.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.715 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 116.16 -7.66 18.77 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.653 -1.379 . . . . 40.0 109.653 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.515 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 6.8 m-20 -74.31 -153.83 0.03 OUTLIER 'General case' 0 C--O 1.189 -2.106 0 O-C-N 121.375 -1.073 . . . . 40.0 110.194 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.1 mp -131.68 141.29 46.07 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.027 0 N-CA-C 108.355 -0.98 . . . . 40.0 108.355 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.618 ' O ' ' N ' ' A' ' 58' ' ' ASN . 14.4 t80 -110.69 90.94 3.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.116 -0.99 . . . . 40.0 108.772 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.656 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.6 p -60.27 39.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.625 -0.672 . . . . 40.0 110.858 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.618 ' N ' ' O ' ' A' ' 56' ' ' PHE . 47.5 t30 34.35 38.19 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.104 -0.998 . . . . 40.0 111.051 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.656 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 11.4 mtm180 -71.25 38.92 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.027 -1.046 . . . . 40.0 109.847 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.608 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 11.7 mt-10 -146.24 -6.34 0.56 Allowed 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.441 -0.787 . . . . 40.0 110.195 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.28 36.48 62.65 Favored Glycine 0 N--CA 1.498 2.824 0 N-CA-C 109.129 -1.588 . . . . 40.0 109.129 -178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.667 ' NZ ' ' O ' ' A' ' 103' ' ' TYR . 3.5 mttp -120.67 12.58 11.47 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.717 -0.872 . . . . 40.0 109.652 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.452 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.4 mt -137.54 144.41 44.87 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.451 -0.781 . . . . 40.0 109.394 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -62.5 124.75 14.77 Favored 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 122.441 2.094 . . . . 40.0 112.674 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.524 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.22 -178.29 27.57 Favored Glycine 0 N--CA 1.498 2.822 0 N-CA-C 110.054 -1.218 . . . . 40.0 110.054 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.489 ' NZ ' ' O ' ' A' ' 68' ' ' GLY . 10.3 tttt -178.03 153.15 0.78 Allowed 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.272 -1.134 . . . . 40.0 108.625 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.468 ' O ' ' OG ' ' A' ' 67' ' ' SER . 8.5 p -73.09 55.3 0.42 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.755 -1.215 . . . . 40.0 109.099 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.489 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 148.28 78.94 0.03 OUTLIER Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.477 -1.449 . . . . 40.0 109.477 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.552 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -173.66 175.93 2.84 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.759 -0.848 . . . . 40.0 108.95 179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.552 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 87.6 m -154.44 155.25 34.62 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.135 -0.978 . . . . 40.0 110.062 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.718 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 30.2 m95 -124.68 140.71 52.68 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-O 121.267 0.556 . . . . 40.0 110.246 -178.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.624 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -131.63 149.83 52.36 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.881 -1.137 . . . . 40.0 110.216 179.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.53 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -113.35 167.76 10.3 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.321 1.057 . . . . 40.0 111.91 -179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.67 137.85 4.88 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.754 -0.591 . . . . 40.0 110.378 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.751 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -59.82 153.69 20.13 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 116.151 -0.477 . . . . 40.0 110.959 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.78 HD11 ' CG2' ' A' ' 88' ' ' ILE . 42.7 mm -136.18 144.8 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 O-C-N 121.419 -0.801 . . . . 40.0 110.04 179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 56.28 70.82 0.61 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.486 0.66 . . . . 40.0 110.598 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.786 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 62.4 t80 -130.73 155.49 46.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.132 -0.98 . . . . 40.0 109.34 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.577 ' OG1' ' N ' ' A' ' 80' ' ' SER . 24.0 p -134.96 -73.46 0.47 Allowed 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.63 0.729 . . . . 40.0 110.064 179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.611 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -153.46 105.69 2.86 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.03 -0.729 . . . . 40.0 109.03 -178.499 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.479 ' N ' ' OH ' ' A' ' 78' ' ' TYR . . . 159.13 -102.35 0.21 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 109.733 -1.347 . . . . 40.0 109.733 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 35.4 t80 -140.81 -167.55 2.39 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.638 -0.919 . . . . 40.0 109.895 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.639 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.3 mtm180 -74.19 -157.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.179 -0.95 . . . . 40.0 110.147 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.566 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 11.4 p30 -164.59 -149.25 0.12 Allowed 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.939 -1.134 . . . . 40.0 107.939 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.496 ' OG ' ' O ' ' A' ' 100' ' ' THR . 64.1 p -103.94 -9.07 19.18 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.809 -1.182 . . . . 40.0 109.409 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.479 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -85.67 113.77 22.13 Favored 'General case' 0 N--CA 1.509 2.481 0 CA-C-O 121.787 0.803 . . . . 40.0 111.688 -179.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.856 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.43 150.22 46.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.986 -1.071 . . . . 40.0 110.617 179.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.78 ' CG2' HD11 ' A' ' 76' ' ' ILE . 7.3 tt -116.4 140.78 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 CA-C-O 122.131 0.967 . . . . 40.0 109.833 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.581 HD13 ' O ' ' A' ' 72' ' ' ARG . 3.0 mm? -119.24 125.99 50.44 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.361 -0.978 . . . . 40.0 108.361 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.666 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -119.89 129.4 54.35 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.824 -0.806 . . . . 40.0 108.824 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.718 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 2.9 p -94.1 157.8 15.91 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 122.297 1.046 . . . . 40.0 112.448 -178.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.7 p -68.41 -17.49 64.23 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.559 -0.904 . . . . 40.0 108.559 177.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.491 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -85.82 8.54 19.66 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.567 -0.853 . . . . 40.0 109.482 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.466 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 78.9 25.39 0.5 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.611 -0.68 . . . . 40.0 110.496 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 19.5 mt -95.71 138.02 33.95 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.135 -0.978 . . . . 40.0 109.108 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.479 ' CG2' HD11 ' A' ' 109' ' ' ILE . 43.1 mm -112.04 121.16 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.587 -0.696 . . . . 40.0 110.417 -178.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.414 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.5 m-85 -122.98 144.95 48.9 Favored 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 120.245 -0.582 . . . . 40.0 109.496 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.479 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 5.3 tptp -133.7 145.71 50.14 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.083 -1.011 . . . . 40.0 110.84 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.484 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.2 t -125.89 168.36 13.98 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.761 -0.829 . . . . 40.0 108.761 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.496 ' O ' ' OG ' ' A' ' 85' ' ' SER . 71.2 p -141.79 -8.15 0.95 Allowed 'General case' 0 N--CA 1.51 2.544 0 O-C-N 121.21 -0.931 . . . . 40.0 109.717 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.677 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -108.81 16.63 22.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.125 -0.984 . . . . 40.0 110.104 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 81.85 61.18 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.221 0.534 . . . . 40.0 110.217 178.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.667 ' O ' ' NZ ' ' A' ' 62' ' ' LYS . 31.5 m-85 71.41 -20.43 0.23 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.577 -0.702 . . . . 40.0 110.87 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.413 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.6 mt-30 -45.2 -74.34 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.024 -1.047 . . . . 40.0 110.001 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.536 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 23.6 p -104.59 164.02 12.05 Favored 'General case' 0 C--O 1.194 -1.829 0 O-C-N 120.901 -1.124 . . . . 40.0 108.115 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.573 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -137.9 139.68 39.95 Favored 'General case' 0 C--N 1.273 -2.753 0 O-C-N 121.351 -0.843 . . . . 40.0 109.932 -179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 30.5 m -126.73 137.01 53.19 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.156 -1.053 . . . . 40.0 108.156 178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.6 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 14.9 tttp -83.87 146.05 28.29 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.837 -1.164 . . . . 40.0 109.679 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.479 HD11 ' CG2' ' A' ' 96' ' ' ILE . 14.5 pt -121.75 -33.77 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.283 -0.885 . . . . 40.0 109.043 179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.643 HH21 ' CG ' ' A' ' 8' ' ' ASP . 72.2 mtt180 . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 118.173 -0.918 . . . . 40.0 108.993 178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.658 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 17.6 t . . . . . 0 N--CA 1.484 1.269 0 N-CA-C 109.389 -0.596 . . . . 40.0 109.389 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 tt -176.4 152.64 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.27 -0.894 . . . . 40.0 109.169 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -142.71 24.16 1.89 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.805 -1.185 . . . . 40.0 111.215 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 10' ' ' VAL . 10.9 p -105.74 153.16 22.25 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.679 0.752 . . . . 40.0 110.172 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.491 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -55.96 -63.11 1.29 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.036 -1.04 . . . . 40.0 111.052 -178.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.631 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -58.56 -41.08 84.81 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.506 -0.746 . . . . 40.0 109.745 -179.35 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -56.35 -45.14 89.39 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.712 -1.355 . . . . 40.0 109.712 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.54 HG22 ' HG2' ' A' ' 21' ' ' PRO . 71.1 t -67.39 -43.68 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.578 -0.954 . . . . 40.0 108.787 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.508 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -59.94 -59.15 5.88 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.947 -0.76 . . . . 40.0 108.947 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.24 -56.74 8.37 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.951 -0.759 . . . . 40.0 108.951 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.733 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 39.9 t80 -52.3 -51.96 55.63 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.048 0.451 . . . . 40.0 110.441 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 18' ' ' HIS . 2.2 tt -72.04 -52.58 16.24 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.64 -0.663 . . . . 40.0 111.056 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 11' ' ' ALA . 63.7 mt-30 -51.59 -27.25 10.6 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.23 -1.544 . . . . 40.0 110.721 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.7 m -92.35 -49.84 5.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.585 -1.322 . . . . 40.0 111.347 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 19' ' ' LYS . 92.7 m-85 -100.85 16.0 26.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.845 -1.159 . . . . 40.0 110.114 -177.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.497 ' N ' ' O ' ' A' ' 14' ' ' LEU . 25.1 m80 41.43 24.25 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.64 0 O-C-N 121.8 -0.563 . . . . 40.0 110.976 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 17' ' ' TYR . 3.6 pttp -135.48 158.78 43.51 Favored 'General case' 0 C--O 1.178 -2.7 0 O-C-N 121.177 -0.952 . . . . 40.0 110.771 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mp -79.25 144.28 62.13 Favored Pre-proline 0 C--N 1.271 -2.847 0 O-C-N 120.9 -1.125 . . . . 40.0 108.88 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.733 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 81.8 Cg_exo -38.73 155.64 0.03 OUTLIER 'Trans proline' 0 N--CA 1.502 2.003 0 C-N-CA 123.803 3.002 . . . . 40.0 114.433 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.658 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.4 OUTLIER -67.61 50.11 0.05 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 122.283 1.039 . . . . 40.0 109.253 -179.51 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.531 ' HA ' ' HD3' ' A' ' 49' ' ' LYS . 0.8 OUTLIER -173.86 26.24 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.129 -0.982 . . . . 40.0 110.552 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -120.21 111.92 18.42 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.294 -1.504 . . . . 40.0 110.122 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.428 HG21 HD13 ' A' ' 25' ' ' ILE . 23.0 pt -118.28 138.22 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.248 -1.019 . . . . 40.0 108.248 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.769 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.6 OUTLIER -72.4 168.93 17.42 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 123.372 1.558 . . . . 40.0 113.357 -178.283 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.509 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 24.3 mtmt -60.66 -39.38 88.14 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 105.801 -1.925 . . . . 40.0 105.801 176.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.53 ' OG ' ' OG1' ' A' ' 26' ' ' THR . 1.1 m -36.37 -70.86 0.08 Allowed 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.749 -0.834 . . . . 40.0 108.749 176.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.56 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.7 mp0 -64.22 -55.43 21.69 Favored 'General case' 0 C--O 1.201 -1.473 0 N-CA-C 106.098 -1.815 . . . . 40.0 106.098 -176.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.56 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -35.44 -51.87 0.62 Allowed 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 118.562 -1.255 . . . . 40.0 109.573 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -55.45 -68.43 0.2 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.992 -1.067 . . . . 40.0 111.67 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.37 -24.31 54.54 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.263 -0.898 . . . . 40.0 111.141 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 54.7 tp -69.88 -21.2 63.35 Favored 'General case' 0 N--CA 1.509 2.475 0 N-CA-C 106.878 -1.527 . . . . 40.0 106.878 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.7 43.61 0.53 Allowed Glycine 0 N--CA 1.504 3.184 0 N-CA-C 111.523 -0.631 . . . . 40.0 111.523 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.54 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -77.88 138.97 39.2 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.725 -1.456 . . . . 40.0 109.531 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 88.9 t -135.7 130.33 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.685 0 O-C-N 121.154 -0.966 . . . . 40.0 109.302 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.48 -46.74 86.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.832 -0.543 . . . . 40.0 110.014 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.5 p -71.45 44.01 0.09 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-O 121.431 0.634 . . . . 40.0 110.644 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.585 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 ttpm? -177.43 -50.5 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.495 -0.753 . . . . 40.0 109.174 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 63.18 59.26 9.24 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 108.934 -1.666 . . . . 40.0 108.934 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.585 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -74.82 160.87 30.14 Favored 'General case' 0 C--N 1.291 -1.952 0 O-C-N 121.453 -1.028 . . . . 40.0 110.641 -177.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.872 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 57.1 tp -173.32 -69.5 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.999 -1.063 . . . . 40.0 110.385 179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.554 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.07 -23.0 63.43 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 120.947 -1.096 . . . . 40.0 110.028 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.4 p-10 -73.28 -64.89 0.89 Allowed 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.702 0.763 . . . . 40.0 109.218 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG13 ' OD2' ' A' ' 44' ' ' ASP . 28.7 m -76.78 -15.17 14.76 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 N-CA-C 109.205 -0.665 . . . . 40.0 109.205 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.584 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -144.22 71.34 16.29 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.501 -0.749 . . . . 40.0 110.16 -178.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.04 117.16 3.8 Favored 'Trans proline' 0 N--CA 1.504 2.128 0 C-N-CA 123.375 2.717 . . . . 40.0 113.788 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 73.61 37.73 52.13 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.167 -1.573 . . . . 40.0 109.167 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.584 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 8.5 mmtm -135.2 162.3 32.92 Favored 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 108.856 -0.794 . . . . 40.0 108.856 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.448 ' HA ' HD21 ' A' ' 42' ' ' LEU . 65.7 m -138.22 166.55 23.9 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.326 1.06 . . . . 40.0 110.594 -177.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 18.7 mm -84.1 124.11 39.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 CA-C-N 115.876 -0.602 . . . . 40.0 111.508 -179.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 178.08 159.67 23.18 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.506 -1.438 . . . . 40.0 109.506 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.769 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 115.75 -7.17 19.94 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.623 -1.275 . . . . 40.0 110.92 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.441 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 5.2 m-20 -76.02 -152.26 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.381 -1.658 . . . . 40.0 110.072 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.7 mp -131.12 143.85 39.54 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.016 0 N-CA-C 108.327 -0.99 . . . . 40.0 108.327 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.636 ' O ' ' N ' ' A' ' 58' ' ' ASN . 13.7 t80 -113.51 90.97 3.48 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.217 -0.927 . . . . 40.0 108.78 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.653 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.6 p -59.07 38.0 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.705 0.764 . . . . 40.0 110.735 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.636 ' N ' ' O ' ' A' ' 56' ' ' PHE . 43.5 t30 34.67 38.57 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.293 -0.88 . . . . 40.0 110.671 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.653 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.8 mtm180 -69.91 36.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.196 -0.94 . . . . 40.0 110.483 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.608 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 14.6 mt-10 -145.36 -4.82 0.68 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.135 -0.978 . . . . 40.0 110.332 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.65 36.97 66.32 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 109.635 -1.386 . . . . 40.0 109.635 -178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.608 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 5.1 mttp -120.36 12.3 11.65 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.575 -0.956 . . . . 40.0 109.502 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.422 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -136.4 142.93 41.35 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.564 -0.71 . . . . 40.0 109.36 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -61.75 122.72 11.41 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 122.392 2.061 . . . . 40.0 112.344 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.513 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -101.18 -178.27 28.92 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 110.535 -1.026 . . . . 40.0 110.535 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.422 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 8.9 tttt -177.6 152.75 0.83 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.138 -1.213 . . . . 40.0 108.267 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.4 p -72.07 53.62 0.27 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.841 -1.162 . . . . 40.0 109.258 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.401 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 151.26 80.34 0.03 OUTLIER Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.826 -1.31 . . . . 40.0 109.826 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.559 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.96 177.31 2.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.533 -0.981 . . . . 40.0 109.037 179.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.559 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 90.1 m -154.75 154.92 33.59 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.124 -0.985 . . . . 40.0 110.043 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.713 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 30.0 m95 -124.14 139.86 53.52 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.384 0.612 . . . . 40.0 109.671 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.638 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.52 149.83 52.01 Favored 'General case' 0 N--CA 1.507 2.388 0 O-C-N 120.794 -1.191 . . . . 40.0 109.897 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.509 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -116.19 167.69 10.78 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.068 -1.02 . . . . 40.0 112.006 -179.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -162.9 138.57 6.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.653 -0.654 . . . . 40.0 111.351 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.741 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -59.6 154.22 18.12 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.656 -0.652 . . . . 40.0 110.934 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.741 HD13 ' O ' ' A' ' 75' ' ' ASP . 42.7 mm -137.43 145.87 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.499 -0.75 . . . . 40.0 110.394 179.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.1 m-80 57.38 70.08 0.68 Allowed 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.483 0.659 . . . . 40.0 110.524 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.872 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 70.2 t80 -131.86 155.65 47.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.039 -1.038 . . . . 40.0 110.112 179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.609 ' OG1' ' N ' ' A' ' 80' ' ' SER . 19.2 p -136.64 -73.34 0.44 Allowed 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 121.124 0.488 . . . . 40.0 110.202 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.609 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -153.01 106.47 3.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.554 -0.716 . . . . 40.0 109.416 -178.466 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 159.93 -104.32 0.24 Allowed Glycine 0 N--CA 1.496 2.67 0 N-CA-C 109.747 -1.341 . . . . 40.0 109.747 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.481 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 47.2 t80 -139.94 -167.01 2.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 122.013 -0.698 . . . . 40.0 109.382 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.638 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.1 mtm180 -73.12 -154.34 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.166 -0.959 . . . . 40.0 110.075 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.555 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 11.6 p30 -168.05 -150.24 0.1 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.262 -1.014 . . . . 40.0 108.262 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.516 ' OG ' ' O ' ' A' ' 100' ' ' THR . 71.6 p -103.3 -8.0 20.66 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.64 -1.288 . . . . 40.0 109.313 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.521 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.6 114.15 23.95 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-O 122.063 0.935 . . . . 40.0 111.473 -179.764 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.858 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.28 151.0 47.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.871 -1.143 . . . . 40.0 110.426 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.675 ' CG2' HD11 ' A' ' 76' ' ' ILE . 5.7 tt -117.99 136.71 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.794 0.807 . . . . 40.0 109.825 178.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.536 HD13 ' O ' ' A' ' 72' ' ' ARG . 3.1 mm? -115.84 125.16 52.3 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.798 -0.815 . . . . 40.0 108.798 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.682 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.94 129.53 55.22 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 122.077 0.942 . . . . 40.0 108.997 -179.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.713 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 3.7 p -94.65 158.9 15.32 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 122.41 1.1 . . . . 40.0 112.504 -177.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.7 p -68.59 -18.14 64.27 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.234 -1.025 . . . . 40.0 108.234 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.502 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -86.32 9.17 18.66 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.666 -0.646 . . . . 40.0 109.647 179.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.462 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.76 26.48 0.64 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.661 -0.649 . . . . 40.0 110.361 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 20.9 mt -95.99 137.47 35.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.118 -0.989 . . . . 40.0 109.093 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.516 ' CG2' HD11 ' A' ' 109' ' ' ILE . 40.2 mm -111.77 119.15 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.634 -0.666 . . . . 40.0 110.564 -178.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.434 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 8.0 m-85 -121.83 144.32 48.9 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.357 -0.537 . . . . 40.0 109.766 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.521 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 4.8 tptp -133.25 144.5 49.8 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.372 -0.83 . . . . 40.0 110.849 -178.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.616 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.9 t -123.12 166.69 14.76 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 108.84 -0.8 . . . . 40.0 108.84 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.516 ' O ' ' OG ' ' A' ' 85' ' ' SER . 45.0 p -140.29 -10.31 1.1 Allowed 'General case' 0 N--CA 1.509 2.49 0 O-C-N 121.556 -0.715 . . . . 40.0 109.672 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.69 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -107.75 12.7 27.15 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.007 -1.058 . . . . 40.0 110.203 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 84.97 61.82 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.404 0.621 . . . . 40.0 110.305 179.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.638 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 23.2 m-85 71.62 -21.9 0.21 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.446 -0.784 . . . . 40.0 110.812 179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.417 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.9 mt-30 -44.37 -73.41 0.04 OUTLIER 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.091 -1.006 . . . . 40.0 109.932 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.512 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 22.0 p -106.07 166.4 10.53 Favored 'General case' 0 C--O 1.193 -1.9 0 N-CA-C 107.763 -1.199 . . . . 40.0 107.763 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.529 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -140.06 139.16 35.86 Favored 'General case' 0 C--N 1.27 -2.887 0 O-C-N 121.065 -1.022 . . . . 40.0 109.779 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.1 m -124.65 136.35 53.85 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.355 -0.98 . . . . 40.0 108.355 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.529 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 19.3 tttp -84.95 145.54 27.69 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.779 -1.201 . . . . 40.0 109.652 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.516 HD11 ' CG2' ' A' ' 96' ' ' ILE . 12.8 pt -120.71 -34.42 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.884 -1.135 . . . . 40.0 109.318 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.631 HH21 ' CG ' ' A' ' 8' ' ' ASP . 78.7 mtt180 . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.081 -1.012 . . . . 40.0 108.769 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.628 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 17.0 t . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.319 -0.623 . . . . 40.0 109.319 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -178.27 151.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.393 -0.817 . . . . 40.0 109.587 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -142.53 23.96 1.93 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.16 -0.963 . . . . 40.0 111.684 -177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 10' ' ' VAL . 18.6 p -105.85 153.98 21.17 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.981 0.896 . . . . 40.0 110.456 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -56.39 -64.48 0.85 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.617 -1.302 . . . . 40.0 110.833 -179.288 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.615 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -56.84 -41.43 77.88 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.05 -1.032 . . . . 40.0 110.034 -179.294 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.21 -44.99 84.17 Favored Glycine 0 N--CA 1.504 3.181 0 N-CA-C 110.164 -1.174 . . . . 40.0 110.164 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.585 HG22 ' HG2' ' A' ' 21' ' ' PRO . 69.5 t -68.77 -42.49 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.587 -0.949 . . . . 40.0 108.798 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.511 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.35 -59.38 5.49 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.489 -0.93 . . . . 40.0 108.489 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.23 -56.77 8.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.55 -0.719 . . . . 40.0 109.334 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.75 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 40.8 t80 -52.74 -51.41 60.62 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.915 -0.491 . . . . 40.0 110.353 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 18' ' ' HIS . 4.0 tt -72.36 -51.4 20.71 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.7 -0.625 . . . . 40.0 110.945 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 11' ' ' ALA . 57.3 mt-30 -52.39 -28.36 19.35 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.051 -1.655 . . . . 40.0 110.129 179.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 m -91.53 -51.28 5.34 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.781 -1.2 . . . . 40.0 111.249 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -99.04 12.8 34.96 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.29 -0.881 . . . . 40.0 110.258 -177.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.518 ' N ' ' O ' ' A' ' 14' ' ' LEU . 20.7 m80 42.47 25.67 0.05 OUTLIER 'General case' 0 N--CA 1.516 2.856 0 O-C-N 121.477 -0.764 . . . . 40.0 110.92 178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.9 pttp -136.63 158.61 44.03 Favored 'General case' 0 C--O 1.184 -2.367 0 CA-C-O 121.916 0.865 . . . . 40.0 110.188 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mp -78.31 147.83 73.12 Favored Pre-proline 0 C--N 1.265 -3.093 0 O-C-N 120.659 -1.275 . . . . 40.0 108.684 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.75 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 83.3 Cg_exo -41.47 156.09 0.07 OUTLIER 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 123.272 2.648 . . . . 40.0 114.102 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.628 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -67.07 49.49 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.124 0.964 . . . . 40.0 109.48 -179.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -173.67 26.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.256 -0.902 . . . . 40.0 110.701 -179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -118.19 109.75 16.74 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.76 -1.213 . . . . 40.0 110.487 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.4 HD13 HG21 ' A' ' 25' ' ' ILE . 15.4 pt -119.07 132.88 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 108.169 -1.049 . . . . 40.0 108.169 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.868 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.4 OUTLIER -69.48 173.35 6.03 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-O 124.24 1.972 . . . . 40.0 113.443 -177.395 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.651 ' HB3' ' NE2' ' A' ' 31' ' ' GLN . 14.6 mtmt -62.53 -40.12 95.75 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 106.266 -1.753 . . . . 40.0 106.266 177.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.511 ' OG ' ' OG1' ' A' ' 26' ' ' THR . 2.9 m -32.97 -74.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 123.028 1.394 . . . . 40.0 109.666 174.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.501 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.4 mp0 -63.13 -56.47 16.49 Favored 'General case' 0 C--O 1.2 -1.509 0 CA-C-N 114.392 -1.277 . . . . 40.0 108.041 -177.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.501 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -38.26 -51.64 1.48 Allowed 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.956 -1.09 . . . . 40.0 109.918 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.651 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 24.1 mt-30 -56.85 -64.63 0.81 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.676 -1.265 . . . . 40.0 110.351 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.47 -25.29 64.29 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.113 -0.992 . . . . 40.0 109.471 -178.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.1 tp -65.66 -24.52 67.04 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.729 -0.841 . . . . 40.0 108.729 178.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.11 48.22 0.29 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.243 -1.143 . . . . 40.0 110.243 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.579 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -85.72 137.47 32.79 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.461 -1.023 . . . . 40.0 109.906 -179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.5 t -134.16 131.41 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.705 0 O-C-N 121.49 -0.756 . . . . 40.0 109.956 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.64 -47.92 82.77 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.743 -0.836 . . . . 40.0 108.743 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.1 p -69.87 43.64 0.06 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.627 -0.67 . . . . 40.0 110.907 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.499 ' HZ3' ' CG ' ' A' ' 41' ' ' ASN . 1.1 ttpm? -176.8 -49.83 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.314 -0.866 . . . . 40.0 109.13 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.17 59.7 9.11 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 108.349 -1.9 . . . . 40.0 108.349 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.579 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.1 OUTLIER -76.57 159.84 29.96 Favored 'General case' 0 C--N 1.29 -2.004 0 O-C-N 121.654 -0.909 . . . . 40.0 110.833 -177.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.816 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 56.1 tp -173.92 -68.32 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.53 -0.868 . . . . 40.0 111.04 178.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.6 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -60.64 -22.08 63.44 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.812 -1.18 . . . . 40.0 109.36 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.5 p-10 -74.64 -62.3 1.58 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.13 -0.693 . . . . 40.0 109.13 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.4 m -78.56 -13.52 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 N-CA-C 109.122 -0.696 . . . . 40.0 109.122 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.455 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -147.12 72.57 12.14 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.637 -0.664 . . . . 40.0 110.058 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -56.7 118.58 5.45 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 123.178 2.586 . . . . 40.0 113.911 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.37 39.64 56.69 Favored Glycine 0 N--CA 1.497 2.709 0 N-CA-C 109.69 -1.364 . . . . 40.0 109.69 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.445 ' NZ ' ' HB3' ' A' ' 23' ' ' ASN . 7.2 mmtm -134.39 168.89 18.09 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-O 121.859 0.838 . . . . 40.0 109.829 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.7 m -144.39 160.83 40.4 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 120.827 -1.171 . . . . 40.0 111.381 -176.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 17.3 mm -81.25 123.04 37.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 CA-C-N 115.437 -0.801 . . . . 40.0 110.557 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 74' ' ' ALA . . . 177.16 154.56 12.2 Favored Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.555 -1.418 . . . . 40.0 109.555 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.868 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 120.54 -13.55 10.08 Favored Glycine 0 N--CA 1.497 2.713 0 C-N-CA 119.162 -1.494 . . . . 40.0 111.236 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.47 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 4.3 m-20 -71.41 -152.0 0.02 OUTLIER 'General case' 0 C--O 1.196 -1.747 0 O-C-N 121.202 -1.176 . . . . 40.0 109.781 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.37 142.63 42.84 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.893 0 CA-C-N 115.256 -0.884 . . . . 40.0 109.236 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.652 ' O ' ' N ' ' A' ' 58' ' ' ASN . 11.1 t80 -111.17 89.76 3.14 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.347 -0.845 . . . . 40.0 109.696 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.669 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.9 p -58.71 38.38 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 CA-C-O 121.921 0.867 . . . . 40.0 110.774 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.652 ' N ' ' O ' ' A' ' 56' ' ' PHE . 40.8 t30 33.66 40.01 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.275 -0.89 . . . . 40.0 110.484 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.669 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 11.4 mtm180 -70.85 37.23 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.957 -1.089 . . . . 40.0 110.056 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.606 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 14.1 mt-10 -146.6 -1.05 0.72 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.998 -1.064 . . . . 40.0 110.29 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 51.11 39.42 41.65 Favored Glycine 0 N--CA 1.496 2.667 0 N-CA-C 109.681 -1.368 . . . . 40.0 109.681 -178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.606 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 3.5 mttp -121.68 12.34 10.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.657 -0.908 . . . . 40.0 109.366 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.47 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.5 mt -137.33 143.62 42.18 Favored Pre-proline 0 N--CA 1.498 1.952 0 O-C-N 121.66 -0.65 . . . . 40.0 109.541 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -61.38 122.68 11.46 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.296 1.997 . . . . 40.0 112.137 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.525 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.98 -177.29 26.69 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.866 -1.293 . . . . 40.0 109.866 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.415 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 8.0 tttt -177.94 154.73 0.92 Allowed 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 107.871 -1.159 . . . . 40.0 107.871 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.2 p -73.2 55.47 0.44 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.995 -1.066 . . . . 40.0 109.172 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.98 81.4 0.04 OUTLIER Glycine 0 N--CA 1.495 2.618 0 N-CA-C 109.753 -1.339 . . . . 40.0 109.753 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.559 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.31 178.29 2.06 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.493 -1.004 . . . . 40.0 108.713 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.559 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 92.4 m -155.24 153.01 29.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.017 -1.052 . . . . 40.0 109.921 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.717 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 28.8 m95 -122.7 140.38 52.93 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.194 0.521 . . . . 40.0 110.006 -179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.613 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -131.42 147.11 52.53 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 120.96 -1.087 . . . . 40.0 110.392 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.565 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -111.84 168.2 9.76 Favored 'General case' 0 N--CA 1.507 2.396 0 O-C-N 120.979 -1.076 . . . . 40.0 112.278 -179.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.431 ' HA ' ' HA2' ' A' ' 52' ' ' GLY . . . -163.76 139.75 6.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.241 -0.912 . . . . 40.0 110.225 178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.732 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -61.29 154.71 23.0 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 120.976 0.417 . . . . 40.0 110.576 -179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.732 HD13 ' O ' ' A' ' 75' ' ' ASP . 32.6 mm -138.11 146.01 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.587 -0.696 . . . . 40.0 110.325 178.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 56.4 71.05 0.59 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.582 0.706 . . . . 40.0 110.839 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.816 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 67.7 t80 -132.45 156.66 46.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.196 -0.94 . . . . 40.0 109.471 179.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.596 ' OG1' ' N ' ' A' ' 80' ' ' SER . 21.4 p -137.97 -72.44 0.42 Allowed 'General case' 0 N--CA 1.511 2.614 0 CA-C-O 121.44 0.638 . . . . 40.0 109.491 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.6 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -152.99 105.69 2.95 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.653 -0.654 . . . . 40.0 109.57 -178.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 162.06 -103.96 0.23 Allowed Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.467 -1.349 . . . . 40.0 110.156 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 49.2 t80 -142.16 -167.55 2.5 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.53 -0.915 . . . . 40.0 108.53 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.659 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.3 mtm180 -72.9 -156.48 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.04 -1.038 . . . . 40.0 110.398 -179.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.501 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 10.1 p30 -165.67 -149.38 0.11 Allowed 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.132 -1.062 . . . . 40.0 108.132 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.512 ' OG ' ' O ' ' A' ' 100' ' ' THR . 60.3 p -104.14 -7.46 20.16 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 120.804 -1.185 . . . . 40.0 109.252 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.509 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.97 113.09 23.28 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-O 121.898 0.856 . . . . 40.0 111.642 -179.263 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.86 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.44 150.06 46.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.055 -1.028 . . . . 40.0 110.391 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.675 ' CG2' HD11 ' A' ' 76' ' ' ILE . 5.1 tt -116.69 141.51 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 122.404 1.097 . . . . 40.0 109.777 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.584 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.8 mm? -121.02 124.42 44.8 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.294 -1.002 . . . . 40.0 108.294 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.679 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.15 129.38 55.49 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.82 0.819 . . . . 40.0 108.816 -179.813 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.717 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.2 p -93.56 159.99 14.99 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 122.322 1.058 . . . . 40.0 112.467 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 18.4 p -70.04 -18.11 63.28 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.241 -1.022 . . . . 40.0 108.241 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.463 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -86.15 8.69 19.96 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 120.052 -0.659 . . . . 40.0 109.498 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.447 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.88 26.79 0.6 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.497 -0.752 . . . . 40.0 109.955 179.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.441 HD12 HH21 ' A' ' 69' ' ' ARG . 27.1 mt -94.94 137.2 34.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.121 -0.987 . . . . 40.0 108.471 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.52 ' CG2' HD11 ' A' ' 109' ' ' ILE . 37.2 mm -112.15 119.84 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.533 -0.73 . . . . 40.0 110.338 -178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -122.2 144.74 48.78 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.935 -0.706 . . . . 40.0 109.663 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.509 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 3.7 tptp -133.66 145.04 49.59 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.109 -0.995 . . . . 40.0 110.87 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.531 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.5 t -124.01 167.12 14.6 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 109.02 -0.733 . . . . 40.0 109.02 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.512 ' O ' ' OG ' ' A' ' 85' ' ' SER . 38.7 p -140.47 -9.43 1.09 Allowed 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.213 -0.93 . . . . 40.0 109.922 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.68 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -108.16 13.27 26.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 40.0 109.997 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 84.36 62.08 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.263 0.554 . . . . 40.0 110.308 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.659 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 22.7 m-85 70.61 -20.64 0.2 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.722 -0.611 . . . . 40.0 110.864 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.7 mt-30 -44.07 -73.7 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.162 -0.961 . . . . 40.0 109.472 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.477 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 22.0 p -106.25 167.88 9.52 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 107.316 -1.364 . . . . 40.0 107.316 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.584 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -140.32 140.12 35.57 Favored 'General case' 0 C--N 1.268 -2.966 0 O-C-N 121.645 -0.66 . . . . 40.0 109.866 179.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.2 m -125.14 135.75 52.94 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.267 -1.012 . . . . 40.0 108.267 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.612 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 19.3 tttp -84.56 145.91 27.82 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.801 -1.187 . . . . 40.0 109.619 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.52 HD11 ' CG2' ' A' ' 96' ' ' ILE . 15.1 pt -121.03 -35.01 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.445 -0.785 . . . . 40.0 109.476 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.615 HH21 ' CG ' ' A' ' 8' ' ' ASP . 78.9 mtt180 . . . . . 0 N--CA 1.488 1.474 0 O-C-N 121.169 -0.957 . . . . 40.0 109.091 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.607 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 12.8 t . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 109.786 -0.45 . . . . 40.0 109.786 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -175.01 153.55 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 109.375 -0.602 . . . . 40.0 109.375 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.1 p-10 -144.58 24.68 1.54 Allowed 'General case' 0 N--CA 1.484 1.23 0 O-C-N 120.853 -1.154 . . . . 40.0 110.36 -178.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 10' ' ' VAL . 14.9 p -105.95 152.34 23.45 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.792 0.806 . . . . 40.0 109.541 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.493 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -55.24 -65.1 0.65 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.987 -1.071 . . . . 40.0 110.922 -178.829 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.595 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.7 OUTLIER -56.71 -41.75 77.96 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.344 -0.847 . . . . 40.0 110.304 -179.286 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.96 -44.87 87.8 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 109.255 -1.538 . . . . 40.0 109.255 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.559 HG22 ' HG2' ' A' ' 21' ' ' PRO . 72.1 t -67.48 -42.42 87.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.837 -0.801 . . . . 40.0 108.879 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -61.65 -57.66 11.14 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.553 -0.717 . . . . 40.0 109.212 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.25 -56.64 8.71 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-O 121.615 0.722 . . . . 40.0 109.186 178.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.734 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 41.7 t80 -53.31 -52.49 58.96 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.147 0.499 . . . . 40.0 110.677 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' A' ' 18' ' ' HIS . 1.2 tt -71.98 -51.61 21.07 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.594 -0.692 . . . . 40.0 110.132 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.541 ' N ' ' O ' ' A' ' 11' ' ' ALA . 63.1 mt-30 -51.25 -29.43 14.46 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.278 -1.514 . . . . 40.0 110.273 179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 m -90.04 -50.77 5.82 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.841 -1.162 . . . . 40.0 111.627 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 19' ' ' LYS . 87.7 m-85 -99.88 14.81 29.14 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.386 -0.821 . . . . 40.0 109.874 -178.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 14' ' ' LEU . 19.9 m80 41.82 24.01 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.532 0 CA-C-O 121.407 0.622 . . . . 40.0 111.141 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 17' ' ' TYR . 4.4 pttp -134.31 158.66 43.22 Favored 'General case' 0 C--O 1.184 -2.373 0 O-C-N 121.305 -0.872 . . . . 40.0 109.939 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.6 mp -79.28 145.06 63.55 Favored Pre-proline 0 C--N 1.263 -3.173 0 O-C-N 120.945 -1.097 . . . . 40.0 109.554 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.734 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 82.3 Cg_exo -37.94 155.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.512 2.578 0 C-N-CA 123.473 2.782 . . . . 40.0 114.7 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.607 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.5 OUTLIER -67.73 50.37 0.05 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.138 -0.976 . . . . 40.0 108.964 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.8 OUTLIER -174.94 24.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 118.952 -1.099 . . . . 40.0 110.764 -179.42 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.411 ' OH ' ' O ' ' A' ' 75' ' ' ASP . 3.5 m-85 -118.26 109.78 16.74 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.981 0.896 . . . . 40.0 110.332 -178.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 25' ' ' ILE . 12.5 pt -118.47 134.13 63.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 N-CA-C 107.931 -1.137 . . . . 40.0 107.931 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.84 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.3 OUTLIER -70.32 173.43 6.81 Favored 'General case' 0 C--N 1.284 -2.272 0 CA-C-O 124.092 1.901 . . . . 40.0 113.371 -177.339 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.458 ' HE2' ' OD1' ' A' ' 54' ' ' ASP . 16.8 mtmt -63.29 -35.83 81.67 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 106.648 -1.612 . . . . 40.0 106.648 177.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.511 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 5.1 m -37.54 -70.24 0.1 Allowed 'General case' 0 N--CA 1.483 1.206 0 CA-C-O 122.28 1.038 . . . . 40.0 108.962 175.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.476 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.2 mp0 -68.1 -50.0 57.62 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.988 -1.115 . . . . 40.0 107.988 -178.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.476 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -43.18 -49.4 6.49 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.263 -1.375 . . . . 40.0 108.888 177.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.423 ' NE2' ' HB3' ' A' ' 27' ' ' LYS . 34.3 mt-30 -59.68 -62.08 2.14 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.275 -0.891 . . . . 40.0 111.454 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.01 -24.15 66.87 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.219 -0.925 . . . . 40.0 109.118 179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.2 tp -68.1 -21.57 64.95 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.236 -0.986 . . . . 40.0 108.596 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 120.35 43.75 0.46 Allowed Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.266 -1.133 . . . . 40.0 110.266 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.542 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -80.96 143.22 32.74 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.034 -1.274 . . . . 40.0 109.38 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 83.9 t -140.99 131.54 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.755 0 O-C-N 120.969 -1.082 . . . . 40.0 109.217 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -58.25 -48.78 79.36 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.913 -0.492 . . . . 40.0 110.342 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.3 p -70.82 45.63 0.09 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.158 -0.963 . . . . 40.0 110.263 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.482 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.2 ttpm? -177.07 -51.43 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.892 -0.781 . . . . 40.0 108.892 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.7 58.93 10.18 Favored Glycine 0 N--CA 1.499 2.842 0 N-CA-C 108.202 -1.959 . . . . 40.0 108.202 -179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.542 ' O ' ' NE1' ' A' ' 35' ' ' TRP . 0.0 OUTLIER -75.56 159.52 31.16 Favored 'General case' 0 C--N 1.293 -1.854 0 O-C-N 121.77 -0.841 . . . . 40.0 110.288 -177.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.733 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 59.4 tp -173.76 -66.75 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.232 -0.987 . . . . 40.0 110.538 178.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.62 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -61.68 -19.91 62.86 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.03 -1.044 . . . . 40.0 109.935 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 3.7 p-10 -78.11 -61.34 2.03 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.681 -0.859 . . . . 40.0 108.681 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.1 m -78.74 -10.17 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.412 0 O-C-N 121.644 -0.66 . . . . 40.0 110.088 178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -150.37 71.54 9.15 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.393 -0.817 . . . . 40.0 109.838 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.96 117.5 4.2 Favored 'Trans proline' 0 N--CA 1.502 1.973 0 C-N-CA 123.649 2.899 . . . . 40.0 113.135 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 74.81 37.89 43.54 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.081 -1.208 . . . . 40.0 110.081 178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.497 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 7.3 mmtm -134.99 173.6 11.54 Favored 'General case' 0 N--CA 1.511 2.585 0 CA-C-O 121.72 0.771 . . . . 40.0 110.537 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 67.0 m -147.54 162.76 38.42 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 120.954 -1.091 . . . . 40.0 112.013 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.6 mm -82.72 124.23 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 115.26 -0.882 . . . . 40.0 110.643 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 175.55 157.56 17.15 Favored Glycine 0 N--CA 1.5 2.927 0 N-CA-C 109.64 -1.384 . . . . 40.0 109.64 178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.84 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 117.63 -9.83 14.5 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 118.938 -1.601 . . . . 40.0 110.107 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.458 ' OD1' ' HE2' ' A' ' 27' ' ' LYS . 5.3 m-20 -75.69 -151.97 0.04 OUTLIER 'General case' 0 C--O 1.193 -1.897 0 O-C-N 120.8 -1.412 . . . . 40.0 109.853 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.4 mp -130.68 142.39 43.8 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.895 0 CA-C-N 115.102 -0.954 . . . . 40.0 108.679 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.613 ' O ' ' N ' ' A' ' 58' ' ' ASN . 12.9 t80 -110.3 90.96 3.47 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.095 -0.706 . . . . 40.0 109.095 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.659 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.9 p -60.3 38.74 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.457 -0.777 . . . . 40.0 110.705 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.613 ' N ' ' O ' ' A' ' 56' ' ' PHE . 45.6 t30 33.89 38.95 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.13 -0.981 . . . . 40.0 110.721 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.659 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.5 mtm180 -69.34 35.52 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.119 -0.988 . . . . 40.0 110.086 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.628 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 15.1 mt-10 -144.86 -3.74 0.77 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.052 -1.03 . . . . 40.0 110.348 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.421 ' HA2' HD21 ' A' ' 58' ' ' ASN . . . 54.16 37.91 60.09 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.275 -1.53 . . . . 40.0 109.275 -178.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.628 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 5.0 mttp -120.32 11.66 11.54 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.537 -0.978 . . . . 40.0 109.778 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.453 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -136.88 143.98 44.72 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 109.389 -0.597 . . . . 40.0 109.389 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -61.83 124.64 14.91 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.605 2.203 . . . . 40.0 112.267 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.526 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -104.33 -178.75 25.1 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 110.076 -1.21 . . . . 40.0 110.076 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.438 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 9.5 tttt -177.16 152.57 0.89 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.363 -1.08 . . . . 40.0 108.435 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.6 p -71.3 53.41 0.19 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.304 -1.497 . . . . 40.0 109.438 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 151.48 80.16 0.03 OUTLIER Glycine 0 N--CA 1.497 2.752 0 N-CA-C 110.084 -1.206 . . . . 40.0 110.084 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.577 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -175.36 178.83 1.6 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.706 -0.879 . . . . 40.0 108.864 179.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.577 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 87.1 m -155.52 155.98 34.38 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.331 -0.947 . . . . 40.0 109.83 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.697 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 27.5 m95 -124.91 140.01 53.31 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 109.78 -0.452 . . . . 40.0 109.78 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.635 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.64 149.55 52.25 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.738 -1.226 . . . . 40.0 109.685 179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.52 ' O ' ' OH ' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -115.79 168.82 9.71 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-O 122.283 1.04 . . . . 40.0 112.304 -179.464 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.13 138.5 4.66 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.846 -0.615 . . . . 40.0 111.11 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.724 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.4 OUTLIER -60.41 154.79 19.64 Favored 'General case' 0 N--CA 1.499 2.003 0 CA-C-O 121.453 0.644 . . . . 40.0 111.091 179.495 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.724 HD13 ' O ' ' A' ' 75' ' ' ASP . 40.2 mm -137.82 145.19 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 C-N-CA 119.962 -0.695 . . . . 40.0 110.596 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 57.83 68.4 0.85 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.738 -0.601 . . . . 40.0 110.697 179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.733 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 61.0 t80 -129.84 157.2 42.9 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.097 -1.002 . . . . 40.0 109.867 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.541 ' OG1' ' N ' ' A' ' 80' ' ' SER . 24.2 p -137.31 -71.07 0.44 Allowed 'General case' 0 N--CA 1.507 2.422 0 O-C-N 121.517 -0.739 . . . . 40.0 109.718 179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.62 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -153.68 107.15 2.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.6 -0.687 . . . . 40.0 109.388 -178.344 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 158.28 -107.22 0.31 Allowed Glycine 0 N--CA 1.495 2.598 0 C-N-CA 119.667 -1.254 . . . . 40.0 110.191 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.477 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 41.6 t80 -137.29 -166.73 1.98 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.772 -0.84 . . . . 40.0 109.355 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.664 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.8 mtm180 -73.99 -155.5 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.805 -1.184 . . . . 40.0 109.643 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -166.52 -150.75 0.12 Allowed 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.888 -1.153 . . . . 40.0 107.888 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' A' ' 100' ' ' THR . 60.1 p -102.32 -7.49 22.02 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.004 -1.06 . . . . 40.0 109.539 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.536 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.67 113.88 23.76 Favored 'General case' 0 N--CA 1.509 2.505 0 CA-C-O 121.89 0.852 . . . . 40.0 111.552 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.857 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -139.35 148.55 43.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.951 -1.093 . . . . 40.0 110.84 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.662 ' CG2' HD11 ' A' ' 76' ' ' ILE . 5.5 tt -114.72 140.06 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-O 122.144 0.973 . . . . 40.0 110.158 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.541 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 3.1 mm? -118.77 125.13 48.92 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.609 -0.886 . . . . 40.0 108.609 179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.672 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -119.52 129.41 54.68 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-O 121.594 0.711 . . . . 40.0 109.203 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.697 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.7 p -93.93 160.14 14.86 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.668 1.223 . . . . 40.0 112.797 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.1 p -69.92 -17.03 63.31 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.138 -1.06 . . . . 40.0 108.138 177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.474 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -88.19 10.03 20.87 Favored 'General case' 0 N--CA 1.499 2.023 0 C-N-CA 119.773 -0.771 . . . . 40.0 109.686 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.458 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.6 27.36 0.62 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.765 -0.585 . . . . 40.0 110.259 179.469 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 26.0 mt -96.48 136.93 36.31 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.273 -0.892 . . . . 40.0 109.061 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.508 ' CG2' HD11 ' A' ' 109' ' ' ILE . 41.1 mm -111.72 119.95 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.772 -0.58 . . . . 40.0 110.649 -178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.406 ' CD1' ' HH2' ' A' ' 71' ' ' TRP . 7.7 m-85 -122.91 144.57 49.14 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 120.524 -0.47 . . . . 40.0 109.934 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.536 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 4.2 tptp -134.29 145.02 48.68 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.042 -1.036 . . . . 40.0 110.593 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.593 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.6 t -123.37 166.9 14.54 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.567 -0.901 . . . . 40.0 108.567 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.517 ' O ' ' OG ' ' A' ' 85' ' ' SER . 35.8 p -139.73 -10.29 1.19 Allowed 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.03 -1.044 . . . . 40.0 109.723 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.713 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.1 p30 -107.13 10.78 30.03 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.25 -0.907 . . . . 40.0 110.259 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 86.68 63.06 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.346 0.593 . . . . 40.0 110.494 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.664 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 24.4 m-85 70.61 -23.23 0.17 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.369 -0.832 . . . . 40.0 110.883 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 102' ' ' ALA . 2.0 mt-30 -43.4 -73.45 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.293 -0.879 . . . . 40.0 109.97 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.491 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 24.8 p -106.18 167.53 9.75 Favored 'General case' 0 C--O 1.196 -1.756 0 N-CA-C 107.718 -1.215 . . . . 40.0 107.718 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.541 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -140.93 139.16 34.27 Favored 'General case' 0 C--N 1.268 -2.942 0 O-C-N 121.51 -0.744 . . . . 40.0 109.836 -179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 49.7 m -124.48 135.98 53.65 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.143 -1.058 . . . . 40.0 108.143 178.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.54 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 18.1 tttp -84.64 145.57 27.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.903 -1.123 . . . . 40.0 109.656 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.508 HD11 ' CG2' ' A' ' 96' ' ' ILE . 14.6 pt -121.35 -34.42 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.157 -0.964 . . . . 40.0 109.528 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.595 HH21 ' CG ' ' A' ' 8' ' ' ASP . 76.3 mtt180 . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 118.176 -0.916 . . . . 40.0 108.969 178.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.636 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 17.9 t . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 108.992 -0.744 . . . . 40.0 108.992 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -175.9 153.79 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.066 -0.716 . . . . 40.0 109.066 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.4 p-10 -144.43 26.05 1.48 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.109 -0.994 . . . . 40.0 110.688 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.492 ' O ' HG23 ' A' ' 10' ' ' VAL . 21.2 p -104.26 151.94 22.81 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-O 121.463 0.649 . . . . 40.0 109.473 -179.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.479 ' CD1' ' N ' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -55.25 -64.16 0.93 Allowed 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.716 -1.24 . . . . 40.0 110.734 -179.191 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.604 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.7 OUTLIER -57.03 -41.83 79.32 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.193 -0.942 . . . . 40.0 110.107 -179.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.4 -45.28 84.18 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.702 -1.359 . . . . 40.0 109.702 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.59 HG22 ' HG2' ' A' ' 21' ' ' PRO . 71.1 t -67.09 -43.36 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 O-C-N 121.674 -0.898 . . . . 40.0 108.824 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.43 -58.79 6.99 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.283 -0.636 . . . . 40.0 109.283 179.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.56 -56.47 9.8 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.118 -0.989 . . . . 40.0 109.358 178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.758 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 39.0 t80 -51.49 -53.07 41.19 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.942 -0.572 . . . . 40.0 110.418 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.544 ' O ' ' N ' ' A' ' 18' ' ' HIS . 1.9 tt -72.74 -50.1 26.79 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.336 0.589 . . . . 40.0 110.982 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 11' ' ' ALA . 63.3 mt-30 -53.17 -28.27 25.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.059 -1.65 . . . . 40.0 109.925 179.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.9 m -91.61 -51.14 5.4 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.014 -1.054 . . . . 40.0 110.763 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.416 ' O ' ' N ' ' A' ' 19' ' ' LYS . 84.9 m-85 -99.11 14.03 30.79 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.268 -0.895 . . . . 40.0 110.427 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.544 ' N ' ' O ' ' A' ' 14' ' ' LEU . 20.9 m80 41.95 25.01 0.03 OUTLIER 'General case' 0 N--CA 1.512 2.67 0 O-C-N 121.565 -0.71 . . . . 40.0 111.023 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 17' ' ' TYR . 4.1 pttp -134.89 158.65 43.71 Favored 'General case' 0 C--O 1.185 -2.3 0 O-C-N 121.2 -0.937 . . . . 40.0 109.967 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.4 mp -79.35 146.03 65.44 Favored Pre-proline 0 C--N 1.269 -2.905 0 N-CA-C 107.961 -1.126 . . . . 40.0 107.961 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.758 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 82.2 Cg_exo -39.34 157.72 0.03 OUTLIER 'Trans proline' 0 N--CA 1.501 1.933 0 C-N-CA 123.213 2.608 . . . . 40.0 114.6 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.636 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.8 OUTLIER -69.47 51.26 0.1 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.817 -1.177 . . . . 40.0 109.62 179.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.48 ' HA ' ' HD3' ' A' ' 49' ' ' LYS . 0.9 OUTLIER -175.92 26.71 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.026 -1.047 . . . . 40.0 110.149 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -119.59 109.72 16.02 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.498 -1.376 . . . . 40.0 111.045 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 10.0 pt -116.85 134.94 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.441 -0.904 . . . . 40.0 108.704 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.758 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.3 OUTLIER -69.51 169.98 11.5 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-O 123.756 1.741 . . . . 40.0 113.269 -177.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.528 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 23.1 mtmt -62.34 -37.87 87.31 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 105.96 -1.867 . . . . 40.0 105.96 177.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.504 ' OG ' ' OG1' ' A' ' 26' ' ' THR . 1.1 m -37.69 -70.84 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.667 -0.864 . . . . 40.0 108.667 176.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.545 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.5 mp0 -63.34 -57.62 9.79 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 106.823 -1.547 . . . . 40.0 106.823 -177.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.545 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -33.31 -52.03 0.36 Allowed 'General case' 0 N--CA 1.509 2.525 0 C-N-CA 119.165 -1.014 . . . . 40.0 109.251 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -56.52 -67.06 0.34 Allowed 'General case' 0 N--CA 1.516 2.864 0 O-C-N 120.906 -1.121 . . . . 40.0 111.524 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.4 -21.64 62.43 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.746 -1.221 . . . . 40.0 110.494 -179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.516 HD21 ' HB ' ' A' ' 45' ' ' VAL . 60.5 tp -70.54 -24.47 62.81 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.349 -1.352 . . . . 40.0 107.349 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.7 48.15 0.28 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.6 -1.0 . . . . 40.0 110.6 178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.595 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -81.14 142.31 33.39 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.009 -1.289 . . . . 40.0 108.633 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 55.7 t -136.47 128.24 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 N-CA-C 108.439 -0.948 . . . . 40.0 108.439 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.12 -48.58 81.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.776 -0.577 . . . . 40.0 109.531 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 53.7 p -70.83 46.95 0.1 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.028 -1.045 . . . . 40.0 109.899 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.613 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.1 ttpm? -178.6 -50.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.916 -0.772 . . . . 40.0 108.916 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 62.39 59.8 8.85 Favored Glycine 0 N--CA 1.503 3.146 0 N-CA-C 108.593 -1.803 . . . . 40.0 108.593 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.613 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -76.6 160.56 29.32 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.344 -1.092 . . . . 40.0 111.59 -177.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.835 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 45.5 tp -172.46 -70.14 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.451 -0.9 . . . . 40.0 110.529 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.59 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -59.98 -21.45 61.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.852 -1.155 . . . . 40.0 109.77 -178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 5.0 p-10 -75.87 -62.64 1.52 Allowed 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.185 -0.672 . . . . 40.0 109.185 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.516 ' HB ' HD21 ' A' ' 33' ' ' LEU . 15.8 m -77.76 -13.28 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 109.063 -0.718 . . . . 40.0 109.063 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.474 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -147.74 72.92 11.54 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 121.34 -0.85 . . . . 40.0 110.148 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -56.68 118.04 4.81 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 123.01 2.474 . . . . 40.0 113.959 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.513 ' O ' ' NZ ' ' A' ' 49' ' ' LYS . . . 75.16 36.48 45.64 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 109.25 -1.54 . . . . 40.0 109.25 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 48' ' ' GLY . 7.3 mmtm -135.5 163.55 29.82 Favored 'General case' 0 N--CA 1.511 2.586 0 CA-C-O 121.739 0.781 . . . . 40.0 110.364 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.483 ' HA ' HD21 ' A' ' 42' ' ' LEU . 50.5 m -138.56 166.57 23.99 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-O 122.12 0.962 . . . . 40.0 111.325 -176.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.402 ' CG2' ' HG3' ' A' ' 27' ' ' LYS . 10.3 mm -83.98 121.66 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 CA-C-N 115.344 -0.843 . . . . 40.0 111.689 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 178.27 155.24 13.86 Favored Glycine 0 N--CA 1.502 3.097 0 C-N-CA 119.847 -1.168 . . . . 40.0 110.604 177.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.758 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 119.7 -7.87 12.04 Favored Glycine 0 N--CA 1.496 2.655 0 C-N-CA 119.342 -1.409 . . . . 40.0 110.217 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.417 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 4.5 m-20 -75.65 -150.79 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.088 -1.242 . . . . 40.0 109.824 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.5 mp -132.36 143.33 40.23 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.882 0 CA-C-N 115.067 -0.969 . . . . 40.0 108.848 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.644 ' O ' ' N ' ' A' ' 58' ' ' ASN . 14.9 t80 -112.04 89.68 3.13 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.488 -0.93 . . . . 40.0 108.488 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.667 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.8 p -59.23 37.57 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 121.597 0.713 . . . . 40.0 110.611 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.644 ' N ' ' O ' ' A' ' 56' ' ' PHE . 44.2 t30 34.42 39.18 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.066 -1.021 . . . . 40.0 110.656 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.667 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 9.8 mtm180 -70.02 35.54 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.731 -1.231 . . . . 40.0 110.45 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.605 ' CD ' ' NZ ' ' A' ' 62' ' ' LYS . 14.8 mt-10 -144.91 -1.85 0.84 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.033 -1.042 . . . . 40.0 109.943 -179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.58 37.84 50.91 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.662 -1.375 . . . . 40.0 109.662 -178.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.605 ' NZ ' ' CD ' ' A' ' 60' ' ' GLU . 4.3 mttp -119.89 12.36 12.04 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.458 -1.025 . . . . 40.0 109.407 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.479 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.6 mt -137.54 143.85 42.55 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.702 -0.624 . . . . 40.0 109.646 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -61.54 123.74 13.32 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.505 2.137 . . . . 40.0 112.466 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.54 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -103.43 -177.81 26.16 Favored Glycine 0 N--CA 1.497 2.71 0 N-CA-C 110.205 -1.158 . . . . 40.0 110.205 -179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.43 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . 8.4 tttt -178.12 154.09 0.84 Allowed 'General case' 0 N--CA 1.501 2.091 0 N-CA-C 108.024 -1.102 . . . . 40.0 108.024 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.4 p -73.29 56.04 0.47 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.774 -1.204 . . . . 40.0 109.041 -179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 149.16 81.76 0.04 OUTLIER Glycine 0 N--CA 1.498 2.815 0 N-CA-C 109.899 -1.28 . . . . 40.0 109.899 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.57 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -177.34 178.18 1.11 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.544 -0.974 . . . . 40.0 108.874 -179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.57 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 92.8 m -154.97 155.12 33.65 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.219 -0.926 . . . . 40.0 109.945 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.713 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 29.7 m95 -123.36 139.45 54.02 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.708 -0.479 . . . . 40.0 109.708 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.597 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.26 149.02 52.14 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 120.705 -1.247 . . . . 40.0 109.713 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.529 ' O ' ' OH ' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -114.52 169.94 8.68 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.897 -1.127 . . . . 40.0 112.331 -179.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.99 137.24 3.71 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.745 -0.597 . . . . 40.0 110.958 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.722 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.3 OUTLIER -59.14 154.54 15.76 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 120.917 0.389 . . . . 40.0 110.896 179.701 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.722 HD13 ' O ' ' A' ' 75' ' ' ASP . 41.6 mm -137.09 144.33 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.323 -0.861 . . . . 40.0 110.294 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 17.7 m-20 57.77 71.05 0.6 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.527 -0.733 . . . . 40.0 110.58 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.835 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 69.2 t80 -131.67 155.06 48.27 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.866 -1.146 . . . . 40.0 109.804 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.596 ' OG1' ' N ' ' A' ' 80' ' ' SER . 27.2 p -135.79 -73.05 0.45 Allowed 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.618 -0.676 . . . . 40.0 110.138 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.596 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.3 OUTLIER -153.65 102.32 2.54 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.481 -0.562 . . . . 40.0 109.481 -177.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.427 ' N ' ' OH ' ' A' ' 78' ' ' TYR . . . 164.01 -103.08 0.21 Allowed Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.855 -1.164 . . . . 40.0 110.397 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.486 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 45.8 t80 -141.3 -166.95 2.29 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.842 -0.799 . . . . 40.0 108.955 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.649 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 5.9 mtm180 -73.45 -154.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.924 . . . . 40.0 110.429 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.597 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 9.4 p30 -167.58 -150.91 0.11 Allowed 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.333 -0.988 . . . . 40.0 108.333 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.514 ' OG ' ' O ' ' A' ' 100' ' ' THR . 82.5 p -102.82 -8.06 21.09 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.799 -1.188 . . . . 40.0 109.309 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.522 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -87.25 113.67 23.19 Favored 'General case' 0 N--CA 1.509 2.48 0 CA-C-O 121.794 0.807 . . . . 40.0 111.483 -179.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.854 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.73 150.79 46.53 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.852 -1.155 . . . . 40.0 110.551 179.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.693 ' CG2' HD11 ' A' ' 76' ' ' ILE . 4.9 tt -116.93 141.02 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.511 -0.743 . . . . 40.0 109.908 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 72' ' ' ARG . 2.8 mm? -119.54 124.95 47.67 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.574 -0.899 . . . . 40.0 108.574 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.677 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.66 129.53 55.35 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.873 0.844 . . . . 40.0 108.776 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.713 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.9 p -94.69 159.66 14.97 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-O 122.581 1.181 . . . . 40.0 112.413 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.6 p -69.42 -17.81 63.69 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 108.117 -1.068 . . . . 40.0 108.117 178.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.476 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -87.06 10.06 17.75 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.778 -0.769 . . . . 40.0 109.736 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.453 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.66 26.54 0.65 Allowed 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.62 -0.675 . . . . 40.0 110.259 179.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.5 mt -95.69 135.55 37.24 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.362 -0.837 . . . . 40.0 109.092 178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.523 ' CG2' HD11 ' A' ' 109' ' ' ILE . 38.6 mm -110.96 119.02 58.68 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-O 121.389 0.614 . . . . 40.0 110.722 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -122.28 144.88 48.72 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 120.276 -0.57 . . . . 40.0 109.637 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.522 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 4.8 tptp -133.83 144.42 48.95 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.19 -0.943 . . . . 40.0 110.644 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.59 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.7 t -123.17 166.7 14.77 Favored 'General case' 0 N--CA 1.503 2.198 0 N-CA-C 108.688 -0.856 . . . . 40.0 108.688 177.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.514 ' O ' ' OG ' ' A' ' 85' ' ' SER . 40.7 p -140.08 -9.82 1.15 Allowed 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.277 -0.889 . . . . 40.0 109.66 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.69 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -108.47 14.01 25.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.155 -0.966 . . . . 40.0 110.261 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.69 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 84.41 61.92 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 CA-C-O 121.13 0.491 . . . . 40.0 110.329 178.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.649 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 24.6 m-85 70.73 -21.64 0.19 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.494 -0.754 . . . . 40.0 110.881 179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.426 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.2 mt-30 -43.72 -72.55 0.06 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.088 -1.007 . . . . 40.0 109.599 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.465 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 26.4 p -107.41 169.44 8.58 Favored 'General case' 0 C--O 1.193 -1.9 0 N-CA-C 108.048 -1.093 . . . . 40.0 108.048 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.546 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -141.42 140.13 33.57 Favored 'General case' 0 C--N 1.272 -2.794 0 O-C-N 121.355 -0.84 . . . . 40.0 110.114 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 46.4 m -125.31 135.51 52.55 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.551 -0.907 . . . . 40.0 108.551 178.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.596 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 21.7 tttp -84.46 145.08 28.33 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.759 -1.213 . . . . 40.0 109.879 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.523 HD11 ' CG2' ' A' ' 96' ' ' ILE . 14.1 pt -120.32 -34.72 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.172 -0.955 . . . . 40.0 109.527 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.604 HH21 ' CG ' ' A' ' 8' ' ' ASP . 78.3 mtt180 . . . . . 0 N--CA 1.487 1.378 0 O-C-N 121.186 -0.946 . . . . 40.0 108.638 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.648 ' N ' ' OD2' ' A' ' 22' ' ' ASP . 20.7 t . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 109.294 -0.632 . . . . 40.0 109.294 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 tt -177.1 152.4 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 N-CA-C 108.981 -0.748 . . . . 40.0 108.981 -179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 53.3 p-10 -144.29 25.78 1.52 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.733 -1.229 . . . . 40.0 110.604 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 10' ' ' VAL . 17.4 p -105.38 152.82 22.49 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.528 0.68 . . . . 40.0 110.057 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.498 ' HA ' HD12 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -56.29 -62.74 1.51 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.459 -1.401 . . . . 40.0 111.482 -179.198 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.646 ' CG ' HH21 ' A' ' 110' ' ' ARG . 0.6 OUTLIER -59.1 -40.83 86.54 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 120.976 -1.077 . . . . 40.0 109.738 -179.345 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -55.45 -44.88 85.3 Favored Glycine 0 N--CA 1.507 3.377 0 N-CA-C 109.682 -1.367 . . . . 40.0 109.682 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.513 HG22 ' HG2' ' A' ' 21' ' ' PRO . 70.5 t -67.55 -43.48 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.805 -0.821 . . . . 40.0 108.976 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' A' ' 15' ' ' GLN . . . -60.88 -56.48 20.64 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.967 -0.753 . . . . 40.0 108.967 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -51.04 -56.02 14.63 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.89 -0.782 . . . . 40.0 108.89 178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.695 ' CE2' ' HA ' ' A' ' 21' ' ' PRO . 38.7 t80 -53.02 -51.78 60.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 122.017 -0.427 . . . . 40.0 110.87 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' A' ' 18' ' ' HIS . 3.9 tt -71.89 -51.06 24.14 Favored 'General case' 0 N--CA 1.505 2.276 0 CA-C-O 121.414 0.626 . . . . 40.0 110.43 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.495 ' N ' HD23 ' A' ' 14' ' ' LEU . 58.8 mt-30 -53.22 -28.77 28.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 119.983 -1.698 . . . . 40.0 110.316 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.3 m -92.31 -50.18 5.78 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.612 -1.305 . . . . 40.0 110.964 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.401 ' O ' ' N ' ' A' ' 19' ' ' LYS . 86.5 m-85 -99.28 12.47 36.15 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.89 -1.131 . . . . 40.0 110.308 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.569 ' N ' ' O ' ' A' ' 14' ' ' LEU . 23.5 m80 42.6 24.2 0.03 OUTLIER 'General case' 0 N--CA 1.517 2.916 0 CA-C-O 121.484 0.659 . . . . 40.0 111.226 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 17' ' ' TYR . 5.1 pttp -135.98 156.57 48.54 Favored 'General case' 0 C--O 1.183 -2.413 0 CA-C-O 121.646 0.736 . . . . 40.0 109.804 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 24' ' ' TYR . 4.5 mp -77.62 145.63 71.6 Favored Pre-proline 0 C--N 1.268 -2.976 0 O-C-N 120.899 -1.126 . . . . 40.0 109.71 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.695 ' HA ' ' CE2' ' A' ' 13' ' ' TYR . 88.9 Cg_exo -40.33 155.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.503 2.038 0 C-N-CA 123.267 2.645 . . . . 40.0 113.922 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.648 ' OD2' ' N ' ' A' ' 3' ' ' VAL . 0.3 OUTLIER -66.06 49.19 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.15 0.976 . . . . 40.0 109.376 -179.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.528 ' N ' ' O ' ' A' ' 21' ' ' PRO . 0.9 OUTLIER -173.92 26.99 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.189 -0.944 . . . . 40.0 110.687 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.425 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 2.9 m-85 -119.59 108.26 14.27 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.523 -1.361 . . . . 40.0 109.628 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 18.7 pt -116.94 132.11 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 C-N-CA 119.436 -0.905 . . . . 40.0 108.89 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.782 HG22 ' HA3' ' A' ' 53' ' ' GLY . 0.5 OUTLIER -67.17 172.02 5.1 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-O 123.609 1.671 . . . . 40.0 113.536 -177.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.501 ' NZ ' ' OE2' ' A' ' 73' ' ' GLU . 19.5 mtmt -63.36 -35.99 82.23 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 106.458 -1.682 . . . . 40.0 106.458 176.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.566 ' CB ' ' OG1' ' A' ' 26' ' ' THR . 5.1 m -35.56 -71.7 0.07 Allowed 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 123.57 1.652 . . . . 40.0 109.222 175.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.504 ' O ' ' C ' ' A' ' 30' ' ' ALA . 2.1 mp0 -65.53 -56.18 13.76 Favored 'General case' 0 C--O 1.192 -1.93 0 N-CA-C 107.488 -1.301 . . . . 40.0 107.488 -177.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.504 ' C ' ' O ' ' A' ' 29' ' ' GLU . . . -37.26 -50.29 0.99 Allowed 'General case' 0 N--CA 1.517 2.914 0 O-C-N 120.574 -1.329 . . . . 40.0 110.647 178.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -58.93 -62.04 2.18 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.382 -1.449 . . . . 40.0 110.848 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.81 -25.98 67.83 Favored 'General case' 0 N--CA 1.512 2.662 0 O-C-N 120.679 -1.263 . . . . 40.0 110.027 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.0 tp -65.02 -25.33 67.8 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.178 -1.045 . . . . 40.0 108.178 178.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 121.33 46.2 0.33 Allowed Glycine 0 N--CA 1.502 3.068 0 N-CA-C 110.244 -1.142 . . . . 40.0 110.244 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.476 ' NE1' ' O ' ' A' ' 41' ' ' ASN . 0.0 OUTLIER -80.54 139.85 36.12 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.969 -1.312 . . . . 40.0 109.422 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 90.7 t -136.09 130.15 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.241 0 CA-C-O 121.6 0.714 . . . . 40.0 109.576 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.47 -48.18 79.87 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 109.298 -0.63 . . . . 40.0 109.298 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 60.2 p -69.7 44.85 0.06 Allowed 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.33 -0.856 . . . . 40.0 110.704 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.603 ' NZ ' ' OD1' ' A' ' 41' ' ' ASN . 1.5 ttpm? -178.48 -51.99 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.203 -0.936 . . . . 40.0 109.066 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.43 62.68 4.89 Favored Glycine 0 N--CA 1.497 2.746 0 N-CA-C 108.788 -1.725 . . . . 40.0 108.788 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.603 ' OD1' ' NZ ' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -78.78 160.1 27.57 Favored 'General case' 0 C--N 1.29 -1.982 0 O-C-N 121.495 -1.003 . . . . 40.0 111.024 -177.787 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.842 HD23 ' CZ ' ' A' ' 78' ' ' TYR . 52.0 tp -173.67 -69.4 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.479 -0.763 . . . . 40.0 110.544 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.565 ' HB2' ' HA ' ' A' ' 80' ' ' SER . . . -61.37 -21.76 64.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.731 -1.231 . . . . 40.0 109.31 -178.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 42' ' ' LEU . 4.8 p-10 -74.16 -62.8 1.39 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 109.221 -0.659 . . . . 40.0 109.221 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.8 m -80.4 -10.04 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.914 -0.491 . . . . 40.0 110.298 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.554 ' HB1' ' HB2' ' A' ' 49' ' ' LYS . . . -148.21 72.23 11.06 Favored Pre-proline 0 N--CA 1.489 1.487 0 CA-C-O 121.489 0.662 . . . . 40.0 109.518 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -55.35 115.53 2.51 Favored 'Trans proline' 0 N--CA 1.505 2.2 0 C-N-CA 123.779 2.986 . . . . 40.0 113.381 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 72.72 38.2 57.06 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.992 -1.243 . . . . 40.0 109.992 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.554 ' HB2' ' HB1' ' A' ' 46' ' ' ALA . 6.3 mmtt -133.12 163.3 29.57 Favored 'General case' 0 N--CA 1.51 2.535 0 O-C-N 121.795 -0.827 . . . . 40.0 110.008 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.4 ' HA ' HD21 ' A' ' 42' ' ' LEU . 67.2 m -139.13 161.1 38.23 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-O 122.432 1.11 . . . . 40.0 110.84 -176.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 19.6 mm -79.93 124.78 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-N 114.619 -1.173 . . . . 40.0 110.721 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.24 156.12 13.22 Favored Glycine 0 N--CA 1.486 2.006 0 C-N-CA 119.529 -1.319 . . . . 40.0 109.967 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.782 ' HA3' HG22 ' A' ' 26' ' ' THR . . . 118.29 -10.73 13.06 Favored Glycine 0 N--CA 1.502 3.091 0 C-N-CA 119.531 -1.319 . . . . 40.0 110.163 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.437 ' CG ' ' HB ' ' A' ' 26' ' ' THR . 4.9 m-20 -72.62 -151.15 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.538 -1.566 . . . . 40.0 109.68 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.4 mp -132.72 141.0 46.18 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 CA-C-N 115.132 -0.94 . . . . 40.0 109.304 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.627 ' O ' ' N ' ' A' ' 58' ' ' ASN . 11.7 t80 -109.28 91.76 3.77 Favored 'General case' 0 C--N 1.29 -2.0 0 O-C-N 121.295 -0.878 . . . . 40.0 109.198 178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.624 ' OG ' ' NE ' ' A' ' 59' ' ' ARG . 1.5 p -60.27 38.21 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.92 0.867 . . . . 40.0 110.625 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.627 ' N ' ' O ' ' A' ' 56' ' ' PHE . 44.8 t30 33.97 39.27 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.407 -0.808 . . . . 40.0 110.659 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.624 ' NE ' ' OG ' ' A' ' 57' ' ' SER . 10.3 mtm180 -70.37 36.3 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.516 -1.365 . . . . 40.0 110.348 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.614 ' OE2' ' NZ ' ' A' ' 62' ' ' LYS . 15.1 mt-10 -145.17 -2.76 0.78 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.347 -0.845 . . . . 40.0 109.954 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.29 37.95 56.09 Favored Glycine 0 N--CA 1.502 3.098 0 N-CA-C 109.579 -1.409 . . . . 40.0 109.579 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.614 ' NZ ' ' OE2' ' A' ' 60' ' ' GLU . 5.8 mttp -120.1 11.46 11.66 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.267 -1.137 . . . . 40.0 109.505 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.405 ' HG ' ' C ' ' A' ' 62' ' ' LYS . 1.5 mt -136.38 144.26 46.88 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.64 -0.663 . . . . 40.0 109.498 -179.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -62.53 123.8 13.04 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.188 1.925 . . . . 40.0 112.527 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.531 ' C ' HH11 ' A' ' 69' ' ' ARG . . . -102.67 -175.84 27.05 Favored Glycine 0 N--CA 1.5 2.901 0 N-CA-C 110.235 -1.146 . . . . 40.0 110.235 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.462 ' NZ ' ' O ' ' A' ' 68' ' ' GLY . 9.0 tttt -179.12 152.17 0.54 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.065 -1.256 . . . . 40.0 107.791 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.6 p -70.87 53.53 0.16 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.643 -1.286 . . . . 40.0 109.106 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.462 ' O ' ' NZ ' ' A' ' 66' ' ' LYS . . . 150.89 80.98 0.03 OUTLIER Glycine 0 N--CA 1.496 2.692 0 N-CA-C 110.277 -1.129 . . . . 40.0 110.277 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.553 ' CG ' ' N ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -174.67 177.97 1.99 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.735 -0.862 . . . . 40.0 108.799 179.105 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.553 ' N ' ' CG ' ' A' ' 69' ' ' ARG . 96.7 m -154.36 155.16 34.56 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.254 -0.904 . . . . 40.0 110.039 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.741 ' CH2' ' HB3' ' A' ' 91' ' ' SER . 31.8 m95 -124.99 138.92 54.21 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.982 -0.449 . . . . 40.0 109.893 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.581 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -130.68 147.71 52.38 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.028 -1.045 . . . . 40.0 109.88 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.501 ' OE2' ' NZ ' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -113.24 168.74 9.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.679 -1.263 . . . . 40.0 111.9 -179.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.45 139.56 5.71 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.799 0.809 . . . . 40.0 111.063 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.743 ' O ' HD13 ' A' ' 76' ' ' ILE . 0.2 OUTLIER -60.51 154.83 19.88 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.85 -0.531 . . . . 40.0 111.275 179.641 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.743 HD13 ' O ' ' A' ' 75' ' ' ASP . 33.9 mm -138.14 145.4 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.513 -0.742 . . . . 40.0 109.946 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 56.77 70.69 0.63 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.499 0.666 . . . . 40.0 110.782 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.842 ' CZ ' HD23 ' A' ' 42' ' ' LEU . 65.6 t80 -132.29 154.9 49.21 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.917 -1.114 . . . . 40.0 109.436 178.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.574 ' OG1' ' N ' ' A' ' 80' ' ' SER . 22.9 p -136.17 -72.16 0.45 Allowed 'General case' 0 N--CA 1.507 2.385 0 CA-C-O 121.214 0.531 . . . . 40.0 109.934 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.574 ' N ' ' OG1' ' A' ' 79' ' ' THR . 0.5 OUTLIER -153.4 103.67 2.69 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.387 -0.821 . . . . 40.0 109.299 -178.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.402 ' N ' ' OH ' ' A' ' 78' ' ' TYR . . . 163.42 -106.19 0.27 Allowed Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.608 -1.282 . . . . 40.0 110.212 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.469 ' CG ' ' N ' ' A' ' 83' ' ' ARG . 52.4 t80 -138.21 -165.16 1.75 Allowed 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.789 -0.819 . . . . 40.0 108.789 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.647 ' NH2' ' OH ' ' A' ' 103' ' ' TYR . 6.1 mtm180 -75.72 -155.84 0.06 Allowed 'General case' 0 N--CA 1.507 2.407 0 O-C-N 120.335 -1.478 . . . . 40.0 109.961 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.547 ' OD1' ' NH2' ' A' ' 87' ' ' ARG . 9.5 p30 -165.13 -149.18 0.12 Allowed 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.217 -1.031 . . . . 40.0 108.217 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 100' ' ' THR . 82.7 p -104.21 -7.58 20.0 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.709 -1.244 . . . . 40.0 108.929 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.482 ' OD2' ' NZ ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -87.6 113.42 23.27 Favored 'General case' 0 N--CA 1.508 2.432 0 CA-C-O 121.878 0.846 . . . . 40.0 111.71 -179.435 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.863 ' NH1' ' HG2' ' A' ' 87' ' ' ARG . 0.0 OUTLIER -138.55 150.61 46.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.879 -1.138 . . . . 40.0 110.519 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.729 ' CG2' HD11 ' A' ' 76' ' ' ILE . 6.7 tt -117.3 139.26 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-O 122.831 1.301 . . . . 40.0 110.028 178.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.528 HD23 ' HZ ' ' A' ' 106' ' ' PHE . 2.9 mm? -118.86 124.44 47.16 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.421 -0.955 . . . . 40.0 108.421 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.678 ' N ' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -118.54 129.5 55.39 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.846 0.831 . . . . 40.0 109.125 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.741 ' HB3' ' CH2' ' A' ' 71' ' ' TRP . 4.5 p -93.35 159.21 15.36 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 122.268 1.032 . . . . 40.0 112.221 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.8 p -69.23 -18.41 63.88 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.805 -1.183 . . . . 40.0 107.805 177.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.491 ' CG ' HH21 ' A' ' 69' ' ' ARG . 0.0 OUTLIER -86.05 9.4 17.3 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 120.189 -0.604 . . . . 40.0 109.629 179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.447 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER 77.12 26.72 0.72 Allowed 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.503 -0.748 . . . . 40.0 110.3 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 22.8 mt -96.29 134.99 38.73 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.398 -0.814 . . . . 40.0 109.156 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.558 ' CG2' HD11 ' A' ' 109' ' ' ILE . 39.2 mm -109.52 120.66 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.438 -0.788 . . . . 40.0 110.452 -178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -122.95 144.18 49.41 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 109.239 -0.652 . . . . 40.0 109.239 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.482 ' NZ ' ' OD2' ' A' ' 86' ' ' ASP . 4.7 tptp -133.89 144.84 49.13 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 119.569 -0.852 . . . . 40.0 110.979 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.549 ' CG2' ' HB2' ' A' ' 87' ' ' ARG . 1.8 t -122.95 166.74 14.58 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 108.939 -0.764 . . . . 40.0 108.939 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.464 ' O ' ' OG ' ' A' ' 85' ' ' SER . 40.7 p -140.3 -9.0 1.13 Allowed 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.36 -0.837 . . . . 40.0 109.626 178.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.674 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 1.2 p30 -108.58 14.63 24.41 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.958 -1.089 . . . . 40.0 110.285 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.674 ' HB3' ' O ' ' A' ' 101' ' ' ASP . . . 83.45 61.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.21 0.528 . . . . 40.0 110.539 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.647 ' OH ' ' NH2' ' A' ' 83' ' ' ARG . 28.5 m-85 71.23 -20.83 0.21 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.59 -0.694 . . . . 40.0 110.651 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . 0.422 ' H ' ' C ' ' A' ' 102' ' ' ALA . 1.7 mt-30 -44.83 -74.13 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.074 -1.016 . . . . 40.0 109.83 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.515 ' H ' ' CG ' ' A' ' 101' ' ' ASP . 21.0 p -106.02 167.01 10.09 Favored 'General case' 0 C--O 1.195 -1.806 0 N-CA-C 107.56 -1.274 . . . . 40.0 107.56 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.528 ' HZ ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -140.02 140.45 36.22 Favored 'General case' 0 C--N 1.264 -3.125 0 O-C-N 121.32 -0.863 . . . . 40.0 109.73 179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 54.5 m -125.4 137.47 54.01 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.318 -0.993 . . . . 40.0 108.318 177.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.546 ' NZ ' ' O ' ' A' ' 110' ' ' ARG . 17.7 tttp -85.1 145.76 27.49 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.834 -1.166 . . . . 40.0 109.919 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.558 HD11 ' CG2' ' A' ' 96' ' ' ILE . 11.3 pt -121.78 -33.32 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.107 -0.996 . . . . 40.0 109.63 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.646 HH21 ' CG ' ' A' ' 8' ' ' ASP . 76.7 mtt180 . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.945 . . . . 40.0 108.737 178.583 . . . . . . . . 1 1 . 1 stop_ save_